<!doctype html>
<html>
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width,initial-scale=1,viewport-fit=cover">
  <title>APEX & Trust Prototype</title>
  <link rel="stylesheet" href="../../apex_trust_panel.css">
  <style>
    @keyframes ticker {
      0% { transform: translateX(0); }
      100% { transform: translateX(-50%); }
    }
    @media (max-width: 768px) {
      #scorecard-ticker { animation: ticker 15s linear infinite; }
    }
  </style>
</head>
<body>
  <!-- CONSOLIDATED STICKY HEADER BLOCK -->
  <div style="position: sticky; top: 0; z-index: 9999; margin: 0; padding: 0; width: 100%; overflow: hidden;">
    
    <!-- Page Header -->
    <div style="background: rgb(26, 35, 54); padding: 0.3rem 1.5rem; margin: 0; border-bottom: 1px solid rgba(10, 132, 255, 0.2);">
      <div style="display: flex; align-items: center; gap: 16px;">
        <div style="font-size: 18px; font-weight: 700; color: white;">üî•APEX Intelligence Terminal</div>
      </div>
    </div>

    <!-- Stock Info Header -->
    <div id="stock-info-header" style="margin: 0; padding: 0;">
      <!-- COMPANY INFO HEADER -->
      <div style="display: flex; align-items: center; justify-content: space-between; gap: 0.75rem; background: rgb(26, 35, 54); box-shadow: 0 2px 8px rgba(0,0,0,0.3); border-bottom: 1px solid rgba(10, 132, 255, 0.4); padding: 0.6rem 1.5rem; margin: 0; width: 100%; position: relative; border-radius: 8px 8px 0 0;">
        <div style="display: flex; align-items: center; justify-content: space-between; gap: 0.6rem; width: 100%; overflow: hidden;">
          <!-- Ticker & Company Name (Left) -->
          <div style="flex: 1 1 auto; min-width: 100px; max-width: 180px;">
            <div id="header-ticker" style="color: white; font-size: 0.95rem; font-weight: 800; letter-spacing: 0.5px;">--</div>
            <div id="header-company" style="color: rgba(255,255,255,0.6); font-size: 0.65rem; line-height: 1; margin-top: 1px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis;">--</div>
          </div>
          
          <!-- Key Metrics (Center) - 3 columns -->
          <div style="display: flex; gap: 0.5rem; align-items: center; flex: 2 1 auto; overflow: hidden;">
            <!-- Current Price (with currency) -->
            <div style="text-align: center; min-width: 60px; flex-shrink: 0;">
              <div style="color: rgba(255,255,255,0.5); font-size: 0.6rem; text-transform: uppercase; letter-spacing: 0.3px; line-height: 1;">
                Price <span id="header-currency" style="color: #f59e0b; font-size: 0.5rem; font-weight: 600;">--</span>
              </div>
              <div id="header-price" style="color: white; font-size: 0.85rem; font-weight: 800; line-height: 1.1; margin-top: 1px;">--</div>
            </div>
            
            <!-- Market Cap -->
            <div style="text-align: center; min-width: 55px; flex-shrink: 0;">
              <div style="color: rgba(255,255,255,0.5); font-size: 0.6rem; text-transform: uppercase; letter-spacing: 0.3px; line-height: 1;">Cap</div>
              <div id="header-mcap" style="color: #10b981; font-size: 0.85rem; font-weight: 800; line-height: 1.1; margin-top: 1px;">--</div>
            </div>
            
            <!-- Exchange (combined Market + Exchange) -->
            <div style="text-align: center; min-width: 60px; flex-shrink: 0;">
              <div style="color: rgba(255,255,255,0.5); font-size: 0.6rem; text-transform: uppercase; letter-spacing: 0.3px; line-height: 1;">Exchange</div>
              <div id="header-exchange" style="font-size: 0.75rem; font-weight: 700; line-height: 1.1; margin-top: 1px;">--</div>
            </div>
          </div>
        </div>
      </div>
      
      <!-- Details Row -->
      <div style="display: flex; gap: 1.5rem; font-size: 0.65rem; background: rgb(26, 35, 54); box-shadow: 0 2px 6px rgba(0,0,0,0.2); border-bottom: 1px solid rgba(10, 132, 255, 0.2); padding: 0.35rem 1.5rem 0.4rem 1.5rem; margin: 0; text-align: left; border-radius: 0 0 8px 8px;">
        <div style="display: flex; align-items: center; gap: 0.4rem; min-width: 100px;">
          <span style="color: #667eea; font-size: 0.6rem; text-transform: uppercase; letter-spacing: 0.4px; font-weight: 500; flex-shrink: 0;">Sector:</span>
          <span id="header-sector" style="color: white; font-weight: 700; font-size: 0.7rem; white-space: nowrap; overflow: hidden; text-overflow: ellipsis;">--</span>
        </div>
        <div style="display: flex; align-items: center; gap: 0.4rem; flex: 1; overflow: hidden;">
          <span style="color: #667eea; font-size: 0.6rem; text-transform: uppercase; letter-spacing: 0.4px; font-weight: 500; flex-shrink: 0;">Ind:</span>
          <span id="header-industry" style="color: white; font-weight: 700; font-size: 0.7rem; white-space: nowrap; overflow: hidden; text-overflow: ellipsis;">--</span>
        </div>
      </div>
    </div>

    <!-- Bloomberg Scorecard Ticker -->
    <div style="background: rgb(26, 35, 54); border-left: 3px solid #0a84ff; padding: 0.5rem 0; margin: 0; font-family: 'Courier New', monospace; font-size: 13px; letter-spacing: 0.5px; box-shadow: 0 2px 4px rgba(0,0,0,0.2); overflow: hidden; width: 100%;">
      <div id="scorecard-ticker" style="display: flex; white-space: nowrap; animation: ticker 20s linear infinite; width: max-content;">
        <div class="ticker-content" style="display: flex; align-items: center; gap: 1.5rem; padding: 0 1.5rem; flex-shrink: 0;">
          <span style="color: rgba(255,255,255,0.6); font-size: 11px; text-transform: uppercase; font-weight: 600;">SCORECARD</span>
          <span id="scorecard-apex" style="background: #10b981; color: white; padding: 6px 12px; border-radius: 6px; font-weight: 700; font-size: 13px;">APEX SCORE:--</span>
          <span id="scorecard-setup" style="color: #3B82F6; font-weight: 700;">SETUP:--</span>
          <span id="scorecard-trust" style="color: #8B5CF6; font-weight: 700;">TRUST:--</span>
          <span id="scorecard-panic" style="color: #EF4444; font-weight: 700;">PANIC:--</span>
          <span id="scorecard-comp" style="color: #F59E0B; font-weight: 700;">COMPRESSION:--</span>
          <span style="color: rgba(255,255,255,0.3); font-weight: 400;">‚îÇ</span>
          <span id="scorecard-timing" style="color: #3b82f6; font-weight: 700;">TIMING:--</span>
          <span style="color: rgba(255,255,255,0.3); font-weight: 400;">‚îÇ</span>
          <span id="scorecard-action" style="color: #ef4444; font-weight: 700;">ACTION:--</span>
        </div>
      </div>
    </div>
  </div>

  <div class="container">
    <!-- Narrative Section Header -->
    <div style="display: flex; align-items: center; gap: 12px; margin: 20px 0 12px 0;">
      <svg width="20" height="20" viewBox="0 0 20 20" fill="none" style="flex-shrink: 0;">
        <rect x="2" y="4" width="16" height="12" stroke="#10B981" stroke-width="1.5" fill="none" rx="2"/>
        <line x1="5" y1="4" x2="5" y2="2" stroke="#10B981" stroke-width="1.5" stroke-linecap="round"/>
        <line x1="15" y1="4" x2="15" y2="2" stroke="#10B981" stroke-width="1.5" stroke-linecap="round"/>
        <line x1="2" y1="7" x2="18" y2="7" stroke="#10B981" stroke-width="1.5"/>
        <circle cx="8" cy="11" r="1.2" fill="#10B981"/>
        <circle cx="12" cy="11" r="1.2" fill="#10B981"/>
        <circle cx="16" cy="11" r="1.2" fill="#10B981"/>
      </svg>
      <span style="color: #10B981; font-weight: 700; font-size: 13px; text-transform: uppercase; letter-spacing: 0.8px;">Company in 30 Seconds</span>
    </div>

    <!-- Narrative Card Stack -->
    <div class="card-stack" id="narrative-stack" style="position: relative; min-height: 180px; overflow: visible; touch-action: pan-y; user-select: none; margin-bottom: 30px;">
      <!-- Card 1: What They Do -->
      <div class="card component-card stack-card narrative-card" data-index="0" style="transition: 0.3s cubic-bezier(0.4, 0, 0.2, 1); transform: translateX(0%) scale(1); opacity: 1; pointer-events: auto; z-index: 10;">
        <div class="panel-header" style="padding:12px;border-bottom:1px solid rgba(16,185,129,0.1);display:flex;align-items:center;gap:10px">
          <svg width="18" height="18" viewBox="0 0 16 16" fill="none" style="flex-shrink:0">
            <rect x="3" y="3" width="10" height="10" stroke="#10B981" stroke-width="1.5" fill="none" rx="1"/>
            <path d="M6 3 L6 1 M10 3 L10 1 M3 6 L13 6" stroke="#10B981" stroke-width="1.5" stroke-linecap="round"/>
            <circle cx="8" cy="9" r="1.5" fill="#10B981"/>
          </svg>
          <div class="card-title" style="font-size:16px;font-weight:800;color:#10B981">What They Do <span class="info-icon" data-field="what" data-tooltip="Company business model and core operations" style="cursor:pointer;opacity:0.6;font-size:14px;transition:all 0.2s ease" onmouseenter="this.style.opacity='1'" onmouseleave="this.style.opacity='0.6'" onclick="showTooltipPopover(event, 'Company business model and core operations')">‚ìò</span></div>
        </div>
        <div style="padding:12px">
          <span id="company-what" style="color: #e5e7eb; line-height: 1.6; font-size: 12px;">--</span>
        </div>
      </div>

      <!-- Card 2: Why It Matters -->
      <div class="card component-card stack-card narrative-card" data-index="1" style="transition: 0.3s cubic-bezier(0.4, 0, 0.2, 1); transform: translateX(100%) scale(0.95); opacity: 0; pointer-events: none; z-index: 5;">
        <div class="panel-header" style="padding:12px;border-bottom:1px solid rgba(16,185,129,0.1);display:flex;align-items:center;gap:10px">
          <svg width="18" height="18" viewBox="0 0 16 16" fill="none" style="flex-shrink:0">
            <circle cx="8" cy="8" r="6" stroke="#10B981" stroke-width="1.5" fill="none"/>
            <circle cx="8" cy="8" r="2" fill="#10B981"/>
            <path d="M8 2 L8 6 M8 10 L8 14 M2 8 L6 8 M10 8 L14 8" stroke="#10B981" stroke-width="1.5" stroke-linecap="round"/>
          </svg>
          <div class="card-title" style="font-size:16px;font-weight:800;color:#10B981">Why It Matters <span class="info-icon" data-field="why" data-tooltip="Market significance and investment thesis" style="cursor:pointer;opacity:0.6;font-size:14px;transition:all 0.2s ease" onmouseenter="this.style.opacity='1'" onmouseleave="this.style.opacity='0.6'" onclick="showTooltipPopover(event, 'Market significance and investment thesis')">‚ìò</span></div>
        </div>
        <div style="padding:12px">
          <span id="company-why" style="color: #e5e7eb; line-height: 1.6; font-size: 12px;">--</span>
        </div>
      </div>

      <!-- Card 3: Current State -->
      <div class="card component-card stack-card narrative-card" data-index="2" style="transition: 0.3s cubic-bezier(0.4, 0, 0.2, 1); transform: translateX(100%) scale(0.95); opacity: 0; pointer-events: none; z-index: 5;">
        <div class="panel-header" style="padding:12px;border-bottom:1px solid rgba(16,185,129,0.1);display:flex;align-items:center;gap:10px">
          <svg width="18" height="18" viewBox="0 0 16 16" fill="none" style="flex-shrink:0">
            <path d="M2 12 L5 9 L8 11 L14 4" stroke="#10B981" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round" fill="none"/>
            <circle cx="5" cy="9" r="1.5" fill="#10B981"/>
            <circle cx="8" cy="11" r="1.5" fill="#10B981"/>
            <circle cx="14" cy="4" r="1.5" fill="#10B981"/>
          </svg>
          <div class="card-title" style="font-size:16px;font-weight:800;color:#10B981">Current State <span class="info-icon" data-field="state" data-tooltip="Latest company situation and metrics" style="cursor:pointer;opacity:0.6;font-size:14px;transition:all 0.2s ease" onmouseenter="this.style.opacity='1'" onmouseleave="this.style.opacity='0.6'" onclick="showTooltipPopover(event, 'Latest company situation and metrics')">‚ìò</span></div>
        </div>
        <div style="padding:12px">
          <span id="company-state" style="color: #e5e7eb; line-height: 1.6; font-size: 12px;">--</span>
        </div>
      </div>

      <!-- Narrative Stack Navigation -->
      <div class="stack-nav" style="bottom: -35px;">
        <div class="stack-dots">
          <span class="stack-dot narrative-dot" data-index="0"></span>
          <span class="stack-dot narrative-dot" data-index="1"></span>
          <span class="stack-dot narrative-dot" data-index="2"></span>
        </div>
        <div class="stack-label" style="color: #10B981;">Company</div>
      </div>
    </div>

    <!-- Scorecard Breakdown Section Header -->
    <div style="display: flex; align-items: center; gap: 12px; margin: 20px 0 12px 0;">
      <svg width="20" height="20" viewBox="0 0 20 20" fill="none" style="flex-shrink: 0;">
        <rect x="2" y="6" width="3" height="12" rx="1" stroke="#fff" stroke-width="1.5" fill="none"/>
        <rect x="7" y="3" width="3" height="15" rx="1" stroke="#fff" stroke-width="1.5" fill="none"/>
        <rect x="12" y="8" width="3" height="10" rx="1" stroke="#fff" stroke-width="1.5" fill="none"/>
        <rect x="17" y="5" width="1" height="13" rx="0.5" stroke="#fff" stroke-width="1.5" fill="none"/>
        <circle cx="10" cy="1" r="1.5" fill="#fff"/>
      </svg>
      <span style="color: #fff; font-weight: 700; font-size: 13px; text-transform: uppercase; letter-spacing: 0.8px;">Scorecard Breakdown</span>
    </div>

    <!-- Main swipeable cards -->
    <div id="component-grid"></div>

    <!-- Bloomberg Phase 2: Collapsible Sections -->
    <div class="bloomberg-sections" style="margin-top: 20px;">
      <!-- CrashDash Intelligence -->
      <div class="bloomberg-section" style="background: rgb(26, 35, 54); border: 1px solid #374151; border-radius: 8px; margin-bottom: 12px; overflow: hidden;">
        <div class="section-header" onclick="toggleSection('crashdash')" style="padding: 12px 16px; cursor: pointer; display: flex; justify-content: space-between; align-items: center; background: rgba(59, 130, 246, 0.1); border-bottom: 1px solid #374151;">
          <div style="display: flex; align-items: center; gap: 12px;">
            <span id="crashdash-arrow" style="color: #3b82f6; font-size: 16px; transition: transform 0.2s;">‚ñ∂</span>
            <span style="font-family: 'Courier New', monospace; font-size: 13px; font-weight: 700; color: #3b82f6; text-transform: uppercase; letter-spacing: 0.5px;">CrashDash Intelligence</span>
          </div>
          <span style="font-family: 'Courier New', monospace; font-size: 11px; color: rgba(255, 255, 255, 0.5);">INDUSTRY PATTERNS ¬∑ RECOVERY PATHS</span>
        </div>
        <div id="crashdash-content" class="section-content" style="display: none; padding: 16px; font-family: 'Courier New', monospace; font-size: 12px; line-height: 1.6;">
          <div id="crashdash-data">Loading...</div>
        </div>
      </div>

      <!-- Catalyst Pipeline -->
      <div class="bloomberg-section" style="background: rgb(26, 35, 54); border: 1px solid #374151; border-radius: 8px; margin-bottom: 12px; overflow: hidden;">
        <div class="section-header" onclick="toggleSection('catalyst')" style="padding: 12px 16px; cursor: pointer; display: flex; justify-content: space-between; align-items: center; background: rgba(16, 185, 129, 0.1); border-bottom: 1px solid #374151;">
          <div style="display: flex; align-items: center; gap: 12px;">
            <span id="catalyst-arrow" style="color: #10b981; font-size: 16px; transition: transform 0.2s;">‚ñ∂</span>
            <span style="font-family: 'Courier New', monospace; font-size: 13px; font-weight: 700; color: #10b981; text-transform: uppercase; letter-spacing: 0.5px;">Catalyst Pipeline</span>
          </div>
          <span style="font-family: 'Courier New', monospace; font-size: 11px; color: rgba(255, 255, 255, 0.5);">UPCOMING EVENTS ¬∑ TIMELINE</span>
        </div>
        <div id="catalyst-content" class="section-content" style="display: none; padding: 16px; font-family: 'Courier New', monospace; font-size: 12px; line-height: 1.6;">
          <div id="catalyst-data">Loading...</div>
        </div>
      </div>

      <!-- Market Tape -->
      <div class="bloomberg-section" style="background: rgb(26, 35, 54); border: 1px solid #374151; border-radius: 8px; margin-bottom: 12px; overflow: hidden;">
        <div class="section-header" onclick="toggleSection('market')" style="padding: 12px 16px; cursor: pointer; display: flex; justify-content: space-between; align-items: center; background: rgba(245, 158, 11, 0.1); border-bottom: 1px solid #374151;">
          <div style="display: flex; align-items: center; gap: 12px;">
            <span id="market-arrow" style="color: #f59e0b; font-size: 16px; transition: transform 0.2s;">‚ñ∂</span>
            <span style="font-family: 'Courier New', monospace; font-size: 13px; font-weight: 700; color: #f59e0b; text-transform: uppercase; letter-spacing: 0.5px;">Market Tape</span>
          </div>
          <span style="font-family: 'Courier New', monospace; font-size: 11px; color: rgba(255, 255, 255, 0.5);">SOCIAL SENTIMENT ¬∑ TRENDS</span>
        </div>
        <div id="market-content" class="section-content" style="display: none; padding: 16px; font-family: 'Courier New', monospace; font-size: 12px; line-height: 1.6;">
          <div id="market-data">Loading...</div>
        </div>
      </div>

      <!-- Investment Decision -->
      <div class="bloomberg-section" style="background: rgb(26, 35, 54); border: 1px solid #374151; border-radius: 8px; margin-bottom: 12px; overflow: hidden;">
        <div class="section-header" onclick="toggleSection('decision')" style="padding: 12px 16px; cursor: pointer; display: flex; justify-content: space-between; align-items: center; background: rgba(239, 68, 68, 0.1); border-bottom: 1px solid #374151;">
          <div style="display: flex; align-items: center; gap: 12px;">
            <span id="decision-arrow" style="color: #ef4444; font-size: 16px; transition: transform 0.2s;">‚ñ∂</span>
            <span style="font-family: 'Courier New', monospace; font-size: 13px; font-weight: 700; color: #ef4444; text-transform: uppercase; letter-spacing: 0.5px;">Investment Decision</span>
          </div>
          <span id="decision-status" style="font-family: 'Courier New', monospace; font-size: 11px; color: rgba(255, 255, 255, 0.5);">ANALYSIS ¬∑ ACTION</span>
        </div>
        <div id="decision-content" class="section-content" style="display: none; padding: 16px; font-family: 'Courier New', monospace; font-size: 12px; line-height: 1.6;">
          <div id="decision-data">Loading...</div>
        </div>
      </div>

      <!-- Top 5 Recent RNS -->
      <div class="bloomberg-section" style="background: rgb(26, 35, 54); border: 1px solid #374151; border-radius: 8px; margin-bottom: 12px; overflow: hidden;">
        <div class="section-header" onclick="toggleSection('rns')" style="padding: 12px 16px; cursor: pointer; display: flex; justify-content: space-between; align-items: center; background: rgba(6, 182, 212, 0.1); border-bottom: 1px solid #374151;">
          <div style="display: flex; align-items: center; gap: 12px;">
            <span id="rns-arrow" style="color: #06b6d4; font-size: 16px; transition: transform 0.2s;">‚ñ∂</span>
            <span style="font-family: 'Courier New', monospace; font-size: 13px; font-weight: 700; color: #06b6d4; text-transform: uppercase; letter-spacing: 0.5px;">Top 5 Recent RNS</span>
          </div>
          <span style="font-family: 'Courier New', monospace; font-size: 11px; color: rgba(255, 255, 255, 0.5);">REGULATORY NEWS ¬∑ ANNOUNCEMENTS</span>
        </div>
        <div id="rns-content" class="section-content" style="display: none; padding: 16px; font-family: 'Courier New', monospace; font-size: 12px; line-height: 1.6;">
          <div id="rns-data">Loading...</div>
        </div>
      </div>
    </div>

    <!-- Bloomberg Terminal Footer (Collapsible) -->
    <div id="footer-container" style="margin-top: 40px; background: linear-gradient(180deg, #0a1628 0%, #020617 100%); border: 1px solid #1e293b; border-radius: 12px; overflow: hidden; box-shadow: 0 20px 50px rgba(0,0,0,0.5);">
        <!-- Header Bar (Always Visible) -->
        <div style="background: rgba(59, 130, 246, 0.08); border-bottom: 1px solid rgba(59, 130, 246, 0.2); padding: 12px 16px; cursor: pointer;" onclick="toggleFooter()">
            <div style="display: flex; align-items: center; justify-content: space-between; gap: 8px; width: 100%;">
                <div style="display: flex; align-items: center; gap: 8px; flex: 1; min-width: 0; overflow: hidden;">
                    <div style="width: 8px; height: 8px; background: #3b82f6; border-radius: 50%; box-shadow: 0 0 12px rgba(59, 130, 246, 0.6); flex-shrink: 0;"></div>
                    <span style="font-family: 'Courier New', monospace; font-size: 12px; font-weight: 700; color: #3b82f6; text-transform: uppercase; letter-spacing: 0.5px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis;">APEX Intelligence Terminal</span>
                    <span id="footer-toggle-icon" style="font-size: 14px; color: #3b82f6; transition: transform 0.3s ease; flex-shrink: 0; margin-left: auto;">‚ñº</span>
                </div>
            </div>
            <div style="font-family: 'Courier New', monospace; font-size: 9px; color: rgba(255, 255, 255, 0.4); letter-spacing: 0.3px; margin-top: 6px; overflow: hidden;">
                GENERATED: <span style="color: #06b6d4;" id="footerDate"></span> ‚Ä¢ SESSION: <span style="color: #10b981;">LIVE</span>
            </div>
        </div>
        
        <!-- Collapsible Content Section -->
        <div id="footer-content" style="display: none;">
            <!-- Content Grid -->
            <div style="padding: 24px; display: grid; grid-template-columns: 1fr 1fr; gap: 24px;">
                <!-- Left Column -->
                <div style="display: flex; flex-direction: column; gap: 20px;">
                    <!-- System Information -->
                    <div>
                        <div style="font-family: 'Courier New', monospace; font-size: 10px; font-weight: 700; color: #3b82f6; margin-bottom: 8px; text-transform: uppercase; letter-spacing: 1px;">System Information</div>
                        <div style="font-family: 'Courier New', monospace; font-size: 10px; color: rgba(255, 255, 255, 0.7); display: flex; gap: 16px; flex-wrap: wrap; align-items: center;">
                            <span><span style="color: rgba(255, 255, 255, 0.4);">VERSION:</span> <span style="color: #06b6d4; font-weight: 700;">APEX v5.0</span></span>
                            <span style="color: rgba(255, 255, 255, 0.2);">‚Ä¢</span>
                            <span><span style="color: rgba(255, 255, 255, 0.4);">ENGINE:</span> <span style="color: #10b981;">CrashDash Intelligence</span></span>
                            <span style="color: rgba(255, 255, 255, 0.2);">‚Ä¢</span>
                            <span><span style="color: rgba(255, 255, 255, 0.4);">COVERAGE:</span> <span style="color: #a855f7;">LSE AIM Micro-Caps</span></span>
                            <span style="color: rgba(255, 255, 255, 0.2);">‚Ä¢</span>
                            <span><span style="color: rgba(255, 255, 255, 0.4);">SOURCES:</span> <span style="color: #ef4444;">RNS ‚Ä¢ Social ‚Ä¢ Trends</span></span>
                        </div>
                    </div>
                    
                    <!-- Risk Disclosure -->
                    <div>
                        <div style="font-family: 'Courier New', monospace; font-size: 10px; font-weight: 700; color: #ef4444; margin-bottom: 12px; text-transform: uppercase; letter-spacing: 1px;">Risk Disclosure</div>
                        <div style="font-family: 'Courier New', monospace; font-size: 10px; color: rgba(255, 255, 255, 0.5); line-height: 1.6;">
                            This analysis is provided for informational purposes only and does not constitute financial advice. AIM micro-cap securities carry significant volatility and liquidity risks. Past performance does not guarantee future results. Always conduct your own due diligence and consult with a qualified financial advisor before making investment decisions.
                        </div>
                    </div>
                </div>
                
                <!-- Right Column -->
                <div style="display: flex; flex-direction: column; gap: 20px;">
                    <!-- Platform Overview -->
                    <div>
                        <div style="font-family: 'Courier New', monospace; font-size: 10px; font-weight: 700; color: #10b981; margin-bottom: 12px; text-transform: uppercase; letter-spacing: 1px;">Platform Overview</div>
                        <div style="font-family: 'Courier New', monospace; font-size: 11px; color: rgba(255, 255, 255, 0.7); line-height: 1.6;">
                            APEX Intelligence Terminal combines technical analysis, sentiment tracking, and regulatory news monitoring to identify high-probability contrarian setups in distressed micro-cap equities. Our proprietary scoring system evaluates setup quality, panic intensity, and compression patterns to surface opportunities before institutional recognition.
                        </div>
                    </div>
                    
                    <!-- Target Users -->
                    <div>
                        <div style="font-family: 'Courier New', monospace; font-size: 10px; font-weight: 700; color: #a855f7; margin-bottom: 12px; text-transform: uppercase; letter-spacing: 1px;">Target Users</div>
                        <div style="display: flex; flex-wrap: wrap; gap: 8px;">
                            <span style="font-family: 'Courier New', monospace; font-size: 10px; padding: 6px 12px; background: rgba(168, 85, 247, 0.1); border: 1px solid rgba(168, 85, 247, 0.3); border-radius: 4px; color: #a855f7; font-weight: 600;">PROP TRADERS</span>
                            <span style="font-family: 'Courier New', monospace; font-size: 10px; padding: 6px 12px; background: rgba(59, 130, 246, 0.1); border: 1px solid rgba(59, 130, 246, 0.3); border-radius: 4px; color: #3b82f6; font-weight: 600;">HEDGE FUNDS</span>
                            <span style="font-family: 'Courier New', monospace; font-size: 10px; padding: 6px 12px; background: rgba(16, 185, 129, 0.1); border: 1px solid rgba(16, 185, 129, 0.3); border-radius: 4px; color: #10b981; font-weight: 600;">QUANT TEAMS</span>
                            <span style="font-family: 'Courier New', monospace; font-size: 10px; padding: 6px 12px; background: rgba(239, 68, 68, 0.1); border: 1px solid rgba(239, 68, 68, 0.3); border-radius: 4px; color: #ef4444; font-weight: 600;">RESEARCH DESKS</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Bottom Bar -->
            <div style="background: rgba(2, 6, 23, 0.6); border-top: 1px solid rgba(59, 130, 246, 0.15); padding: 12px 24px;">
                <div style="display: flex; align-items: center; justify-content: space-between; flex-wrap: wrap; gap: 12px; font-family: 'Courier New', monospace; font-size: 10px;">
                    <div style="color: rgba(255, 255, 255, 0.4);">¬© 2026 APEX Intelligence ‚Ä¢ All Rights Reserved</div>
                    <div style="display: flex; align-items: center; gap: 20px; color: rgba(255, 255, 255, 0.5);">
                        <span>STATUS: <span style="color: #10b981; font-weight: 700;">‚óè OPERATIONAL</span></span>
                        <span>LATENCY: <span style="color: #06b6d4; font-weight: 700;">12ms</span></span>
                        <span>BUILD: <span style="color: #a855f7; font-weight: 700;">5.0.2</span></span>
                    </div>
                </div>
            </div>
        </div>
    </div>
    
    <script>
        function toggleFooter() {
            const content = document.getElementById('footer-content');
            const icon = document.getElementById('footer-toggle-icon');
            
            if (content.style.display === 'none') {
                content.style.display = 'block';
                icon.style.transform = 'rotate(180deg)';
            } else {
                content.style.display = 'none';
                icon.style.transform = 'rotate(0deg)';
            }
        }

        // Mobile-friendly tooltip popover
        function showTooltipPopover(event, tooltipText) {
            event.stopPropagation();
            
            // Close any existing popover
            const existing = document.getElementById('tooltip-popover');
            if (existing) existing.remove();
            
            // Create popover
            const popover = document.createElement('div');
            popover.id = 'tooltip-popover';
            popover.style.cssText = 'position:fixed;background:rgba(20,25,40,0.98);color:#e5e7eb;padding:10px 14px;border-radius:6px;font-size:12px;line-height:1.4;max-width:250px;border:1px solid rgba(16,185,129,0.3);z-index:10000;box-shadow:0 4px 12px rgba(0,0,0,0.4);backdrop-filter:blur(8px);word-wrap:break-word';
            popover.textContent = tooltipText;
            document.body.appendChild(popover);
            
            // Position near clicked element
            const rect = event.target.getBoundingClientRect();
            popover.style.left = Math.min(rect.left, window.innerWidth - 270) + 'px';
            popover.style.top = (rect.bottom + 8) + 'px';
            
            // Close on outside click
            setTimeout(() => {
                document.addEventListener('click', closeTooltip, { once: true });
            }, 0);
        }

        function closeTooltip() {
            const popover = document.getElementById('tooltip-popover');
            if (popover) popover.remove();
        }
    </script>
  </div>
  
  <!-- Mobile Responsive Styles -->
  <style>
    @media(max-width:768px){
        body{padding:10px!important}
        .container{max-width:100%!important}
        #footer-container{margin-top:20px!important}
        div[style*="grid-template-columns: 1fr 1fr"]{grid-template-columns:1fr!important;gap:12px!important}
        div[style*="grid-template-columns: repeat(4"]{grid-template-columns:repeat(2,1fr)!important;gap:10px!important}
        div[style*="padding: 24px"]{padding:16px!important}
        div[style*="padding: 12px 16px"]{padding:10px 12px!important}
        div[style*="gap: 20px"]{gap:14px!important}
        div[style*="font-size: 11px"]{font-size:10px!important}
        div[style*="font-size: 12px"]{font-size:11px!important}
        div[style*="font-size: 13px"]{font-size:12px!important}
    }
    @media(max-width:480px){
        body{padding:6px!important}
        .container{padding:0!important;margin:0!important}
        #footer-container{margin-top:16px!important;margin-left:6px!important;margin-right:6px!important}
        #footer-container > div:first-child{padding:8px 10px!important}
        div[style*="grid-template-columns: 1fr 1fr"]{grid-template-columns:1fr!important;gap:8px!important}
        div[style*="grid-template-columns: repeat(4"]{grid-template-columns:1fr!important;gap:6px!important;padding:8px 10px!important}
        div[style*="grid-template-columns: repeat(2"]{grid-template-columns:1fr!important;gap:6px!important}
        div[style*="padding: 24px"]{padding:10px!important}
        div[style*="padding: 12px 16px"]{padding:8px 10px!important}
        div[style*="padding: 14px 16px"]{padding:8px 10px!important}
        div[style*="padding: 18px"]{padding:10px!important}
        div[style*="gap: 20px"]{gap:8px!important}
        div[style*="gap: 30px"]{gap:10px!important}
        div[style*="gap: 24px"]{gap:10px!important}
        div[style*="gap: 16px"]{gap:6px!important}
        div[style*="gap: 12px"]{gap:6px!important}
        div[style*="gap: 8px"]{gap:4px!important}
        div[style*="font-size: 9px"]{font-size:8px!important}
        div[style*="font-size: 10px"]{font-size:8px!important}
        div[style*="font-size: 11px"]{font-size:9px!important}
        div[style*="font-size: 12px"]{font-size:10px!important}
        div[style*="font-size: 13px"]{font-size:11px!important}
        div[style*="padding: 6px 12px"]{padding:4px 6px!important;font-size:7px!important}
        div[style*="line-height: 1.8"]{line-height:1.4!important}
        div[style*="line-height: 1.6"]{line-height:1.3!important}
        div[style*="line-height: 1.5"]{line-height:1.2!important}
        /* Footer system info on mobile - stack vertically and shrink */
        div[style*="display: flex; gap: 16px; flex-wrap: wrap; align-items: center"] {
          flex-direction: column!important;
          align-items: flex-start!important;
          gap: 4px!important;
          font-size: 7px!important;
        }
    }
  </style>
  
  <script>window.__APEX_PROFILE = {
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "OPTI.L",
  "generated_at": "2026-02-11T23:07:18.113435Z",
  "top_card": {
    "ticker": "OPTI.L",
    "company_name": "OptiBiotix Health Plc",
    "sector": "Healthcare",
    "market_cap_gbp": 6972770,
    "days_active": 958,
    "apex_score_100": 60,
    "confidence_score_100": 40,
    "ai_final_score_25": 12,
    "ai_strength": "MODERATE",
    "timing_regime": "EARLY_BUILD",
    "action": "WATCH",
    "thesis_one_liner": "WATCH - EARLY_BUILD timing with 60/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "OptiBiotix Health Plc",
      "sector": "Healthcare",
      "industry": "Biotechnology",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 6972770,
      "current_close_price": 6.75
    },
    "basics": {
      "ticker": "OPTI.L",
      "current_price": 6.75,
      "ath": 72.7,
      "atl": 5.57,
      "ath_date": "2020-02-04",
      "atl_date": "2023-06-29",
      "week_52_high": 21.0,
      "week_52_low": 5.634,
      "week_52_high_date": "2025-05-06",
      "week_52_low_date": "2026-01-06",
      "drawdown_from_ath_pct": 90.72,
      "data_start": "2020-01-02",
      "data_end": "2026-02-11",
      "total_bars": 1544
    },
    "latest_signal": {
      "date": "2023-06-29",
      "scan_date": "2026-01-26",
      "signal_type": "CRASH ZONE BOTTOM",
      "signal_color": "YELLOW",
      "price": 6.4,
      "drawdown_pct": 84.0,
      "ai_score": 10.0,
      "rsi": 20.5,
      "cycle_position": 0.1618,
      "holding_period_days": 958,
      "current_pnl_pct": 5.47,
      "rally_state": "pulling_back",
      "distance_from_high_pct": -78.27,
      "Rally_Count": 2,
      "days_since_last_high": 14,
      "last_high_date": "2026-01-12",
      "lock_in_reached": true,
      "lock_in_date": "2023-08-04",
      "best_rally_pct": 509.38
    },
    "best_historical_signal": {
      "signal_date": "2023-06-28",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "entry_price": 6.0,
      "peak_price": 43.495,
      "peak_date": "2023-07-26",
      "rally_pct": 624.92,
      "days_to_peak": 28,
      "ai_score": 13.0
    },
    "all_historical_signals": [
      {
        "signal_id": "OPTI.L_2023-06-09",
        "signal_date": "2023-06-09",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.55,
        "current_price": 8.475,
        "current_return_pct": 12.25,
        "best_rally_pct": 416.56,
        "best_rally_date": "2023-08-04",
        "rally_state": "pulling_back",
        "Rally_Count": 3,
        "distance_from_high_pct": -78.27,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 962,
        "status": "historical"
      },
      {
        "signal_id": "OPTI.L_2023-06-27",
        "signal_date": "2023-06-27",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 6.75,
        "current_price": 8.475,
        "current_return_pct": 25.56,
        "best_rally_pct": 477.78,
        "best_rally_date": "2023-08-04",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -78.27,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 944,
        "status": "historical"
      },
      {
        "signal_id": "OPTI.L_2023-06-28",
        "signal_date": "2023-06-28",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 6.0,
        "current_price": 8.475,
        "current_return_pct": 41.25,
        "best_rally_pct": 550.0,
        "best_rally_date": "2023-08-04",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -78.27,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 943,
        "status": "historical"
      },
      {
        "signal_id": "OPTI.L_2023-06-29",
        "signal_date": "2023-06-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 6.4,
        "current_price": 8.475,
        "current_return_pct": 32.42,
        "best_rally_pct": 509.38,
        "best_rally_date": "2023-08-04",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -78.27,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 942,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 4,
      "win_rate_pct": 100.0,
      "avg_rally_pct": 556.25,
      "median_rally_pct": 561.99,
      "best_rally_pct": 624.92,
      "worst_rally_pct": 476.09
    },
    "splits": [],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN"
    ],
    "last_updated": "2026-02-11 20:06:43 UTC",
    "volatility": {
      "atr_normalized": 7.95,
      "stddev_20d": 0.3466
    },
    "trends": {
      "intelligence_signal": "DOWNTREND"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 60/100 indicates strong opportunity quality",
      "Timing regime: EARLY_BUILD",
      "Historical profile: 2 rallies, 509% best run"
    ],
    "main_risk": "Confidence 40/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "OPTI.L",
      "latest": [
        {
          "title": "Large Order and Record Early Orders for 2026",
          "announcement_date": "21st Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "Today 07:00\nRNS Number : 6737P\nOptiBiotix Health PLC\n21 January 2026\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nLarge order and Record Early Orders for 2026\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces that it has received four orders totalling twenty-four metric tonnes (24mt) of SlimBiome from Meelung Trading, Taiwan (\"Meelung\"). These orders will be delivered at approximately three-month intervals throughout 2026 when they will be recorded in the Company's management accounts and reported for the 12 months ended 31 December 2026 (\"FY2026\").\nMeelung started trading in 1949 as a pharmaceutical company before expanding into nutraceuticals in 1992 to exploit the growing market opportunity. It describes itself as one of the most important nutritional supplement distributors in Taiwan with a focus on patented, branded products with clinical studies. OptiBiotix signed an agreement with Meelung in June 2025 and has seen rapid sales growth with regular recurring orders of increasing size.\nThese orders reflect a growing confidence in SlimBiome and a growing trend with an increasing number of partners placing orders for FY2026 to secure supply. This enables OptiBiotix to plan ahead and consolidate multiple orders, allowing it to negotiate preferential pricing with suppliers and reduce cost. The Company gains flexibility to pass on any cost savings to partners for larger orders while maintaining or improving margins, supporting increased sales growth.\nThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\nThese confirmed orders reflect the growing interest in ingredients like SlimBiome which support hunger control and appetite reduction similar to the anti-obesity drugs. This alternative GLP1 market is new and fast evolving and estimated to be worth\n$1.2 billion in 2024\nand projected to reach\n$4.8 billion by 2033\n,\ngrowing at a compound annual growth rate of 16.7% (Market Intelo, 2024) see\nGLP-1 Support Supplements Market Research Report 2033\n.\u00a0SlimBiome, with its four clinical studies, international awards, and 'on pack health claims' is well positioned to exploit this opportunity.\nStephen O'Hara, CEO of OptiBiotix Health plc said\n: \"\nWe are pleased to announce this large order from Meelung as well as record orders for the start of 2026. To have already secured orders totalling over \u00a3800k before the end of our first month of the year puts us in a strong position for the year ahead. These orders reflect the growing interest in bringing patented, branded ingredients, with human studies demonstrating hunger and appetite reduction to the fast growing 'natural alternative to GLP1' market.\nThe Company intends to provide a trading update for the financial year 2025 once figures have been finalised which will show another year of continued strong growth. With the start that we've had so far for 2026, the Company is in the strongest position it has been in with its first-generation products whilst having overcome a number of challenges with partners on large scale production (>100,000 mt) of our second-generation products as we move these along the pathway to launch.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nEngage with the OptiBiotix management team directly by asking questions, watching video summaries and seeing what other shareholders have to say.\nView the full announcement and submit questions to management via our website:\nhttps://optibiotix.com/link/Pm5WaP\nSubscribe to the new website to get regular updates here:\nhttps://optibiotix.com/auth/signup\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF),\nOptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease.\nSince the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like\nSlimBiome\u00ae, WellBiome\u00ae, SweetBiotix\u00ae and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio of technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.\nCaution regarding forward looking statements\nCertain statements in this announcement, are, or may be deemed to be, forward-looking statements. Forward-looking statements are identi\ufb01ed by their use of terms and phrases such as ''believe'', ''could'', \"should\" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', \"expect\", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward-looking statements re\ufb02ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nCNTURRWRNBUAUAR",
          "rns_number": "RNS Number : 6737P"
        },
        {
          "title": "New Investor Website",
          "announcement_date": "20th Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS-R",
          "content": "20 Jan 2026 07:00\nRNS Number : 5070P\nOptiBiotix Health PLC\n20 January 2026\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\nN\new Investor Website\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces the launch of a new interactive investor website. The new investor website brings all OptiBiotix content including corporate, commercial and research into a single platform to better inform and engage with prospective and existing investors and other stakeholders. The website includes:\n\u25cf Announcements (RNS and Reach)\n\u25cf Annual and Interim reports\n\u25cf Investor presentations, podcasts and video updates\n\u25cf Research publications, product and technology overviews\n\u25cf Interviews with the CEO\n\u25cf Interviews and videos with research/ industry partners on its technology and products\nThe website provides users with the ability to ask the management team questions to provide context on announcements including progress or concerns via an interactive portal which will be monitored and responded to in a timely manner. The overall aim is to give existing and prospective shareholders the opportunity to engage directly with the management team and have access to reliable information on which they can make a judgement. We would encourage all existing shareholders and prospective investors to sign up to the website (it should take less than one minute) and use it as your primary interface and information source for the business.\nHow to sign up for the OptiBiotix investor website:\n1. Visit\nwww.optibiotix.com\n2. Follow the prompts on the top right-hand side of the website marked SIGN UP\n3. Complete your account profile (name/email)\nStephen O'Hara, Chief Executive Officer, commented:\n\"The Board is keen to improve communications with our shareholders and give them access to reliable information on which to make their investment decisions. This new 'InvestorHub' enables us to discuss commercial progress with partners, share development progress and launch plans for our second-generation products like SweetBiotix, in more depth and context than is possible through RNS announcements alone, while remaining fully compliant with market disclosure obligations.\nWe encourage all stakeholders to explore the site, engage with our content, and share their questions and feedback. Your input is invaluable as we continue refining our communication channels and building a profitable and valuable business.\"\nEnds\nEngage with the OptiBiotix management team directly by asking questions, watching video summaries and seeing what other shareholders have to say.\nNavigate to our Interactive Investor website here:\nhttps://optibiotix.com/link/P2zk3P\nSubscribe to the new website to get regular updates here:\nhttps://optibiotix.com/auth/signup\nFor further enquiries\n, please visit\nwww.optibiotix.com\nor contact:\nOptiBiotix Health PLC\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nWe encourage all investors to share questions on this announcement via our investor website.\nhttps://optibiotix.com/announcements\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF),\nOptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease.\nSince the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like\nSlimBiome\u00ae, WellBiome\u00ae, SweetBiotix\u00ae and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio of technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.\nThis communication is a \"Reach\" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRAKZGMMRLRGVZM",
          "rns_number": "RNS Number : 5070P"
        },
        {
          "title": "Holding(s) in Company",
          "announcement_date": "2nd Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "2 Jan 2026 07:00\nRNS Number : 3675N\nSkinBioTherapeutics PLC\n02 January 2026\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BF33H870\nIssuer Name\nSKINBIOTHERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of financial instruments\n3. Details of person subject to the notification obligation\nName\nOptibiotix Health plc\nCity of registered office (if applicable)\nYork\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n30-Dec-2025\n6. Date on which Issuer notified\n31-Dec-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n5.640000\n0.000000\n5.640000\n14600000\nPosition of previous notification (if applicable)\n6.410000\n0.000000\n6.410000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nOrdinary\n14600000\n5.640000\nSub Total 8.A\n14600000\n5.640000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n31-Dec-2025\n13. Place Of Completion\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLBBMATMTTMBPF",
          "rns_number": "RNS Number : 3675N"
        },
        {
          "title": "SweetBiotix Overview and Update",
          "announcement_date": "24th Nov 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "24 Nov 2025 07:00\nRNS Number : 6314I\nOptiBiotix Health PLC\n24 November 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\nSweetBiotix\n\u00ae Overview and Update\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes\nprovides an overview and update on its SweetBiotix\n\u00ae\nproduct range for new and existing investors.\nWhat are SweetBiotix\u00ae?\nSweetBiotix\u00ae are a portfolio of natural, sweet, high fibre, low-calorie products developed to replace sugar and sugar substitutes. They are produced using a patented technology developed by OptiBiotix which enzymatically modifies existing natural sweeteners like steviol glycosides and mogrosides and converts them into dietary fibres, providing sweetness with added nutritional and health benefits.\nIs SweetBiotix protected?\nSweetBiotix\u00ae are trademarked and patented products protected by a significant intellectual property portfolio comprising over 25 patents with a number of recent additional filings. Patents must demonstrate novelty/uniqueness, inventiveness (i.e. no one else has invented it), and industry applicability confirming the uniqueness of SweetBiotix. OptiBiotix patents cover synthesis, composition, and the application of SweetBiotix in food and beverages. They protect OptiBiotix's commercial interests, prevent competitors from entering the market, and create licensing opportunities with partners. SweetBiotix\u00ae is a registered trademark in international markets.\nThe\nSweetBiotix\n\u00ae Opportunity\nWidespread concern over the use of sugar in food and drinks has led to the development and use of sugar substitutes. These may be natural (e.g stevia, mogrosides, polyols) which often do not offer optimal taste profiles or artificial (e.g aspartame, sucralose, saccharin). Health concerns with artificial sugar substitutes have been widely reported and have been previously summarised (See RNS 30 January 2024). SweetBiotix are unique as a sugar substitute as they have been developed to overcome health concerns, are high in fibre, and have prebiotic functionality providing nutritional and health benefits not present in existing products. This a market estimated to be worth $29.9bn by 2029 (Markets and Markets: Oct 2024).\nWhat is the evidence that SweetBiotix\u00ae are sweet and have health benefits\nSweetBiotix\n\u00ae\nproducts\nhave been tested by academic groups who have published five papers in peer reviewed journals providing an independent assessment of SweetBiotix's\n\u00ae\ntaste and health benefits. One publication on an early SweetBiotix product\nconcluded\n'\nThis new ingredient could provide health benefits when evaluated in human studies by combining sweetness and prebiotic fiber functionality'.\n(see\nPrebiotic Potential of a New Sweetener Based on Galactooligosaccharides and Modified Mogrosides - PubMed (nih.gov)\n.\nThe Company has provided SweetBiotix samples under Material Transfer Agreements (MTA) to a number of partners, many of whom have specialist expertise in taste testing and sugar substitutes. This has led to a formal agreement with a USA partner and DSM Firmenich, a $12bn ingredients supplier, and several food and beverage companies supporting SweetBiotix development with a view to the use of SweetBiotix in their products. The combination of academic and i\nndustry validation with an industry leader specialist in the field committing manufacturing resources should give investors' confidence in these products.\nWhat has happened to the manufacture of these products?\nManufacturing scale up of SweetBiotix has been carried out by partners and shown flavour and texture comparable to laboratory scale\n. Scale up with Firmenich's contract manufacturer slowed during and after its merger with DSM and was subsequently transferred to DSM due to its inhouse manufacturing capability and the scale of the opportunity. The new team were unable to consistently reach high yields using the original enzyme extract. As part of its ongoing SweetBiotix partner development program, OptiBiotix screened over 50 enzymes and was able to identify\na new single enzyme (i.e. not an extract) which produced extremely high yields (~90%) of the same SweetBiotix. This simplifies the manufacturing process to produce a cleaner, more concentrated product with higher sweetness intensity and a significantly improved flavour profile. This enzyme works on both mogrosides and stevia glycosides allowing the\ngeneration of multiple SweetBiotix products of high purity, with the same enzyme, with a wide sweetness range compared to sucrose\n. This increases the number of product opportunities, and, from an industry viewpoint, reduces the need for multiple enzymes and manufacturing processes with a substantial reduction in production costs.\nOne other unique aspect of the new enzyme is that it produces SweetBiotix from sucrose (sugar). This reduces ingredient input costs and valorises an unhealthy, commoditised ingredient (sugar) with a rapidly reducing customer base into a healthy prebiotic fibre. This changes the positioning with sugar producers who have previously seen SweetBiotix\u00ae as a competitor, to a potential partner, by offering a unique, patented process which can utilise and modify commoditised sucrose into higher valued SweetBiotix products.\nImportantly, whilst there is a material change in the enzymatic process there is no change to the resulting SweetBiotix\u00ae product other than higher yields which significantly increases the purity (~90%) of the final product. The Company believes that most of the process changes are covered within its existing patent portfolio but has extended its filings on the enzyme use and composition given the uniqueness and commercial potential of their properties.\nNext Steps\nThe Company is producing quantities of SweetBiotix for its development, manufacturing, and application partners and sharing the new enzymatic process with DSM Firmenich, our US partner, and major sugar producers given its potential to valorise sugar.\nThe Company continues to receive an annual milestone of \u00a3100k from its US partner related to work on Mogrosides with total received to end of 2024 of \u00a3550k. Milestone payments are rarely seen in the food, beverage and supplement industry, even less so prior to commercial launch and should give investors' confidence in the value attributed to this technology by industry.\nSubject to any partner constraints, the Company hopes to be in a position to demonstrate a range of SweetBiotix products to investors in H1 2026.\nS\nte\np\nhe\nn O'H\na\nr\na\n,\nC\nEO\no\nf\nO\np\nt\ni\nB\ni\no\nt\ni\nx\n,\nc\no\nm\nme\nn\nte\nd\n:\n\"The Company has made a breakthrough in improving the manufacturing process of its SweetBiotix products. By using a new enzyme, rather than an enzyme extract, the Company is able to achieve substantially higher yields of a purer, more concentrated, better tasting product with lower ingredient and production costs\n. These are significant benefits when producing at large scale. This new enzyme works on both mogrosides and stevia glycosides allowing the\ngeneration of multiple SweetBiotix products using the same enzyme creating products with a wide sweetness range.\nThis increases the number of partnering and product opportunities and reduces the need for multiple enzymes and manufacturing processes with a substantial reduction in production costs. Whilst there have been the inevitable complexity and technical challenges in scaling up a new product with new partners these recent improvements have led us to a more efficient, cost-effective process, and an enhanced commercial proposition. The new enzyme not only improves yields but\nvalorises an unhealthy, commoditised ingredient (sugar) into higher value, healthy, SweetBiotix products.\nThe Company believes these improvements reflect a material change in the outlook for SweetBiotix products.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Ludovico Lazzaretti / James Western\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF),\nOptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease.\nSince the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like\nSlimBiome\u00ae, WellBiome\u00ae, SweetBiotix\u00ae and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nUPDPPGCGGUPAPUW",
          "rns_number": "RNS Number : 6314I"
        },
        {
          "title": "Order with well-known Weight Management Company",
          "announcement_date": "17th Nov 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "17 Nov 2025 07:00\nRNS Number : 7302H\nOptiBiotix Health PLC\n17 November 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nFirst order with well-known Weight Management Company\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces it has received a first order from a well-known weight management company (the \"Distributor\"). The order follows on from an agreement announced on 20 August 2025. The low six-figure first order includes the supply of a range of private label SlimBiome\u00ae finished products (gummies, bars, drinks) and a WellBiome\u00ae product planned for delivery and launch in Europe under the Distributor's own brand in H1 2026. This is consistent with the Company's strategy of providing more finished product either via ecommerce or, as in this case, private label products to customers.\nThe order reflects the interest in bringing ingredients with human studies which show appetite reduction similar to the anti-obesity drugs to traditional weight management brands, and new brands looking to enter the fast evolving 'natural alternative to GLP1 market', which is redefining the weight management market. This market is estimated to be worth\n$1.2 billion in 2024\nand is projected to reach\n$4.8 billion by 2033\n,\ngrowing at a compound annual growth rate of 16.7% (Market Intelo, 2024).\nThis follows on from the launch of SlimBiome with a number of large partners and well-known brands internationally including:-\nI.\nHydroxycut, a brand which describes itself as the No. 1 selling weight loss supplement brand in the United States of America (\"USA\"), which is sold online and via major retail outlets including Walmart across the USA.\nII.\nLightLife, a new brand from Dr Morepen which was launched online in December 2024 and is now expanding into retail across India and looking to extend their product range.\nIII.\nThe launch of SlimBiome in Holland and Barrett's SlimExpert range. We anticipate new positioning of products in 2026 reflecting the evolution of the weight management market.\nIV.\nThe inclusion of SlimBiome as LeanBiome in leading sports brands like Muscletech and Myprotein.\nStephen O'Hara, CEO of OptiBiotix Health plc said\n: \"\nWe are pleased to announce this large first order with a well-known European weight management company. The order reflects the growing interest in bringing ingredients with human studies demonstrating appetite reduction, similar to the anti-obesity drugs, to brands looking to enter this fast growing 'natural alternative to GLP1 market'.\n\"This is another example of the Company launching products with well-known brands in international markets which helps build the SlimBiome brand and, if successful individually and collectively, have\nthe potential to make a significant contribution to future sales growth and shareholder value.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Ludovico Lazzaretti / James Western\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF),\nOptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease.\nSince the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like\nSlimBiome\u00ae, WellBiome\u00ae, SweetBiotix\u00ae and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCFLFFTLVLRLIE",
          "rns_number": "RNS Number : 7302H"
        }
      ],
      "themes": [
        "drilling",
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 877,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "DOWNTREND"
    },
    "volatility": {
      "atr_normalized": 7.95,
      "stddev_20d": 0.3466
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "all_events": [
      {
        "event_id": "RNS-20th Jan 2026-newinves",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348388Z",
        "source": "LSE_RNS",
        "data": {
          "title": "New Investor Website",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/OPTI/new-investor-website-rrq15mnezam0mcf.html",
          "rns_number": "RNS Number : 5070P",
          "full_content": "20 Jan 2026 07:00\nRNS Number : 5070P\nOptiBiotix Health PLC\n20 January 2026\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\nN\new Investor Website\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces the launch of a new interactive investor website. The new investor website brings all OptiBiotix content including corporate, commercial and research into a single platform to better inform and engage with prospective and existing investors and other stakeholders. The website includes:\n\u25cf Announcements (RNS and Reach)\n\u25cf Annual and Interim reports\n\u25cf Investor presentations, podcasts and video updates\n\u25cf Research publications, product and technology overviews\n\u25cf Interviews with the CEO\n\u25cf Interviews and videos with research/ industry partners on its technology and products\nThe website provides users with the ability to ask the management team questions to provide context on announcements including progress or concerns via an interactive portal which will be monitored and responded to in a timely manner. The overall aim is to give existing and prospective shareholders the opportunity to engage directly with the management team and have access to reliable information on which they can make a judgement. We would encourage all existing shareholders and prospective investors to sign up to the website (it should take less than one minute) and use it as your primary interface and information source for the business.\nHow to sign up for the OptiBiotix investor website:\n1. Visit\nwww.optibiotix.com\n2. Follow the prompts on the top right-hand side of the website marked SIGN UP\n3. Complete your account profile (name/email)\nStephen O'Hara, Chief Executive Officer, commented:\n\"The Board is keen to improve communications with our shareholders and give them access to reliable information on which to make their investment decisions. This new 'InvestorHub' enables us to discuss commercial progress with partners, share development progress and launch plans for our second-generation products like SweetBiotix, in more depth and context than is possible through RNS announcements alone, while remaining fully compliant with market disclosure obligations.\nWe encourage all stakeholders to explore the site, engage with our content, and share their questions and feedback. Your input is invaluable as we continue refining our communication channels and building a profitable and valuable business.\"\nEnds\nEngage with the OptiBiotix management team directly by asking questions, watching video summaries and seeing what other shareholders have to say.\nNavigate to our Interactive Investor website here:\nhttps://optibiotix.com/link/P2zk3P\nSubscribe to the new website to get regular updates here:\nhttps://optibiotix.com/auth/signup\nFor further enquiries\n, please visit\nwww.optibiotix.com\nor contact:\nOptiBiotix Health PLC\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nWe encourage all investors to share questions on this announcement via our investor website.\nhttps://optibiotix.com/announcements\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF),\nOptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease.\nSince the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like\nSlimBiome\u00ae, WellBiome\u00ae, SweetBiotix\u00ae and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio of technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.\nThis communication is a \"Reach\" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and",
          "content_length": 5116
        },
        "ingested_at": "2026-01-21T02:42:53.348424Z"
      },
      {
        "event_id": "RNS-2nd Jan 2026-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348442Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-ch1kz052qaluui1.html",
          "rns_number": "RNS Number : 3675N",
          "full_content": "2 Jan 2026 07:00\nRNS Number : 3675N\nSkinBioTherapeutics PLC\n02 January 2026\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BF33H870\nIssuer Name\nSKINBIOTHERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of financial instruments\n3. Details of person subject to the notification obligation\nName\nOptibiotix Health plc\nCity of registered office (if applicable)\nYork\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n30-Dec-2025\n6. Date on which Issuer notified\n31-Dec-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n5.640000\n0.000000\n5.640000\n14600000\nPosition of previous notification (if applicable)\n6.410000\n0.000000\n6.410000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nOrdinary\n14600000\n5.640000\nSub Total 8.A\n14600000\n5.640000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n31-Dec-2025\n13. Place Of Completion\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLBBMATMTTMBPF",
          "content_length": 3824
        },
        "ingested_at": "2026-01-21T02:42:53.348457Z"
      },
      {
        "event_id": "RNS-2nd Jan 2026-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348471Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-4h4vkr3ls204x8g.html",
          "rns_number": "RNS Number : 3675N",
          "full_content": "2 Jan 2026 07:00\nRNS Number : 3675N\nSkinBioTherapeutics PLC\n02 January 2026\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BF33H870\nIssuer Name\nSKINBIOTHERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of financial instruments\n3. Details of person subject to the notification obligation\nName\nOptibiotix Health plc\nCity of registered office (if applicable)\nYork\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n30-Dec-2025\n6. Date on which Issuer notified\n31-Dec-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n5.640000\n0.000000\n5.640000\n14600000\nPosition of previous notification (if applicable)\n6.410000\n0.000000\n6.410000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nOrdinary\n14600000\n5.640000\nSub Total 8.A\n14600000\n5.640000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n31-Dec-2025\n13. Place Of Completion\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLBBMATMTTMBPF",
          "content_length": 3824
        },
        "ingested_at": "2026-01-21T02:42:53.348484Z"
      },
      {
        "event_id": "RNS-24th Nov 2025-sweetbio",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348498Z",
        "source": "LSE_RNS",
        "data": {
          "title": "SweetBiotix Overview and Update",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/sweetbiotix-overview-and-update-6mzgvfsbbg2nnag.html",
          "rns_number": "RNS Number : 6314I",
          "full_content": "24 Nov 2025 07:00\nRNS Number : 6314I\nOptiBiotix Health PLC\n24 November 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\nSweetBiotix\n\u00ae Overview and Update\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes\nprovides an overview and update on its SweetBiotix\n\u00ae\nproduct range for new and existing investors.\nWhat are SweetBiotix\u00ae?\nSweetBiotix\u00ae are a portfolio of natural, sweet, high fibre, low-calorie products developed to replace sugar and sugar substitutes. They are produced using a patented technology developed by OptiBiotix which enzymatically modifies existing natural sweeteners like steviol glycosides and mogrosides and converts them into dietary fibres, providing sweetness with added nutritional and health benefits.\nIs SweetBiotix protected?\nSweetBiotix\u00ae are trademarked and patented products protected by a significant intellectual property portfolio comprising over 25 patents with a number of recent additional filings. Patents must demonstrate novelty/uniqueness, inventiveness (i.e. no one else has invented it), and industry applicability confirming the uniqueness of SweetBiotix. OptiBiotix patents cover synthesis, composition, and the application of SweetBiotix in food and beverages. They protect OptiBiotix's commercial interests, prevent competitors from entering the market, and create licensing opportunities with partners. SweetBiotix\u00ae is a registered trademark in international markets.\nThe\nSweetBiotix\n\u00ae Opportunity\nWidespread concern over the use of sugar in food and drinks has led to the development and use of sugar substitutes. These may be natural (e.g stevia, mogrosides, polyols) which often do not offer optimal taste profiles or artificial (e.g aspartame, sucralose, saccharin). Health concerns with artificial sugar substitutes have been widely reported and have been previously summarised (See RNS 30 January 2024). SweetBiotix are unique as a sugar substitute as they have been developed to overcome health concerns, are high in fibre, and have prebiotic functionality providing nutritional and health benefits not present in existing products. This a market estimated to be worth $29.9bn by 2029 (Markets and Markets: Oct 2024).\nWhat is the evidence that SweetBiotix\u00ae are sweet and have health benefits\nSweetBiotix\n\u00ae\nproducts\nhave been tested by academic groups who have published five papers in peer reviewed journals providing an independent assessment of SweetBiotix's\n\u00ae\ntaste and health benefits. One publication on an early SweetBiotix product\nconcluded\n'\nThis new ingredient could provide health benefits when evaluated in human studies by combining sweetness and prebiotic fiber functionality'.\n(see\nPrebiotic Potential of a New Sweetener Based on Galactooligosaccharides and Modified Mogrosides - PubMed (nih.gov)\n.\nThe Company has provided SweetBiotix samples under Material Transfer Agreements (MTA) to a number of partners, many of whom have specialist expertise in taste testing and sugar substitutes. This has led to a formal agreement with a USA partner and DSM Firmenich, a $12bn ingredients supplier, and several food and beverage companies supporting SweetBiotix development with a view to the use of SweetBiotix in their products. The combination of academic and i\nndustry validation with an industry leader specialist in the field committing manufacturing resources should give investors' confidence in these products.\nWhat has happened to the manufacture of these products?\nManufacturing scale up of SweetBiotix has been carried out by partners and shown flavour and texture comparable to laboratory scale\n. Scale up with Firmenich's contract manufacturer slowed during and after its merger with DSM and was subsequently transferred to DSM due to its inhouse manufacturing capability and the scale of the opportunity. The new team were unable to consistently reach high yields using the original enzyme extract. As part of its ongoing SweetBiotix partner development program, OptiBiotix screened over 50 enzymes and was able to identify\na new single enzyme (i.e. not an extract) which produced extremely high yields (~90%) of the same SweetBiotix. This simplifies the manufacturing process to produce a cleaner, more concentrated product with higher sweetness intensity and a significantly improved flavour profile. This enzyme works on both mogrosides and stevia glycosides allowing the\ngeneration of multiple SweetBiotix products of high purity, with the same enzyme, with a wide sweetness range compared to sucrose\n. This increases the number of product opportunities, and, from an industry viewpoint, reduces the need for multiple enzymes and manufacturing processes with a substantial reduction in production costs.\nOne other unique aspect of the new enzyme is that it produces SweetBiotix from sucrose (sugar). This reduces ingredient input costs and ",
          "content_length": 10028
        },
        "ingested_at": "2026-01-21T02:42:53.348513Z"
      },
      {
        "event_id": "RNS-17th Nov 2025-orderwit",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348526Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Order with well-known Weight Management Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/order-with-well-known-weight-management-company-17qfj3u80gn9vge.html",
          "rns_number": "RNS Number : 7302H",
          "full_content": "17 Nov 2025 07:00\nRNS Number : 7302H\nOptiBiotix Health PLC\n17 November 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nFirst order with well-known Weight Management Company\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces it has received a first order from a well-known weight management company (the \"Distributor\"). The order follows on from an agreement announced on 20 August 2025. The low six-figure first order includes the supply of a range of private label SlimBiome\u00ae finished products (gummies, bars, drinks) and a WellBiome\u00ae product planned for delivery and launch in Europe under the Distributor's own brand in H1 2026. This is consistent with the Company's strategy of providing more finished product either via ecommerce or, as in this case, private label products to customers.\nThe order reflects the interest in bringing ingredients with human studies which show appetite reduction similar to the anti-obesity drugs to traditional weight management brands, and new brands looking to enter the fast evolving 'natural alternative to GLP1 market', which is redefining the weight management market. This market is estimated to be worth\n$1.2 billion in 2024\nand is projected to reach\n$4.8 billion by 2033\n,\ngrowing at a compound annual growth rate of 16.7% (Market Intelo, 2024).\nThis follows on from the launch of SlimBiome with a number of large partners and well-known brands internationally including:-\nI.\nHydroxycut, a brand which describes itself as the No. 1 selling weight loss supplement brand in the United States of America (\"USA\"), which is sold online and via major retail outlets including Walmart across the USA.\nII.\nLightLife, a new brand from Dr Morepen which was launched online in December 2024 and is now expanding into retail across India and looking to extend their product range.\nIII.\nThe launch of SlimBiome in Holland and Barrett's SlimExpert range. We anticipate new positioning of products in 2026 reflecting the evolution of the weight management market.\nIV.\nThe inclusion of SlimBiome as LeanBiome in leading sports brands like Muscletech and Myprotein.\nStephen O'Hara, CEO of OptiBiotix Health plc said\n: \"\nWe are pleased to announce this large first order with a well-known European weight management company. The order reflects the growing interest in bringing ingredients with human studies demonstrating appetite reduction, similar to the anti-obesity drugs, to brands looking to enter this fast growing 'natural alternative to GLP1 market'.\n\"This is another example of the Company launching products with well-known brands in international markets which helps build the SlimBiome brand and, if successful individually and collectively, have\nthe potential to make a significant contribution to future sales growth and shareholder value.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Ludovico Lazzaretti / James Western\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF),\nOptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease.\nSince the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like\nSlimBiome\u00ae, WellBiome\u00ae, SweetBiotix\u00ae and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us",
          "content_length": 5053
        },
        "ingested_at": "2026-01-21T02:42:53.348541Z"
      },
      {
        "event_id": "RNS-13th Oct 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348554Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-atsmtiwrocjb43l.html",
          "rns_number": "RNS Number : 1594D",
          "full_content": "13 Oct 2025 15:31\nRNS Number : 1594D\nSkinBioTherapeutics PLC\n13 October 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BF33H870\nIssuer Name\nSKINBIOTHERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of financial instruments\n3. Details of person subject to the notification obligation\nName\nOptibiotix Health plc\nCity of registered office (if applicable)\nYork\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n10-Oct-2025\n6. Date on which Issuer notified\n13-Oct-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n6.410000\n0.000000\n6.410000\n16600000\nPosition of previous notification (if applicable)\n7.950000\n0.000000\n7.950000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nOrdinary\n16600000\n0\n6.410000\n0.000000\nSub Total 8.A\n16600000\n6.410000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n13-Oct-2025\n13. Place Of Completion\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLMJBITMTTBBIA",
          "content_length": 3836
        },
        "ingested_at": "2026-01-21T02:42:53.348567Z"
      },
      {
        "event_id": "RNS-2nd Oct 2025-director",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348580Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Director/PDMR Shareholding",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/directorpdmr-shareholding-5v0ha6wwig8571b.html",
          "rns_number": "RNS Number : 7141B",
          "full_content": "2 Oct 2025 07:00\nRNS Number : 7141B\nOptiBiotix Health PLC\n02 October 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\nDirector/PDMR Shareholding\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces\nthat the Company has been informed that David Blain, a Director of the Company, made the following purchase of ordinary shares in the capital of the Company. Further details are set out in the Notification of Dealing Form below.\nDirector\nPurchase price\nOrdinary shares purchased\nResultant interest in ordinary shares\nResultant percentage of issued ordinary shares\nDavid Blain\n11.75 pence\n84,053\n84,053\n0.08%\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Ludovico Lazzaretti / James Western\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nNotification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014\n1\nDetails of the person discharging managerial responsibilities/person closely associated\na.\nName\nDavid Blain\n2\nReason for notification\na.\nPosition/Status\nFinance Director\nb.\nInitial notification/\nAmendment\nInitial Notification\n3\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\na.\nName\nOptiBiotix Health Plc\nb.\nLEI\n4\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\na.\nDescription of the financial instrument, type of instrumentIdentification Code\nOrdinary shares of 2p each\nISIN: GB00BP0RTP38\nb.\nNature of the transaction\nPurchase of ordinary shares\nc.\nPrice(s) and volume(s)\nPrice(s) per share\nVolume(s)\n11.75 pence\n84,053\nd.\nAggregated information\n-\nVolume\n-\nPrice\n84,053 shares\n11.75 pence per share\ne.\nDate of the transaction\n1 October 2025\nf.\nPlace of the transaction\nLondon Alternative Market (AIMX)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nDSHFSMFMFEISEDS",
          "content_length": 4036
        },
        "ingested_at": "2026-01-21T02:42:53.348592Z"
      },
      {
        "event_id": "RNS-24th Sep 2025-director",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348605Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Director/PDMR Shareholding",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/directorpdmr-shareholding-t6ibdhlb3bc6r82.html",
          "rns_number": "RNS Number : 6689A",
          "full_content": "24 Sep 2025 12:28\nRNS Number : 6689A\nOptiBiotix Health PLC\n24 September 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\nDirector/PDMR Shareholding\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces\nthat the Company has been informed that Stephen O'Hara, a Director of the Company, made the following purchases of ordinary shares in the capital of the Company. Further details are set out in the Notification of Dealing Form below.\nDirector\nPurchase price (Aggregated)\nOrdinary shares purchased\nResultant interest in ordinary shares\nResultant percentage of issued ordinary shares\nStephen O'Hara\n10.13 pence\n195,238\n10,408,224\n10.08%\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Ludovico Lazzaretti / James Western\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nNotification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014\n1\nDetails of the person discharging managerial responsibilities/person closely associated\na.\nName\nStephen O'Hara\n2\nReason for notification\na.\nPosition/Status\nDirector - Chief Executive Officer\nb.\nInitial notification/\nAmendment\nInitial Notification\n3\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\na.\nName\nOptiBiotix Health Plc\nb.\nLEI\n4\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\na.\nDescription of the financial instrument, type of instrumentIdentification Code\nOrdinary shares of 2p each\nISIN: GB00BP0RTP38\nb.\nNature of the transaction\nPurchase of ordinary shares\nc.\nPrice(s) and volume(s)\nPrice(s) per share\nVolume(s)\n9.77p\n50,000\n9.78p\n50,000\nd.\nAggregated information\n-\nVolume\n-\nPrice\n100,000 shares\n9.77 pence per share\ne.\nDate of the transaction\n22 September 2025\nf.\nPlace of the transaction\nLondon\nNotification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014\n1\nDetails of the person discharging managerial responsibilities/person closely associated\na.\nName\nStephen O'Hara\n2\nReason for notification\na.\nPosition/Status\nDirector - Chief Executive Officer\nb.\nInitial notification/\nAmendment\nInitial Notification\n3\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\na.\nName\nOptiBiotix Health Plc\nb.\nLEI\n4\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\na.\nDescription of the financial instrument, type of instrumentIdentification Code\nOrdinary shares of 2p each\nISIN: GB00BP0RTP38\nb.\nNature of the transaction\nPurchase of ordinary shares\nc.\nPrice(s) and volume(s)\nPrice(s) per share\nVolume(s)\n10.5p\n47,619\n10.5p\n47,619\nd.\nAggregated information\n-\nVolume\n-\nPrice\n95,238 shares\n10.5 pence per share\ne.\nDate of the transaction\n23 September 2025\nf.\nPlace of the transaction\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our co",
          "content_length": 5176
        },
        "ingested_at": "2026-01-21T02:42:53.348619Z"
      },
      {
        "event_id": "RNS-16th Sep 2025-half-yea",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348632Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Half-year Report",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/half-year-report-k1vtfrl2lgvi6qn.html",
          "rns_number": "RNS Number : 4148Z",
          "full_content": "16 Sep 2025 07:00\nRNS Number : 4148Z\nOptiBiotix Health PLC\n16 September 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nHalf Year Report\nStrong period of growth\nOptiBiotix Health plc (AIM: OPTI; OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces its\nunaudited results for the six months ended 30 June 2025.\nHighlights\n\u00b7\nSignificantly increased sales with revenue up 102% to \u00a3557K (H1 2024: \u00a3276K)\n\u00b7\nGross profit margin increased to 54% (H1 2024: 40%)\n\u00b7\nGross profit up 173% to \u00a3303K (H1 2024: \u00a3111K)\n\u00b7\nAdministrative costs (including selling, R&D and patent costs and excluding shared based payments, depreciation, and amortisation) remain relatively stable at \u00a31.15m (H1 2024: \u00a31.07m)\n\u00b7\nStrong cash balance of \u00a31.3m (H1 2024: \u00a31.3m)\n\u00b7\nFirst order received of six metric tonnes from Brenntag, the Company's new Australian distributor\n\u00b7\nLaunch of products in the USA with two new partners (NHT Global and Nouri)\n\u00b7\nThe number of e-commerce customers up by 38% to 5,095 customers (H1 2024: 3,702 customers) due to a 57.7% increase in Amazon orders to 4,159 (H1 2024: 2,638)\n\u00b7\nE-commerce Amazon sales up 87.6% to \u00a393,767 (H1 2024: \u00a349,995)\n\u00b7\nAppointed new trading partner in China with a focus on TMALL sales\n\u00b7\nGrowing list of new customers in Asia and the USA\nPost period\n\u00b7\nLaunch of SlimBiome\u00ae in Hydroxycut, which markets itself as the No. 1 selling weight loss supplement brand in the United States of America (\"USA\")\n\u00b7\nSigning of a distribution agreement with a well-known direct selling weight management company with a first order expected in H2 and product launch in H1 2026\n\u00b7\nFirst order received from a new partner in Taiwan, Meelung Trading\n\u00b7\nDiscovery of a new enzyme for SweetBiotix which has substantially higher yields which will significantly improve manufacturing costs. The same enzyme can\ngenerate multiple SweetBiotix products with a wide sweetness range when compared to sucrose\nThe Company delivered strong financial performance in H1 2025, with sales more than doubling compared to\nH1 2024, supported by improved margins. Equally important is that we are now seeing a growing contribution from our India and USA businesses. We anticipate continued momentum in sales growth with the full year effect of 2024 launches, new and existing partners launching new products in USA and Asia, e-commerce continuing its growth trajectory with launch of products on Amazon India, and annual license revenues from SweetBiotix occurring in H2 2025.\nThe Company should see the effect of reductions in PR, broker, and staff costs in H2 2025 and a recently negotiated 30% reduction in IP costs. It continues to work on further margin improvements by negotiating reductions in the cost of goods from volume discounts, and supplying Asia from India, which has lower manufacturing costs.\nStephen O'Hara, CEO of OptiBiotix Health plc said:\n\"The strong growth in 2024 has continued with increased momentum into H1 2025\nand\nsales growth across all areas of business. Equally important are the steps we have taken to reduce costs and improve margins whilst continuing to grow sales.\n\"The Company has increasing sales and margins, regulatory approvals and health claims approved in all major territories, and a network of more reliable global manufacturing and distribution partners. This gives the Company a broad base on which to deliver future revenue growth with the aim of achieving profitability across all parts of the business and the Group generating positive cashflow.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Ludovico Lazzaretti / James Western\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI; OTCQB: OPTBF), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, car",
          "content_length": 34707
        },
        "ingested_at": "2026-01-21T02:42:53.348649Z"
      },
      {
        "event_id": "RNS-21st Aug 2025-admissio",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348663Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Admission to Trading on the OTCQB Venture Market",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/admission-to-trading-on-the-otcqb-venture-market-vt376otclaa0ehc.html",
          "rns_number": "RNS Number : 1599W",
          "full_content": "21 Aug 2025 07:00\nRNS Number : 1599W\nOptiBiotix Health PLC\n21 August 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nAdmission to Trading on the OTCQB Venture Market in the United States\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces\u00a0that its shares (\"Ordinary Shares\") have been approved to trade on the OTCQB Venture Market (\"OTCQB\") in the United States and will commence trading on the stock market at open on Thursday 21 August 2025 under the symbol \"OPTBF\".\nTrading on the OTCQB market will not impact on existing ordinary shares admitted to trading on the AIM Market of the London Stock Exchange and no new ordinary shares were issued through this process. The Company will continue to make all announcements and disclosures to the London Stock Exchange through the Regulatory News Service and is not subject to any Sarbanes-Oxley or US Securities and Exchange Commission reporting requirements.\nOTCQB is provided through OTC Markets Group Inc. (\"OTC Markets\"), located in New York. OTC Markets operates the world's largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. OTCQB is a well-established market designed to provide enhanced visibility and liquidity for international companies seeking to broaden their U.S. investor base. Independent studies show that trading on the OTC by an international company offers a positive effect on the liquidity of its shares.\nStephen O'Hara CEO, commented:\n\"\nOptiBiotix is building its consumer presence in the USA as shown by the recent launch of its appetite reducing SlimBiome\u00a8 in Hydroxycut, the No. 1 selling weight loss supplement brand in the USA. This follows on from launches earlier this year with new US partners such as NHT and Daily Nouri. As we increase our brand presence in the USA the Board believe joining the OTCQB Market will help increase our visibility to the US investment community, broadening our shareholder base\u00a0and improving liquidity.\"\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCBLGDIGUDDGUG",
          "content_length": 4274
        },
        "ingested_at": "2026-01-21T02:42:53.348676Z"
      },
      {
        "event_id": "RNS-20th Aug 2025-agreemen",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348689Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Agreement with Weight Management Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/agreement-with-weight-management-company-rhcn1i9z08lu64t.html",
          "rns_number": "RNS Number : 9607V",
          "full_content": "20 Aug 2025 07:00\nRNS Number : 9607V\nOptiBiotix Health PLC\n20 August 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nAgreement with well-known Weight Management Company\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces the signing of a distribution agreement with a well-known direct selling weight management company (the \"Distributor\").\nOptiBiotix will provide a range of SlimBiome\u00ae finished products under the Distributor's own branding and a WellBiome\u00ae product which will be included in their product range. The Distributor plans to launch in its biggest territory by sales first, which, if successful, will be followed by subsequent launches in other European countries. The products will be sold via a long standing and established distribution channel of consultants and via e-commerce. As part of this agreement, a first order is expected to be placed within the first three months of signing the agreement. Further information on the Distributor and brand will be announced on launch which OptiBiotix anticipates will be in H1 2026.\nThis agreement reflects the interest OptiBiotix is seeing in bringing functionality to weight management with traditional brands looking to leverage the interest in products which reduce hunger and cravings generated by the anti-obesity drugs. This agreement opens new opportunities to include science backed functional ingredients into well-known weight management brands.\nStephen O'Hara, CEO of OptiBiotix Health plc said\n: \"\nWe are pleased to announce this agreement with a well-known and established weight management company. This agreement brings together the trust, loyalty, and customer base of a recognised brand with the science and functionality of SlimBiome\n\u00ae\n.\n\"Following the launch of anti-obesity drugs, natural, scientifically proven, non-drug alternatives to reduce hunger and cravings are actively being sought by consumers. This announcement demonstrates that the science and multiple human studies carried out on SlimBiome\u00ae is attracting the interest of major brands around the world.\"\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nCaution regarding forward looking statements\nCertain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identi\ufb01ed by their use of terms and phrases such as ''believe'', ''could'', \"should\" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', \"expect\", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements re\ufb02ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse ",
          "content_length": 5324
        },
        "ingested_at": "2026-01-21T02:42:53.348705Z"
      },
      {
        "event_id": "RNS-14th Aug 2025-launchof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348719Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Launch of SlimBiome in leading US brand",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/launch-of-slimbiome-in-leading-us-brand-l8yjj35s9hsd8yu.html",
          "rns_number": "RNS Number : 2309V",
          "full_content": "14 Aug 2025 07:00\nRNS Number : 2309V\nOptiBiotix Health PLC\n14 August 2025\n14 August 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\nLaunch of SlimBiome\n\u00ae\nin leading US brand\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes\nannounces the launch of a product containing its award-winning appetite reducing SlimBiome\n\u00ae in Hydroxycut, which markets itself as the No. 1 selling weight loss supplement brand in the United States of America (\"USA\").\nThis announcement confirms the launch of the first product under the brand name 'Hydroxycut Hunger Control', and follows on from the first order\nannouncement\non\n15 April\n2025\n.\nThe product is sold through online outlets and retail outlets such as Walmart (as shown\nhere\n), and product marketing includes two studies carried out by OptiBiotix which demonstrate reduction in hunger of 74% and 83%. Orders for a second product application have been received and expected to be launched later this year.\nHydroxycut is America's No.1 selling weight loss supplement brand and has sold over 100 million bottles of its product over the last two decades*. Hydroxycut products are sold online and via major retail outlets across the USA such as Walmart, Kroger, Target, GNC, Kmart, Albertsons, CVS Pharmacies and more. The brand has high customer awareness and in recent years has become increasingly known for its science backed products. The introduction of SlimBiome\u00ae, with its scientifically substantiated health claims of hunger control, helps to differentiate these products from other weight management products on the market.\nThis news is significant for the Company as it represents the inclusion of SlimBiome\u00ae in the products of one of the USA's most popular weight management brands which has led to orders totalling just under five metric tonnes for SlimBiome\u00ae in 2025. The Board believes that the opportunity has potential for future development and will provide further updates in due course.\nStephen O'Hara, CEO of OptiBiotix, commented:\n\"\nWe are pleased to announce the launch of products containing our patented award winning SlimBiome\n\u00ae\nin\nthe USA. The Company has been working with Hydroxycut for almost two years to carry out human studies which allows the brand to make health claims of reductions in hunger of 74% and 83% in the USA.\nThe launch with Hydroxycut substantiates the science behind SlimBiome and helps build the SlimBiome brand in consumer markets around the world. This is another example of the Company launching products with well-known brands in key international markets which if successful, individually and collectively, have\nthe potential to make a significant contribution to future sales growth and shareholder value.\"\n*\nHydroxycut: America's Best Selling Weight Loss Supplement\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nCaution regarding forward looking statements\nCertain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identi\ufb01ed by their use of terms and phrases such as ''believe'', ''could'', \"should\" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', \"expect\", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of fund",
          "content_length": 6008
        },
        "ingested_at": "2026-01-21T02:42:53.348735Z"
      },
      {
        "event_id": "RNS-6th Aug 2025-resultof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348748Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Result of AGM",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/result-of-agm-4ork6y0ngiyg4a3.html",
          "rns_number": "RNS Number : 2890U",
          "full_content": "6 Aug 2025 16:08\nRNS Number : 2890U\nOptiBiotix Health PLC\n06 August 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nResult of AGM\nOptiBiotix Health plc (AIM: OPTI),\na li\nf\ne\nsc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nve\nl\no\np\ni\nn\ng c\no\nm\npounds\nto tack\nl\ne o\nb\nesi\nt\ny,\ncardiovascular disease\nand\nd\nia\nb\nete\ns,\nannounces that at its Annual General Meeting held earlier today resolutions 1-4 were duly passed. Resolution 5, a Special Resolution which sought to give the Directors power to issue new ordinary shares for cash other than to the Company's shareholders on a pro rata basis, was not passed.\nThe result of the vote on Resolution 5 does not affect the strategy or the day-to-day running of the business and the Directors do not currently envisage that the business would need to raise new funds through the issue of new shares on a non pre-emptive basis before the 2026 AGM. Should such need arise, a separate General Meeting would be convened to seek shareholder approval at the relevant time.\nThe full voting results will be available on the website in due course here:\nhttps://www.optibiotix-ir.com/content/investors/\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nRAGPFMATMTMMBIA",
          "content_length": 3134
        },
        "ingested_at": "2026-01-21T02:42:53.348760Z"
      },
      {
        "event_id": "RNS-6th Aug 2025-issueofo",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348773Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Issue of Options",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/issue-of-options-v07whwtlfzix58q.html",
          "rns_number": "RNS Number : 1015U",
          "full_content": "6 Aug 2025 07:00\nRNS Number : 1015U\nOptiBiotix Health PLC\n06 August 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\nIssue of Options\nOptiB\ni\not\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n: O\nP\nTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare\n,\na\nnn\no\nun\nces that the Company has issued 358,772 options over new ordinary shares with an exercise price of 11 pence per share (\"New Options\") to Sofia Kolyda, a Director of the Company.\nThe New Options expire on 6 August 2035 with 269,079 of the New Options vesting on the first anniversary of the options being granted being 6 August 2026 and the balance (comprising 89,693 New Options) vesting once the Company signs a commercial agreement with a partner providing equal or greater than \u00a3100k revenues per annum for products containing SweetBiotix.\nThe issue of the New Options follows the expiration of 358,772 options of ordinary shares granted to Sofia Kolyda which expired in March 2025 of which 75% had vested.\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nNotification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014\n1\nDetails of the person discharging managerial responsibilities/person closely associated\na.\nName\nSofia Kolyda\n2\nReason for notification\na.\nPosition/Status\nDirector\nb.\nInitial notification/\nAmendment\nInitial Notification\n3\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\na.\nName\nOptiBiotix Health Plc\nb.\nLEI\n4\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\na.\nDescription of the financial instrument, type of instrumentIdentification Code\nOptions over new ordinary shares of 2p each\nISIN: GB00BP0RTP38\nb.\nNature of the transaction\nIssue of options pursuant to the New Options\nc.\nPrice(s) and volume(s)\nPrice(s) per share\nVolume(s)\n11p\n358,772\nd.\nAggregated information\n-\nVolume\n-\nPrice\nN/A\ne.\nDate of the transaction\n6 August 2025\nf.\nPlace of the transaction\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nDSHSSDFIIEISEIA",
          "content_length": 4318
        },
        "ingested_at": "2026-01-21T02:42:53.348786Z"
      },
      {
        "event_id": "RNS-28th Jul 2025-tradingu",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348798Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Trading update",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/trading-update-bfbq9x9m3ewcj4u.html",
          "rns_number": "RNS Number : 6847S",
          "full_content": "28 Jul 2025 07:00\nRNS Number : 6847S\nOptiBiotix Health PLC\n28 July 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nTrading update\nStrong period of growth\nOptiBiotix Health plc (AIM: OPTI),\na li\nf\ne\nsc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nve\nl\no\np\ni\nn\ng c\no\nm\npounds\nto tack\nl\ne o\nb\nesi\nt\ny,\ncardiovascular disease\nand\nd\nia\nb\nete\ns,\nprovides\nthe following unaudited trading update for the six months ended 30 June 2025.\n\u00b7\nGross revenue up 102% to \u00a3557K (H1 2024: \u00a3276K)\n\u00b7\nGross profit up 173% to \u00a3303K (H1 2024: \u00a3111K)\n\u00b7\nGross profit margin increased to 54% (H1 2024: 40%)\n\u00b7\nOther administrative costs (including selling, R&D and patent costs and excluding shared based payments and depreciation) remain stable at \u00a31.14m (H1 2024: \u00a31.07m)\n\u00b7\nStrong cash balance of \u00a31.3m (H1 2024: \u00a31.2m)\n\u00b7\nGrowing list of new customers\n\u00fc\n30 new customers in Asia in 2025\n\u00fc\nEcommerce customers in H1 2025 up by 38% to 5,095 (H1 2024: 3,702)\n\u00fc\nLaunch of products in the USA with two new partners and first order received from a leading USA weight management brand looking to launch in H2 online and subsequently in Walmart USA\n\u00fc\nNew six metric tonne order received and shipped from Brenntag in H1 2025, the Company's new Australian distributor\nThe Company has made strong financial progress in H1 2025 with sales growing\nat an increased momentum at more than double H1 2024 and at an improved margin. We anticipate continued solid momentum in sales growth with the full year effect of 2024 launches, new and existing partners launching new products in USA and Asia, ecommerce continuing its growth trajectory with launch of products on Amazon India, and annual license revenues from SweetBiotix occurring in H2 2025.\nThe Company should see an effect of its reductions in PR, broker, and staff costs in H2 2025 and a recently negotiated 30% reduction in IP costs. Whilst margins will vary according to the revenue mix, the Company expects continued margin improvements with the removal of the stock overhang outlined in the full year accounts, reductions in the cost of goods from volume discounts, and supplying Asia from India, which has lower manufacturing costs.\nWith sales growing strongly, and significant further product opportunities still in the pipeline, the Board is confident that OptiBiotix has the potential to deliver substantial growth in shareholder value in the years ahead.\nStephen O'Hara, CEO of OptiBiotix Health plc said:\n\"The strong growth in 2024 has continued at an increased momentum into H1 2025\nwith\nsales growth across all areas of business. Equally important are the changes we made to reduce costs and improve margins whilst growing our top line which are beginning to impact positively on gross profit and should have a greater impact in H2 and into 2026.\n\"Our investments in sales and marketing are starting to deliver a multi-channel, multi territory revenue stream, reducing reliance on a single partner or territory. Regulatory approvals and health claims have now been approved in all major territories and a network of global manufacturing and distribution partners established. This gives the Company a broad base on which to deliver future revenue growth.\nAs the impact of the Company reducing costs takes full effect, it\ncontinues to grow its top line and improve margins with the aim of achieving profitability across all parts of the business and the Group generating positive cashflow.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial C",
          "content_length": 5661
        },
        "ingested_at": "2026-01-21T02:42:53.348812Z"
      },
      {
        "event_id": "RNS-30th Jun 2025-changeof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348825Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Change of Broker",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/change-of-broker-cn0nqo821x1loiq.html",
          "rns_number": "RNS Number : 8583O",
          "full_content": "30 Jun 2025 07:00\nRNS Number : 8583O\nOptiBiotix Health PLC\n30 June 2025\nOpt\ni\nB\ni\not\ni\nx Heal\nth p\nlc\n(\n\"\nOpti\nBi\not\ni\nx\"\nor the\n\"\nCompany\n\")\nChange of Broker\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces the appointment of Cairn Financial Advisers LLP as broker to the Company with immediate effect. Cairn Financial Advisers LLP will also continue to act as the Company's Nominated Adviser.\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD & Broker)\nTel: 020 7213 0880\nLiam Murray / Ludovico Lazzaretti\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCSEDFEUEISEDM",
          "content_length": 2612
        },
        "ingested_at": "2026-01-21T02:42:53.348837Z"
      },
      {
        "event_id": "RNS-30th Jun 2025-finalres",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348850Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Final Results",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/final-results-n7rcbz1xpjperks.html",
          "rns_number": "RNS Number : 8580O",
          "full_content": "30 Jun 2025 07:00\nRNS Number : 8580O\nOptiBiotix Health PLC\n30 June 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\nFinal results\nNotice of Annual General Meeting & Investor Presentation\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitute\na\nnn\no\nun\nces\nits audited results for the 12 months ended 31 December 2024.\nHighlights\n\u00b7\n\u00a31,004k orders received with reportable revenue for the year up 35% to \u00a3870k (2023: \u00a3644k)\n\u00b7\nSales and marketing investment in Ecommerce, India and the USA starting to show strong returns across all areas of the business reducing dependency on a small number of partners or territories:-\n\u00a7\nEcommerce sales up from \u00a3186k to \u00a3387k (+108%) with Amazon sales up 156% and a 290% increase in subscriptions\n\u00a7\nLaunch of products in India with Morepen in December 2024 leading to \u00a3171k of revenues, up from marginal revenues in 2023\n\u00a7\nGood early sales growth in Asia, albeit from a low base\n\u00a7\nFirst order received from a USA partner, Daily Nouri\n\u00b7\nLaunch of LeanBiome in MuscleTech, a market leader in sports nutrition\n\u00b7\nClearance of the large stock overhang at Maxum (48mt) and Cambridge Commodities (16mt) which has impacted on reportable revenues in the last few years\n\u00b7\nFixed operating costs are slightly lower for the year \u00a31,605k (2023: \u00a31,662k). We anticipate fixed costs to reduce in 2025 through reductions in PR, Broker and staff costs\n\u00b7\nThe Company ended 2024 with a strong balance sheet of \u00a39m (2023: \u00a39.4m), a strong cash position of \u00a3739k (2023: \u00a3635k), no debt and a growing pipeline of existing customers reordering and new customers looking to launch\nPost period end\n\u00b7\nThe recovery in sales\nin 2023 and sales growth in 2024 has continued into 2025 with order book for Q1 2025 higher than the sales achieved H1 2024.\n\u00b7\nLaunch of\nmultiple SlimBiome\u00ae containing products on Amazon India\n\u00b7\nLaunch of first product in the USA, a FeelFull prebiotic lemonade containing SlimBiome\u00ae, by Daily Nouri\n\u00b7\nLaunch of products containing SlimBiome\u00ae with a NASDAQ listed partner\n\u00b7\nFirst order from a leading weight management brand in the USA looking to launch two products containing SlimBiome online and subsequently in Walmart USA\n\u00b7\nNew six metric tonne order received from Brenntag in Q2, the Company's new Australian distributor\n\u00b7\nNew customers in Asia in 2025 at various stages of product development and launch ensuring continued strong growth in this region\n\u00b7\nRepeat order from Morepen in H1 with larger order expected in H2 as the products enter retail. New product development underway to expand product range\n\u00b7\nStudy published in European Journal of Nutrition looking at glycaemic control and insulin response. Study conducted in partnership with leading US weight management brand\n\u00b7\nSuccessful placing to raise\n\u00a3750,000 in May 2025 to support sales growth in the USA\n\u00b7\nOngoing discussions with a number of major brands to incorporate SweetBiotix and microbiome modulators in their products\nThe Annual Report and Financial Statements, which will be sent to shareholders today,\ncontains a Notice of Annual General Meeting (\"AGM\") which will be held\nat 12pm on 6\nAugust 2025 at\nthe offices of Walbrook PR,\n75 King William St, London, EC4N 7BE\n.\nInvestor briefing\nStephen O'Hara and his team\u00a0will provide a live presentation to investors\u00a0to discuss the results via the Investor Meet Company platform on\u00a0Thursday, 3 July 2025 at 2pm BST.\nThe presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.\nInvestors can sign up to Investor Meet Company for free and add to meet\u00a0OptiBiotix.\nTo register for the presentation, please use this link:\nhttps://www.investormeetcompany.com/optibiotix-health-plc/register-investor\nStephen O'Hara, CEO of OptiBiotix Health plc said:\n\"After restructuring the management team in 2023 and focus on investing in key strategic markets in the USA, India, and ecommerce, 2024 has seen strong sales growth across all areas of these businesses. Sales have continued to grow in 2025 and should accelerate as we see the full year effect of 2024 launches, new partners launching products in the USA and Asia, and ecommerce continuing its growth trajectory with the launch of products on Amazon India.\n\"Our investments in sales and marketing are starting to deliver a multi-channel, multi territory revenue stream, reducing reliance on a single partner or territory. We continue to see sales momentum building across all areas with Q1 sales and orders in 2025 higher than H2 2024 and continuing in Q2. This has been helped by a 6mt order from Brenntag in Australia.\nWe are particularly pleased to have cleared the large stock overhang held in Australia and the UK which has impacted on reportable revenues in the last f",
          "content_length": 104224
        },
        "ingested_at": "2026-01-21T02:42:53.348867Z"
      },
      {
        "event_id": "RNS-11th Jun 2025-slimbiom",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348881Z",
        "source": "LSE_RNS",
        "data": {
          "title": "SlimBiome\u00ae study in European Journal of Nutrition",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/OPTI/slimbiome174-study-in-european-journal-of-nutrition-h5lupu4mht3zuha.html",
          "rns_number": "RNS Number : 2784M",
          "full_content": "11 Jun 2025 07:00\nRNS Number : 2784M\nOptiBiotix Health PLC\n11 June 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nNew SlimBiome\u00ae study published in European Journal of Nutrition\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces the publication of a\nnew peer-reviewed study\non SlimBiome\u00ae in the European Journal of Nutrition. The European Journal of Nutrition is a peer reviewed, international journal that has a high impact factor with its articles widely cited and influential in its field.\nThe double-blind placebo-controlled study, led by Adele Costabile, Professor of Clinical Nutrition and the Microbiome at the University of Roehampton, found a single 3g dose of SlimBiome significantly reduced insulin levels, hunger, and the desire to eat whilst increasing the feeling of fullness. These are key factors in appetite regulation and the study conclusion highlights the potential of SlimBiome\u00ae as a non-pharmaceutical approach to weight management.\nProf Costabile will present her findings at the\n18th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health being held on 24-26 June 2025.\nThese findings on the impact of a single dose of SlimBiome\u00ae are consistent with other published studies, consumer studies, and customer feedback which have shown SlimBiome\u00ae reduces hunger and food cravings leading to users both reducing the amount of food and the type of food they eat, leading to more sustainable weight management.\nThe study was carried out to support health claims for appetite regulation and hunger control in products of one of the\nUSA's leading weight management brands (see announcement on 15 April 2025). Scientifically substantiated health claims help to differentiate SlimBiome\u00ae from other products on the market. OptiBiotix now has acute and long-term studies in healthy, overweight, and obese individuals which have allowed the Company to make on pack health claims in Europe, Australia/New Zealand, India, Asia, Canada, and the USA leading to agreements and multiple product launches with major international and national companies and brands (e.g Morepen, Muscletech, Myprotein). In the changing\nlandscape of this market, brought about by the anti-obesity drugs, traditional approaches to weight management are being replaced by science backed products which provide functional benefits such as reduced hunger and desire to eat. SlimBiome\u00ae meets this developing trend.\nThe University of Roehampton has published a press release which is set out below in Appendix I.\nStephen O'Hara, CEO of OptiBiotix Health plc commented:\n\"We are really pleased to see this study published in such a well-respected journal. The study adds further evidence to demonstrate the efficacy of SlimBiome\u00ae in reducing hunger and food cravings leading to changes in the amount and type of food people eat. Whilst the anti-obesity drugs have\nstrong risk-benefits in the 16%* of the world adult population who are obese, they may not be the best choice for the 43%* who are overweight.\nSlimBiome\u00ae represents a natural alternative, particularly for overweight individuals, and has been widely used with no reported adverse side effects\".\n*See WHO report\nObesity and overweight\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nAnna Dunphy\nMob: 07876 741 001\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis communication is a \"Reach\" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disse",
          "content_length": 10344
        },
        "ingested_at": "2026-01-21T02:42:53.348895Z"
      },
      {
        "event_id": "RNS-23rd May 2025-placinga",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348908Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Placing and Issue of Warrants",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/placing-and-issue-of-warrants-w8b3w93kbi2edpe.html",
          "rns_number": "RNS Number : 8779J",
          "full_content": "23 May 2025 07:00\nRNS Number : 8779J\nOptiBiotix Health PLC\n23 May 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\nPlacing and Issue of Warrants\nNew Subsidiary\nOptiB\ni\not\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n: O\nP\nTI), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nproducts which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes\n,\na\nnn\no\nun\nces that it has raised \u00a3750,000 through the issue of 5,357,143 new ordinary shares of 2 pence each (\"Ordinary Shares\") in the Company (\"Placing Shares\") at a price of 14 pence per share (\"Issue Price\") (\"Placing\").\nAs part of the Placing, the Company has issued one warrant for every two new Ordinary Shares subscribed for, exercisable at a price of 21 pence per share for a period of 3 years from the date of Admission (as defined further below).\nA new USA institutional investor subscribed for approximately \u00a3500,000 of new Ordinary Shares as part of the Placing, with previous experience of investing in companies with weight management products who became aware of OptiBiotix's recent launches of SlimBiome products in the USA.\nThe net proceeds of the Placing will be utilised to include the following:-\n\u00b7\nLeasing a US warehousing and logistics facility, manufacturing and warehousing 5-10 metric tonnes of SlimBiome in the USA to support partner forecasts and the lead times (2-3 weeks) required by the growing number of ecommerce and retail partners. Current lead times are 12-16 weeks and increasingly impacted by shipping companies taking longer to fill cargoes and customs delays at USA ports.\n\u00b7\nInvesting in growing sales with existing and new partners in the USA. The Company is seeing increased interest from established brands both globally, and particularly in the USA, who are currently providing traditional weight management products looking for science based ingredients with health claims to bring functionality to existing well known, but declining product ranges.\n\u00b7\nIncreasing the number of new partners in Asia, India, Europe, and the USA to reduce dependency on a limited range of partners in each territory\n\u00b7\nInvesting in social media advertising to increase awareness of OptiBiotix's own label products on Ecommerce platforms in India, including Amazon, Flipkart, and HealthKart\nNew Subsidiary\nThe Company is pleased to announce that as part of its strategy of growing its presence in the USA it has established a 100% owned subsidiary, OptiBiotix Health USA. This will help mitigate risks of tariffs and establish a physical presence in a large and important market.\nAdmission\nApplication will be made to the London Stock Exchange to admit the Placing Shares to trading on AIM (\"Admission\"). Admission of the new Ordinary Shares is expected to occur on or around 30 May 2025. The new Ordinary Shares will rank\npari passu\nwith the existing Ordinary Shares.\nTotal Voting Rights\nFor the purpose of the Disclosure and Transparency Rules, following Admission the enlarged issued share capital of the Company will comprise 103,300,304 Ordinary Shares of 2p each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.\nStephen O'Hara, CEO of OptiBiotix, commented:\n\"We are pleased that recent product launches in the USA has attracted a new US institutional investor. This investor has seen returns from previous investments in weight management products and recognised the growth potential of our products. The Company is determined to ensure that funds raised are used to accelerate sales growth and take the Company to profitability.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey/ Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to i",
          "content_length": 7030
        },
        "ingested_at": "2026-01-21T02:42:53.348925Z"
      },
      {
        "event_id": "RNS-20th May 2025-launchof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348938Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Launch of SlimBiome products with US partner",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/launch-of-slimbiome-products-with-us-partner-rkxe1spo05lg017.html",
          "rns_number": "RNS Number : 2916J",
          "full_content": "20 May 2025 07:00\nRNS Number : 2916J\nOptiBiotix Health PLC\n20 May 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nLaunch of SlimBiome\n\u00ae\nproducts with NASDAQ listed US partner\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces the launch of products containing SlimBiome\n\u00ae\nwith a NASDAQ listed partner, Natural Health Trends Corp (NASDAQ: NHTC) (\"NHT\").\nNHT is an international direct selling and ecommerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality products under the NHT global brand. The product, which was produced and shipped in final product format by OptiBiotix is a Tomato Soup formulation,\nTwinSlim Tomato Soup\n,\ndeveloped specifically for NHT and its global markets.\nThe product has been launched in Hong Kong for the Chinese market with the product shipped for launch in the USA in the upcoming weeks. OptiBiotix has been involved in presentations to NHT's Asian distributors and filming videos explaining the science and benefits of SlimBiome\n\u00ae\nfor both the Asian and USA markets.\nThis is the second USA partner launching SlimBiome\n\u00ae\nproducts in the last few months, with a third, one of the USA's leading weight management brands, expected to launch in the near future. This is all part of the Company's strategy to develop and market clinically proven and patented products with functional benefits (for SlimBiome\n\u00ae\n: reduce hunger and food cravings) and grow our business in the high growth markets of Asia, particularly India, and the large USA market, through a mix of ingredient and finished products sold by brand owners, specialised distributors and e-commerce channels. OptiBiotix is now beginning to see returns from the investments made in clinical studies, intellectual property, and more recently supporting partners in their marketing at a time when the anti-obesity drugs have enhanced consumer awareness of the benefits of appetite suppression in weight management. We are now seeing regular launches of SlimBiome\n\u00ae\nproducts with larger partners in more countries around the world, enhancing brand recognition and creating greater interest. The focus now is on increasing the number of large partners and delivering regular repeat orders to reach group profitability.\nStephen O'Hara, CEO of OptiBiotix Health plc said\n: \"\nWe are pleased to announce the launch of SlimBiome\n\u00ae\ncontaining products with a well-known global brand like NHT. TwinSlim Tomato soup was developed specifically for NHT to create a healthy snack which reduces hunger and food cravings and meets the needs of Asian and US markets and extends the range of products containing SlimBiome\n\u00ae\nin the USA and Asia markets. This is part of a growing trend to incorporate science backed functional ingredients into everyday products.\"\n\"As the dynamics continue to change in the weight management industry, brought about by the anti-obesity drugs, SlimBiome\n\u00ae'\ns IP and human studies are meeting a developing market need for added functionality in weight management products. More specifically, following the launch of the anti-obesity drugs, natural non-drug alternatives to reduce hunger and cravings are actively being sought by consumers. This announcement demonstrates that the science and multiple human studies carried out on SlimBiome\n\u00ae\nis now attracting the interest of well-known health brands around the world.\"\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nAnna Dunphy\nMob: 07876 741 001\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nForward-Looking Statements\nCertain statements made in this a",
          "content_length": 7166
        },
        "ingested_at": "2026-01-21T02:42:53.348952Z"
      },
      {
        "event_id": "RNS-15th Apr 2025-firstord",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348965Z",
        "source": "LSE_RNS",
        "data": {
          "title": "First order from US weight management brand",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/first-order-from-us-weight-management-brand-9x24mqlby6zak25.html",
          "rns_number": "RNS Number : 9670E",
          "full_content": "15 Apr 2025 07:00\nRNS Number : 9670E\nOptiBiotix Health PLC\n15 April 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nFirst order from leading US weight management brand\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces it has received its first order from a leading weight management brand in the United States of America (\"USA\").\nThe order is for SlimBiome\n\u00ae\nas an ingredient which will be incorporated into a range of flavoured drinks, similar to SlimBiome Medical, which reduces hunger. The products will be included in one of the USA's leading weight management brands. SlimBiome\n\u00ae\nhas undergone multiple human studies which show its ability to reduce hunger and food cravings which leads to lower calorie intake. OptiBiotix has been working with this brand for over 18 months to carry out human studies which allows the brand to make health claims of hunger control on its products in the USA. Scientifically substantiated health claims help to differentiate these products from others on the market. In the changing\nlandscape of this market, brought about by the anti-obesity drugs, consumers are actively looking for natural, science backed appetite support products. SlimBiome\n\u00ae\nmeets this developing trend.\nOptiBiotix expect further orders for a second product, a tablet containing SlimBiome\n\u00ae\n, within H1 2025. Whilst it is too early to understand the potential scale of the opportunity, this news is material in that it represents the inclusion of SlimBiome\n\u00ae\nin products of one of the USA's most popular weight management brands. Further information on the partner and brand will be announced on launch which the Company anticipates will be in H1 2025. However, the Company reminds investors that launch timescales are dictated by the brand owner and these can be subject to change.\nStephen O'Hara, CEO of OptiBiotix Health plc said\n: \"\nWe are pleased to announce the first order for the use of SlimBiome\n\u00ae\nin one of the USA's leading weight management brands. The use of SlimBiome\n\u00ae\nhas allowed the brand to make health claims of hunger control on its products which differentiate them from other products on the market. We anticipate more orders and product launches with this brand as it extends the range of products containing SlimBiome\n\u00ae\nin the USA market in 2025.\n\"Following the launch of the anti-obesity drugs, natural non-drug alternatives to reduce hunger and cravings are actively being sought by consumers. This announcement demonstrates that the science and multiple human studies carried out on SlimBiome\n\u00ae\nis now attracting the interest of major brands around the world.\"\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nAnna Dunphy\nMob: 07876 741 001\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCIIMATMTIBBAA",
          "content_length": 4929
        },
        "ingested_at": "2026-01-21T02:42:53.348978Z"
      },
      {
        "event_id": "RNS-7th Apr 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.348990Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-rc85n98bwenip9o.html",
          "rns_number": "RNS Number : 9972D",
          "full_content": "7 Apr 2025 17:34\nRNS Number : 9972D\nSkinBioTherapeutics PLC\n07 April 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BF33H870\nIssuer Name\nSKINBIOTHERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights\n3. Details of person subject to the notification obligation\nName\nOptibiotix Health plc\nCity of registered office (if applicable)\nYork\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n31-Mar-2025\n6. Date on which Issuer notified\n07-Apr-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n8.460000\n0.000000\n8.460000\n19600000\nPosition of previous notification (if applicable)\n9.580000\n0.000000\n9.580000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nOrdinary\n19600000\n8.460000\nSub Total 8.A\n19600000\n8.460000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n07-Apr-2025\n13. Place Of Completion\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLIRMFTMTJMBTA",
          "content_length": 3814
        },
        "ingested_at": "2026-01-21T02:42:53.349002Z"
      },
      {
        "event_id": "RNS-18th Mar 2025-commerci",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349015Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Commercial Update",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/commercial-update-32f0sa5c2an5l83.html",
          "rns_number": "RNS Number : 0159B",
          "full_content": "18 Mar 2025 07:00\nRNS Number : 0159B\nOptiBiotix Health PLC\n18 March 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nCommercial Update\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, provides the following unaudited commercial update for the financial year ended 31 December 2024.\nWe are pleased to report good progress on all our main strategic objectives set out for 2024 which were:-\n\u00b7\nincreasing our number of partners and sales in our key target markets of the USA and Asia;\n\u00b7\ninvesting in e-commerce channels to increase direct-to-consumer sales;\n\u00b7\ngrowing our sales of final branded and white label products containing our ingredients to deliver a dual income stream.\nThe strong sales momentum re-established after management changes in 2023 has continued, with \u00a31,004,266 orders (56% increase) placed by the end of 2024 of which \u00a3869,507 (35% increase) were delivered in 2024 with the difference (\u00a3134,759) taken forward into 2025. Sales orders for Q1 2025 have already passed sales orders for H1 2024 with a number of weeks to go and are a record start to the year. We are pleased that the 48 metric tonnes of stock purchased during the Covid years in 2020/2021 by Maxum in Australia and the 16 metric tonnes of stock held by Cambridge Commodities has now been cleared. We are also pleased that Brenntag, a \u20ac9.2bn specialist ingredient and pharmaceutical supplier has now replaced Maxum as our SlimBiome\n\u00ae\ndistributor in Australia and will also supply Asia going forward. This large stock overhang has had two effects: despite growing sales from these partners to their customers (Optipharm, H&B) this has not been fully recognised in our 2024 accounts, secondarily, OptiBiotix bought back some of this stock in 2023 and 2024 at the original sale price to supply its customers in Asia, Europe, and the USA and this has temporarily impacted on margins (as we are buying back stock from a partner and reselling at a small increase). Now this stock overhang has been cleared t\nhe Company should see an increase in gross margins and sale revenues from SlimBiome to these partners in 2025.\nOverview\nJust under half of sales in 2024 were from Ecommerce with India and B2B ingredients sales in Europe and Asia making up just under 40%. License fees received accounted for over 10% with a small percentage of sales from the USA. We anticipate India and the USA to make increased contributions in 2025 as we include full year sales from Morepen and Amazon India and we bring on a number of new customers from the USA. The first of these is the Daily Nouri FeelFull lemonade product which has shown strong early sales with excellent reviews and a high ranking on Amazon USA\nhttps://www.amazon.com/Nouri-Prebiotic-Microbiome-Metabolic-Packs-Take/dp/B0DTBRCQTL\n. We are also pleased to report strong sales growth with Morepen in India. Nouri and Morepen have already placed repeat orders in Q1 2025 and we have received a number of new orders from Asia. This has contributed to record orders at the start of 2025.\nThe last year has seen a significant change in industry and consumer awareness of the impact of reducing hunger and cravings on weight management, something OptiBiotix first reported in consumer studies on its SlimBiome\n\u00ae\nproduct in 2016 (RNS: 6 September 2016). SlimBiome's\n\u00ae\nability to reduce hunger and cravings has now been confirmed in a number of independent human studies and published in peer reviewed journals. This has allowed health claims for reduced hunger and cravings to be made in markets around the world which has been important in differentiating our products in a crowded market. This has led to us attracting partners who are willing to invest significant amounts in advertising to quickly grow market share. In previous years, partners have been reluctant to invest in marketing as they felt this was educating the consumer and wouldn't lead to a high return on investment. This has now changed with the anti-obesity drugs increasing consumer awareness about the benefits of reducing hunger in weight management.\nThe Company now has approved health claims, a broad IP portfolio, a network of manufacturing and distribution partners, and is growing its brand in multiple markets around the world. Whilst building sales in multiple international markets takes longer than just building sales in home markets it reduces the risk of our products being copied in other territories and builds the potential for multiple revenue streams. This creates the foundations for a substantial global business in the years ahead.\nThe Company is at a significant point with its second-generation products with discussions ongoing with a number of major partners, including two well-known brands of popular beverages, which we hope will lead to material news flow in the near future. These brands are interested in",
          "content_length": 18051
        },
        "ingested_at": "2026-01-21T02:42:53.349030Z"
      },
      {
        "event_id": "RNS-18th Feb 2025-launchof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349044Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Launch of Daily Nouri FeelFull product in America",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/launch-of-daily-nouri-feelfull-product-in-america-hg337uro44iaoo7.html",
          "rns_number": "RNS Number : 4226X",
          "full_content": "18 Feb 2025 07:00\nRNS Number : 4226X\nOptiBiotix Health PLC\n18 February 2025\nOpt\ni\nB\ni\not\ni\nx Heal\nth p\nlc\n(\n\"\nOpti\nBi\not\ni\nx\"\nor the\n\"\nCompany\n\")\nLaunch of Daily Nouri FeelFull product in America\nSlimBiome\u00ae\ncontaining finished products\nOptiBi\no\ntix Health plc (AIM\n:\nOPT\nI\n), a life sciences business de\nv\nel\no\nping co\nm\np\no\nunds to tac\nk\nle\no\nbesit\ny\n, high cholest\ne\nr\no\nl, diabe\nt\ne\ns and skincare,\nannounces the launch of FeelFull, containing SlimBiome\u00ae, by Daily Nouri (\"Nouri\") in the United States of America (USA).\nDaily Nouri is a well-known brand in the USA known for its science-backed, clinically supported probiotic and prebiotic solutions which impact on gut health.\nNouri sell their products in their online store (\nwww.\ndailynouri.com\n),\non Amazon, and in stores of some of the largest retailers in the USA such as Walmart and Albertsons\n.\nFeelFull is a prebiotic lemonade drink containing SlimBiome\n\u00ae formulated by Nouri which has been created \"\nto help\nconsumers regulate appetite, curb cravings, and support metabolic health by increasing viscosity in the stomach, slowing gastric emptying, and stabilising blood sugar levels to create a feeling of fullness and help satiate overall desire for food intake.\".\nThe lemonade is a powdered drink in portable stick packs which can be mixed with water with 'on pack' health claims which state daily use supports 'reduced appetite and cravings' and a 'feeling of fullness' derived from OptiBiotix's multiple clinical studies. 'On pack' health claims are important in differentiating products in the weight management market and are an area of high consumer interest since the launch of the appetite reducing anti-obesity drugs. Nouri forecast a requirement for ten metric tons of SlimBiome\n\u00ae\nin year one.\nStephen O'Hara, CEO of Opt\ni\nB\ni\not\nix\n,\nc\nommented\n:\n\"Nouri\nis a well-known and respected brand in the USA with an online presence and products in major retailers like Walmart and Albertsons, the second largest supermarket in the USA. This initial launch is for a FeelFull lemonade product with the potential for further products within the FeelFull range depending on sales progress. This launch represents a step forward for the Company's products in the USA market and the first of a number of launches planned with partners across the USA.\n\"With recent product launches in India (Morepen, Amazon), China, large parts of Asia (Philippines, Vietnam, Indonesia, Malysia and Thailand) and now the USA, the Company is growing its brand presence in international markets around the world. This global approach, whilst taking longer than a single market approach but with greater upside, has the potential to create multiple revenue streams and build a substantial global business in the years ahead.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nForward-Looking Statements\nCertain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to ",
          "content_length": 6512
        },
        "ingested_at": "2026-01-21T02:42:53.349057Z"
      },
      {
        "event_id": "RNS-20th Jan 2025-launchof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349070Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Launch of products on Amazon India",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/OPTI/launch-of-products-on-amazon-india-qmqvjw1wiis5ss8.html",
          "rns_number": "RNS Number : 8336T",
          "full_content": "20 Jan 2025 07:00\nRNS Number : 8336T\nOptiBiotix Health PLC\n20 January 2025\nOpt\ni\nB\ni\not\ni\nx Heal\nth p\nlc\n(\n\"\nOpti\nBi\not\ni\nx\"\nor the\n\"\nCompany\n\")\nLaunch of products on Amazon India\nOptiBi\no\ntix Health plc (AIM\n:\nOPT\nI\n), a life sciences business de\nv\nel\no\nping co\nm\np\no\nunds to tac\nk\nle\no\nbesit\ny\n, high cholest\ne\nr\no\nl, diabe\nt\ne\ns and skincare,\nannounces the launch of multiple SlimBiome\u00ae containing products under OptiBiotix's GoFigure\u00ae brand on Amazon India.\nIndia is already the most populous nation on Earth, anticipated to have the world's largest cohort of medium to high level income consumers by 2035. With obesity prevalence currently measured at 40.3%, India represents a huge area of opportunity for weight management products.\nOptiBiotix's wholly owned subsidiary, OptiBiotix India, will sell GoFigure\n\u00ae\nproducts via Amazon and continue to sell in store through Apollo Pharmacies and Apollo's own website across India as part of a multi-channel approach. Launching meal replacement and flavoured shots on Amazon India is part of a planned strategy to invest in high growth markets and increase final product sales to customers through ecommerce channels. This multichannel approach complements our core business-to-business activities by raising the awareness of SlimBiome\u00ae containing products across multiple channels and partners.\nThe Amazon India launch has coincided with a rebrand of packaging and relaunch with Apollo pharmacies. The new packaging is more colourful allowing it to stand out and Tata's\nFossence\u00ae branding is more\nprominent on pack. The Gofigure\n\u00ae\nproducts are made in India by local manufacturers and include ingredients such as\nTata's proprietary\nFossence\u00ae which bring the assurance and familiarity of a branded ingredient from a well-known and respected local source to the attention of Indian consumers.\nStephen O'Hara, CEO of Opt\ni\nB\ni\not\nix\n,\nc\nommented\n:\n\"Launching products on Amazon India\nis another step forward in building a presence for the Company's products in the strategically important Indian market. We are now building SlimBiome's\u00ae presence across India via our own brand products through Amazon India and via Apollo pharmacies, and as private label partnerships following the recent launch by Dr Morepen. This initial launch will include four products with subsequent launches taking place throughout 2025 dependent on sales progress.\"\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis communication is a \"Reach\" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRAUBVVRVAUAAAR",
          "content_length": 4783
        },
        "ingested_at": "2026-01-21T02:42:53.349083Z"
      },
      {
        "event_id": "RNS-8th Jan 2025-director",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349095Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Directorate Change",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/directorate-change-fpzr58yfr8n4rd9.html",
          "rns_number": "RNS Number : 4568S",
          "full_content": "8 Jan 2025 07:00\nRNS Number : 4568S\nOptiBiotix Health PLC\n08 January 2025\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\nDirectorate change\nOptiB\ni\not\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n: O\nP\nTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare\n,\na\nnn\no\nun\nces that, further to the announcement on 23 October 2024, David Blain has been appointed to the Board as Finance Director and Company Secretary effective from 7 January 2025\n.\nDavid is a member of the Institute of Chartered Accountants in England & Wales and has extensive financial, commercial and Board experience in a number of private and public companies, including Iksuda Therapeutics Ltd, Applied Graphene Materials plc, Nanoco Group plc and Inspired Capital plc (formerly Renovo Group plc). Mr Blain is currently Financial Director (non-board position) at Iksuda Therapeutics Ltd.\nDavid's appointment to this part-time role will see him work closely with the OptiBiotix team to support the\nfocus on driving each business unit and the Group to profitability.\nPursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of David Jonathan Blain (aged 63):\nCurrent Directorships\nPrevious Directorships held in the past five years\nBlain Associates Limited\nApplied Graphene Materials Limited (formerly Applied Graphene Materials plc)\nApplied Graphene Materials LLC\nApplied Graphene Ventures Limited\nUniversal Matter GBR Ltd (formerly Applied Graphene Materials UK Limited)\nDavid Blain does not hold any ordinary shares, options or warrants over new ordinary shares in the Company.\nThere is no further information regarding David Blain required to be disclosed under the AIM Rules.\nStephen O'Hara, CEO of OptiBiotix commented:\n\"\nWe are pleased to confirm the\nappointment of David as Finance Director and Company Secretary. The appointment reflects the Board's focus on managing costs and building revenues to create profitable business units and an international business with well-known global brands.\"\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Joint Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nBOAZDLFBEFLEBBK",
          "content_length": 4232
        },
        "ingested_at": "2026-01-21T02:42:53.349131Z"
      },
      {
        "event_id": "RNS-20th Dec 2024-issueofo",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349146Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Issue of Options",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/issue-of-options-lf0ppez135u9osc.html",
          "rns_number": "RNS Number : 9600Q",
          "full_content": "20 Dec 2024 12:00\nRNS Number : 9600Q\nOptiBiotix Health PLC\n20 December 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\nIssue of Options and Related Party Transaction\nOptiB\ni\not\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n: O\nP\nTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare\n,\na\nnn\no\nun\nces that, the Company has issued 6,099,135 options over new ordinary shares with an exercise price of 16 pence per share (\"New Options\") to Stephen O'Hara, CEO of the Company. The New Options expire on 17 December 2034 and vest on the first anniversary of the options being granted being 17 December 2025.\nThe issue of the New Options follows the expiration of 6,099,135 options over new ordinary shares with an exercise price of 8 pence per share, granted to Stephen O'Hara, which expired in September 2024.\nRelated Party Transaction\nThe issuance of the New Options to Stephen O'Hara (\"Transaction\") is a related party transaction pursuant to Rule 13 of the AIM Rules.\nThe directors of the Company independent of the Transaction, having consulted with the Company's nominated adviser, Cairn Financial Advisers LLP, consider the terms of the Transaction to be fair and reasonable insofar as the Company's shareholders are concerned.\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Joint Broker)\nTel: 020 7220 9797\nDuncan Vasey/ Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nNotification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014\n1\nDetails of the person discharging managerial responsibilities/person closely associated\na.\nName\nStephen O'Hara\n2\nReason for notification\na.\nPosition/Status\nDirector\nb.\nInitial notification/\nAmendment\nInitial Notification\n3\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\na.\nName\nOptiBiotix Health Plc\nb.\nLEI\n213800UKYQFT941QHS14\n4\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\na.\nDescription of the financial instrument, type of instrumentIdentification Code\nOptions over new ordinary shares of 2p each\nISIN: GB00BP0RTP38\nb.\nNature of the transaction\nIssue of options pursuant to the New Options\nc.\nPrice(s) and volume(s)\nPrice(s) per share\nVolume(s)\n16p\n6,099,135\nd.\nAggregated information\n-\nVolume\n-\nPrice\ne.\nDate of the transaction\n17 December 2024\nf.\nPlace of the transaction\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nDSHFELFFSELSEDE",
          "content_length": 4676
        },
        "ingested_at": "2026-01-21T02:42:53.349159Z"
      },
      {
        "event_id": "RNS-12th Dec 2024-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349172Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-c70e5or7ldf5v6f.html",
          "rns_number": "RNS Number : 9122P",
          "full_content": "12 Dec 2024 14:45\nRNS Number : 9122P\nSkinBioTherapeutics PLC\n12 December 2024\nTR-1: Standard form for notification of major\nholdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are\nattached:\nSkinBioTherapeutics plc\nCompany No: 09632164 (England)\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if\nappropriate)\nNon-UK\nissuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an\n\"X\")\nAn acquisition or disposal of voting\nrights\nX\nAn acquisition or disposal of financial\ninstruments\nAn event changing the breakdown of voting\nrights\nOther (please\nspecify):\n3. Details of person subject to the notification\nobligation\nName\nOptibiotix Health PLC\nCity and country of registered office (if\napplicable)\nYork (UK)\n4. Full name of shareholder(s)\n(if different from\n3.)\nName\nCity and country of registered office (if\napplicable)\n5. Date on which the threshold was crossed or reached:\n10 December 2024\n6. Date on which issuer notified\n(DD/MM/YYYY):\n12 December 2024\n7. Total positions of person(s) subject to the notification\nobligation\n% of voting rights attached to shares (total of 8. A)\n% of voting rights through financial\ninstruments\n(total of 8.B 1 + 8.B\n2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n9.58%\n9.58%\n21,884,389\nPosition of previous notification (if\napplicable)\n10.92%\n10.92%\n24,940,639\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nA: Voting rights attached to\nshares\nClass/type of\nshares\nISIN code (if\npossible)\nNumber of voting\nrights\n% of voting\nrights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nOrdinary\n21,884,389\n9.58%\nSUBTOTAL 8.\nA\n21,884,389\n9.58%\nB 1: Financial Instruments according to DTR5.3.1R (1)\n(a)\nType of financial\ninstrument\nExpiration\ndate\nx\nExercise/\nConversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting\nrights\nSUBTOTAL 8. B\n1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1)\n(b)\nType of\nfinancial instrument\nExpiration\ndate\nx\nExercise/ Conversion\nPeriod\nxi\nPhysical or\ncash\nSettlement\nxii\nNumber of voting rights\n% of voting\nrights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the applicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or\nthe\nfinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)\nxiv\nName\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable\nthreshold\nTotal of both if it equals or is higher than the notifiable\nthreshold\n10.\nIn case of proxy voting, please\nidentify:\nName of the proxy\nholder\nThe number and % of voting rights\nheld\nThe date until which the voting rights will be\nheld\n11. Additional\ninformation\nPlace of\ncompletion\nLondon\nDate of\ncompletion\n11 December 2024\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLTTBITMTIBBTI",
          "content_length": 4390
        },
        "ingested_at": "2026-01-21T02:42:53.349185Z"
      },
      {
        "event_id": "RNS-3rd Dec 2024-launchof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349197Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Launch of Dr Morepen LightLife in India",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/launch-of-dr-morepen-lightlife-in-india-rpy4bbm2vyuo52o.html",
          "rns_number": "RNS Number : 4801O",
          "full_content": "3 Dec 2024 07:00\nRNS Number : 4801O\nOptiBiotix Health PLC\n03 December 2024\nOpt\ni\nB\ni\not\ni\nx Heal\nth p\nlc\n(\n\"\nOpti\nBi\not\ni\nx\"\nor the\n\"\nCompany\n\")\nLaunch of Dr Morepen LightLife in India\nSlimBiome\u00ae\ncontaining finished products\nOptiBi\no\ntix Health plc (AIM\n:\nOPT\nI\n), a life sciences business de\nv\nel\no\nping co\nm\np\no\nunds to tac\nk\nle\no\nbesit\ny\n, high cholest\ne\nr\no\nl, diabe\nt\ne\ns and skincare,\nannounces the upcoming launch of multiple SlimBiome\u00ae containing products under Dr Morepen's (\"Morepen\") newly developed LightLife brand in India. This is being supported by a \u00a31.5million+ marketing investment and follows on from the partnership agreement signed with Morepen in\nMarch 2024\nfor the sale of SlimBiome\n\u00ae\ncontaining products in India.\nDr Morepen Ltd is a 100% owned subsidiary of Morepen Laboratories Ltd (\"Morepen Laboratories\"), an Indian pharmaceutical company listed on the Indian Stock Exchange. Morepen Laboratories has more than 2,300 employees and sells over 800 products to over 82 countries. Morepen is a well-known and trusted brand in India, launched in 2001 to encourage customers to be in charge of their own health and wellbeing. Morepen has direct access to over 200,000 pharmacies across India and indirect access to another 300,000 pharmacies. Products will be sold online, in pharmacies, and direct to physicians across India.\nMorepen's launch will include five flavoured variants of SlimBiome\u00ae containing sachets and a meal replacement with further products to be added during Q1 2025 and throughout the year. The LightLife brand will be positioned as India's first 360\n\u00b0 weight management plan. As part of this launch, Morepen will be providing personalised nutrition plans, expert nutrition and expert fitness counselling which will be available to LightLife consumers via a newly developed app. This has been designed to offer support to consumers throughout their weight loss journey by offering free app videos and content with specifically tailored plans for individuals.\nThis is the first time OptiBiotix has co-invested in marketing with a partner on this scale and includes a significant and comprehensive marketing plan and budget of \u00a31.5m+. This will include significant use of influencers, PR, and numerous digital marketing activities and strategies with the aim of rapidly gaining a significant market share. The products will be sold on Morepen's website, across all major online ecommerce platforms in India and will be available in 5,000+ pharmacies across all key cities in India within the first year of launch.\nObesity is a significant and rapidly growing issue across India, expected to worsen as India's middle class continues to grow. According to the Indian National Family Health Survey (NFHS-5) 2019-2021, around 23% of Indian men and 24% of Indian women are overweight or obese, leading to cardiovascular, diabetes, respiratory and knee joint health issues. Morepen estimate the target market for LightLife in India to be approximately 197 million adults.\nRevenues will be both generated through raw material sales of SlimBiome\u00ae to our contract manufacturer KAG Industries (RNS: 30 April 2024) and as a second larger revenue stream for the finished product sold direct to Morepen.\nStephen O'Hara, CEO of Opt\ni\nB\ni\not\nix\n,\nc\nommented\n:\n\"\nMorepen is an established, well known, and trusted brand and this launch represents a material step forward for the Company's products in the Indian market. This initial launch will involve six products with subsequent launches at the start of 2025.\n\"\nBased on Morepen's current forecasts, this agreement could contribute in the region of\n\u00a3\n6-7 million revenue per annum to OptiBiotix in the next four to five years. The partnership has the potential to make a significant financial impact to the Company. We are very excited to announce the upcoming launch and look forward to seeing the progress following the investments Morepen has made in marketing, product development and in supporting customers to reach their weight management goals. We are pleased to be part of such an innovative approach which sets a new benchmark for the weight management industry.\"\nVarun Suri, CEO of Dr Morepen commented:\n\"\nWe see the partnership between Dr. Morepen and OptiBiotix as an important one and have high regard for the success OptiBiotix enjoys globally because of the science and functionality of the ingredient and trust in their brand. The upcoming launch of LightLife will be a first of its kind product in the Indian market and we have designed the products and the brand ethos to create a successful business and brand. The strategy teams, the PR partners and OptiBiotix India are all working in tandem to position the brand and the product as the most relevant in the lifestyle category of healthy weight management. We have top quality products with applications that complement the lifestyle of an urban Indian consumer and are excited for its future.\"\nThis announcement contains information which, prior to i",
          "content_length": 8701
        },
        "ingested_at": "2026-01-21T02:42:53.349211Z"
      },
      {
        "event_id": "RNS-30th Oct 2024-requisit",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349224Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Requisition update",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/requisition-update-n4x5hftzdtgvhxk.html",
          "rns_number": "RNS Number : 1251K",
          "full_content": "30 Oct 2024 07:00\nRNS Number : 1251K\nOptiBiotix Health PLC\n30 October 2024\n30 October 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nRequisition update\nOptiBiotix Health plc (AIM: OPTI) (\"OptiBiotix\") the life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, advises that in relation to the requisitioned general meeting of ProBiotix Heath plc (\"ProBiotix\" or \"PBX\") (the \"Requisitioned General Meeting\"), Peterhouse Capital Limited (\"Peterhouse\") has refused a request for consent from OptiBiotix to vote its shares at the Requisitioned General Meeting.\nOptiBiotix, ProBiotix and,\ninter alia\n, Peterhouse are party to a relationship agreement made when ProBiotix was spun out of OptiBiotix (the \"Relationship Agreement\"). The Relationship Agreement contains certain positive and negative covenants and includes a provision that restricts OptiBiotix from voting its shares on the appointment or removal of any director of the company without the consent of Peterhouse.\nPeterhouse have refused a request to allow OptiBiotix to vote their shares, stating:\n\"As Aquis Corporate Adviser to ProBiotix, Peterhouse believes that removing Steen Andersen as Chief Executive of the Company, without an identified replacement, is not in the best interests of the Company and its shareholders.\nAs Aquis Corporate Adviser to ProBiotix, Peterhouse believes that allowing OPTI and SOH to vote in favour of the Resolutions at the Requisitioned General Meeting would serve to further undermine the integrity and purpose of the already breached Relationship Agreement, to which Peterhouse is a party, and to further deprive ProBiotix of the freedom of action and freedom from interference that the Relationship Agreement was intended to provide.\"\nWe find these reasons less than compelling:\n(1) Had consent been granted and Mr Andersen removed as a director, we would have expected a sensible dialogue to find a replacement; it is not our role or intent to populate the ProBiotix board with persons nominated by ourselves. Further had consent been granted by Peterhouse, shareholders holding not less than 42% of the shares would be voting to implement the resolutions at the Requisitioned General Meeting, excluding the shareholding of Holdingselskabet of 29. Juni 2010 Aps., that accounts for more than 50% of the shares in ProBiotix held by shareholders who have a very different view of what is in their best interests, and, in our opinion, the best interest of all shareholders;\n(2) We fundamentally disagree that the integrity and purpose of the Relationship Agreement would be damaged or ProBiotix deprived of the freedom of action and freedom from interference; the purpose of the Requisitioned General Meeting it to remove directors who we consider have an agenda that is not in the best interests of shareholders as a whole; the Relationship Agreement requires us to keep independent directors in place but also to exercise our voting rights to ensure that the company is managed by the Directors for the benefit of shareholders as a whole. For all the reasons that we and Seneca Partners have previously given, we do not believe this to currently be the case and, as significant investors (which neither Peterhouse nor the independent directors are), we believe that our interests are far more aligned with shareholders generally.\nWe also note that Mr Anderson does not hold any shares or options in PBX which we believe does not align his interest with the interests of PBX shareholders.\nIn summary as we have explained previously, when Stephen O'Hara handed over to Steen Andersen as CEO in January 2023, the ProBiotix share price was 22.5p with a market cap of circa \u00a326m, today the share price is 5p and market cap circa \u00a38m (and has been as low as \u00a35m).\nBetween January 2023 and May 2024 when ProBiotix first approached us with a request to support delisting, there was virtually no news-flow from ProBiotix to allow shareholders to understand how the business was performing; this continued until the recent dilutive subscription had been announced.\nThe recent dilutive subscription was clearly in contemplation prior to the holding of the ProBiotix annual general meeting yet shareholders were not given any details or information when being asked to pass the enabling resolutions at the annual general meeting. Stephen O'Hara, a director of ProBiotix, was only told about the proposed subscription the evening prior to its intended announcement. Treating shareholders (and non-executive directors) in this way is not acceptable.\nWhilst we cannot vote given we are now subject to a Court order not to vote our shares, Stephen O'Hara, Neil Davidson and Sean Christie intend to vote in favour of the resolutions in respect of their aggregate holding of 6,479,783\nordinary shares in the capital of PBX representing 4.10% of the voting rights of PBX.\nFor all the reasons given above, we accordingly urge all PBX shareholders to ",
          "content_length": 7066
        },
        "ingested_at": "2026-01-21T02:42:53.349238Z"
      },
      {
        "event_id": "RNS-25th Oct 2024-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349251Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-wu14pxtevev1y3h.html",
          "rns_number": "RNS Number : 7444J",
          "full_content": "25 Oct 2024 16:29\nRNS Number : 7444J\nSkinBioTherapeutics PLC\n25 October 2024\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nSkinBioTherapeutics plc\nCompany No: 09632164 (England)\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nOptibiotix Health PLC\nCity and country of registered office (if applicable)\nYork (UK)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n16/10/2024\n6.\nDate on which issuer notified (DD/MM/YYYY):\n23/10/2024\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n10.92%\n10.92%\n24,940,639\nPosition of previous notification (if\napplicable)\n11.03%\n11.03%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nOrdinary\n24,940,639\n11.03%\nSUBTOTAL 8. A\n24,940,639\n11.03%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nLondon\nDate of completion\n23/10/2024\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLMABATMTTTBAI",
          "content_length": 4392
        },
        "ingested_at": "2026-01-21T02:42:53.349264Z"
      },
      {
        "event_id": "RNS-24th Oct 2024-totalvot",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349276Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Total Voting Rights",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/total-voting-rights-chk75mo1khc5jt5.html",
          "rns_number": "RNS Number : 3839J",
          "full_content": "24 Oct 2024 07:00\nRNS Number : 3839J\nOptiBiotix Health PLC\n24 October 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nTotal Voting Rights\nOptiB\ni\no\nt\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n:\nO\nP\nT\nI\n), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nv\ne\nl\no\np\ni\nn\ng c\no\nm\np\no\nu\nn\nd\ns to tac\nk\nl\ne\no\nb\nesi\nt\ny\n,\nh\ni\ng\nh chole\ns\nt\ne\nr\no\nl,\nd\nia\nb\ne\nt\ne\ns and skincare confirms that its issued share capital and total voting rights is 97,943,161.\nThis figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to issue a notification of their interest in, or of a change in their interest in the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.\nThe Company is aware that an invalid allotment of 3,125,000 shares (\"Invalid Allotment Shares\") was entered onto its register in August 2024. This allotment was made as a result of an administrative error by the Company. The Company is in the process of correcting this error. The Invalid Allotment Shares have not been notified to the market nor have they been admitted to trading on AIM.\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTVRBCBDGIXDDGSX",
          "content_length": 3222
        },
        "ingested_at": "2026-01-21T02:42:53.349289Z"
      },
      {
        "event_id": "RNS-23rd Oct 2024-director",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349301Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Directorate Change",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/directorate-change-8c37lq50oqoqgto.html",
          "rns_number": "RNS Number : 2080J",
          "full_content": "23 Oct 2024 07:00\nRNS Number : 2080J\nOptiBiotix Health PLC\n23 October 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nDirectorate change\nOptiBiotix Health plc (\"OptiBiotix\") announces that Graham Myers, Finance Director of the Company, has notified the Company that he will step down from the Board on 30 November 2024.\nDavid Blain will join the Company as acting Finance Director on 1 November 2024. Mr Blain's appointment to the Board of the Company will be subject to normal regulatory due diligence.\nDavid is a member of ICAEW and has extensive financial, commercial and Board experience in a number of private and public companies, including Iksuda Therapeutics Ltd, Applied Graphene Materials plc, Nanoco Group plc and Inspired Capital plc (formerly Renovo Group plc). Mr Blain is currently Financial Director (non-board position) at Iksuda Therapeutics Ltd.\nThe Company notes recent speculation in relation to the health of the Company's Chief Executive Officer Stephen O'Hara. Mr O'Hara is recovering after a short illness and expects to be back at work shortly.\nNeil Davidson, Chairman of OptiBiotix Health plc said:\n\"On behalf of the Board, I would like to thank Graham for his contribution to the Company over the last year and welcome David as we move to our next stage of growth.\"\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nBOAFLLLLZBLXFBD",
          "content_length": 3387
        },
        "ingested_at": "2026-01-21T02:42:53.349313Z"
      },
      {
        "event_id": "RNS-18th Oct 2024-response",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349327Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Response to Publication of Circular by ProBiotix",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/response-to-publication-of-circular-by-probiotix-1lv8dstw53cjhov.html",
          "rns_number": "RNS Number : 6829I",
          "full_content": "18 Oct 2024 07:00\nRNS Number : 6829I\nOptiBiotix Health PLC\n18 October 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nResponse to Publication of Circular by ProBiotix Health plc\nOptiBiotix Health plc (AIM: OPTI) (\"OptiBiotix\") the life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, notes that ProBiotix Health plc (\"PBX\") has announced that it has published a circular to shareholders (the \"Circular\") containing details of a requisitioned general meeting of PBX (the \"Requisitioned General Meeting\"). The Requisitioned General Meeting will be held at 10:00 a.m. on 1 November 2024 at the offices of BPE Solicitors LLP, St James House, St James Square, Cheltenham, GL50 3PR.\nThe provisions of the Companies Act 2006 restrict the requisitioner of the meeting to including a statement of 1,000 words with the requisition notice. Despite specifically referring to the Seneca statement in the PBX RNS as an appendix, the Seneca supporting statement was not included in the RNS. We recommend that all shareholders in PBX read the Seneca statement carefully (which is included in the appendix to this announcement). Seneca is an institutional shareholder committed to creating long term value for its own investors with a highly experienced investment committee; Seneca behaves in a very objective manner and would not be taking this action absent compelling and urgent measures being needed to be taken to avoid detriment to shareholders. The statement from Seneca Partners is included in the Circular but given the length of the rebuttal produced by PBX we are publishing our own reasons for supporting the action taken by Seneca Partners.\nFor all the reasons given below we urge shareholders in PBX to support the resolution and to vote in favour of the resolutions, which we intend to do in respect of our holding of 53,533,333 ordinary shares in the capital of PBX representing 33.85% of the voting rights of PBX. In addition, Stephen O'Hara, Neil Davidson and Sean Christie intend to vote in favour of the resolutions in respect of their aggregate holding of 6,479,783 ordinary shares in the capital of PBX representing 4.10% of the voting rights of PBX. We also note that Mr Anderson does not hold any shares or options in PBX which we believe does not align his interest with the interests of PBX shareholders.\nThe real agenda at PBX\nOn 7 May 2024, a virtual meeting took place between Mr Reynolds, Mr Anderson and the OptBiotix Board at the request of PBX. Mr Reynolds set out that because of a lack of liquidity in the AQSE market a recent PBX fundraise had failed. During the call OptiBiotix was informed that there was a Danish investor keen to make a substantial investment in the PBX business and was willing to be a long-term supporter. However, the investor (who we conclude to be Mr Bruhn-Petersen or his family office) did not want to invest into a business that was traded on AQSE. Mr Andersen and Mr Reynolds went on to propose this as justification for delisting and sought OptiBiotix's support for this course of action. Delisting would, of course, require a vote of the shareholders of PBX and given the interest of OptiBiotix at that time (and before the recent dilutive share issue) could only proceed if OptiBiotix was in agreement.\nThis suggested course of action prompted an outright refusal from OptiBiotix. OptiBiotix advised of its recent successful fundraise of \u00a31.35m by the Company and identified lack of market communication by Mr Andersen as the main reason for the failed PBX fundraise. OptiBiotix requested that PBX increase its news flow to potentially support the share price and build positive investor sentiment or at least to allow the market to track developments in the PBX business. We firmly believe that Mr Andersen was pursuing a strategy to suppress the share price to justify his preferred strategy of taking the company private. In 2023 PBX published just 2 business update releases in the whole year. In 2024, there were only 2 business related announcements prior to the announcement of the subscription with Mr Bruhn-Petersen and only one prior to OptiBiotix challenging the board of PBX to be more transparent with the market; by contrast the last 3 months have seen 3 positive news-flow announcements.\nPBX have stated that they started discussions with Mr Bruhn-Petersen in April 2024 (we believe that it was earlier than this). The discussions with Mr Bruhn-Petersen were not disclosed to the full board of PBX, with Mr O'Hara only being informed of the investment on the evening prior to its announcement. It is against this backdrop that Seneca are taking action that we support. It is the most appalling example of corporate governance to effectively conduct negotiations to bring in a new major shareholder in secret and to only inform all board members hours before announcing it. Shareholders in PBX are being asked to believe that Mr Bruhn rapidly made his inves",
          "content_length": 19007
        },
        "ingested_at": "2026-01-21T02:42:53.349341Z"
      },
      {
        "event_id": "RNS-10th Oct 2024-slimbiom",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349353Z",
        "source": "LSE_RNS",
        "data": {
          "title": "SlimBiome study update",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/slimbiome-study-update-ud786fq7932i8um.html",
          "rns_number": "RNS Number : 6136H",
          "full_content": "10 Oct 2024 07:00\nRNS Number : 6136H\nOptiBiotix Health PLC\n10 October 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nSlimBiome study update\nOptiB\ni\no\nt\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n:\nO\nP\nT\nI\n), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nv\ne\nl\no\np\ni\nn\ng c\no\nm\np\no\nu\nn\nd\ns to tac\nk\nl\ne\no\nb\nesi\nt\ny\n,\nh\ni\ng\nh chole\ns\nt\ne\nr\no\nl,\nd\nia\nb\ne\nt\ne\ns and skincare,\nannounces further positive study results.\nThe Company has completed a fourth human study on SlimBiome\u00ae, which followed recommended industry guidelines and was designed to investigate the acute impact of a single dose of\u00a0SlimBiome\u00ae\u00a0in the presence of 50g sugar (12 teaspoons) on 20 overweight volunteers on their glycaemic response, hunger, and cravings. Feelings of hunger, fullness, desire to eat, and amount of food desired were assessed at 0, 75 and 150min using the visual analogue scale, a validated questionnaire used in nutrition research to assess appetite and food intake.\nThe researchers at the Brunel University of London reported results showing significant impact on multiple parameters important to appetite and hunger regulation including: -\n\u00b7\nA statistically significant reduction (26.85%) in hunger (p=0.007) with the intake of SlimBiome\u00ae\n\u00b7\nParticipants were approximately seven times less hungry when taking SlimBiome\u00ae compared to sugar\n\u00b7\nA statistically significant increase (46.9%) in fullness compared to baseline (p=0.009)\n\u00b7\nParticipants were approximately two times fuller when taking SlimBiome\u00ae compared to sugar\nNo safety, compliance, or tolerance issues were reported by volunteers. The results of this study are aligned with the Company's earlier study on the acute impact of SlimBiome\u00ae in healthy weight volunteers and provide further evidence of the ability of a single dose of SlimBiome\u00ae to moderate the impact of the ingestion of a large amount of sugar on appetite related parameters and support fullness. Researchers at the University of Nottingham report that in stomach simulation laboratory experiments, SlimBiome resulted in a six-fold increase in viscosity when taken with sugar and in a 9.6-fold increase in viscosity when taken with a meal replacement which is related with the ability of SlimBiome to support the feeling of fullness and reduce hunger.\nThe results are consistent with consumer feedback and customer product reviews who report feeling less hungry leading to reduced snacking and lower food intake leading to an average weight loss of 1.2kg per week.\nThese findings show SlimBiome\u00ae can have a role as a functional ingredient by itself as in SlimBiome Medical\u00ae, in meal replacements as in GoFigure\u00ae, or as part of a healthy snack in controlling hunger and desire to eat as part of a calorie controlled diet.\nStephen O'Hara, CEO of OptiBiotix Health plc commented:\n\"\nWe are delighted that this additional study of\nSlimBiome\u00ae\nhas further cemented its role as a functional ingredient either standalone or as part of a calorie controlled diet aimed at weight loss.\n\"Moreover, we note the recent positive trading update from ProBiotix Health. As the largest shareholder of ProBiotix Health, we are pleased to see their strong sales figures and balance sheet. In our interim results released in September, we also reported a significantly increased order book and solid sales performance for the first half of the year, and the strong strategic and commercial progress we achieved in this period has continued in the second half to date.\n\"We are confident that our strategy will deliver an improved sales performance for the rest of this year, and will continue in 2025, and look forward to demonstrating the long-term growth potential of the Group.\"\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the n",
          "content_length": 5737
        },
        "ingested_at": "2026-01-21T02:42:53.349368Z"
      },
      {
        "event_id": "RNS-27th Sep 2024-half-yea",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349380Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Half-year Report",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/half-year-report-lro6nk1h2psy4xn.html",
          "rns_number": "RNS Number : 8786F",
          "full_content": "27 Sep 2024 07:00\nRNS Number : 8786F\nOptiBiotix Health PLC\n27 September 2024\n27 September 2024\nHalf yearly Report\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\nHalf Year Report\nOptiB\ni\not\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n: O\nP\nTI), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nve\nl\no\np\ni\nn\ng c\no\nm\np\no\nu\nn\nd\ns to tack\nl\ne o\nb\nesi\nt\ny, cardiovascular disease,\nd\nia\nb\nete\ns and skincare,\na\nnn\no\nun\nces\nits unaudited results for the six months ended 30 June 2024.\nHighlights\n\u00b7\nSignificantly increased order book and\nsolid sales performance\n\u00b7\nReported revenues decreased by 21.3% to \u00a3276K (H1 2023: \u00a3351k), although sales orders received during the period were substantially higher than in H1 2023\n\u00b7\nStrong strategic and commercial progress achieved in the first half has continued in the second half to date\n\u00b7\nE-commerce sales increased three-fold\n\u00b7\nHealthy balance sheet with gross assets of \u00a38.0m (30 June 2023: \u00a39.9m), no debt and cash of \u00a31,263K (30 June 2023: \u00a3893K)\n\u00b7\nSuccessful placing to raise\n\u00a31,350,500 through the issue of 6,752,500 new ordinary shares of 2 pence each in the Company in March 2024\n\u00b7\nLaunch of\nLeanBiome\u00ae in Muscletech\u00ae,\na\nleading sports nutrition brand\n\u00b7\nPartnership agreement with Morepen for SlimBiome\u00ae containing finished products\n\u00b7\nManufacturing agreement with KAG Industries\n\u00b7\nRoehampton University submitting the results of a third human study on SlimBiome\u00ae for publication, which demonstrated statistically significant benefits to appetite and hunger regulation with no safety, compliance or tolerance issues reported by the participating volunteers. This study underlined the effectiveness of a single dose of SlimBiome\u00ae in delivering hunger-free weight loss by non-invasive means, and was timely in view of the growing consumer, media and pharmaceutical interest in this field\nStephen O'Hara, CEO of OptiBiotix Health plc said:\n\"\nThe fundamentals of our marketplace remain very exciting, with a range of recent market reports highlighting that products across the entire OptiBiotix portfolio have the potential to meet growing demand as solutions to a wide and increasing range of lifestyle-related health challenges. Given the excellent customer reviews, high customer return rates, multiple industry awards, and new customers launching products in key markets we believe there is a substantive opportunity to leverage market interest by increasing customer awareness of our products either directly through social media channels or indirectly through investing with our partners, and so build a successful and profitable business.\n\"The commercial traction we are now enjoying in our first-generation products with large partners in key markets, and the interest shown by other partners in our potentially industry-changing second-generation products, allows us to look to the future with a high degree of confidence. In the shorter term, based on orders already placed, we are also confident that full year revenues will be well ahead of those reported in 2023.\n\"With appetite suppression, gut health, sugar alternatives and modulation of the human microbiome all attracting ever-increasing interest, we believe that the Company is strongly placed to achieve profitability through growing sales of its now proven first-generation products, while progressing towards the commercialisation of our even more exciting second-generation products, SweetBiotix\u00ae and human microbiome modulators.\n\"We are confident that our strategy will deliver an improved sales performance for the rest of this year, and will continue in 2025, and look forward to demonstrating the long-term growth potential of the Group.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nForward-Looking Statements\nCertain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date o",
          "content_length": 36552
        },
        "ingested_at": "2026-01-21T02:42:53.349396Z"
      },
      {
        "event_id": "RNS-26th Sep 2024-response",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349410Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Response to Probiotix Health requisition notice",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/response-to-probiotix-health-requisition-notice-r1isosib5au8m44.html",
          "rns_number": "RNS Number : 7028F",
          "full_content": "26 Sep 2024 07:00\nRNS Number : 7028F\nOptiBiotix Health PLC\n26 September 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nProBiotix Health plc - response to requisition notice\nOptiBiotix Health plc (\"OptiBiotix\") notes the announcement made by ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, on 25 September 2024, that it has received a notice requisitioning a General Meeting (the \"\nRequisition Notice\n\") which has been served by Platform Securities Nominees Limited, on behalf of Seneca Partners.\nOptiBiotix is aware of the Requisition Notice and of the detailed reasons given by Seneca Partners for resorting to this course of action.\nOptiBiotix intends to vote its holding of 53,533,333 ordinary shares in support of the resolutions proposed by Seneca Partners and will publish its full reasons for supporting the proposals put forward by Seneca Partners in due course.\nIn the meantime, OptiBiotix believes that it is important that ProBiotix Health plc clarify its issued share capital which is stated to be 158,166,666 shares carrying voting rights in its announcement of 4 September 2024 but is stated to be 121,666,666 shares carrying voting rights on its website at\nhttps://probiotixhealth-ir.com/share-information/shareholder-information\n.\nNeil Davidson, Chairman of OptiBiotix Health plc said:\n\"I am sure that Seneca Partners have only taken this action as an institutional shareholder after much careful consideration and for good reason. Shareholder activism led by institutional shareholders is an important aspect of corporate governance and should generally be seen as an indication that serious failings have been identified which need to be addressed in the best interests of all shareholders.\"\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nRSPFLFITADIEFIS",
          "content_length": 3874
        },
        "ingested_at": "2026-01-21T02:42:53.349422Z"
      },
      {
        "event_id": "RNS-5th Sep 2024-probioti",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349435Z",
        "source": "LSE_RNS",
        "data": {
          "title": "ProBiotix Health plc Fundraise",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/probiotix-health-plc-fundraise-8yi5tz3xmyhbje9.html",
          "rns_number": "RNS Number : 0782D",
          "full_content": "5 Sep 2024 10:32\nRNS Number : 0782D\nOptiBiotix Health PLC\n05 September 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nProBiotix Health plc Fundraise\nOptiBiotix plc (\"OptiBiotix\") notes the announcement made by ProBiotix Health plc (AQSE: PBX) (\"ProBiotix\"), the life sciences business developing probiotics to support cardiometabolic health, on 4 September 2024, that it has raised \u00a31,226,400 through a share subscription (the \"Subscription\").\nThe shares comprised in the Subscription appear to be issued pursuant to an authority purported to be taken from shareholders by ProBiotix Health plc at its annual general meeting held on 8 August 2024. However, OptiBiotix legal advisors have advised the Company that resolution 6 set out in ProBiotix's notice of annual general meeting (which has still not been filed at Companies House in breach of section 30 of the Companies Act 2006) contains a fundamental error (which was not brought to the attention of, or corrected by the requisite majority at the annual general meeting) by cross referencing the conditionality of resolution 6 to the passing of \"Resolution 8\" (which did not exist). The special resolution is accordingly invalid in accordance with section 283(6)(c), Companies Act 2006. OptiBiotix will bring this defect to the attention of AQUIS.\nNeil Davidson, Chairman of OptiBiotix Health plc said:\n\"Given previous public statements of sufficient funds by ProBiotix, OptiBiotix were surprised at the timing and level of discount of the Subscription and its highly dilutive effect on long term investors. OptiBiotix's legal advisors have explained that, as a consequence of the invalidity of the special resolution purportedly passed at the 2024 annual general meeting, ProBiotix do not currently have the right to issue equity on a non pre-emptive basis given that the prior authority taken at the 2023 annual general meeting expired at the conclusion of the 2024 annual general meeting. OptiBiotix will bring this matter to the attention of AQUIS.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nIOEUPUGWBUPCUBA",
          "content_length": 4346
        },
        "ingested_at": "2026-01-21T02:42:53.349448Z"
      },
      {
        "event_id": "RNS-20th Aug 2024-commerci",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349460Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Commercial update",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/commercial-update-gmo3momqt3qpcip.html",
          "rns_number": "RNS Number : 9946A",
          "full_content": "20 Aug 2024 07:00\nRNS Number : 9946A\nOptiBiotix Health PLC\n20 August 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nCommercial update\nOptiBiotix Health plc (AIM: OPTI),\na li\nf\ne\nsc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nve\nl\no\np\ni\nn\ng c\no\nm\npounds\nto tack\nl\ne o\nb\nesi\nt\ny,\ncardiovascular disease\nand\nd\nia\nb\nete\ns,\nprovides\nthe following unaudited commercial update. This report provides a general update of sales progress on the areas of commercial focus for 2024. These are:-\n1. Increasing the number of partners and sales in the USA as the world's largest economy\n2. Increasing the number of partners and sales in Asia recognising its high growth rate and large and growing consumer markets with over 60% of the world's population, with China (1), India (2) and Indonesia (4) forecast to become three of the world's largest four economies by the 2050s\n3. Investing in e-commerce channels nationally, and subsequently internationally to drive direct-to-consumer sales, reducing reliance on retail partners and increase gross profit margins\n4.\nA trend towards selling more final branded or white label products which include the Company's ingredients to partners. This leads to\ntwo sales streams: the ingredient which goes in the final product and the finished product sale\nThis update will show progress in each of these areas and the investments in India and the USA starting to deliver larger partners in key strategic markets with large initial orders being placed and the potential for high volume sales.\nGeneral\nThe recovery of sales activity in 2023 has continued into the current year, helped by strong e-commerce sales, a number of new large partners placing large orders for final products including Dr Morepen in India, a NASDAQ listed USA e-commerce and direct selling company placing an order for a tomato soup final product, the launch of\nLeanBiome\u00ae in Muscletech\u00ae at the start of 2024, and continued growth in Asian markets. As these partners build their brands in their respective markets and grow sales they have the potential to\ntransform the business.\nSales orders for the first six months of the current year were under \u00a3600K approaching the FY 2023 reported revenue of\n\u00a3644K which was subsequently surpassed at the end of July 2024. These sales orders include confirmed orders received in the first six months of the year and are provided as a general update on progress. The figures will differ from reported revenue in the half year accounts to 30 June 2024, which under IFRS 15 accounting rules are only included when goods are accepted by the customer, even though prepayment may have been received. The difference reflects the success of attracting new overseas corporate partners who have ordered final product and the longer timescales this entails between placing an order for a new product launch and the customer receiving goods. Excluding milestone payments received in H2 2023, reported revenues in H1 2024 will be ahead of H2 2023.\nConsumer Health and Ecommerce\nOptiBiotix has made significant investments in its e-commerce business to drive direct-to-consumer sales as a strategic move to reduce reliance on retail partners and increase profit margins. The Consumer Health division has the advantage of receiving online sales income immediately and allows more control over the Company's brands and messaging whilst reducing reliance on distributors.\nThe Consumer Health division continues to grow rapidly during the year with sales to 30 June 2024 exceeding \u00a3200K, higher than the \u00a3185K achieved for the whole of 2023. The biggest contributor to sales was China, with OptiBiotix online and Amazon UK making up the rest with a roughly equal split with a small contribution from Amazon UAE which launched late in H1 2024. The change from TikTok to Tmall reported in the annual accounts has led to less sales as expected, but at a much lower marketing cost. OptiBiotix online, with much lower marketing costs, has returned a net profit every month in 2024 to date. Amazon UK has shown the highest growth rate but has been loss making every month in 2024, reflecting the investment in marketing to grow OptiBiotix's customer base on this platform. However, 25% of all Amazon customers pay by monthly subscription as repeat customers. As the Company grows its customer and subscriber base and increase sales from repeat purchases, marketing costs tend to reduce as a percentage of sales which is expected to lead to profitability.\nSlimBiome\u00ae remains among Amazon's top sellers for appetite suppressants and achieved record sales during Prime month in July 2024 and was awarded Amazon choice in Q1 2024.\nAfter waiting many months for a European VAT certificate, the Company can now sell through new Amazon channels in Germany with Amazon India expected to follow in late September or early October 2024. As OptiBiotix increases the number of countries it sells into via Amazon and optimises its product offering in different markets, the Board anticipates c",
          "content_length": 14023
        },
        "ingested_at": "2026-01-21T02:42:53.349475Z"
      },
      {
        "event_id": "RNS-8th Aug 2024-resultof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349487Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Result of AGM",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/result-of-agm-v7xf4s604r7m50e.html",
          "rns_number": "RNS Number : 7693Z",
          "full_content": "8 Aug 2024 12:29\nRNS Number : 7693Z\nOptiBiotix Health PLC\n08 August 2024\n8 August 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\nResult of AGM\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care\na\nnn\no\nun\nces that at the AGM held earlier today, all resolutions were duly passed.\nThe full voting results will be available on the website in due course here:\nhttps://www.optibiotix-ir.com/content/investors/\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nRAGPPMBTMTTMBPI",
          "content_length": 2588
        },
        "ingested_at": "2026-01-21T02:42:53.349499Z"
      },
      {
        "event_id": "RNS-8th Aug 2024-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349512Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-nedjt4ks28pyfsa.html",
          "rns_number": "RNS Number : 6182Z",
          "full_content": "8 Aug 2024 07:00\nRNS Number : 6182Z\nSkinBioTherapeutics PLC\n08 August 2024\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nSKINBIOTHERAPEUTICS PLC\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nX\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nOptibiotix Health Plc\nCity and country of registered office (if applicable)\nUK\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n07/08/2024\n6.\nDate on which issuer notified (DD/MM/YYYY):\n07/08/2024\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n11.03%\n11.03%\n24,940,639\nPosition of previous notification (if\napplicable)\n12.94%\n12.94%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BF33H870\n24,940,639\n11.03%\nSUBTOTAL 8. A\n24,940,639\n11.03%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nLondon\nDate of completion\n07/08/2024\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLPRMFTMTTMBJI",
          "content_length": 4356
        },
        "ingested_at": "2026-01-21T02:42:53.349524Z"
      },
      {
        "event_id": "RNS-30th Jul 2024-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349537Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-aqhw3huvwdv526c.html",
          "rns_number": "RNS Number : 3954Y",
          "full_content": "30 Jul 2024 10:03\nRNS Number : 3954Y\nOptiBiotix Health PLC\n30 July 2024\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nOptibiotix Health plc\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nFinance Yorkshire Seedcorn Fund (FYSCF)\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n25/07/2024\n6.\nDate on which issuer notified (DD/MM/YYYY):\n29/07/2024\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n4.81%\n4.81%\n4,713,314\nPosition of previous notification (if\napplicable)\n5.83%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BP0RTP38\n4,713,314\n4.81%\nSUBTOTAL 8. A\n4,713,314\n4.81%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nUK\nDate of completion\n29/07/2024\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLWPUPUMUPCUBU",
          "content_length": 4347
        },
        "ingested_at": "2026-01-21T02:42:53.349550Z"
      },
      {
        "event_id": "RNS-28th Jun 2024-finalres",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349562Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Final Results",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/final-results-42z3dn0910277o3.html",
          "rns_number": "RNS Number : 2397U",
          "full_content": "28 Jun 2024 07:00\nRNS Number : 2397U\nOptiBiotix Health PLC\n28 June 2024\n28 June 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\nFinal results\nNotice of Annual General Meeting\nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care\na\nnn\no\nun\nces its audited results for the 12 months ended 31 December 2023.\nHighlights\n\u00b7\nRevenue for the year of \u00a3644,000, a 41% increase over 2022 (\u00a3457,000). There were a further circa \u00a362k of sales orders received in December 2023 which were delivered in 2024 and carried forward into 2024 accounts.\n\u00b7\nA circa 30% reduction in administrative expenses (excluding non-cash items such as share-based payments and amortisation) to \u00a31.78m (2022: \u00a32.50m), reflecting cost saving measures, the removal of ProBiotix Health plc (PBX)'s costs after March 2022 and recovery of some of the doubtful debt provided in the 2022 accounts.\n\u00b7\nAn increase in sales of\nLeanBiome\u00ae to The Hut Group and\nsales of SlimBiome\u00ae to Holland & Barrett, albeit from a very low base in 2022.\n\u00b7\nAn increase in sales of\nSlimBiome\u00ae to Paradise Fruits, a German company producing gummies for Walmart and for sale online in China.\n\u00b7\nIncreased sales of our\nOptiBiome\u00ae\nprebiotic fibre (an alternative trademark to\nSlimBiome\u00ae) to\nOptipharm in Australia following the launch online of their Optislim and Optiman ready meal ranges incorporating a ready meal OptiBiome sprinkle and a significant new investment in marketing.\n\u00b7\nA reduction in\nstock: there was 13.9 metric tonnes of\nSlimBiome\n\u00ae\ntaken from stock held by two partners (Maxum and Cambridge Commodities) in 2023 compared to 2022 (up 39%) representing a value of approximately \u00a3417K based on retail price of \u00a330 per kg. Once this stock overhang is depleted, the Company should see sales of SlimBiome to these partners contributing to future revenues.\n\u00b7\nRecruiting four new partners for\nSlimBiome\u00ae in Asia through our partnership with Nutraconnect Pte, all of whom placed initial orders before the end of 2023 and which we expect to contribute revenues of \u00a3125,000 to \u00a3150,000 in 2024.\n\u00b7\nSecuring a license agreement with Tata Chemicals - part of the $300bn turnover Tata Group - to incorporate its proprietary\nFossence\u00ae into our SlimBiome\u00ae and WellBiome\u00ae products for the Indian market. This brings the assurance and familiarity of a branded ingredient from a well-known and trusted local source to the attention of Indian consumers.\n\u00b7\nReaching a new distribution agreement for\nSlimBiome\u00ae in Australia and New Zealand with Ravenswood Ingredients, part of the Brenntag group which is a global leader in specialised food ingredients.\n\u00b7\nOne of our partners, Optipharm, securing an international listing for products containing SlimBiome\u00ae with CostCo, the fifth largest retailer in the world.\n\u00b7\nOngoing discussions with a leading US corporate on a global launch of\nSlimBiome\u00ae in 2025 in multiple territories.\nPost period end\n\u00b7\nThe recovery in sales in 2023 has carried forward into 2024 with sales order in H1 approaching FY 2023.\n\u00b7\nLaunch of LeanBiome\n\u00ae\nin MuscleTech\n\u00ae, a leading sports nutrition brand.\n\u00b7\nPartnership agreement with Morepen for SlimBiome\u00ae containing finished products.\n\u00b7\nManufacturing agreement with KAG Industries in India.\n\u00b7\nRoehampton University submitting the results of a third human study on SlimBiome\u00ae for publication, which demonstrated statistically significant benefits to appetite and hunger regulation with no safety, compliance or tolerance issues reported by the participating volunteers. This study underlined the effectiveness of a single dose of SlimBiome\u00ae in delivering hunger-free weight loss by non-invasive means, and was timely in view of the growing consumer, media and pharmaceutical interest in this field.\n\u00b7\nSuccessful placing to raise\n\u00a31,350,500 through the issue of 6,752,500 new ordinary shares of 2 pence each in the Company in March 2024.\nThe Report & Accounts which will be shortly posted to shareholders contains a Notice of Annual General Meeting (\"AGM\") which will be held at 12 noon on 8 August 2024 at the offices of Peterhouse Capital Limited, 3rd Floor, 80 Cheapside, London EC2V 6EE.\nStephen O'Hara, CEO of OptiBiotix Health plc said:\n\"2023 was a year where we restructured the senior management team and focused on restoring sales growth through more active management of existing accounts, broadening our partner base by securing a number of new corporate partners in key strategic markets like the USA and Asia, and investing in ecommerce channels, while reducing operating costs. We continue to see sales momentum building in 2024 with our highest ever single order of over \u00a3200,000 and\nsales orders in H1 approaching FY 2023.\nWith appetite suppression, gut health, sugar alternatives, and modulation of the human microbiome attracting ever-increasing interest, w\ne look to the future with a high degree of confidence. With the Company's first generation products having multiple",
          "content_length": 109691
        },
        "ingested_at": "2026-01-21T02:42:53.349579Z"
      },
      {
        "event_id": "RNS-10th May 2024-investor",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349592Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Investor update",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/investor-update-dlhjck8r6wspsr1.html",
          "rns_number": "RNS Number : 8691N",
          "full_content": "10 May 2024 07:00\nRNS Number : 8691N\nOptiBiotix Health PLC\n10 May 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\n10 May 2024\nInvestor update\nOptiB\ni\not\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n: O\nP\nTI), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nve\nl\no\np\ni\nn\ng c\no\nm\np\no\nu\nn\nd\ns to tack\nl\ne o\nb\nesi\nt\ny, cardiovascular disease,\nd\nia\nb\nete\ns and skincare, a\nnnounces that Stephen O'Hara, CEO of OptiBiotix\u00a0will provide a live presentation to investors\u00a0via the Investor Meet Company platform on\u00a0Monday, 20 May 2024 at 2pm BST.\nStephen will use this opportunity to update investors on OptiBiotix's commercial progress and opportunity pipeline, and the Company's progress in e-commerce, and in the USA, and Asia, and plans for the launch of second generation products.\nThe presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.\nInvestors can sign up to Investor Meet Company for free and add to meet\u00a0OptiBiotix.\nTo register for the presentation, please use this link:\nhttps://www.investormeetcompany.com/optibiotix-health-plc/register-investor\nInvestors who already follow\u00a0OptiBiotix\u00a0on the Investor Meet Company platform will automatically be invited.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nThis communication is a \"Reach\" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRAQKCBKABKDKPK",
          "content_length": 3622
        },
        "ingested_at": "2026-01-21T02:42:53.349604Z"
      },
      {
        "event_id": "RNS-30th Apr 2024-manufact",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349617Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Manufacturing agreement with KAG Industries",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/manufacturing-agreement-with-kag-industries-8f5qimngnyie2nw.html",
          "rns_number": "RNS Number : 4745M",
          "full_content": "30 Apr 2024 07:00\nRNS Number : 4745M\nOptiBiotix Health PLC\n30 April 2024\nO\np\nt\ni\nB\ni\no\nt\ni\nx H\neal\nth p\nl\nc\n(\n\"O\np\nt\ni\nBi\no\nt\ni\nx\" or the \"Company\")\nManufacturing agreement with KAG Industries\nSupply of Slimbiome\u00ae in India as a finished product\nOptiB\ni\no\nt\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n:\nO\nP\nT\nI\n), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nv\ne\nl\no\np\ni\nn\ng c\no\nm\np\no\nu\nn\nd\ns to tac\nk\nl\ne\no\nb\nesi\nt\ny\n,\nh\ni\ng\nh chole\ns\nt\ne\nr\no\nl,\nd\nia\nb\ne\nt\ne\ns and skincare,\nannounces that its wholly owned Indian subsidiary, OptiBiotix Health India Private Limited (\"OHI\"), has signed a manufacturing agreement with KAG Industries (\"KAG\") for the supply of Slimbiome\n\u00ae\ncontaining products ready for sale. KAG have developed five flavours unique to the Indian market which will be sold by OHI to Dr Morepen, a well-known brand in India, launched in 2001 to encourage customers to be in charge of their own health and wellbeing.\nKAG is a specialised contract manufacturer of nutritional powders with its own research and development laboratories allowing it to create customised finished products for its clients. These include well known international companies like Unilever and well known and trusted Indian brands like Apollo and Dr Morepen. These clients require a high level of food industry accreditation including HACCP, GMP, FSSC 22000 certification.\nZeon Lifesciences Ltd will manufacture and supply the SlimBiome\n\u00ae\nin Dr Morepen products, creating a local manufacturing and sales base for ingredient and finished product. This would not be possible without having a physical presence in India.\nWith a population of 1.4 billion people and\nobesity\nprevalence at\n40.3% (\nhttps://journals.sagepub.com/doi/full/10.1177/0972753120987465\n), India is a market of strategic importance to OptiBiotix. The middle-class population in India is expected to reach\n475 million by 2030. Currently most middle-class consumers live in the European Union (EU) and the United States, but over the next decade, the majority will shift heavily toward India, with one in four global middle-class consumers expected to reside in India by 2035 (\nhttps://www.asianstudies.org/publications/eaa/archives/the-middle-class-in-india-from-1947-to-the-present-and-beyond/\n) representing a significant growth opportunity.\nThe appointment of KAG brings another well respected and established provider into the supply chain within India.\nS\nte\np\nhe\nn O'H\na\nr\na\n,\nC\nEO\no\nf\nO\np\nt\ni\nB\ni\no\nt\ni\nx\n,\nc\no\nm\nme\nn\nte\nd\n:\n\"We are pleased to announce this agreement with KAG to support the launch of SlimBiome\n\u00ae\ncontaining products with Dr Morepen, a well-known and trusted supplier to pharmacies, physicians, and retail customers across India. We look forward to the upcoming launch of products across India with Dr Morepen and our manufacturing partners.\"\nAnuj Agarwal, Chairman & Managing Director of KAG Industries, commented:\n\"\nDr Morepen boasts a rich legacy of over three decades, renowned for its expertise in developing reliable health products tailored for the Indian market. The collaboration between KAG, OHI and Dr Morepen signifies a promising endeavour, aiming to create mutually beneficial outcomes for all involved parties.\"\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nForward-Looking Statements\nCertain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known a",
          "content_length": 7017
        },
        "ingested_at": "2026-01-21T02:42:53.349631Z"
      },
      {
        "event_id": "RNS-15th Apr 2024-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349644Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-0smlx863ck3hypu.html",
          "rns_number": "RNS Number : 6093K",
          "full_content": "15 Apr 2024 08:49\nRNS Number : 6093K\nOptiBiotix Health PLC\n15 April 2024\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nOptibiotix Health plc\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nFinance Yorkshire Seedcorn Fund (FYSCF)\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n28/03/2024\n6.\nDate on which issuer notified (DD/MM/YYYY):\n09/04/2024\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n5.83%\n5,713,314\nPosition of previous notification (if\napplicable)\n6.27%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BP0RTP38\n5,713,314\n5.83%\nSUBTOTAL 8. A\n5,713,314\n5.83%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nUK\nDate of completion\n9/4/2024\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLGPUMCCUPCUMA",
          "content_length": 4340
        },
        "ingested_at": "2026-01-21T02:42:53.349657Z"
      },
      {
        "event_id": "RNS-25th Mar 2024-placing,",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349670Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Placing, Subscription and Director Dealing",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/placing-subscription-and-director-dealing-5eands3kw4w0ooy.html",
          "rns_number": "RNS Number : 0510I",
          "full_content": "25 Mar 2024 07:00\nRNS Number : 0510I\nOptiBiotix Health PLC\n25 March 2024\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\nPlacing, Subscription and Director Dealing\nOptiB\ni\not\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n: O\nP\nTI), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nve\nl\no\np\ni\nn\ng c\no\nm\np\no\nu\nn\nd\ns to tack\nl\ne o\nb\nesi\nt\ny, cardiovascular disease,\nd\nia\nb\nete\ns and skincare,\na\nnn\no\nun\nces it has raised in aggregate \u00a31,350,500 through the issue of 6,752,500 new ordinary shares of 2 pence each in the Company (\"Fundraise Shares\") at a price of 20 pence per share (\"Issue Price\") (together, the \"Fundraise\") handled by Peterhouse Capital Limited.\nThe Fundraise comprises a placing of 6,627,500 new ordinary shares at the Issue Price, raising gross proceeds of \u00a31,325,500 (the \"Placing\") and a subscription for 125,000 new ordinary shares at the Issue Price, raising gross proceeds of \u00a325,000, by Graham Myers, a director of the Company (the \"Subscription\").\nFollowing the Subscription, Graham Myers will be interested in 125,000 ordinary shares in the Company, representing 0.13 per cent. of the Company's issued share capital following Admission (as defined below).\nThe net proceeds of the Fundraise will be utilised to invest in driving sales growth by:-\n1. active account management of existing partners by co-investing in publicity, marketing, and promotions to increase sales;\n2. increased presence of the Company's stands at major exhibitions to attract new partners, particularly in the USA and India to mitigate dependency on a small number of partners;\n3. investing in marketing the Company's products to grow sales on e-commerce platforms in India, China, USA, Europe, and the Gulf States; and\n4. launch its second generation SweetBiotix and MicroBiome Modulator products.\nRelated Party Transaction\nThe participation of Graham Myers in the Subscription is a related party transaction pursuant to AIM Rule 13 (the \"Transaction\"). The directors independent of the Transaction, having consulted with the Company's nominated adviser, believe that the terms of the Transaction are fair and reasonable insofar as shareholders are concerned.\nAdmission\nApplication will be made to the London Stock Exchange to admit the 6,752,500 new Fundraise Shares to trading on AIM (\"Admission\"). Admission of the new Ordinary Shares is expected to occur on or around 28 March 2024. The new Ordinary Shares will rank\npari passu\nwith the existing Ordinary Shares.\nTotal Voting Rights\nFor the purpose of the Disclosure and Transparency Rules, following the issue of shares detailed above the enlarged issued share capital of the Company will comprise 97,943,161 ordinary shares of 2p each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.\nStephen O'Hara, CEO of OptiBiotix, commented:\n\"\nThe Company has made strong progress over the last 12 months with our first-generation products returning to sales growth, a number of well-known corporate partners reaching agreements (e.g. Tata, Brenntag, Morepen) and the launch of new products with major brands (MuscleTech, Dr Morepen) in new channels. We are also seeing growth of online sales, particularly in China, and the potential to replicate this success in other territories, such as India and the USA.\n\"More recently we have seen strong interest in SlimBiome from partners in the USA looking for a natural, clinically proven alternative to the anti-obesity drugs currently available. Given the scale of the opportunities\n, the Board has decided to raise additional capital to\ncapitalise on these growth opportunities and build shareholder value.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Joint Broker)\nTel: 020 7220 9797\nDuncan Vasey/ Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies ",
          "content_length": 8174
        },
        "ingested_at": "2026-01-21T02:42:53.349684Z"
      },
      {
        "event_id": "RNS-18th Mar 2024-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349696Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-ql5yk463p7d4zci.html",
          "rns_number": "RNS Number : 2571H",
          "full_content": "18 Mar 2024 11:36\nRNS Number : 2571H\nSkinBioTherapeutics PLC\n18 March 2024\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nSKINBIOTHERAPEUTICS PLC\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nx\nOther (please specify)iii:\n3. Details of person subject to the notification obligation\niv\nName\nOptibiotix Health Plc\nCity and country of registered office (if applicable)\nUK\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n12/03/2024\n6. Date on which issuer notified (DD/MM/YYYY):\n15/03/2024\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights of issuer\nvii\nResulting situation on the date on which threshold was crossed or reached\n12.94%\n24,940,639\nPosition of previous notification (if\napplicable)\n13.52%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(Art 9 of Directive 2004/109/EC) (DTR5.1)\nIndirect\n(Art 10 of Directive 2004/109/EC) (DTR5.2.1)\nDirect\n(Art 9 of Directive 2004/109/EC) (DTR5.1)\nIndirect\n(Art 10 of Directive 2004/109/EC) (DTR5.2.1)\n24,940,639\n12.94%\nSUBTOTAL 8. A\n24,940,639\n%\nB 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nsettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\nxiv\n(please add additional rows as necessary)\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nLondon\nDate of completion\n15/03/2024\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLJPMBTMTJBBFI",
          "content_length": 4516
        },
        "ingested_at": "2026-01-21T02:42:53.349709Z"
      },
      {
        "event_id": "RNS-13th Mar 2024-partners",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349722Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Partnership agreement with Morepen for SlimBiome",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/partnership-agreement-with-morepen-for-slimbiome-gfe9s2kbywmraug.html",
          "rns_number": "RNS Number : 5803G",
          "full_content": "13 Mar 2024 07:00\nRNS Number : 5803G\nOptiBiotix Health PLC\n13 March 2024\nO\np\nt\ni\nB\ni\no\nt\ni\nx H\neal\nth p\nl\nc\n(\n\"O\np\nt\ni\nBi\no\nt\ni\nx\" or the \"Company\")\nPartnership agreement with Morepen for SlimBiome\u00ae containing finished products\nOptiB\ni\no\nt\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n:\nO\nP\nT\nI\n), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nv\ne\nl\no\np\ni\nn\ng c\no\nm\np\no\nu\nn\nd\ns to tac\nk\nl\ne\no\nb\nesi\nt\ny\n,\nh\ni\ng\nh chole\ns\nt\ne\nr\no\nl,\nd\nia\nb\ne\nt\ne\ns and skincare,\nannounces it has signed a partnership agreement with Dr Morepen Ltd (\"Morepen\") for the sale of SlimBiome\n\u00ae\ncontaining products in India under the Dr Morepen brand.\nMorepen is a 100% owned subsidiary of Morepen Laboratories Ltd (\"Morepen Laboratories\"), an Indian pharmaceutical company listed on the Indian Stock Exchange.\nMorepen Laboratories has more than 2,300 employees and sells over 800 products to over 82 countries. Morepen is a well-known and trusted brand in India, launched in 2001 to encourage customers to be in charge of their own health and wellbeing. Morepen has direct access to over 200,000 pharmacies across India and indirect access to another 300,000 pharmacies. Products will be sold online, in store, and direct to physicians across India.\nS\nte\np\nhe\nn O'H\na\nr\na\n,\nC\nEO\no\nf\nO\np\nt\ni\nB\ni\no\nt\ni\nx\n,\nc\no\nm\nme\nn\nte\nd\n:\n\"We are pleased to announce this agreement with Morepen, a well-known and trusted supplier to pharmacies, physicians, and retail customers across India.\nMorepen brings an extensive sales team with experience of highly differentiated scientific products and countrywide access to a network of around 500,000 pharmacies across India. Based on current forecasts, the Directors anticipate this agreement could contribute in the region of \u00a36-7 million revenue per annum in the next four to five years.\"\nThe Directors of the Company are responsible for the release of this announcement.\nFor further information, please contact:\nOptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nContact via Walbrook below\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nPeterhouse Capital Limited (Broker)\nTel: 020 7220 9797\nDuncan Vasey / Lucy Williams\nWalbrook PR Ltd\nMob: 07876 741 001\nAnna Dunphy\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\nOptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.\nOptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.\nForward-Looking Statements\nCertain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance wi",
          "content_length": 5364
        },
        "ingested_at": "2026-01-21T02:42:53.349735Z"
      },
      {
        "event_id": "RNS-8th Mar 2024-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349748Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/holdings-in-company-x3yy2cyu2suw3zo.html",
          "rns_number": "RNS Number : 2231G",
          "full_content": "8 Mar 2024 16:09\nRNS Number : 2231G\nOptiBiotix Health PLC\n08 March 2024\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nOptibiotix Health plc\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nFinance Yorkshire Seedcorn Fund (FYSCF)\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n01/03/2024\n6.\nDate on which issuer notified (DD/MM/YYYY):\n06/03/2024\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n6.27%\n6.27%\n5,713,314\nPosition of previous notification (if\napplicable)\n7.77%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BP0RTP38\n5,713,314\n6.27%\nSUBTOTAL 8. A\n5,713,314\n6.27%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nX\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nUK\nDate of completion\n06/03/2024\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUPUMUWUPCGQR",
          "content_length": 4347
        },
        "ingested_at": "2026-01-21T02:42:53.349760Z"
      },
      {
        "event_id": "RNS-27th Feb 2024-strategi",
        "event_type": "rns_announcement",
        "date": "2026-01-21T02:42:53.349773Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Strategic and commercial update",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/strategic-and-commercial-update-xjm00z0q0ii4n3p.html",
          "rns_number": "RNS Number : 5131E",
          "full_content": "27 Feb 2024 07:00\nRNS Number : 5131E\nOptiBiotix Health PLC\n27 February 2024\nO\np\nt\ni\nB\ni\no\nt\ni\nx H\neal\nth p\nl\nc\n(\n\"O\np\nt\ni\nBi\no\nt\ni\nx\" or the \"Company\")\nStrategic and commercial update\nOptiB\ni\no\nt\ni\nx\nH\nealth\np\nl\nc (A\nI\nM\n:\nO\nP\nT\nI\n), a li\nf\ne sc\ni\nences\nbu\ns\ni\nn\ness\nd\ne\nv\ne\nl\no\np\ni\nn\ng c\no\nm\np\no\nu\nn\nd\ns to tac\nk\nl\ne\no\nb\nesi\nt\ny\n,\nh\ni\ng\nh chole\ns\nt\ne\nr\no\nl,\nd\nia\nb\ne\nt\ne\ns and skincare,\nprovides a strategic and commercial update.\nStrategic overview\nThe Company believes that the business is now at a strategic inflection point with first generation products gaining widespread acceptance in international markets with large partners and the imminent launch of second\ngeneration products affording potential for future sales growth and uplifts in shareholder value.\nThis update seeks to capture the progress made with first generation products since the restructuring of the management team in 2023 and maps out the opportunities for 2024.\nThe Company recognised the risk of bringing new technology and products in an unproven field, the microbiome, to a conservative global food and supplement market where uniformity and risk avoidance is fundamental and innovation and acceptance of new technology and products is notoriously slow. To mitigate this risk, it founded and developed three companies in the emerging microbiome field: OptiBiotix Health plc (OPTI), ProBiotix Health plc (\"PBX\" or \"ProBiotix\")) and SkinBioTherapeutics plc (\"SBTX\"). These have similar science but use different approaches to modify the microbiome and have different applications and markets. OptiBiotix develops prebiotic fibres which are largely sold as food supplements and nutraceuticals, ProBiotix develops probiotics which are sold as supplements, whilst SkinBioTherapeutics develop solutions to improve skin health. Spinning these companies out of the OptiBiotix Group plc through listings on the public markets creates a tangible asset which can be disposed of to provide investors a dividend, as with the \u00a310.25m dividend issued to OptiBiotix shareholders on the PBX listing in March 2022, or funds as with the \u00a35.4m worth of share sales in SBTX since listing. This means that OptiBiotix has no debt, a strong balance sheet, and multiple plays in different areas of the emerging microbiome space.\nIn addition to founding and developing three companies, OptioBiotix layered its development portfolio by\ncreating first generation products (\nprincipally\nSlimBiome\u00ae and subsequently WellBiome\u00ae in prebiotics and LPLDL\u00ae in probiotics)\nof relatively moderate development risk using existing science,\nwhilst in parallel developing more innovative second-generation products (SweetBiotix\n\u00ae, MicroBiome Modulators) that offer the potential for larger future returns.\nThis strategy allowed the Company to achieve\ncombined revenues of \u00a32.2m in 2021 with both the probiotic (now ProBiotix Health plc) and prebiotic trading businesses being EBITDA profitable in both years.\nWhilst global economic conditions temporarily impacted on progress during 2022\nwith high stock levels, lower retail footfall, and a lack of new product innovation in the industry, the last three quarters of 2023 have seen a gradual return to strong sales growth.\nCommercial update\nSince the restructuring of the management team in spring 2023 and Stephen O'Hara taking over commercial activities from Rene Kamminga, the Company has focussed on three main areas for sales growth:-\n1. more active management of existing key accounts to increase sales;\n2. increasing the number of partners, particularly in the USA and India to mitigate dependency on a small number of partners and;\n3. investing in e-commerce channels nationally, and subsequently internationally.\nThe Company reports progress in each of these areas below and how this may impact on future growth.\nActive management of existing key accounts\nThe Company is pleased to report progress on all of its key accounts in 2023 with unaudited sales reports showing:-\nI.\nSales of LeanBiome\n\u00ae\nto The Hut Group (\"THG\") 36.8% higher in 2023 than in 2022. THG's forecast for 2024 show a further 39% increase on 2023.\nII.\nHolland & Barrett sales up substantially, albeit from a very low base in 2022.\nIII.\nSales of SlimBiome to Paradise Fruits, a German company who produce gummies for Wallmart and for its online sales to China up 744% on 2022.\nIV.\nStock: there was 13.9metric tonne of\nSlimBiome\n\u00ae\ntaken from stock held by two partners (Maxum and Cambridge Commodities) in 2023 compared to 2022 (up 39%) representing a value of \u00a3417K. Stock held by Cambridge Commodities, who supply the UK market including Holland & Barrett and THG, currently stands at 8.5metric tonne of SlimBiome and Maxum, who supply OptiPharm, hold 16.0metric tonne. The Company has commenced manufacture of replacement stock for Cambridge Commodities as it anticipates most of this stock will be used for existing orders planned for delivery in the next few months. Maxum stock use is averaging 1 metric tonne per month. The rec",
          "content_length": 17194
        },
        "ingested_at": "2026-01-21T02:42:53.349787Z"
      },
      {
        "event_id": "RNS-21st Jan 2026-largeord",
        "event_type": "rns_announcement",
        "date": "2026-01-21T22:15:54.380981Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Large Order and Record Early Orders for 2026",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/OPTI/large-order-and-record-early-orders-for-2026-14su4lbqgvuq5rj.html",
          "rns_number": "RNS Number : 6737P",
          "full_content": "Today 07:00\nRNS Number : 6737P\nOptiBiotix Health PLC\n21 January 2026\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\nLarge order and Record Early Orders for 2026\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces that it has received four orders totalling twenty-four metric tonnes (24mt) of SlimBiome from Meelung Trading, Taiwan (\"Meelung\"). These orders will be delivered at approximately three-month intervals throughout 2026 when they will be recorded in the Company's management accounts and reported for the 12 months ended 31 December 2026 (\"FY2026\").\nMeelung started trading in 1949 as a pharmaceutical company before expanding into nutraceuticals in 1992 to exploit the growing market opportunity. It describes itself as one of the most important nutritional supplement distributors in Taiwan with a focus on patented, branded products with clinical studies. OptiBiotix signed an agreement with Meelung in June 2025 and has seen rapid sales growth with regular recurring orders of increasing size.\nThese orders reflect a growing confidence in SlimBiome and a growing trend with an increasing number of partners placing orders for FY2026 to secure supply. This enables OptiBiotix to plan ahead and consolidate multiple orders, allowing it to negotiate preferential pricing with suppliers and reduce cost. The Company gains flexibility to pass on any cost savings to partners for larger orders while maintaining or improving margins, supporting increased sales growth.\nThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\nThese confirmed orders reflect the growing interest in ingredients like SlimBiome which support hunger control and appetite reduction similar to the anti-obesity drugs. This alternative GLP1 market is new and fast evolving and estimated to be worth\n$1.2 billion in 2024\nand projected to reach\n$4.8 billion by 2033\n,\ngrowing at a compound annual growth rate of 16.7% (Market Intelo, 2024) see\nGLP-1 Support Supplements Market Research Report 2033\n.\u00a0SlimBiome, with its four clinical studies, international awards, and 'on pack health claims' is well positioned to exploit this opportunity.\nStephen O'Hara, CEO of OptiBiotix Health plc said\n: \"\nWe are pleased to announce this large order from Meelung as well as record orders for the start of 2026. To have already secured orders totalling over \u00a3800k before the end of our first month of the year puts us in a strong position for the year ahead. These orders reflect the growing interest in bringing patented, branded ingredients, with human studies demonstrating hunger and appetite reduction to the fast growing 'natural alternative to GLP1' market.\nThe Company intends to provide a trading update for the financial year 2025 once figures have been finalised which will show another year of continued strong growth. With the start that we've had so far for 2026, the Company is in the strongest position it has been in with its first-generation products whilst having overcome a number of challenges with partners on large scale production (>100,000 mt) of our second-generation products as we move these along the pathway to launch.\"\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.\nEngage with the OptiBiotix management team directly by asking questions, watching video summaries and seeing what other shareholders have to say.\nView the full announcement and submit questions to management via our website:\nhttps://optibiotix.com/link/Pm5WaP\nSubscribe to the new website to get regular updates here:\nhttps://optibiotix.com/auth/signup\nFor further information, please contact: OptiBiotix Health plc\nwww.optibiotix.com\nNeil Davidson, Chairman\nStephen O'Hara, Chief Executive\nCairn Financial Advisers LLP (NOMAD and Broker)\nTel: 020 7213 0880\nLiam Murray / Jo Turner / Ludovico Lazzaretti\nAbout OptiBiotix\n-\nwww.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF),\nOptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease.\nSince the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like\n",
          "content_length": 7177
        },
        "ingested_at": "2026-01-21T22:15:54.381019Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261745-lordload--3850754",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.743829",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Forget my stamp duty comment below, as that doesn't apply with Aim shares. But the spread does still.",
          "sentiment": 0.0,
          "engagement": "3,746",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-22T21:47:32.754577+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261819-Makingmi-46932315",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.743418",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Hi lord. My comment related to Sbtx where I sold yesterday afternoon and bought back this afternoon. 20.05 for most sale and 19.78 for main repurchase but all bought back at below price sold at. Not a lot as I said. Not happy trying to trade as I expected it to drop back fairly quickly. This is share I want to be in and was concerned when the fall did not materialise today. Will hold now as originally intended, too easy to get timing wrong and miss out If it falls I know it will come back so not trying that again. Hope that clarifies. I have no reason to mislead. It was as much about a note and warning to myself in reality. Regards",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-22T21:47:32.754560+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261821-Makingmi-75386570",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.742999",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Also lord for info, I deal with IG and pay nos charges, commissions or fees which also helps.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-22T21:47:32.754542+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261828-Makingmi--8330515",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.742587",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Hi Dad. Yes thanks for that. It was in fact reading through that Rns that caused my interest and original post. To me that feels promising but having also read the comments about past promises not materialising I was looking for some balanced views. Can only be a personal decision to invest and judge the risk / reward and this is obviously not an easy one but am keeping a close watch and ready to jump onboard. Thanks",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-22T21:47:32.754525+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20262116-Bk2011--3356113",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.742169",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bk2011",
          "content": "BBC News - https://www.bbc.co.uk/news/articles/c050ljnrv2qo.amp People coming off weight-loss injections risk fast weight gain - BBC News",
          "sentiment": 0.0,
          "engagement": "252",
          "price_at_post": "6.25",
          "thread_title": "Bbc article",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=E8329E7F-4026-4975-87F8-526698347C1C"
        },
        "ingested_at": "2026-01-22T21:47:32.754507+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20260657-aspex--6065130",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.741737",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "Mentioned here before is that a Slimbiome  based dieting would help these patients to a longer term answer to weight gain.",
          "sentiment": 0.0,
          "engagement": "127",
          "price_at_post": "6.25",
          "thread_title": "RE: Bbc article",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=E8329E7F-4026-4975-87F8-526698347C1C"
        },
        "ingested_at": "2026-01-22T21:47:32.754489+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20260845-Siouks--1194734",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.741321",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I convince you all to buys some of OPTi products, try them and you will see what's the differents between GLP injections and what they have on offer. I believe there is a huge difference between injections - what works only when you take them and a last long, much cheaper products they have on offer. A bit of marketing and off you go...",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.25",
          "thread_title": "Offer",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=6C8C89BD-CC8E-4C38-80CC-B48EE1160CEE"
        },
        "ingested_at": "2026-01-22T21:47:32.754471+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20260849-Makingmi-10155293",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.740900",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Decided to make small starting investment, just over \u00a31500, to give incentive to monitor and research a bit more. Buys were marked as sells but that\u2019s not unusual. Hope there can be some positive outcomes and will add more as/if things seem to be going in right direction. Meanwhile my main investment will stay with SBTX.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "Small buy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=13A94F2F-B191-4F96-801C-D4C463838EDC"
        },
        "ingested_at": "2026-01-22T21:47:32.754453+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20261028-Punter12--8518454",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.740479",
        "source": "LSE_CHAT",
        "data": {
          "author": "Punter1234",
          "content": "Stamp duty lol? somebody doesn't know much about AIM obviously. Think before posting saves making fool of yourself",
          "sentiment": 0.0,
          "engagement": "3,042",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-22T21:47:32.754435+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20261231-Makingmi--8431421",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.740053",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well, if reading the last 12 month news flow, without the knowledge input from longer term holders, it would be difficult not to be exited by prospects here. But I can equally understand that they probably initially invested here with that similar excitement. Do feel that I will end up getting more very soon. If investing now from this extremely low level you have to take the view that things should only get better. Here\u2019s hoping.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-22T21:47:32.754418+00:00"
      },
      {
        "event_id": "SOCIAL-10Jan20260946-Makingmi-78045677",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.739629",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Followed my advice and doubled up in afternoon for a start. Amazing how if it doubles people will want to buy, but sometimes best gains come from getting in early. Will keep drip feeding in and hope for some good news",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "5.90",
          "thread_title": "Few more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=78E3BF06-02A2-4238-A4EC-C5278933D58F"
        },
        "ingested_at": "2026-01-22T21:47:32.754399+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260927-Makingmi--8615666",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.739217",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "More bought again but joined by few others now which is a good sign. Fingers crossed very tightly.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.10",
          "thread_title": "And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754382+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260931-Makingmi-36567232",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.738790",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "This is a bit more like it.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.10",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754364+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260949-Makingmi--3425863",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.738379",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Looking at chart, imo, 10 should be first stop. Anyway, I have all I want now and will sit back and watch. No more pointless comment.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.20",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754346+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261007-Andrew7--9196277",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.737948",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andrew7",
          "content": "I understand the frustration as a long term shareholder. I do however agree that from a neutral point of view this share could well be a 7 or 8 bagger from its current position.  Disregarding Sweetbiotix for a moment, even a significant uptick in sales in H2 2025  from H2 2024 should be enough to start a positive trajectory. Normally a trading update late Feb or early March so we will see.",
          "sentiment": 0.0,
          "engagement": "93",
          "price_at_post": "6.25",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754328+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261135-shandypa--7790764",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.737539",
        "source": "LSE_CHAT",
        "data": {
          "author": "shandypants2",
          "content": "I've been in and out of opti for about 10 years and currently out. I like the products and potential but the slow pace of market penetration has been incredibly disappointing. Now we have fat jabs (for good or bad) perhaps we have now missed the boat, despite there still being a big gap in the market. For me we need c 5 times annual revenues of c\u00a35m to breakeven (based on 50% gross margin and current admin spend).  We seem light years away from this, so i will continue to watch from the side lines. Recently was in H&B and could not see any Opti products - surely a terrible sign.",
          "sentiment": 0.0,
          "engagement": "3,296",
          "price_at_post": "6.25",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754310+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261308-Siouks--3693923",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.737116",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Tend to dissegree with you. There are fat jabs available in the market for over \u00a3300 for a max dose ( mounjaro ) / 4 weeks were in this particular case you stop - you go back to your previous weight if not higher. That's why I posted before - if you want to discuss, go in their website and buy it/try it. 4 weeks sachets with all promo codes cost around \u00a370 and are safer then injections. All here seems to be down due to marketing and that's what I would invest in myself. You can't sell it if people don't know this product exist...simple",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754293+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261327-Siouks--2290826",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.736685",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If I'm a GLP-1 jab producer / owner I would rather look to take over a company like OPTi and promote it the right way. Fat jabs are expensive and not so convenient to use, with side effect building up after a time. This one you just mix with water etc etc. No side effects, easy and cheap. This company at this price is more a subject to take over for bigger and effective ( possible - one of the jabs producers ) player. Jabs going to pass momentum especially once people realise they have to spend over \u00a3300 a month for years to keep it up. Everybody will look for cheaper and safer option - like OPTi products. So whoever buy them at that price and properly promote them will win for many years to come",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754275+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261420-martinu--1518412",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.736266",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH is a bit reluctant re takeover ideas.  Having himself thought that he'd sold out a previous company too cheaply.  As I understand it, there has been a fair bit of marketing around Dr Morepen in India.  I think companies have possibly shared expense.  Dr M were very bullish about f/c sales, but seems like they have exaggerated.   We will only know when, as said , we get the March update. The SP rise today gives a good %age increase for ST punters.  I am , unfortunately a LTH, well underwater.   Glug, glug...",
          "sentiment": 0.5,
          "engagement": "1,676",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754257+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261524-shandypa-31594501",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.735835",
        "source": "LSE_CHAT",
        "data": {
          "author": "shandypants2",
          "content": "Siouks - i did say there is still a big gap in the market for opti products but it is clearly not filling it and it's been 10 years now. Clearly the fat jabs aren't cheap and have massive side effects, but ultimately most people are lazy and will take the easy option. Marketing costs money - something opti doesn't have. The fact that H&B seem to be phasing out Slimbiome speaks volumes IMHO. BTW i'm 56 and weigh the same as i did at 18 - i eat sensibly and exercise, so not an issue for me. Not everyone invested in opti is fat.",
          "sentiment": 0.0,
          "engagement": "3,296",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754235+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks--8943043",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.735406",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754217+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload--8045863",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.734858",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,746",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754198+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang--8450298",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.734433",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "1,975",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754180+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35-86576638",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.734006",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,904",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754162+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu--7741716",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:32.733574",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,676",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754144+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu-35761651",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:30.003288",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,676",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-22T21:47:32.754124+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex-58309237",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:30.002865",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "127",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-01-22T21:47:32.754084+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi-11560116",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:30.002438",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.754066+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload-56531798",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:30.002010",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,746",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.754048+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi--2337865",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:30.001588",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.754030+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu--5491284",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:30.001177",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,676",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.754012+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi-85269746",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:30.000750",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753994+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49--7199367",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:30.000340",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753975+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35--8801651",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.999914",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,904",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753957+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi-49752213",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.999500",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753940+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba--5146098",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.999069",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-22T21:47:32.753922+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks-18993921",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.998663",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753904+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman-67186272",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.998241",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "402",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753886+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu--2801289",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.997815",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,676",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-22T21:47:32.753868+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi-83656725",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.997394",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-22T21:47:32.753850+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL-54016117",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.996962",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "11",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-22T21:47:32.753832+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-19944678",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.996553",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "402",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753814+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--8957070",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.996137",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "402",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753796+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons--5192783",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.995716",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753778+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul-47541378",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.995305",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,393",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753760+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman-67744766",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.994827",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "402",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753742+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul-59689790",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.994413",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,393",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753724+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu--8989662",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.993983",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,676",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753706+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920--6415302",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.993566",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753688+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu--7454250",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:29.993124",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,676",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753670+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu-45652649",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.935268",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,676",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-22T21:47:32.753653+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu-39637843",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.934855",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,676",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-22T21:47:32.753635+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun--3832293",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.934442",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "187",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-22T21:47:32.753617+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260802-Makingmi-88215908",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.934026",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well pleased with today\u2019s and yesterday\u2019s news. Things starting to look more positive going forward. No need to be racing to buy in now as already all in. Just sit and wait. Very positive feelings confirmed and even Blubs must consider those comments justified. lol.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753599+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260943-skid35--7499557",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.933606",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Positive RNS today, glad to see all shareholders being treated equally from yesterdays RNS. Still hope there was something in the director buys late last year well above the current share price.",
          "sentiment": 0.0,
          "engagement": "3,904",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753581+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-martinu--8985802",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.933193",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes positive update.  Good that clarification was given that these orders will be recorded as revenues in FY 26. As sometimes Opti orders take months to be recognised.  Fingers crossed for more progress.",
          "sentiment": 0.0,
          "engagement": "1,676",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753563+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-Letitrun--2283364",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.932779",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Should be an easy bag or possibly 2 from here following today\u2019s news. With \u00a3800k in the bag for the year ahead & 11+ months left the share price seems to have fallen well below where it should on sentiment alone. They also have \u00a3100k milestone for Sweetbiotix & in 2024 their e-commerce business did just shy of \u00a3400k to add to 2026. Looking like momentum is actually gathering here. Any serious news on sweetbiotix this will have a major rerate",
          "sentiment": 0.0,
          "engagement": "187",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753545+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261100-Dad41325--7727610",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.932369",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Was looking back on RNS 23/05/25 \u00a3500k investment from an American institutional investor at 14p a share, Asia seems to be going well maybe the US will be next to bring in some big orders.",
          "sentiment": 0.0,
          "engagement": "277",
          "price_at_post": "7.50",
          "thread_title": "Bold investment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=86086D0C-7204-4260-867E-ED4A91DB1A3E"
        },
        "ingested_at": "2026-01-22T21:47:32.753526+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261110-Friedman-58125425",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.931937",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Good news. Actual numbers. Let\u2019s hope we can build from here.",
          "sentiment": 0.0,
          "engagement": "402",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753508+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261446-Siouks-66892575",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.931527",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Such a high volume today with over 100k buys and this is only on 17% raise... wierd.  With such an important update I was looking for over a 10 with sp, and we are basicly were it was. Whoever bought at 6 will sell it at over 7 and we still wait for proper news. If it would be higher maybe worth again to open shorts",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "7.50",
          "thread_title": "Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-22T21:47:32.753490+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261509-Bottmzup-48765328",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.931118",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bottmzup",
          "content": "In my experience, after a positive update on a lot of shares, there's always a slow or delayed reaction while the news is digested by the wider market. After being in an oversold level for a period of time, I'm guessing the same thing to happen here. Todays high volume has broken above a falling trend line on the chart which has been falling since Aug '25, that will get noticed.",
          "sentiment": 0.0,
          "engagement": "6,741",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-22T21:47:32.753472+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261532-Siouks--4501721",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.930683",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "As I said. There is a huge potential in a market, all depends how they going to use it. In my opinion marketing is the key but we all have our own opionion",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-22T21:47:32.753454+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261533-Adyan920-91666431",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.930273",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753436+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261604-lordload--5377923",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.929818",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,746",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753419+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261617-Letitrun--1307014",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.929397",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "187",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753400+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262019-Adyan920--6715187",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.928955",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753382+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262020-Friedman-31661909",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.928524",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "402",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753364+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262058-skid35-19399518",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.928072",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,904",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753344+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262159-Letitrun--6712467",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.927653",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "187",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753326+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262216-Letitrun--6385748",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.927242",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "\u2018this approach has delivered a record start to FY2026, with over \u00a3800k in orders secured from four partners. These will be delivered at various points throughout 2026 where they will be reported and recorded in the company\u2019s full year 2026 accounts.\u2019 Later states these 4 partners are the order from November for delivery in H1 2026, Meelung and two other partners.",
          "sentiment": 0.0,
          "engagement": "187",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753308+00:00"
      },
      {
        "event_id": "SOCIAL-Today1207-Adyan920--8828779",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.926813",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "@skid35 - The RNS did confuse me too at first, but on second read it made sense. Generally, when customers place orders they won't be recorded in our accounts until delivery. By adding that line, it clarified that: 1. The Nov order won't show in the 2025 account 2. It is instead  included in the the \u00a3800k order confirmed for 2026, which should also be delivered in 2026. This actually is being more open, as they could have easily not included that line and investors could have easily assumed the Nov order will be in the 2025 accounts and all the \u00a3800k announced are all brand new orders not mentioned before.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "8.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753289+00:00"
      },
      {
        "event_id": "SOCIAL-Today1247-skid35-77530543",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.926379",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "\"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\" Looking at this again, this really is just appalling, shockingly poor. So - \u00a3800k from four partners where the order have been received in 2026 - but in a later sentence somehow the \u00a3800k of orders  received in 2026 now includes the order from November 2025 ??????? So it is 1. we have a record start with orders received in 2026 together with the order in November now providing a backlog of \u00a3800k  2. Or a higher amount (say \u00a3950k but not explicitly mentioned) will be recognised in 2026 - the \u00a3800k of new orders plus unknown value of the Nov deal.",
          "sentiment": 0.0,
          "engagement": "3,904",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753271+00:00"
      },
      {
        "event_id": "SOCIAL-Today1305-martinu-30131503",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.925936",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "I would guess (and that's the point we shouldn't have to), that the Nov 25 order (included in the \u00a3800k total) will be booked in 2026.  This is an opportunity to seek clarity via the new Q&A portal.  Responses are coming within a day.",
          "sentiment": 0.0,
          "engagement": "1,676",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753252+00:00"
      },
      {
        "event_id": "SOCIAL-Today1315-Letitrun-24587627",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.925510",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "It doesn\u2019t say received it says orders \u2018secured\u2019 as a great start for 2026. It doesn\u2019t need clarifying it\u2019s quite clear and literally quotes all will be reported in 2026 accounts.",
          "sentiment": 0.0,
          "engagement": "187",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753232+00:00"
      },
      {
        "event_id": "SOCIAL-Today1835-Tatty99-32252133",
        "event_type": "social_post",
        "date": "2026-01-22T21:47:25.925058",
        "source": "LSE_CHAT",
        "data": {
          "author": "Tatty99",
          "content": "Adyan is correct. No accounting entry can be made until goods dispatched.  So the order cannot be recognised as income or 'receivable' until goods dispatched i.e this year.",
          "sentiment": 0.0,
          "engagement": "947",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-22T21:47:32.753210+00:00"
      },
      {
        "event_id": "SOCIAL-11Dec20250816-lordload--4818842",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.223425",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "So basically someone sold a lot of shares, but someone else bought them so we can\u2019t read a lot into it either way.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.75",
          "thread_title": "RE: Huge volume selling",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=92E125BE-8AB0-4B1C-88A0-665B0CA8EE27"
        },
        "ingested_at": "2026-01-21T22:16:14.239517+00:00"
      },
      {
        "event_id": "SOCIAL-11Dec20250836-Friedman--6619531",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.223006",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Volume plus price normally means something. Huge volume and a drop is a  worse portent than huge volume and a rise.",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.75",
          "thread_title": "RE: Huge volume selling",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=92E125BE-8AB0-4B1C-88A0-665B0CA8EE27"
        },
        "ingested_at": "2026-01-21T22:16:14.239499+00:00"
      },
      {
        "event_id": "SOCIAL-11Dec20250904-Siouks-51471464",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.222594",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Sometimes mean even take over... negative manipulation",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.75",
          "thread_title": "Manipulation",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=8D5BA814-7A15-4310-920E-B91F38437DD5"
        },
        "ingested_at": "2026-01-21T22:16:14.239481+00:00"
      },
      {
        "event_id": "SOCIAL-11Dec20250904-lordload--5352258",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.222185",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Meaningless either way. Ultimately all that really counts for now is next spring's commercial update. Not a few punters' take on things.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.75",
          "thread_title": "RE: Huge volume selling",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=92E125BE-8AB0-4B1C-88A0-665B0CA8EE27"
        },
        "ingested_at": "2026-01-21T22:16:14.239463+00:00"
      },
      {
        "event_id": "SOCIAL-11Dec20251750-martinu--1653672",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.221767",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Chief of Hara won again at Taunton Races today.  I have made back \u00a33.75 of my losses. \ud83d\ude0a\ud83c\udfc7",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.75",
          "thread_title": "RE: Huge volume selling",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=92E125BE-8AB0-4B1C-88A0-665B0CA8EE27"
        },
        "ingested_at": "2026-01-21T22:16:14.239444+00:00"
      },
      {
        "event_id": "SOCIAL-13Dec20252227-simplici-37058290",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.221355",
        "source": "LSE_CHAT",
        "data": {
          "author": "simplicius",
          "content": "Has TW sold?",
          "sentiment": 0.0,
          "engagement": "63",
          "price_at_post": "6.75",
          "thread_title": "RE: Huge volume selling",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=92E125BE-8AB0-4B1C-88A0-665B0CA8EE27"
        },
        "ingested_at": "2026-01-21T22:16:14.239426+00:00"
      },
      {
        "event_id": "SOCIAL-14Dec20251707-7777--7504888",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.220937",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "MAJOR WEEKEND RNS !! The board of OPTI and the 'bored' of the Fake, lying, paranoid, share price destroying, cult website...are delighted & extremely excited to announce the following result (particularly as west ham were leading twice LOLOL !!).... & in preperation for possible relegation to the championship... WEST HAM UNITED 2 ASTON VILLA 3 .....ENDS.",
          "sentiment": 0.0,
          "engagement": "55",
          "price_at_post": "6.75",
          "thread_title": "SUNDAY RNS !",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=8EAE330E-16CB-4113-A0C0-0D477B871D65"
        },
        "ingested_at": "2026-01-21T22:16:14.239407+00:00"
      },
      {
        "event_id": "SOCIAL-18Dec20250924-Siouks-10647127",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.220508",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Good job keeping all positives up so well. I said when we were at 11.00 - see you at 6... wondering if shorting target we be reached in 2 weeks.... well done to those downing this one by such a wonderful comments:) those probably shorting it as well.",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.75",
          "thread_title": "RE: SUNDAY RNS !",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=8EAE330E-16CB-4113-A0C0-0D477B871D65"
        },
        "ingested_at": "2026-01-21T22:16:14.239389+00:00"
      },
      {
        "event_id": "SOCIAL-27Dec20251336-7777--6446116",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.220084",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "4 more days to get ripped off before you get ripped off even more...at the moment there are more woofer speakers than gullible audience cult members... Who in their right mind would waste time attending this rubbish....go and get 'bored' watching paint dry or better still...get a chair and watch your winter grass grow..much more exciting and educational.",
          "sentiment": 0.0,
          "engagement": "55",
          "price_at_post": "6.75",
          "thread_title": "SHARESTOCK 26",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=6707F433-996D-4E87-87C5-F58BB66E2439"
        },
        "ingested_at": "2026-01-21T22:16:14.239371+00:00"
      },
      {
        "event_id": "SOCIAL-28Dec20250215-PizzaGat-74176967",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.219672",
        "source": "LSE_CHAT",
        "data": {
          "author": "PizzaGate",
          "content": "7777 FILTERED!",
          "sentiment": 0.0,
          "engagement": "205",
          "price_at_post": "6.75",
          "thread_title": "RE: SUNDAY RNS !",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=8EAE330E-16CB-4113-A0C0-0D477B871D65"
        },
        "ingested_at": "2026-01-21T22:16:14.239352+00:00"
      },
      {
        "event_id": "SOCIAL-2Jan20260845-Friedman--3474820",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.219260",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I guess the Christmas bonuses and party had to be paid for. Worth buying some Skin because when this selling pressure is over from SOH, that price will explode",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.75",
          "thread_title": "More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.239334+00:00"
      },
      {
        "event_id": "SOCIAL-2Jan20260935-skid35-16897325",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.218837",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "No point is having \"a strong balance sheet\" (which it isnt) if you're not selling assets to generate return, but as you say FS just to pay directors.",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "6.75",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.239316+00:00"
      },
      {
        "event_id": "SOCIAL-2Jan20261050-martinu--9180777",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.218426",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes, a complete disappointment!  With admin costs between \u00a32-\u00a32.5m p.a. , sales around \u00a31m with gross margin around 50%, this is still a long way from break even.  Most of SBTX holding sold and PBX presumably waiting in the wings.  Plus the ever lengthening wait for Sweet to be commercialised.",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.75",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.239299+00:00"
      },
      {
        "event_id": "SOCIAL-3Jan20261706-7777--6806689",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.218010",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "URGENT SATURDAY RNS The board of OPTI/ SBTX, proposed board of SWBTX, & Sir Paul Mathieson, plus the 'bored' of the moaning, pathetic FCA useless letter writing fake lyin website is absolutely & extremely delighted to announce the following humilating & embarrassing result for West Ham United... WOLVERHAMPTON WANDERERS 3 WEST HAM UNITED 0 Congratulations to Rob Edwards on a much needed victory !! It is looking highly likely there will be a relegation party at our offices in May....Tickets will be free on a first come first serve basis & not rip off sharestock prices...(cult members who are none west ham fans who moan constantly and spread negativity will be turned away at the door ...sorry for the inconvenience.)",
          "sentiment": 0.0,
          "engagement": "55",
          "price_at_post": "6.75",
          "thread_title": "FOR IMMEDIATE RELEASE",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F835A9F7-F062-4830-B17D-0D60AFDDE5FC"
        },
        "ingested_at": "2026-01-21T22:16:14.239280+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261309-foggy100-42912304",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.217577",
        "source": "LSE_CHAT",
        "data": {
          "author": "foggy100",
          "content": "Tom Winnifrith announces this rnorning that he has Sold his OPTI shares",
          "sentiment": 0.0,
          "engagement": "2,066",
          "price_at_post": "6.75",
          "thread_title": "Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239262+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261439-gibsonj4--3247524",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.217169",
        "source": "LSE_CHAT",
        "data": {
          "author": "gibsonj45",
          "content": "His whole 'business' has been based on the fact that he would tell subscribers in ADVANCE if he planned to sell a stock. He did the same thing with SBTX recently (which has since increased its sp by a significant degree). How can he possibly hold onto subscribers if he behaves like this to them.",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "6.75",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239244+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261513-7777--4550793",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.216749",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "WHOOO  ?? - RAYYY..:))) The cult leading relegation loon is OUT... Yipppeee... Just like SBTX....When binned off.. The only way is UP. LOL",
          "sentiment": 0.0,
          "engagement": "55",
          "price_at_post": "6.75",
          "thread_title": "LOL !!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=70936DE6-75BB-4EFF-9C9E-3702C9F49F3D"
        },
        "ingested_at": "2026-01-21T22:16:14.239225+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261532-martinu--1394759",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.216325",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "if the ****is out then these are a buy.",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.75",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239207+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261559-skid35-28021038",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.215911",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "TW really is such a pathetic little man, the investor version of Dominic Cummings. No doubt has traded in and out and made millions. SOH, with advice from the the \"pr professionals\" Walbrook, should have steered well clear and not considered him an insider, releasing juicy titbits for him to put behind a paywall. Anyway - over to you SOH to prove him wrong, unfortunately based on history seems very unlikely.",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239188+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261822-cyberbub-79137230",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.215494",
        "source": "LSE_CHAT",
        "data": {
          "author": "cyberbub",
          "content": "Just looking in here. I recall buying some shares in the 20s a long time ago, I think I made a small profit. Surely 6p (\u00a36m cap) seems ridiculously undervalued, for a company in a hot sector, making deals with big companies across the world, shipping 6 tons to Australia in H1, with scientific backing for its claims and a large IP portfolio? With all these deals, look at the last results, how did it only sell \u00a3577k in H1? Is the product basically dirt cheap? Eg. the 6 tonnes to Australia was priced at only \u00a31k per tonne or something?? Or they make only a few quid per tonne from licensed manufacturing? Or is it that the big US distributor still hadn't started selling any significant volume, but will do so imminently? Or does Mr Market expect a placing for say \u00a32m imminently, despite the company still having \u00a32m worth of SBTX shares to sell? What an I missing here? Is there something I should know? Or is this a hidden gem about to treble or quadruple? Thanks for any info/views...",
          "sentiment": 0.0,
          "engagement": "1,084",
          "price_at_post": "6.25",
          "thread_title": "Views",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=ABB2510D-293B-4AA7-B96B-72FD10D08FF0"
        },
        "ingested_at": "2026-01-21T22:16:14.239170+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261957-PGlancy-89645344",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.215046",
        "source": "LSE_CHAT",
        "data": {
          "author": "PGlancy",
          "content": "He lost a few when he sold his sbtx. They were also 7% down until then q&a with you know who. Tw will hide behind the \u201ci told subs to sell yonks ago\u201d which isn't the same deal is it. His trust is in the toilet.",
          "sentiment": 0.0,
          "engagement": "642",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239151+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20262248-Friedman--8383923",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.214629",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I can\u2019t believe people pay for information from people like him and another prominent ex Opti. cheerleader. It\u2019s almost as big a waste of money as being invested here.",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239132+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20262255-lordload--8316670",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.214208",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - agreed about TW & Eldico. But I\u2019m expecting an upwards re-rate in Opti\u2019s SP post- next results.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239093+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20260727-Siouks--3694118",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.213734",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I'm about to reach the target of 0.06. As I said easier to put shorts here with those ,,investors,. Then will rethink to set a new target  around 0.01 No point to listen fake investors website about potential and target around 0.72",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239074+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20260749-jockmart-68578317",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:14.213293",
        "source": "LSE_CHAT",
        "data": {
          "author": "jockmartin",
          "content": "I sold all my OPTI shares 6 months ago after holding for some 10 years.  Massive letdown. SOH's claim that he had learnt from previous experience when it came to be dealing making proved to be empty. Would you care to share the reasons you think a re-rate is potentially on the cards? I would love to get some money back!",
          "sentiment": 0.0,
          "engagement": "23",
          "price_at_post": "5.75",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239056+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20260805-Friedman--8310609",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.040135",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Big difference for me between holding here and buying in. I'm holding now more out of habit than anything else having been in here for nigh on 10 years myself. I'm fortunate that other investments have done well over that time and this is now something I can just hold in the evermore ridiculous hope that ONE DAY SWEET MAY COME GOOD. As for reasons to buy in, they are solely based on SOH's view of the future revenue from deals signed. And speaking personally, if I was to continue to trust a word he says about future deals given his past record, I'd be the living embodiment of that quote about insanity being someone who does the same thing expecting different results. In short, given we still make a loss after all these years, our assets are rapidly disappearing, and all we have are the hopes that have repeatedly been dashed for 10 years, there's little reason other than an outrageous punt to buy in here.",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.00",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239037+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20260840-jockmart-50017675",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.039707",
        "source": "LSE_CHAT",
        "data": {
          "author": "jockmartin",
          "content": "Thanks FS. I can only agree re mad punt. Bring on the madness...",
          "sentiment": 0.0,
          "engagement": "23",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.239018+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20260853-skid35--1989280",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.039295",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "FS, well said. There is a real issue with the basic culture, credibility and integrity of the board and leadership team, unfortunately once lost it is very difficult to re establish. The official statement from the company that they have never spoken with TW and Elrico, while sponsoring their output as the key investor relations communication behind a paywall, was Orwellian in the extreme and undermines anything coming out of OPTI. I hope that the market buys by the CFO and SOH at higher values a few short months ago were actually based on some sort of realism, but sometimes if you are too close to a company there is a massive bias which is not based on a realistic assessment of your position. If we have another SOH presentation reiterating the market opportunity in the last five years, with no real material sales and where OPTI has failed to establish itself but where he and OPTI have done a great job, I will scream.",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238987+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261015-VeritasL-32859065",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.038874",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, I dont think I have ever seen an 'official  statement' from the Company saying they have never spoken to TW or Elric.  I have seen periods when they have said they have not spoken to TW and/or Elric over specific comments.  I think the company has gone  very broad too quickly for its size (I think 7 people) building sales teams and partnerships in multiple countries around the world and having first and second generation products. This dilutes focus on one area and means funds are spent on building partnerships and health claims  from studies  on first generation products and research and development of second generation products which are very expensive.  On the up side the investment in these ares should now be complete and they should be able to reduce costs whilst building sales.  if they can launch SweetBiotix this year and/or the other second generation product there should be a big upside.",
          "sentiment": 0.0,
          "engagement": "11",
          "price_at_post": "5.75",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238960+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261047-martinu--3409550",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.038456",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Some good contributions  from posters on this thread. Great products, poor commercialisation.  I still hold.  There might be a bounce when we get interims.  That will depend on continued modest sales growth and cost control. From memory, think revenue from H1 was just over \u00a3500k.  Last year's interims were March.  The earlier they come out the more positive.  Not much good news recently. Also need annual revenue of between \u00a34-5m to break even at recent cost levels.",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "5.75",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238941+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261056-lordload-49654888",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.038031",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Jockmartin - as always, a lot still hinges on a Sweet deal finally materialising. But sales from its larger partners seemed to be going better and there'll be another \u00a3100k licence payment hitting in the next set of results. I still think any short term downwards pressure is largely down to TW's lemming-like disciples following his disposal. So best ignored.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "5.75",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238923+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261101-VeritasL--3299618",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.037611",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "The issue you have on AIM is that with the new MAR regulations from a few years ago there are now very few research reports and very few investment journalists writing in the Times/Mail etc.  TW and Elric have filled this gap  with less knowledge and expertise and with TW personal vendettas.  AIM has recognised this in their recent report to the FCA - extract below 3. Bulletin Board Challenges AIM\u2019s strength over the years has been that it attracts a range of investors. However, we recognise the regulatory and commercial challenges for companies to attract sufficient research coverage and ensure that the research that is written is distributed to the widest audience of current and potential investors. We have contributed to the Investment Research Review led by Rachel Kent and support her findings and the subsequent work the FCA has done to make it easier for institutions to pay for equity research. We also recognise that whilst progress continues to be made in this area, many investors, particularly individuals can find it difficult to access high quality research on smaller companies. In some cases, this can lead to a vacuum which is filled by bulletin board users. Many bulletin board users act responsibly and in compliance with UK law. However, respondents have noted the challenge for AIM from bulletin board users who target a company, its directors and/or nominated advisers in a manner that is inappropriate and/or seek to influence the share price. We have been discussing with the FCA our concerns in respect of the conduct of certain platforms, social media influencers and bulletin board users and have highlighted potential cases that give rise to concerns of market abuse. We would encourage companies, market practitioners and bulletin board users who have reasonable cause for concern of this type of behaviour to report matters to Contact us | FCA. The FCA has confirmed that posting information which gives, or is likely to give, a false or misleading impression about an issuer - where the person knew or should have known this would be the case - may constitute a breach of UK MAR. This applies to both positive and negative statements. In addition, the FCA has confirmed to us that while a genuine, reasoned opinion is unlikely to breach UK MAR, an opinion expressed in a way that misrepresents facts or is intended to create a misleading impression can still amount to market abuse. We also note the conduct of some of these bulletin board users gives rise to concerns from companies that they are being subjected to unacceptable public abuse that would be unlikely to arise in private markets, and the feedback is that this is a disincentive for companies and individual directors to join AIM. We consider it is unacceptable for AIM companies and directors to be exposed to such pressure, and the Exchange will make detailed referrals of any incidents we identify to relevant enforcement agencies,",
          "sentiment": 0.0,
          "engagement": "11",
          "price_at_post": "5.75",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238905+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261153-martinu-83335837",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.037070",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Veritas, thanks for sharing.  I agree with comments that BB users should not be abusive.  But based on a handful of  companies that I have either bought shares in or just followed, CEOs often bring criticism upon themselves.",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238887+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261154-Mick_the--1969132",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.036659",
        "source": "LSE_CHAT",
        "data": {
          "author": "Mick_the_Fish",
          "content": "The quote FS referred to (that is often misattributed to Einstein) that \"insanity being someone who does the same thing expecting different results\" hardly respects the true quantum nature of the universe - just saying! As for Opti, I reckon there may well be another turnaround or two left in the old dog...",
          "sentiment": 0.0,
          "engagement": "14",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238869+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261205-Friedman--2807724",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.036255",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Regarding BB and research. We have lost two from here in the last year who both provided extensive, well-researched posts for free. Better than anything I\u2019ve seen from paywalled posters. I\u2019m speaking of Mol and Aquae who both sold up after years of failure. It is pretty telling when two of the people who knew the most about Opti sold up completely and it was a real indictment of the trust people have in SOH\u2019s predictions of future revenue. And yes, many CEOs do bring criticism on themselves although it is better not to be personal",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238851+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261236-martinu--3353738",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.035828",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "On AIM CEOs, one point I forgot was that they are often drawing salaries of \u00a3100-200k from the outset.  And continue to do so , whether the company starts doing well (the minority?) or does poorly (the majority?).  It is often argued that these high salaries are required to attract the best talent.  Some of the CEOs' talents are not necessarily what you would wish for.  And our Chancellor is keen to get more younger people to invest in such companies!",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238831+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261441-skid35--8200345",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.035421",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Veritas, email to myself through their official IR PR company. \"Stephen does not communicate with Tom Winnifrith or Elric Langton as I have previously said, so if they have said this then is a false statement\". They were both dropped after my complaint to OPTI. I did upset little Tommy with this.",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "6.25",
          "thread_title": "RE: Tom Winnifrith out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=BF28A085-7971-4B68-A51F-A04BF29FA5E7"
        },
        "ingested_at": "2026-01-21T22:16:14.238796+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20262207-7777-83150700",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.035007",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "amazing ai rns !!! the board of opti, sbtx, proposed board of swbtx & sir paul mathieson & the 'bored' of the pathetic fca usless letter writing fake lyin website are extremely excited an deliriously happy to announce another sad embarrassing & humiliating evening for west ham united & the following result. west ham united 1 nottingham forest 2 we have the cult members all but gone & booted out of opti & sbtx (and should be barred from re- entering) west ham almost gone & booted out of the premiership...now we just need all ****neys booted out of wales !! the only way is up ...lol ends",
          "sentiment": 0.0,
          "engagement": "55",
          "price_at_post": "6.25",
          "thread_title": "TUES EVE URGENT RNS !!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D3AA227E-F9DC-423B-B22D-8C39AB0B121E"
        },
        "ingested_at": "2026-01-21T22:16:14.238769+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261444-Friedman-19159703",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.034572",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Please God will he stop selling now for a while. We should have enough cash for at least all of 2026 given all the sales of stock, the cash at hand previously, and any revenue coming. If we're not in a decent state by then we should just give up and become a holding company for SBTX until that rises by enough to give shareholders some of their money back",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.238749+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261505-Friedman--3873144",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.034164",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Seriously though at some point there must be some value in Opti selling the IP to some of the bigger companies in exchange for a few and some % of future earnings, and then cutting back completely on staffing other costs while holding our remaining shares in Skin and PBX. Granted there won't be the wages in it for SOH and his family/mates, but it would be financially beneficial to the owners of the company (SOH excluded)",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.238717+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261702-elrico--8771370",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.033741",
        "source": "LSE_CHAT",
        "data": {
          "author": "elrico",
          "content": "It seems I must once again endure the minor indignity of responding to individuals I long ago consigned to the filter list \u2014 not out of malice, but in a bid to avoid wasting time on a relentless stream of misinformation, half-truths, and the kind of obsessive behaviour that borders on parody. A screenshot from Skid35 has done the rounds, suggesting that OptiBiotix has cut communications with both TW and me. Let\u2019s be absolutely clear, since clarity appears in short supply: I terminated dialogue with O\u2019Hara after he misled both my son and me regarding the US fundraiser. My son, being principled and brought up to value integrity, publicly apologised after being told his concerns were factually incorrect. As it turned out, they were entirely accurate. That betrayal of trust severed any remaining confidence we had in the Company. If I were Skid35, I\u2019d be less concerned about who\u2019s on speaking terms with whom, and more focused on the commercial substance \u2014 like why the Company appears to have quietly dropped the GoFigure shakes from its online store, and or why there is not evidence in H&B stores I have visited, where SlimExpert is on sale. Emails in our possession raise serious concerns on that front, with potential knock-on effects for SlimBiome partnerships, or at least the perception thereof, unless the Company chooses to clarify. Why no RNS? Isn't it deemed price sensitive? Perhaps not, if sales were poor and non-material. I guess not. And what's this we're hearing from H&B store insiders, that SlimExpert stock is being discontinued? Is this a localised issue, or something broader? So, Skid35, if you're reading this: direct your fire elsewhere and consider raising the tone of the debate. Respectfully. Before you respond with the BS, we became bitter after losing our sponsorship. Our members are well aware that we were openly critical for several months during the sponsorship and did not allow it to affect our opinions, even though TW praised us for this and disliked the sponsorship. The sponsorship was pulled as a measure to censor us, a punishment, if you will. No need to respond to me on a personal level, as I won't be back for a while, if ever. Be blessed.",
          "sentiment": 0.0,
          "engagement": "2,332",
          "price_at_post": "6.25",
          "thread_title": "Misinformation",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=13DBEF44-2553-45FA-8467-81648D29E54C"
        },
        "ingested_at": "2026-01-21T22:16:14.238689+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261735-lordload-52820242",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.033292",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - Given his age & his family's stake in Opti, SOH has far more incentive to boost the SP than simply to carry on drawing a salary for the next N years. Admittedly he can't lose either way. But he'd win far bigger if he managed to boost revenues enough to make the company sustainably profitable. And the most obvious way to do that is if we eventually manage a breakthrough with Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.238670+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261905-Friedman--1399198",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.032864",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Don't forget that his son is employed too. Also, Elrico is weird, and fully complicit in the misleading of investors for years through his complete reluctance to ask anything like probing questions on the multiple occasions when he had the chance because he prioritised access over integrity",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.238652+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20262014-awhawh--8340932",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.032450",
        "source": "LSE_CHAT",
        "data": {
          "author": "awhawh",
          "content": "That's unfair, Friedman Elric's mistake was to trust what SOH was telling him, though perhaps defended him for too long. TW also fell into the same trap. Only SOH is to blame for misleading investors",
          "sentiment": 0.0,
          "engagement": "83",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.238625+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20262214-skid35-65581427",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.032022",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Elric, like myself you are a nobody - but you think you are some top deep thinking analyst. Get over yourself.",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "6.25",
          "thread_title": "RE: Misinformation",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=13DBEF44-2553-45FA-8467-81648D29E54C"
        },
        "ingested_at": "2026-01-21T22:16:14.238591+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20260946-Friedman--7128025",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.031605",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I don't criticise Elric for trusting SOH, at least not initially, but he continued to have interviews with him for years where he wouldn't ask even the most gently probing questions about SOH's prior misleading statements. That was despite people on here with genuine, well thought out suggestions. For all those years he repeated the propaganda when many of us knew there were questions to be asked. He absolutely is at fault for that. As for TW, I wouldn't trust him as far as I could throw one his grifting sharefests. I'm convinced there was something in it for him, with Elrico I suspect it was access he was addicted to after all, he went from just being a poster on forums to having the CEOs ear and charging people for content.",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.238563+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261317-lordload-28340896",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.031175",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - agreed. Anyone paying the slightest attention to Elric or TW (let alone payiing for their content) only has themselves to blame when things go t(w)its up.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T22:16:14.238545+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261408-Makingmi--2734118",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.030743",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Am buyer of SBTX & there is a lot of cross chat also about OPTI on there so was interested to take a look. Seems to be disaster area looking at price after continuing sales after dissatisfaction from long term holders and failed promises etc. But SBTX is going up and when it doubles its present price, if OPTI are still holding current shareholding it will almost cover the present market cap. So, given all the history etc. is it all possible that the planned progress here could actually happen. Looking with a possible new shareholders eyes, if that was a possibility this would seem to be a good time to get in. But can also understand why many thought it was a good time to get out. Are there any positive viewpoints here.  ???",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238526+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261508-DireCons-68114564",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.030310",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "O'Hara will not realise any value here as he needs the SBTX cash to prop up OPTI, which at current burn rate will last about 18 months. When that goose is cooked he'll probably start selling off PBX. I just wish he would sell up and move on.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238507+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261521-martinu--8540448",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:10.029857",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Mm, I'm a LT Opti shareholder, though my holding is quite small.  It is hard to find the positives here.  Sales revenue has picked up the the last two published HY figures.  Both around \u00a3500k.  Based mostly on SlimBiome (WellBiome and LeanBiome).  But these products , in various guises have been in a competitive  market for a few years now.  Unusually they are backed by scientific studies, but this doesn't seemed to have gained the advantage that it could have.  The potential revenues from new deals are often exaggerated (by the partner, I think).  But SOH uses these f/c revenues in reporting. For me, the disappointing thing is that old partners often fall by the wayside , as new partners are announced.  Thus revenues have not built over time.  I think the FY unaudited",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238489+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261529-martinu-23717116",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.516909",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "... figures might show the same old story.  Usually due in March. The unknown is SweetBiotix.  Again scientifically backed, but years in the commercialisation.   If this were to come good Opti would be a buy.  But so far, not good. I will continual hold .  Not much choice now ;) But the FY 25 figures will be telling. Probably around \u00a31m i would guess. On SBTX stake, this has been dissipated to shore up losses.  The stake in PBX might not be so easy to sell as on Aquis.  A less liquid exchange.  Would likely have to find a private buyer.  But PBX is steadily improving after an inauspicious start.",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238471+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261602-DireCons-42071199",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.516485",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "O'Hara will be looking at retirement in the next 18 months having drained most of the assets to his benefit. He's often quoted as saying he sold off his last company too cheap and wouldn't make that mistake again. Maybe he's trying to claw back the loss through OPTI investors? All imvho. Just trying to understand where my heavy losses are going after years of false promises.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238453+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261625-Makingmi-53111950",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.516067",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Thanks all for those thoughts. It\u2019s easy to look at things a bit more positively when just considering now, but think best to hold off for moment and take a watching brief. Would be good though if some of the promise comes good. If keep making money on Sbtx there might be a bit to find for a bit of a gamble later. Not normally trading shares but did sell out yesterday to try to buy back lower. Worried ever since as it hardly moved down so bought all back in after lunch and proved to be just in time, making a small gain on number held, but not doing that again. Things can change too quickly. Thanks again",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238435+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261715-Dad41325--7325894",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.515645",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Read the RNS 24/11 this should help to give some idea of potential",
          "sentiment": 0.0,
          "engagement": "277",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238417+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261742-lordload--6023028",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.515236",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Makingmillions - forgive me if I'm wrong, but given the spread (not to mention 0.5% stamp duty on repurchase + potentially dealing commission), I'd be amazed if you could have sold & rebought same day at a profit, when intraday SP typically isn't that volatile.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238399+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261745-lordload--1711862",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.514820",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Forget my stamp duty comment below, as that doesn't apply with Aim shares. But the spread does still.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238381+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261819-Makingmi--1910772",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.514408",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Hi lord. My comment related to Sbtx where I sold yesterday afternoon and bought back this afternoon. 20.05 for most sale and 19.78 for main repurchase but all bought back at below price sold at. Not a lot as I said. Not happy trying to trade as I expected it to drop back fairly quickly. This is share I want to be in and was concerned when the fall did not materialise today. Will hold now as originally intended, too easy to get timing wrong and miss out If it falls I know it will come back so not trying that again. Hope that clarifies. I have no reason to mislead. It was as much about a note and warning to myself in reality. Regards",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238363+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261821-Makingmi-15171516",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.513993",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Also lord for info, I deal with IG and pay nos charges, commissions or fees which also helps.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238345+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261828-Makingmi-12392764",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.513583",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Hi Dad. Yes thanks for that. It was in fact reading through that Rns that caused my interest and original post. To me that feels promising but having also read the comments about past promises not materialising I was looking for some balanced views. Can only be a personal decision to invest and judge the risk / reward and this is obviously not an easy one but am keeping a close watch and ready to jump onboard. Thanks",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238327+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20262116-Bk2011--4644425",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.513169",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bk2011",
          "content": "BBC News - https://www.bbc.co.uk/news/articles/c050ljnrv2qo.amp People coming off weight-loss injections risk fast weight gain - BBC News",
          "sentiment": 0.0,
          "engagement": "252",
          "price_at_post": "6.25",
          "thread_title": "Bbc article",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=E8329E7F-4026-4975-87F8-526698347C1C"
        },
        "ingested_at": "2026-01-21T22:16:14.238309+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20260657-aspex-30286943",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.512742",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "Mentioned here before is that a Slimbiome  based dieting would help these patients to a longer term answer to weight gain.",
          "sentiment": 0.0,
          "engagement": "127",
          "price_at_post": "6.25",
          "thread_title": "RE: Bbc article",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=E8329E7F-4026-4975-87F8-526698347C1C"
        },
        "ingested_at": "2026-01-21T22:16:14.238291+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20260845-Siouks-49827817",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.512326",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I convince you all to buys some of OPTi products, try them and you will see what's the differents between GLP injections and what they have on offer. I believe there is a huge difference between injections - what works only when you take them and a last long, much cheaper products they have on offer. A bit of marketing and off you go...",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.25",
          "thread_title": "Offer",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=6C8C89BD-CC8E-4C38-80CC-B48EE1160CEE"
        },
        "ingested_at": "2026-01-21T22:16:14.238273+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20260849-Makingmi-48060563",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.511909",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Decided to make small starting investment, just over \u00a31500, to give incentive to monitor and research a bit more. Buys were marked as sells but that\u2019s not unusual. Hope there can be some positive outcomes and will add more as/if things seem to be going in right direction. Meanwhile my main investment will stay with SBTX.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "Small buy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=13A94F2F-B191-4F96-801C-D4C463838EDC"
        },
        "ingested_at": "2026-01-21T22:16:14.238255+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20261028-Punter12-46796789",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.511489",
        "source": "LSE_CHAT",
        "data": {
          "author": "Punter1234",
          "content": "Stamp duty lol? somebody doesn't know much about AIM obviously. Think before posting saves making fool of yourself",
          "sentiment": 0.0,
          "engagement": "3,016",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238237+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20261231-Makingmi-26101019",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.511063",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well, if reading the last 12 month news flow, without the knowledge input from longer term holders, it would be difficult not to be exited by prospects here. But I can equally understand that they probably initially invested here with that similar excitement. Do feel that I will end up getting more very soon. If investing now from this extremely low level you have to take the view that things should only get better. Here\u2019s hoping.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T22:16:14.238219+00:00"
      },
      {
        "event_id": "SOCIAL-10Jan20260946-Makingmi-44230591",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.510639",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Followed my advice and doubled up in afternoon for a start. Amazing how if it doubles people will want to buy, but sometimes best gains come from getting in early. Will keep drip feeding in and hope for some good news",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "5.90",
          "thread_title": "Few more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=78E3BF06-02A2-4238-A4EC-C5278933D58F"
        },
        "ingested_at": "2026-01-21T22:16:14.238201+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260927-Makingmi-60884861",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.510226",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "More bought again but joined by few others now which is a good sign. Fingers crossed very tightly.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.10",
          "thread_title": "And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238183+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260931-Makingmi-51360711",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.509774",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "This is a bit more like it.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.10",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238165+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260949-Makingmi-28751600",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.509359",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Looking at chart, imo, 10 should be first stop. Anyway, I have all I want now and will sit back and watch. No more pointless comment.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.20",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238147+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261007-Andrew7--6081766",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.508926",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andrew7",
          "content": "I understand the frustration as a long term shareholder. I do however agree that from a neutral point of view this share could well be a 7 or 8 bagger from its current position.  Disregarding Sweetbiotix for a moment, even a significant uptick in sales in H2 2025  from H2 2024 should be enough to start a positive trajectory. Normally a trading update late Feb or early March so we will see.",
          "sentiment": 0.0,
          "engagement": "93",
          "price_at_post": "6.25",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238128+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261135-shandypa--7927678",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.508519",
        "source": "LSE_CHAT",
        "data": {
          "author": "shandypants2",
          "content": "I've been in and out of opti for about 10 years and currently out. I like the products and potential but the slow pace of market penetration has been incredibly disappointing. Now we have fat jabs (for good or bad) perhaps we have now missed the boat, despite there still being a big gap in the market. For me we need c 5 times annual revenues of c\u00a35m to breakeven (based on 50% gross margin and current admin spend).  We seem light years away from this, so i will continue to watch from the side lines. Recently was in H&B and could not see any Opti products - surely a terrible sign.",
          "sentiment": 0.0,
          "engagement": "3,295",
          "price_at_post": "6.25",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238089+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261308-Siouks-40190097",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.508089",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Tend to dissegree with you. There are fat jabs available in the market for over \u00a3300 for a max dose ( mounjaro ) / 4 weeks were in this particular case you stop - you go back to your previous weight if not higher. That's why I posted before - if you want to discuss, go in their website and buy it/try it. 4 weeks sachets with all promo codes cost around \u00a370 and are safer then injections. All here seems to be down due to marketing and that's what I would invest in myself. You can't sell it if people don't know this product exist...simple",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238071+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261327-Siouks--2488263",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.507668",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If I'm a GLP-1 jab producer / owner I would rather look to take over a company like OPTi and promote it the right way. Fat jabs are expensive and not so convenient to use, with side effect building up after a time. This one you just mix with water etc etc. No side effects, easy and cheap. This company at this price is more a subject to take over for bigger and effective ( possible - one of the jabs producers ) player. Jabs going to pass momentum especially once people realise they have to spend over \u00a3300 a month for years to keep it up. Everybody will look for cheaper and safer option - like OPTi products. So whoever buy them at that price and properly promote them will win for many years to come",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238053+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261420-martinu--5289747",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.507247",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH is a bit reluctant re takeover ideas.  Having himself thought that he'd sold out a previous company too cheaply.  As I understand it, there has been a fair bit of marketing around Dr Morepen in India.  I think companies have possibly shared expense.  Dr M were very bullish about f/c sales, but seems like they have exaggerated.   We will only know when, as said , we get the March update. The SP rise today gives a good %age increase for ST punters.  I am , unfortunately a LTH, well underwater.   Glug, glug...",
          "sentiment": 0.5,
          "engagement": "1,674",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238035+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261524-shandypa-81716718",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:06.506792",
        "source": "LSE_CHAT",
        "data": {
          "author": "shandypants2",
          "content": "Siouks - i did say there is still a big gap in the market for opti products but it is clearly not filling it and it's been 10 years now. Clearly the fat jabs aren't cheap and have massive side effects, but ultimately most people are lazy and will take the easy option. Marketing costs money - something opti doesn't have. The fact that H&B seem to be phasing out Slimbiome speaks volumes IMHO. BTW i'm 56 and weigh the same as i did at 18 - i eat sensibly and exercise, so not an issue for me. Not everyone invested in opti is fat.",
          "sentiment": 0.0,
          "engagement": "3,295",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.238017+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks--5494550",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.130725",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.237999+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload-19572535",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.130314",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.237980+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang-34520661",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.129884",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "1,970",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.237962+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35--3071352",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.129472",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.237944+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu--3300036",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.129053",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,674",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.237926+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu-29038252",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.128649",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,674",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T22:16:14.237908+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex--4001756",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.128238",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "127",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-01-21T22:16:14.237890+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi--6781110",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.127803",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237872+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload-62494613",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.127390",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237854+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi-85168717",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.126953",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237836+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu-55848280",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.126543",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,674",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237817+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi--7634548",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.126129",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237800+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49--6593500",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.125710",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237782+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35-77071839",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.125302",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237764+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi-50726945",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.124875",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237745+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba-13198712",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.124455",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-21T22:16:14.237727+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks-45896725",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.124034",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237709+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman--4521468",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.123615",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237691+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu--3243405",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.123200",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-21T22:16:14.237673+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi-30084858",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.122772",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-21T22:16:14.237655+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL--7752404",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.122344",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "11",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-21T22:16:14.237636+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--3067574",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.121918",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237618+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-82851204",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.121501",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237600+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons-34478316",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.121078",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237582+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul-55141723",
        "event_type": "social_post",
        "date": "2026-01-21T22:16:04.120637",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,392",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237564+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul-55141723",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.880082",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,392",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237545+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman-80002163",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.879626",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237527+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul--4981827",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.879216",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,392",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237508+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu-20006949",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.878791",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237489+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920--3952393",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.878379",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "174",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237471+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu-86840235",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.877956",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237453+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu-24645825",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.877542",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T22:16:14.237434+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu-89050735",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.877124",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-21T22:16:14.237417+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun--8942292",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.876708",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-21T22:16:14.237398+00:00"
      },
      {
        "event_id": "SOCIAL-Today0802-Makingmi--6171881",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.876298",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well pleased with today\u2019s and yesterday\u2019s news. Things starting to look more positive going forward. No need to be racing to buy in now as already all in. Just sit and wait. Very positive feelings confirmed and even Blubs must consider those comments justified. lol.",
          "sentiment": 0.0,
          "engagement": "80",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237380+00:00"
      },
      {
        "event_id": "SOCIAL-Today0943-skid35-52104108",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.875873",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Positive RNS today, glad to see all shareholders being treated equally from yesterdays RNS. Still hope there was something in the director buys late last year well above the current share price.",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237361+00:00"
      },
      {
        "event_id": "SOCIAL-Today1053-martinu--7619563",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.875457",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes positive update.  Good that clarification was given that these orders will be recorded as revenues in FY 26. As sometimes Opti orders take months to be recognised.  Fingers crossed for more progress.",
          "sentiment": 0.0,
          "engagement": "1,674",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237343+00:00"
      },
      {
        "event_id": "SOCIAL-Today1053-Letitrun--4696166",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.875040",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Should be an easy bag or possibly 2 from here following today\u2019s news. With \u00a3800k in the bag for the year ahead & 11+ months left the share price seems to have fallen well below where it should on sentiment alone. They also have \u00a3100k milestone for Sweetbiotix & in 2024 their e-commerce business did just shy of \u00a3400k to add to 2026. Looking like momentum is actually gathering here. Any serious news on sweetbiotix this will have a major rerate",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237322+00:00"
      },
      {
        "event_id": "SOCIAL-Today1100-Dad41325--7130310",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.874633",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Was looking back on RNS 23/05/25 \u00a3500k investment from an American institutional investor at 14p a share, Asia seems to be going well maybe the US will be next to bring in some big orders.",
          "sentiment": 0.0,
          "engagement": "277",
          "price_at_post": "7.50",
          "thread_title": "Bold investment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=86086D0C-7204-4260-867E-ED4A91DB1A3E"
        },
        "ingested_at": "2026-01-21T22:16:14.237304+00:00"
      },
      {
        "event_id": "SOCIAL-Today1110-Friedman-29851645",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.874214",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Good news. Actual numbers. Let\u2019s hope we can build from here.",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237286+00:00"
      },
      {
        "event_id": "SOCIAL-Today1446-Siouks-66053660",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.873795",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Such a high volume today with over 100k buys and this is only on 17% raise... wierd.  With such an important update I was looking for over a 10 with sp, and we are basicly were it was. Whoever bought at 6 will sell it at over 7 and we still wait for proper news. If it would be higher maybe worth again to open shorts",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "7.50",
          "thread_title": "Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-21T22:16:14.237267+00:00"
      },
      {
        "event_id": "SOCIAL-Today1509-Bottmzup--5727740",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.873389",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bottmzup",
          "content": "In my experience, after a positive update on a lot of shares, there's always a slow or delayed reaction while the news is digested by the wider market. After being in an oversold level for a period of time, I'm guessing the same thing to happen here. Todays high volume has broken above a falling trend line on the chart which has been falling since Aug '25, that will get noticed.",
          "sentiment": 0.0,
          "engagement": "6,738",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-21T22:16:14.237249+00:00"
      },
      {
        "event_id": "SOCIAL-Today1532-Siouks--4806939",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.872959",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "As I said. There is a huge potential in a market, all depends how they going to use it. In my opinion marketing is the key but we all have our own opionion",
          "sentiment": 0.0,
          "engagement": "983",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-21T22:16:14.237231+00:00"
      },
      {
        "event_id": "SOCIAL-Today1533-Adyan920-60492861",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.872555",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "174",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237213+00:00"
      },
      {
        "event_id": "SOCIAL-Today1604-lordload-12509559",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.872108",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,745",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237195+00:00"
      },
      {
        "event_id": "SOCIAL-Today1617-Letitrun--8375455",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.871680",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237175+00:00"
      },
      {
        "event_id": "SOCIAL-Today2019-Adyan920--3619628",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.871271",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "174",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237151+00:00"
      },
      {
        "event_id": "SOCIAL-Today2020-Friedman--6307850",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.870829",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "401",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237113+00:00"
      },
      {
        "event_id": "SOCIAL-Today2058-skid35--2400397",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.870396",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,900",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237079+00:00"
      },
      {
        "event_id": "SOCIAL-Today2159-Letitrun--3619099",
        "event_type": "social_post",
        "date": "2026-01-21T22:15:58.869948",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T22:16:14.237057+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261702-elrico--7917166",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.617433",
        "source": "LSE_CHAT",
        "data": {
          "author": "elrico",
          "content": "It seems I must once again endure the minor indignity of responding to individuals I long ago consigned to the filter list \u2014 not out of malice, but in a bid to avoid wasting time on a relentless stream of misinformation, half-truths, and the kind of obsessive behaviour that borders on parody. A screenshot from Skid35 has done the rounds, suggesting that OptiBiotix has cut communications with both TW and me. Let\u2019s be absolutely clear, since clarity appears in short supply: I terminated dialogue with O\u2019Hara after he misled both my son and me regarding the US fundraiser. My son, being principled and brought up to value integrity, publicly apologised after being told his concerns were factually incorrect. As it turned out, they were entirely accurate. That betrayal of trust severed any remaining confidence we had in the Company. If I were Skid35, I\u2019d be less concerned about who\u2019s on speaking terms with whom, and more focused on the commercial substance \u2014 like why the Company appears to have quietly dropped the GoFigure shakes from its online store, and or why there is not evidence in H&B stores I have visited, where SlimExpert is on sale. Emails in our possession raise serious concerns on that front, with potential knock-on effects for SlimBiome partnerships, or at least the perception thereof, unless the Company chooses to clarify. Why no RNS? Isn't it deemed price sensitive? Perhaps not, if sales were poor and non-material. I guess not. And what's this we're hearing from H&B store insiders, that SlimExpert stock is being discontinued? Is this a localised issue, or something broader? So, Skid35, if you're reading this: direct your fire elsewhere and consider raising the tone of the debate. Respectfully. Before you respond with the BS, we became bitter after losing our sponsorship. Our members are well aware that we were openly critical for several months during the sponsorship and did not allow it to affect our opinions, even though TW praised us for this and disliked the sponsorship. The sponsorship was pulled as a measure to censor us, a punishment, if you will. No need to respond to me on a personal level, as I won't be back for a while, if ever. Be blessed.",
          "sentiment": 0.0,
          "engagement": "2,332",
          "price_at_post": "6.25",
          "thread_title": "Misinformation",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=13DBEF44-2553-45FA-8467-81648D29E54C"
        },
        "ingested_at": "2026-01-21T02:43:14.906346Z"
      },
      {
        "event_id": "SOCIAL-7Jan20261735-lordload-29601534",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.616974",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - Given his age & his family's stake in Opti, SOH has far more incentive to boost the SP than simply to carry on drawing a salary for the next N years. Admittedly he can't lose either way. But he'd win far bigger if he managed to boost revenues enough to make the company sustainably profitable. And the most obvious way to do that is if we eventually manage a breakthrough with Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "3,744",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T02:43:14.906320Z"
      },
      {
        "event_id": "SOCIAL-7Jan20261905-Friedman--7702936",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.616561",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Don't forget that his son is employed too. Also, Elrico is weird, and fully complicit in the misleading of investors for years through his complete reluctance to ask anything like probing questions on the multiple occasions when he had the chance because he prioritised access over integrity",
          "sentiment": 0.0,
          "engagement": "399",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T02:43:14.906293Z"
      },
      {
        "event_id": "SOCIAL-7Jan20262014-awhawh-87048781",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.616147",
        "source": "LSE_CHAT",
        "data": {
          "author": "awhawh",
          "content": "That's unfair, Friedman Elric's mistake was to trust what SOH was telling him, though perhaps defended him for too long. TW also fell into the same trap. Only SOH is to blame for misleading investors",
          "sentiment": 0.0,
          "engagement": "83",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T02:43:14.906267Z"
      },
      {
        "event_id": "SOCIAL-7Jan20262214-skid35--7820200",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.615720",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Elric, like myself you are a nobody - but you think you are some top deep thinking analyst. Get over yourself.",
          "sentiment": 0.0,
          "engagement": "3,897",
          "price_at_post": "6.25",
          "thread_title": "RE: Misinformation",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=13DBEF44-2553-45FA-8467-81648D29E54C"
        },
        "ingested_at": "2026-01-21T02:43:14.906241Z"
      },
      {
        "event_id": "SOCIAL-8Jan20260946-Friedman-51349065",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.615317",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I don't criticise Elric for trusting SOH, at least not initially, but he continued to have interviews with him for years where he wouldn't ask even the most gently probing questions about SOH's prior misleading statements. That was despite people on here with genuine, well thought out suggestions. For all those years he repeated the propaganda when many of us knew there were questions to be asked. He absolutely is at fault for that. As for TW, I wouldn't trust him as far as I could throw one his grifting sharefests. I'm convinced there was something in it for him, with Elrico I suspect it was access he was addicted to after all, he went from just being a poster on forums to having the CEOs ear and charging people for content.",
          "sentiment": 0.0,
          "engagement": "399",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T02:43:14.906215Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261317-lordload--8134676",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.614888",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - agreed. Anyone paying the slightest attention to Elric or TW (let alone payiing for their content) only has themselves to blame when things go t(w)its up.",
          "sentiment": 0.0,
          "engagement": "3,744",
          "price_at_post": "6.25",
          "thread_title": "RE: More family silver sold.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=F0233350-6D51-4396-BB49-241026A9E72B"
        },
        "ingested_at": "2026-01-21T02:43:14.906188Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261408-Makingmi--9221903",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.614475",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Am buyer of SBTX & there is a lot of cross chat also about OPTI on there so was interested to take a look. Seems to be disaster area looking at price after continuing sales after dissatisfaction from long term holders and failed promises etc. But SBTX is going up and when it doubles its present price, if OPTI are still holding current shareholding it will almost cover the present market cap. So, given all the history etc. is it all possible that the planned progress here could actually happen. Looking with a possible new shareholders eyes, if that was a possibility this would seem to be a good time to get in. But can also understand why many thought it was a good time to get out. Are there any positive viewpoints here.  ???",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.25",
          "thread_title": "Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.906162Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261508-DireCons--3765439",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.614033",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "O'Hara will not realise any value here as he needs the SBTX cash to prop up OPTI, which at current burn rate will last about 18 months. When that goose is cooked he'll probably start selling off PBX. I just wish he would sell up and move on.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.906135Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261521-martinu-70433449",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.613617",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Mm, I'm a LT Opti shareholder, though my holding is quite small.  It is hard to find the positives here.  Sales revenue has picked up the the last two published HY figures.  Both around \u00a3500k.  Based mostly on SlimBiome (WellBiome and LeanBiome).  But these products , in various guises have been in a competitive  market for a few years now.  Unusually they are backed by scientific studies, but this doesn't seemed to have gained the advantage that it could have.  The potential revenues from new deals are often exaggerated (by the partner, I think).  But SOH uses these f/c revenues in reporting. For me, the disappointing thing is that old partners often fall by the wayside , as new partners are announced.  Thus revenues have not built over time.  I think the FY unaudited",
          "sentiment": 0.0,
          "engagement": "1,670",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.906107Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261529-martinu--2146985",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.613194",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "... figures might show the same old story.  Usually due in March. The unknown is SweetBiotix.  Again scientifically backed, but years in the commercialisation.   If this were to come good Opti would be a buy.  But so far, not good. I will continual hold .  Not much choice now ;) But the FY 25 figures will be telling. Probably around \u00a31m i would guess. On SBTX stake, this has been dissipated to shore up losses.  The stake in PBX might not be so easy to sell as on Aquis.  A less liquid exchange.  Would likely have to find a private buyer.  But PBX is steadily improving after an inauspicious start.",
          "sentiment": 0.0,
          "engagement": "1,670",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.906071Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261602-DireCons--5020731",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.612740",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "O'Hara will be looking at retirement in the next 18 months having drained most of the assets to his benefit. He's often quoted as saying he sold off his last company too cheap and wouldn't make that mistake again. Maybe he's trying to claw back the loss through OPTI investors? All imvho. Just trying to understand where my heavy losses are going after years of false promises.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.906045Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261625-Makingmi-46340466",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.612327",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Thanks all for those thoughts. It\u2019s easy to look at things a bit more positively when just considering now, but think best to hold off for moment and take a watching brief. Would be good though if some of the promise comes good. If keep making money on Sbtx there might be a bit to find for a bit of a gamble later. Not normally trading shares but did sell out yesterday to try to buy back lower. Worried ever since as it hardly moved down so bought all back in after lunch and proved to be just in time, making a small gain on number held, but not doing that again. Things can change too quickly. Thanks again",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.906019Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261715-Dad41325-62568943",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.611893",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Read the RNS 24/11 this should help to give some idea of potential",
          "sentiment": 0.0,
          "engagement": "275",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.905993Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261742-lordload--1046216",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.611483",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Makingmillions - forgive me if I'm wrong, but given the spread (not to mention 0.5% stamp duty on repurchase + potentially dealing commission), I'd be amazed if you could have sold & rebought same day at a profit, when intraday SP typically isn't that volatile.",
          "sentiment": 0.0,
          "engagement": "3,744",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.905967Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261745-lordload--2392279",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.611058",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Forget my stamp duty comment below, as that doesn't apply with Aim shares. But the spread does still.",
          "sentiment": 0.0,
          "engagement": "3,744",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.905941Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261819-Makingmi--7981980",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.610642",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Hi lord. My comment related to Sbtx where I sold yesterday afternoon and bought back this afternoon. 20.05 for most sale and 19.78 for main repurchase but all bought back at below price sold at. Not a lot as I said. Not happy trying to trade as I expected it to drop back fairly quickly. This is share I want to be in and was concerned when the fall did not materialise today. Will hold now as originally intended, too easy to get timing wrong and miss out If it falls I know it will come back so not trying that again. Hope that clarifies. I have no reason to mislead. It was as much about a note and warning to myself in reality. Regards",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.905915Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261821-Makingmi-62524487",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:06.610208",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Also lord for info, I deal with IG and pay nos charges, commissions or fees which also helps.",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.905888Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261828-Makingmi-28172515",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.898376",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Hi Dad. Yes thanks for that. It was in fact reading through that Rns that caused my interest and original post. To me that feels promising but having also read the comments about past promises not materialising I was looking for some balanced views. Can only be a personal decision to invest and judge the risk / reward and this is obviously not an easy one but am keeping a close watch and ready to jump onboard. Thanks",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.905862Z"
      },
      {
        "event_id": "SOCIAL-8Jan20262116-Bk2011-48828085",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.897957",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bk2011",
          "content": "BBC News - https://www.bbc.co.uk/news/articles/c050ljnrv2qo.amp People coming off weight-loss injections risk fast weight gain - BBC News",
          "sentiment": 0.0,
          "engagement": "252",
          "price_at_post": "6.25",
          "thread_title": "Bbc article",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=E8329E7F-4026-4975-87F8-526698347C1C"
        },
        "ingested_at": "2026-01-21T02:43:14.905836Z"
      },
      {
        "event_id": "SOCIAL-9Jan20260657-aspex-69487475",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.897544",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "Mentioned here before is that a Slimbiome  based dieting would help these patients to a longer term answer to weight gain.",
          "sentiment": 0.0,
          "engagement": "127",
          "price_at_post": "6.25",
          "thread_title": "RE: Bbc article",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=E8329E7F-4026-4975-87F8-526698347C1C"
        },
        "ingested_at": "2026-01-21T02:43:14.905810Z"
      },
      {
        "event_id": "SOCIAL-9Jan20260845-Siouks-25430051",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.897138",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I convince you all to buys some of OPTi products, try them and you will see what's the differents between GLP injections and what they have on offer. I believe there is a huge difference between injections - what works only when you take them and a last long, much cheaper products they have on offer. A bit of marketing and off you go...",
          "sentiment": 0.0,
          "engagement": "981",
          "price_at_post": "6.25",
          "thread_title": "Offer",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=6C8C89BD-CC8E-4C38-80CC-B48EE1160CEE"
        },
        "ingested_at": "2026-01-21T02:43:14.905785Z"
      },
      {
        "event_id": "SOCIAL-9Jan20260849-Makingmi--7988737",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.896720",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Decided to make small starting investment, just over \u00a31500, to give incentive to monitor and research a bit more. Buys were marked as sells but that\u2019s not unusual. Hope there can be some positive outcomes and will add more as/if things seem to be going in right direction. Meanwhile my main investment will stay with SBTX.",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.25",
          "thread_title": "Small buy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=13A94F2F-B191-4F96-801C-D4C463838EDC"
        },
        "ingested_at": "2026-01-21T02:43:14.905759Z"
      },
      {
        "event_id": "SOCIAL-9Jan20261028-Punter12--5094955",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.896308",
        "source": "LSE_CHAT",
        "data": {
          "author": "Punter1234",
          "content": "Stamp duty lol? somebody doesn't know much about AIM obviously. Think before posting saves making fool of yourself",
          "sentiment": 0.0,
          "engagement": "2,987",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.905733Z"
      },
      {
        "event_id": "SOCIAL-9Jan20261231-Makingmi-71715639",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.895888",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well, if reading the last 12 month news flow, without the knowledge input from longer term holders, it would be difficult not to be exited by prospects here. But I can equally understand that they probably initially invested here with that similar excitement. Do feel that I will end up getting more very soon. If investing now from this extremely low level you have to take the view that things should only get better. Here\u2019s hoping.",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.25",
          "thread_title": "RE: Any chance this will come good",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=298C2646-A317-4EE0-A5FC-3DDE7220092E"
        },
        "ingested_at": "2026-01-21T02:43:14.905707Z"
      },
      {
        "event_id": "SOCIAL-10Jan20260946-Makingmi-83618020",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.895467",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Followed my advice and doubled up in afternoon for a start. Amazing how if it doubles people will want to buy, but sometimes best gains come from getting in early. Will keep drip feeding in and hope for some good news",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "5.90",
          "thread_title": "Few more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=78E3BF06-02A2-4238-A4EC-C5278933D58F"
        },
        "ingested_at": "2026-01-21T02:43:14.905680Z"
      },
      {
        "event_id": "SOCIAL-12Jan20260927-Makingmi-31136813",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.895043",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "More bought again but joined by few others now which is a good sign. Fingers crossed very tightly.",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.10",
          "thread_title": "And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905653Z"
      },
      {
        "event_id": "SOCIAL-12Jan20260931-Makingmi--1219742",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.894629",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "This is a bit more like it.",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.10",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905627Z"
      },
      {
        "event_id": "SOCIAL-12Jan20260949-Makingmi-85621531",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.894218",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Looking at chart, imo, 10 should be first stop. Anyway, I have all I want now and will sit back and watch. No more pointless comment.",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.20",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905601Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261007-Andrew7--6855669",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.893794",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andrew7",
          "content": "I understand the frustration as a long term shareholder. I do however agree that from a neutral point of view this share could well be a 7 or 8 bagger from its current position.  Disregarding Sweetbiotix for a moment, even a significant uptick in sales in H2 2025  from H2 2024 should be enough to start a positive trajectory. Normally a trading update late Feb or early March so we will see.",
          "sentiment": 0.0,
          "engagement": "93",
          "price_at_post": "6.25",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905575Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261135-shandypa--4405036",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.893384",
        "source": "LSE_CHAT",
        "data": {
          "author": "shandypants2",
          "content": "I've been in and out of opti for about 10 years and currently out. I like the products and potential but the slow pace of market penetration has been incredibly disappointing. Now we have fat jabs (for good or bad) perhaps we have now missed the boat, despite there still being a big gap in the market. For me we need c 5 times annual revenues of c\u00a35m to breakeven (based on 50% gross margin and current admin spend).  We seem light years away from this, so i will continue to watch from the side lines. Recently was in H&B and could not see any Opti products - surely a terrible sign.",
          "sentiment": 0.0,
          "engagement": "3,294",
          "price_at_post": "6.25",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905549Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261308-Siouks--2946531",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.892955",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Tend to dissegree with you. There are fat jabs available in the market for over \u00a3300 for a max dose ( mounjaro ) / 4 weeks were in this particular case you stop - you go back to your previous weight if not higher. That's why I posted before - if you want to discuss, go in their website and buy it/try it. 4 weeks sachets with all promo codes cost around \u00a370 and are safer then injections. All here seems to be down due to marketing and that's what I would invest in myself. You can't sell it if people don't know this product exist...simple",
          "sentiment": 0.0,
          "engagement": "981",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905523Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261327-Siouks--1310106",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.892535",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If I'm a GLP-1 jab producer / owner I would rather look to take over a company like OPTi and promote it the right way. Fat jabs are expensive and not so convenient to use, with side effect building up after a time. This one you just mix with water etc etc. No side effects, easy and cheap. This company at this price is more a subject to take over for bigger and effective ( possible - one of the jabs producers ) player. Jabs going to pass momentum especially once people realise they have to spend over \u00a3300 a month for years to keep it up. Everybody will look for cheaper and safer option - like OPTi products. So whoever buy them at that price and properly promote them will win for many years to come",
          "sentiment": 0.0,
          "engagement": "981",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905497Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261420-martinu-21843648",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.892120",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH is a bit reluctant re takeover ideas.  Having himself thought that he'd sold out a previous company too cheaply.  As I understand it, there has been a fair bit of marketing around Dr Morepen in India.  I think companies have possibly shared expense.  Dr M were very bullish about f/c sales, but seems like they have exaggerated.   We will only know when, as said , we get the March update. The SP rise today gives a good %age increase for ST punters.  I am , unfortunately a LTH, well underwater.   Glug, glug...",
          "sentiment": 0.5,
          "engagement": "1,670",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905471Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261524-shandypa-77553240",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.891695",
        "source": "LSE_CHAT",
        "data": {
          "author": "shandypants2",
          "content": "Siouks - i did say there is still a big gap in the market for opti products but it is clearly not filling it and it's been 10 years now. Clearly the fat jabs aren't cheap and have massive side effects, but ultimately most people are lazy and will take the easy option. Marketing costs money - something opti doesn't have. The fact that H&B seem to be phasing out Slimbiome speaks volumes IMHO. BTW i'm 56 and weigh the same as i did at 18 - i eat sensibly and exercise, so not an issue for me. Not everyone invested in opti is fat.",
          "sentiment": 0.0,
          "engagement": "3,294",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905444Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks-21593687",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.891275",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "981",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905419Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload--8752939",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.890856",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,744",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905393Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang-30275562",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.890431",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "1,958",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905367Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35--3645897",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.890010",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,897",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905341Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu-55806452",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.889593",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,670",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905315Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu-79312222",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.889179",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,670",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-21T02:43:14.905290Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex-13685758",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.888739",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "127",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-01-21T02:43:14.905264Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi--5799903",
        "event_type": "social_post",
        "date": "2026-01-21T02:43:03.888282",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.905237Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload-51896922",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.467140",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,744",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.905210Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi--8587207",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.466709",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.905184Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu--4208134",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.466299",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,670",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.905158Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi--5168869",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.465878",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.905132Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49--8639154",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.465467",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.905093Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35--6346859",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.465046",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,897",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.905067Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi-48980839",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.464636",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.905041Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba-62161753",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.464215",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-21T02:43:14.905015Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks-57439502",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.463791",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "981",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.904989Z"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman--3436045",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.463375",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "399",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-21T02:43:14.904963Z"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu--5148336",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.462951",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,670",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-21T02:43:14.904937Z"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi-16628262",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.462539",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "78",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-21T02:43:14.904910Z"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL--1505595",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.462112",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "11",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-21T02:43:14.904884Z"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-78980166",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.461694",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "399",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904858Z"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--3668610",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.461281",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "399",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904832Z"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons-57020887",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.460861",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904807Z"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul-66988871",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.460452",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,386",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904781Z"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman--4921773",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.459978",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "399",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904755Z"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul-84825542",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.459566",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,386",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904728Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu-25572759",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.459145",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,670",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904702Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920--2954194",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.458722",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "172",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904675Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu--4404184",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.458300",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,670",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904648Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu-24519068",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.457874",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,670",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-21T02:43:14.904622Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu-32830081",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.457451",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,670",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-21T02:43:14.904594Z"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun-77299206",
        "event_type": "social_post",
        "date": "2026-01-21T02:42:58.456993",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "182",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-21T02:43:14.904562Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251158-VeritasL-72526619",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.478379",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This makes a lot of sense and if the case is unique with massive potential.  Thanks for your insight.",
          "sentiment": 0.0,
          "engagement": "10",
          "price_at_post": "8.15",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.909230Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251203-VeritasL-22710202",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.477958",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, Mogrosides (from Monkfruit) and Stevia (from the Stevia leaf), sucrose and FOS are not artificial so this would be a natural sweetener with nutritional (as its a fibre) and health benefits - something which currently doesn't exist.  This sounds like a turning point.",
          "sentiment": 0.0,
          "engagement": "10",
          "price_at_post": "8.15",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.909203Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251359-Siouks-68498986",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.477549",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "One of not many companies where positive news are turned into negatives by so called investors. Subtotal 6 coming, then deep into 1 and lower. As I said before very good potential to short this sp  down and make money... at the moment all going well and since I said the same 3 months ago,  we went down from 11-12 to 7 ish. Lots of money to be made.",
          "sentiment": 0.0,
          "engagement": "977",
          "price_at_post": "7.75",
          "thread_title": "OPTi",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=59A96348-DB06-4073-881E-335C902D9C1D"
        },
        "ingested_at": "2026-01-21T02:43:14.909177Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251632-Friedman-65754581",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.477143",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The market has spoken. You can't go from an imminent launch to no launch and a changed product 2 years later and expect investors to buy in. SOH's stock is even lower than our company's. He's just not trusted any more and when that happens, news like today is treated with suspicion",
          "sentiment": 0.0,
          "engagement": "392",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.909151Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251646-lordload-62196412",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.476717",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - as letitrun implied, you seem determined to read a negative into literally everything this company says & does. Sure it has been far from perfect and things have always taken way longer than expected. But to state (as you did today) \"We could have had a decent business but sold everything\" is just plain factually wrong. Opti has NOT sold everything. Nor is everything lost.",
          "sentiment": 0.0,
          "engagement": "3,736",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.909121Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251739-Letitrun-39141454",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.476298",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Fried if they can\u2019t manufacturer the product consistently how do you expect them to launch? It would have scuppered any plans. Luckily they\u2019ve managed to resolve the major issue which wouldn\u2019t have been a simple straight line process. This RNS is actually pretty transparent on what has happened. The major players in this space will have budgets 10x the value of Optis cap on R&D and still not there on anything like this. They\u2019re now in an even better position on it\u2026but don\u2019t get too excited!",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.909077Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251752-AquaeSul-48704797",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.475874",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "So why in Mar 24 did the placing that followed the RNS Reach re imminent launch of sweetbiotix say it was in part to \"launch its second generation SweetBiotix and MicroBiome Modulator products.\" and what has happened to that money?",
          "sentiment": 0.0,
          "engagement": "4,370",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.909051Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251838-Letitrun--3066807",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.475464",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Aqua looking at the RNS that was just 1 of 4 things the money was raised for, the other three points the money can quite clearly be seen has been spent on its current commercial business as it outlined. Maybe it utilised the amount put by for second gen across those 3 other areas whilst they sorted things out. We don\u2019t know the details but everything could have been going swimmingly with it scaling up a few times and then suddenly not playing ball\u2026then all bets are off until the issue is resolved. I don\u2019t believe the word \u2018imminently\u2019 was ever used, only that a product had been planned with a partner, yet, as mentioned if they can\u2019t make the stuff it\u2019s not getting supplied for that product. I think some people need to realise things can change on a dime in biotech R&D, especially something so novel that no one has ever done before.",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.909024Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251924-AquaeSul-50903992",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.475038",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "OK let's go with that theory letitrun so \u00a31,325,500 gross placing proceeds were raised to increase revenues to \u00a3557K Hy 2025 from (H1 2024: \u00a3276K), is that good business?",
          "sentiment": 0.0,
          "engagement": "4,370",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908985Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251944-Nig1954-56382519",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.474629",
        "source": "LSE_CHAT",
        "data": {
          "author": "Nig1954",
          "content": "Rumours abound that Reeves intends to increase sugar tax in this weeks budget to cover her spending gap. If that proves  to be true then Optbiotix may benefit  as there will be a stronger commercial incentive for food and beverage manufacturers to use sugar alternatives. Optibiotix previously noted an interest when sugar tax was first mooted but this dissipated when manufacturers realised it didn't merit the commercial cost of reformatting their formulas. However, it may now become a more economically viable and desirable option for the industry. Expansion of the Soft Drinks Industry Levy to include milk based sugary drinks could alter prices and industry dynamics. the planned change isn't being implemented until April 2027 to allow manufacturers a window to adjust recipes or review their product portfolios. the tax currently stands at 18p/litre and they propose increasing it to 24p/litre for drinks  with higher sugar concentrations and the drinks industry says  this tightening of tax policy will undermine years of investment in reformulation. the industry maintains the extended levy will add significant costs and increase retail prices by as much as 5%. the proposed changes if implemented could have a far greater impact this time and Sweetbiotix may become one of   the principal beneficiaries.",
          "sentiment": 0.0,
          "engagement": "291",
          "price_at_post": "7.75",
          "thread_title": "Budget/ Sweetbiotix",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=C81A52FF-4571-41E0-8D6F-48B9A44F64AC"
        },
        "ingested_at": "2026-01-21T02:43:14.908890Z"
      },
      {
        "event_id": "SOCIAL-24Nov20251957-AquaeSul-59041623",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.474203",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Nig no-one will argue with the logic of what you are saying but in the interim Opti spends more than it makes on 1st gen products, refuses to make significant cost reductions in the meantime to balance the books, has sold down what was promised as a future dividend in SBTX holdings to keep the lights on in parallel with the odd fundraise, and holds illiquid stocks in PBX, so the jam tomorrow needs to arrive today",
          "sentiment": 0.0,
          "engagement": "4,370",
          "price_at_post": "7.75",
          "thread_title": "RE: Budget/ Sweetbiotix",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=C81A52FF-4571-41E0-8D6F-48B9A44F64AC"
        },
        "ingested_at": "2026-01-21T02:43:14.908837Z"
      },
      {
        "event_id": "SOCIAL-24Nov20252037-Owennoon--5765137",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.473782",
        "source": "LSE_CHAT",
        "data": {
          "author": "Owennoone",
          "content": "Anyone any additional insights or thoughts on Winnifirth posting this morning regarding CEO sending lawyer letters making demands?",
          "sentiment": 0.0,
          "engagement": "76",
          "price_at_post": "7.75",
          "thread_title": "TW posting",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=7A12C134-88E3-4EEB-A932-68296A2E013B"
        },
        "ingested_at": "2026-01-21T02:43:14.908786Z"
      },
      {
        "event_id": "SOCIAL-24Nov20252145-Letitrun--1994010",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.473376",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Aqa if it supports a continued YOY growth trajectory towards profitability, which the results did show, on top of improving margin & EBITDA then yes it\u2019s good business. Businesses need investment, one of the main reasons company\u2019s go public. How else do you expect them to grow?",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908732Z"
      },
      {
        "event_id": "SOCIAL-24Nov20252220-djframbo-60799085",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.472927",
        "source": "LSE_CHAT",
        "data": {
          "author": "djframboise",
          "content": "TW speaks with forked tongue. Imo, a total shyster never to be trusted and probably playing both sides.",
          "sentiment": 0.0,
          "engagement": "2,157",
          "price_at_post": "7.75",
          "thread_title": "RE: TW posting",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=7A12C134-88E3-4EEB-A932-68296A2E013B"
        },
        "ingested_at": "2026-01-21T02:43:14.908679Z"
      },
      {
        "event_id": "SOCIAL-25Nov20251139-Laura202--1026950",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.472516",
        "source": "LSE_CHAT",
        "data": {
          "author": "Laura2022",
          "content": "N packaged milkshakes and lattes expected to be announced ahead of Budget Health and Social Care Questions BBC Parliament Watch live Live. 17,155 viewing 17155 viewing Live page Updated 1 minute ago Tax on packaged milkshakes and lattes expected to be announced ahead of Budget Health and Social Care Questions BBC Parliament Watch live Summary Pre-packaged milkshakes and lattes are expected to be hit by the sugar tax in an announcement ahead of tomorrow's Budget The move would not include drinks made in cafes and restaurants - this post explains the current sugar tax The government is also expected to lower the sugar content threshold at which the tax applies, impacting more popular brands In her Budget announcement, Chancellor Rachel Reeves is also expected to raise the living wage for workers aged 20 and under Reeves has confirmed that both tax rises and spending cuts are on the table - but according to government sources, she will not raise income tax rates The Budget at a glance: Other possible measures include a new tax on electric vehicles, Isa reform and changes to the two-child benefit cap",
          "sentiment": 0.0,
          "engagement": "14,915",
          "price_at_post": "7.75",
          "thread_title": "Bbc news sugar tax",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=85D3EDC8-DA9A-4D65-8373-B79B4B7F908E"
        },
        "ingested_at": "2026-01-21T02:43:14.908640Z"
      },
      {
        "event_id": "SOCIAL-25Nov20251237-Nig1954--9025850",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.472030",
        "source": "LSE_CHAT",
        "data": {
          "author": "Nig1954",
          "content": "I appreciate all of that but this    morning's announcement regarding  lattes and milkshakes being brought  within the sugar levy tax and lowering the sugar content threshold at  which the tax applies may begin to change  the whole landscape.",
          "sentiment": 0.0,
          "engagement": "291",
          "price_at_post": "7.75",
          "thread_title": "RE: Budget/ Sweetbiotix",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=C81A52FF-4571-41E0-8D6F-48B9A44F64AC"
        },
        "ingested_at": "2026-01-21T02:43:14.908613Z"
      },
      {
        "event_id": "SOCIAL-25Nov20251826-martinu-90857727",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.471624",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "A lot might depend on how quickly/ slowly the SweetBiotix products can be brought to market.  As far as sugar substitutes in drinks are concerned, that would include testing of any drinks with SweetBiotix in.  Which could be years away.  Though, as I understand it. some companies have been working with us. (Ex DSM/ F and the unnamed US partner) * It might be more likely, though still nowhere near imminent, that a SweetBiotix sweetener for tea/ coffee might be easier to get to market. * This has led to a formal agreement with a USA partner and DSM Firmenich, a $12bn ingredients supplier, and several food and beverage companies supporting SweetBiotix development with a view to the use of SweetBiotix in their products.",
          "sentiment": 0.0,
          "engagement": "1,657",
          "price_at_post": "7.75",
          "thread_title": "RE: Budget/ Sweetbiotix",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=C81A52FF-4571-41E0-8D6F-48B9A44F64AC"
        },
        "ingested_at": "2026-01-21T02:43:14.908587Z"
      },
      {
        "event_id": "SOCIAL-26Nov20251844-Bootsox-47455286",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.471206",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bootsox",
          "content": "Direct link: https://www.gov.uk/government/news/soft-drink-levy-extended-to-protect-children-and-improve-health",
          "sentiment": 0.0,
          "engagement": "163",
          "price_at_post": "7.75",
          "thread_title": "RE: Budget/ Sweetbiotix",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=C81A52FF-4571-41E0-8D6F-48B9A44F64AC"
        },
        "ingested_at": "2026-01-21T02:43:14.908561Z"
      },
      {
        "event_id": "SOCIAL-27Nov20250811-Friedman-79787582",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.470785",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "\u201c FS - as letitrun implied, you seem determined to read a negative into literally everything this company says & does.\u201d I can\u2019t deny that I viewed the RNS with pessimism as I have many other news releases recently. In my defence, I\u2019d say my judgement of them has been reflected in the market which seems to place the same value as I do on SOH\u2019s projections and deals. A judgement based on years of previous misses. For balance though, I did say that my hope was that this would lead to a flurry of announcements and that together they might add up to something so I was trying to find a silver lining.",
          "sentiment": 0.0,
          "engagement": "392",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908532Z"
      },
      {
        "event_id": "SOCIAL-27Nov20251020-martinu-68165241",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.470360",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "My view is certainly tempered by what has gone before.  If this week's RNS was the first one on Sweet, I would view it  as positive. But we have been at this stage with Sweet before, apparently ready to go to market, then what seems like an age (2 years?) passes with no progress.  Let's hope we are really ready to show off products to potential customers. On the first generation products (Slim, etc), there does seem to have been a recent good increase in revenue.  Perhaps a full year of \u00a31m revenue.  Let's hope this momentum keeps going, as it hasn't in the past. On profitability, with admin costs at c. \u00a32-2.5m per year and with gross margin of just over 50%,  we will need close to \u00a35m revenue to break even. On funding, all the foresight SOH showed in bringing SBTX to market and realising funds available to Opti of many \u00a3ms, seems to have been squandered. Being used in making up the difference between revenue and costs.  That pot isn't far from empty! (16.5m shares at 16p = \u00a32.6m = 18 to 24 months). Given all of the above, why am I still holding?  Not sure I can answer that.  Hope, inertia, ...    Cheers MU",
          "sentiment": 0.0,
          "engagement": "1,657",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908506Z"
      },
      {
        "event_id": "SOCIAL-27Nov20251040-skid35-64115241",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.469916",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "M. A great summary. With the microbiome being one of the key topics in health it really is amazing just how little the company has achieved in financial results or even more esoteric KPIs like brand recognition and value. The problem with any RNS with future looking statements, including those which appear 80-100% certain, they are completely disregarded with SOHs history of over promising and completely under delivering. Until there is cash in the bank (not \"sales\" as we have seen in the past), anything from SOH, OPTI, Walbrook in an RNS backed by their city nomads is unfortunately completely worthless.",
          "sentiment": 0.0,
          "engagement": "3,881",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908480Z"
      },
      {
        "event_id": "SOCIAL-27Nov20251327-lordload-59077739",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.469495",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Martinu - yes, costs remain way too high given the current turnover level. Even with the reductions recently announced. I wouldn\u2019t say the funding from SBTX sales has necessarily been squandered though. A fair bit has been \u201cinvested\u201d in developing Sweetbiotix. If that eventually gains commercial traction, it could well be a game changer.  But as you suggest, that!s far from certain given Opti\u2019s track record.",
          "sentiment": 0.0,
          "engagement": "3,736",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908454Z"
      },
      {
        "event_id": "SOCIAL-27Nov20251411-Letitrun--1814122",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.469060",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Skid I think they have over promised on the 2nd gen and totally undelivered to date however i do appreciate the complexities of creating something ground-breaking. I think the CEO here whilst being optimistic on sales has always made clear its difficult to see how each partner will perform and why they never put out forecasts. I believe theyve only put one forecast which they hit in 2021. The CEO here then led the PBX growth whilst a new CEO took over at Opti which resulted in the sales collapsing by 50% the following year. Since that point the CEO came back from PBX and has basically been recovering the business. Whilst not explosive growth has steadied the ship and returned the business to consecutive years of growth. They need to continue this and increase the growth rate whilst putting the burners on SweetBiotix to get it to market at a time industry and consumers are crying out for it. If you look at the strategy they set out at the start of they year they appear to be delivering on what they set out i.e move into US, India, grow eccomerce, improve margin etc.",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908428Z"
      },
      {
        "event_id": "SOCIAL-27Nov20251505-VeritasL-20390364",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.468638",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, Not sure your post reflects the facts or reality. It sounds like your information comes from the BB's and not from reliable sources.   The interims report show they have reduced the number of NEDs to the minimum (2), removed the PR Company and broker, and only have 7 people in the team covering multiple territories and products.  The RNS shows they are spending money on overcoming the manufacturing challenges with SweetBiotix and not just on SlimBiome. I have never seen a 'promise' of a future dividend reported and whilst PBX is illiquid if you take time to gather facts and type into google 'Probiotics mergers and acquisitions' you will see this is an area of high activity - at 10-20X revenue.  Lets not repeat Tom Winnifriths gossip and base our blogs on the facts.",
          "sentiment": 0.0,
          "engagement": "10",
          "price_at_post": "7.75",
          "thread_title": "RE: Budget/ Sweetbiotix",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=C81A52FF-4571-41E0-8D6F-48B9A44F64AC"
        },
        "ingested_at": "2026-01-21T02:43:14.908402Z"
      },
      {
        "event_id": "SOCIAL-27Nov20251524-VeritasL-10053832",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:08.468200",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This is a very informed post.  Thank you as it helps me understand.  Just to share some work I did . As a numbers man I looked at how much money they raised on the market by going through all the RNS's (sad but true) and found they have raised \u00a310.4m.  However, they have given \u00a310.3m back to shareholders through a dividend in ProBiotix, have sold over \u00a36m shares in SBTX (from a \u00a3650k stake), and still have \u00a39m of assets on their balance sheet. This to me looks as if they are building a business using their investments in PBX and SBTX to give an early return to shareholders (PBX dividend) and fund development of the second generation using SBTX shares - without going back to the market and raising funds and diluting shareholders.   If the second gen work out this will be seen as a brilliant strategy and not the usual annual fundraise we see on AIM from lifestyle companies. Fingers crossed and hope I am not over analysing this.",
          "sentiment": 0.0,
          "engagement": "10",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908376Z"
      },
      {
        "event_id": "SOCIAL-27Nov20251540-sharepro--6758565",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:04.462939",
        "source": "LSE_CHAT",
        "data": {
          "author": "shareprof1",
          "content": "Aquae, I have been back to the RNS you says talks about the imminent launch of SweetBiotix as i had never seen anything from the Company talking about an imminent launch. It says the money is for investing in driving sales growth in Usa, India, grow Ecommerce channels, and  launch SweetBiotix and Microbiome products.  The first 3 have happened. The launch of SweetBiotix etc hasn't but the recent RNS explains why.  Scaling up the manufacture of a new product is extremely difficult - Croda took 5 years for SBTX.  Lets not rewrite an RNS and introduce new words which change its meaning.",
          "sentiment": 0.0,
          "engagement": "21",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908349Z"
      },
      {
        "event_id": "SOCIAL-27Nov20251704-martinu--3588658",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:04.462541",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Some good points, Veritas.",
          "sentiment": 0.0,
          "engagement": "1,657",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908323Z"
      },
      {
        "event_id": "SOCIAL-27Nov20252031-AquaeSul--8358304",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:04.462140",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Shareprof1 forgive my poetic license with the word imminent and let's replace it with the actual words in the July 24 results RNS \"We are progressing incrementally and have included SweetBiotix\u00ae in a finished product for a large global partner with a view for an upcoming launch. The Company is also working on including SweetBiotix\u00ae in our own products and launching a bulk sugar replacement product with the aim of seeing SweetBiotix\u00ae in an increasing number of products in 2024 and beyond.\"",
          "sentiment": 0.0,
          "engagement": "4,370",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908297Z"
      },
      {
        "event_id": "SOCIAL-28Nov20250758-AquaeSul--3446012",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:04.461726",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Veritas, thankyou for your figure work. Regarding the \u00a310.3 M given back to shareholders in the  form of a dividend, it might be worth doing some further research regarding the PBX sp that was based on at launch, how long the lock in period was before shareholders could take advantage of that dividend and of course what that dividend would actually have been worth based on the sp at the end of the lock-in. Also, to put things into context, the combined pre-biotic and probiotic business with its shared revenues, costs and overheads had a sp of over 40p immediately prior to breaking up the Company",
          "sentiment": 0.0,
          "engagement": "4,370",
          "price_at_post": "8.25",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908271Z"
      },
      {
        "event_id": "SOCIAL-28Nov20250856-Letitrun--5678514",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:04.461322",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Aqua your copy of the RNS only proves the point. Words such as \"We are progressing incrementally\" \"With a view for an upcoming launch\" \"with the aim\". This is drastically different to \"imminently\" and totally changes the tone. At the point this RNS was put out scale up appeared to be going to plan until they had technical issues with the consistency of the yields, which we now know scuppered any plans for a commercially viable launch. The recent RNS explained this but also that they've made a major breakthrough in sorting this out.",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908245Z"
      },
      {
        "event_id": "SOCIAL-28Nov20250900-AquaeSul--2155111",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:04.460910",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Letitrun, you conveniently leave out \" in an increasing number of products in 2024 and beyond\" which makes the word imminent more relevant. Regarding the reason for not launching, why were investors not told about it until mths later!",
          "sentiment": 0.0,
          "engagement": "4,370",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908219Z"
      },
      {
        "event_id": "SOCIAL-28Nov20250901-AquaeSul--2756364",
        "event_type": "social_post",
        "date": "2026-01-10T05:22:04.460510",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "16 mths",
          "sentiment": 0.0,
          "engagement": "4,370",
          "price_at_post": "7.75",
          "thread_title": "RE: Sweetbiotix - New details but what does it mean?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=DE1D15F8-928F-4BCA-ADA0-E2EC1D44A250"
        },
        "ingested_at": "2026-01-21T02:43:14.908193Z"
      },
      {
        "event_id": "SOCIAL-23Jan20261414-Makingmi-87586839",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624513",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Good to get a positive users review. Take a look at the share price graph. I would describe this as being very much still at a low. Very low in fact",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-01-24T02:34:41.642406+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261413-Siouks-59712918",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624946",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I believe that the market did not react to those news yet, but will see soon enough if I was right. At those lvls we see in and out gamblers more then serious holders. Time will tell",
          "sentiment": 0.0,
          "engagement": "984",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642446+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261322-Dad41325--3695790",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625401",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Just bought online gut health 3 boxes with free delivery, very easy to use website delivery was quick & packaging is very good. Product instructions are very clear and easy to use which is great for people like me who hate reading small print! 40% off voucher for next order and a free tomato soup to try. Very happy with the service\u2026 Thinking of buying a few shares a bit annoyed I missed the low but still think it\u2019s worth a go\u2026.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "8.00",
          "thread_title": "Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-01-24T02:34:41.642482+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261312-Makingmi-30427044",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625817",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think I said before, but it\u2019s amazing how people will wait until the price is moving up and buy at much higher prices, missing the perfect opportunity to buy now as we are seeing signs of improvement going forward but still in my view at  a very oversold price. Yes it seems to have taken a long time coming and especially so for long term holders. But if things fall into place it could move up considerably and probably quite quickly once more evidence comes through.",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642508+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261216-Friedman--4856557",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626247",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only surprise for me so far is that word is taking so long to get out and investors haven\u2019t reacted more to this news. I know initially the volume was huge but I expected the price  to grow over the following days",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642526+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261152-skid35-32823915",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626676",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. You shouldn't have to read an RNS a few times to understand it. The title of the RNS is \"Large order and Record Early Orders for 2026\" - its about orders. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". They didnt \"secure\" the \u00a3800k of orders in 2026 did they, what they secured is the backlog and 2026 income associated with the backlog from Nov 25 and Jan 26 orders. You shouldn't have to realise this from other paragraphs. This is like a conversation with a two year old.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642544+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261046-Letitrun-20005359",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627111",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not really Skid they\u2019re being transparent that part of the \u00a3800k for delivery and for reporting in accounts in fy 2026 includes the order from November. They\u2019re quite clearly talking about secured orders for reporting in FY2026. It doesn\u2019t say anywhere these orders were all received in 2026, just that they have \u00a3800k secured for 2026. This is like conversations with my wife!",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642563+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260957-skid35--4200132",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627540",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. 1. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". So these are ordered RECIEVED wholly in 2026 from four partners for \u00a3800k 2. \"These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners\". So still the four partners, but now one of these was from an order in November 2025. So contradictory statements.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642580+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260955-lordload-16907131",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627959",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - totally agree. Hopefully, when it comes to updates, the days of talking in riddles are now over. There suddenly seems to be a concerted attempt to engage with investors much more clearly & directly. Rather than through dodgy middlemen with personal agendas. Long may it continue.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642599+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260908-Friedman-55698338",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628384",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I\u2019m pretty cynical with SOH these days but for what it\u2019s worth, I thought that this RNS was refreshingly clear. It tells me how much revenue there is and when that revenue will be booked and it also adds that this is guaranteed.",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642617+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260848-Letitrun--6782976",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Sorry Skid would have to say you wouldn\u2019t cut it as my accountant\u2026 not sure how there is any issue of clarity \u201cThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts\u201d Clearly defines the value and when they will be delivered AND \u2018when they will be reported in the company accounts for FY2026\u2019 I can only assume you are taking the p**s",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642634+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20262208-skid35--5902279",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629247",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun, so the orders haven't been received but are confirmed with no cancellation? The issue is the lack.of clarity of the value. And as a qualified accountant the contractual terms determine income recognition - you don't have to have shipped to the customer to recognise income, alternatively you still may not have income even if you have delivered.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642652+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261835-Tatty99--8871312",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629659",
        "source": "LSE_CHAT",
        "data": {
          "author": "Tatty99",
          "content": "Adyan is correct. No accounting entry can be made until goods dispatched.  So the order cannot be recognised as income or 'receivable' until goods dispatched i.e this year.",
          "sentiment": 0.0,
          "engagement": "947",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642670+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261315-Letitrun-66344874",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630080",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "It doesn\u2019t say received it says orders \u2018secured\u2019 as a great start for 2026. It doesn\u2019t need clarifying it\u2019s quite clear and literally quotes all will be reported in 2026 accounts.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642688+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261305-martinu-35194468",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630508",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "I would guess (and that's the point we shouldn't have to), that the Nov 25 order (included in the \u00a3800k total) will be booked in 2026.  This is an opportunity to seek clarity via the new Q&A portal.  Responses are coming within a day.",
          "sentiment": 0.0,
          "engagement": "1,677",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642705+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261247-skid35-16670751",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630938",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "\"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\" Looking at this again, this really is just appalling, shockingly poor. So - \u00a3800k from four partners where the order have been received in 2026 - but in a later sentence somehow the \u00a3800k of orders  received in 2026 now includes the order from November 2025 ??????? So it is 1. we have a record start with orders received in 2026 together with the order in November now providing a backlog of \u00a3800k  2. Or a higher amount (say \u00a3950k but not explicitly mentioned) will be recognised in 2026 - the \u00a3800k of new orders plus unknown value of the Nov deal.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642724+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261207-Adyan920-17435394",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631384",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "@skid35 - The RNS did confuse me too at first, but on second read it made sense. Generally, when customers place orders they won't be recorded in our accounts until delivery. By adding that line, it clarified that: 1. The Nov order won't show in the 2025 account 2. It is instead  included in the the \u00a3800k order confirmed for 2026, which should also be delivered in 2026. This actually is being more open, as they could have easily not included that line and investors could have easily assumed the Nov order will be in the 2025 accounts and all the \u00a3800k announced are all brand new orders not mentioned before.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "8.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642744+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262216-Letitrun--8834437",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631804",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "\u2018this approach has delivered a record start to FY2026, with over \u00a3800k in orders secured from four partners. These will be delivered at various points throughout 2026 where they will be reported and recorded in the company\u2019s full year 2026 accounts.\u2019 Later states these 4 partners are the order from November for delivery in H1 2026, Meelung and two other partners.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642762+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262159-Letitrun--5563408",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632226",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642781+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262058-skid35--4633825",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632642",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642799+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262020-Friedman--6066760",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633075",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642817+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262019-Adyan920-57123392",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633514",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642835+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261617-Letitrun--3277059",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633927",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642853+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261604-lordload--8970072",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634361",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642871+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261533-Adyan920--4325660",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-24T02:34:41.642890+00:00"
      },
      {
        "event_id": "SOCIAL-Today1222-VeritasL-75869477",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152145",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-29T12:23:18.147728+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261617-Makingmi--2030990",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152663",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Not sure that\u2019s true. Never actually made any short trades but when experimenting in the past, found shorting was available but not for any share you might decide on. Very unlikely to be available on tiny market cap shares like this. Agree though many more traders operate now, and happy to take a quick profit and move on. And it was a profit worth taking to many, obviously. Whether they will be waiting to get back in once it comes back a bit, we shall see, but a bit of a risky game to play. Without the potential here and the so low price, you could see the attraction of the quick gain, but given those factors, to me anyway, it is more sensible to hold for the much bigger rise to come.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-01-29T12:23:18.147770+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261448-Siouks--3472632",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153194",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Pump a buy orders to raise the price, once you get to the right level, open a short position, start selling all what you bought to drop the price down. This way you also make money on the way down and that's how thing are played here, not a huge secret...",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.25",
          "thread_title": "And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-01-29T12:23:18.147805+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261743-martinu-20190744",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153726",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Also, if any of you haven't signed up for new Q&A facility on website, I strongly recommend you do. This Q&A from / to Andy777 is particularly positive on Amazon, China (after change to partner) and for Asia in FY26 Andy777 \"Hi.  Have the ecommerce sales continued to grow significantly into H2 2025 and early 2026.  How important is the ecommerce relative to deals with companies like Morepen, and the other US and asian companies? Hi, Ecommerce is one of four areas we have been investing in to grow. These are Asia, India, USA and what we call Consumer Health (Amazon, our own website, Ebay, China and recently India). Amazon is one of the worlds biggest ecommerce market place which we have invested in to build a large customer base and it continued to grow in 2025 with marketing investment. Our focus now is on profitability on Amazon which we hope to achieve this month or next. This should then grow into a highly profitable business.  Our own website is already profitable. China should become profitable in Q2 as we changed our partner last summer and have been clearing stock with a short shelf life at discount. Once this is clear we should be profitable in China.  This is all part of building a business - building a brand, product range and customer base.  Ecommerce is part of that mix and reduces our dependency on partners. You cannot have a dependency on one part of the business, one product, one partner, or one country. We need more partners in India and the USA to reduce any future dependency. Asia is showing great growth and will make a significant contribution to sales in 2026. \"",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-29T12:23:18.147840+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261642-lordload-42579817",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154264",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Troajan - thanks for the interview link SOH has oft lamented Opti being undervalued by investors. But it's a bit chicken & egg. Until meaningful (& sustainable) sales come through & profits start to emerge, investors are understandably cautious. The year has started well. We need that momentum to continue - and something meaningful to happen with Sweetbiotix rather than just endless talks. Then the current SP will start looking somewhat ridiculous. But not until then I suspect.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-29T12:23:18.147876+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261519-Siouks-44685197",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154761",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "The same ones who bought shares at 6.00. Sold out at 07.00-08.00 Once they are out we will see what comes next;)",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.147913+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261344-Troajan--2117151",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155300",
        "source": "LSE_CHAT",
        "data": {
          "author": "Troajan",
          "content": "Https://www.proactiveinvestors.co.uk/companies/news/1086319/optibiotix-health-slimbiome-demand-grows-as-glp-1-alternatives-surge-1086319.html",
          "sentiment": 0.0,
          "engagement": "125,652",
          "price_at_post": "7.75",
          "thread_title": "Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-29T12:23:18.147951+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261219-Makingmi-14239013",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155877",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Siouks, Looks like you may have been right. Seems their  patience levels ran out after a week. lol",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.147985+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261532-Siouks-11039332",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.682699",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "As I said. There is a huge potential in a market, all depends how they going to use it. In my opinion marketing is the key but we all have our own opionion",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-29T12:23:18.148016+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261509-Bottmzup-24199254",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683390",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bottmzup",
          "content": "In my experience, after a positive update on a lot of shares, there's always a slow or delayed reaction while the news is digested by the wider market. After being in an oversold level for a period of time, I'm guessing the same thing to happen here. Todays high volume has broken above a falling trend line on the chart which has been falling since Aug '25, that will get noticed.",
          "sentiment": 0.0,
          "engagement": "6,753",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-29T12:23:18.148049+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261446-Siouks--2968877",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683859",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Such a high volume today with over 100k buys and this is only on 17% raise... wierd.  With such an important update I was looking for over a 10 with sp, and we are basicly were it was. Whoever bought at 6 will sell it at over 7 and we still wait for proper news. If it would be higher maybe worth again to open shorts",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-29T12:23:18.148081+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261110-Friedman-40103032",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.684398",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Good news. Actual numbers. Let\u2019s hope we can build from here.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148132+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261100-Dad41325-58788253",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.685311",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Was looking back on RNS 23/05/25 \u00a3500k investment from an American institutional investor at 14p a share, Asia seems to be going well maybe the US will be next to bring in some big orders.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "7.50",
          "thread_title": "Bold investment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=86086D0C-7204-4260-867E-ED4A91DB1A3E"
        },
        "ingested_at": "2026-01-29T12:23:18.148163+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-Letitrun-35933141",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686138",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Should be an easy bag or possibly 2 from here following today\u2019s news. With \u00a3800k in the bag for the year ahead & 11+ months left the share price seems to have fallen well below where it should on sentiment alone. They also have \u00a3100k milestone for Sweetbiotix & in 2024 their e-commerce business did just shy of \u00a3400k to add to 2026. Looking like momentum is actually gathering here. Any serious news on sweetbiotix this will have a major rerate",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148185+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-martinu-24979474",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686917",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes positive update.  Good that clarification was given that these orders will be recorded as revenues in FY 26. As sometimes Opti orders take months to be recognised.  Fingers crossed for more progress.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148223+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260943-skid35--6263342",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.687742",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Positive RNS today, glad to see all shareholders being treated equally from yesterdays RNS. Still hope there was something in the director buys late last year well above the current share price.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148256+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260802-Makingmi-24322740",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.688556",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well pleased with today\u2019s and yesterday\u2019s news. Things starting to look more positive going forward. No need to be racing to buy in now as already all in. Just sit and wait. Very positive feelings confirmed and even Blubs must consider those comments justified. lol.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148293+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun--4539256",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.689333",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-29T12:23:18.148317+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu--7021211",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690126",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-29T12:23:18.148336+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu--7896895",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690882",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148354+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu-19187509",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.691677",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148378+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920-89240345",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.692465",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148407+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu--2270974",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.693251",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148426+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul--7096287",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694043",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148445+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman--3188069",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694840",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148469+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul--2846052",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115085",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148488+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons-61883833",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115632",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148517+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--6837021",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116172",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148543+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-61074049",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116742",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-29T12:23:18.148561+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL-32367135",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117282",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-29T12:23:18.148581+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi--6442656",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117789",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-29T12:23:18.148600+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu--1384566",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118243",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-29T12:23:18.148619+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman-70550567",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118672",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148653+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks-54976264",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119114",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148673+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba-55807624",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119536",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-29T12:23:18.148692+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi--2978103",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119960",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148711+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35-86395187",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.120680",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148730+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49--6133739",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.121481",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148751+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi--6779479",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.122281",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148783+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu-28625596",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123073",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148802+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi-60374399",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123876",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148821+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload--7406090",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.124713",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148840+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi--7891262",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.125517",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.148859+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex-29798644",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.126329",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "128",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-01-29T12:23:18.148885+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu--6730565",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127088",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-29T12:23:18.148914+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu--3511920",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127864",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-29T12:23:18.148932+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35--6496488",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.128643",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-29T12:23:18.148951+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang--2738245",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.129432",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "2,062",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-29T12:23:18.148979+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload-10058377",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.130214",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-29T12:23:18.149014+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks-49399627",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.131000",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-29T12:23:18.149046+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261414-Makingmi--7243710",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624513",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Good to get a positive users review. Take a look at the share price graph. I would describe this as being very much still at a low. Very low in fact",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-01-29T12:23:18.149084+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261413-Siouks-37447316",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624946",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I believe that the market did not react to those news yet, but will see soon enough if I was right. At those lvls we see in and out gamblers more then serious holders. Time will tell",
          "sentiment": 0.0,
          "engagement": "984",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149138+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261322-Dad41325--4465194",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625401",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Just bought online gut health 3 boxes with free delivery, very easy to use website delivery was quick & packaging is very good. Product instructions are very clear and easy to use which is great for people like me who hate reading small print! 40% off voucher for next order and a free tomato soup to try. Very happy with the service\u2026 Thinking of buying a few shares a bit annoyed I missed the low but still think it\u2019s worth a go\u2026.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "8.00",
          "thread_title": "Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-01-29T12:23:18.149174+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261312-Makingmi--4372099",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625817",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think I said before, but it\u2019s amazing how people will wait until the price is moving up and buy at much higher prices, missing the perfect opportunity to buy now as we are seeing signs of improvement going forward but still in my view at  a very oversold price. Yes it seems to have taken a long time coming and especially so for long term holders. But if things fall into place it could move up considerably and probably quite quickly once more evidence comes through.",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149195+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261216-Friedman--5256073",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626247",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only surprise for me so far is that word is taking so long to get out and investors haven\u2019t reacted more to this news. I know initially the volume was huge but I expected the price  to grow over the following days",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149214+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261152-skid35--9009566",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626676",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. You shouldn't have to read an RNS a few times to understand it. The title of the RNS is \"Large order and Record Early Orders for 2026\" - its about orders. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". They didnt \"secure\" the \u00a3800k of orders in 2026 did they, what they secured is the backlog and 2026 income associated with the backlog from Nov 25 and Jan 26 orders. You shouldn't have to realise this from other paragraphs. This is like a conversation with a two year old.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149233+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261046-Letitrun-61988152",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627111",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not really Skid they\u2019re being transparent that part of the \u00a3800k for delivery and for reporting in accounts in fy 2026 includes the order from November. They\u2019re quite clearly talking about secured orders for reporting in FY2026. It doesn\u2019t say anywhere these orders were all received in 2026, just that they have \u00a3800k secured for 2026. This is like conversations with my wife!",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149252+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260957-skid35--2257556",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627540",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. 1. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". So these are ordered RECIEVED wholly in 2026 from four partners for \u00a3800k 2. \"These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners\". So still the four partners, but now one of these was from an order in November 2025. So contradictory statements.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149282+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260955-lordload--6434954",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627959",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - totally agree. Hopefully, when it comes to updates, the days of talking in riddles are now over. There suddenly seems to be a concerted attempt to engage with investors much more clearly & directly. Rather than through dodgy middlemen with personal agendas. Long may it continue.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149317+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260908-Friedman--3688510",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628384",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I\u2019m pretty cynical with SOH these days but for what it\u2019s worth, I thought that this RNS was refreshingly clear. It tells me how much revenue there is and when that revenue will be booked and it also adds that this is guaranteed.",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149352+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260848-Letitrun--7196150",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Sorry Skid would have to say you wouldn\u2019t cut it as my accountant\u2026 not sure how there is any issue of clarity \u201cThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts\u201d Clearly defines the value and when they will be delivered AND \u2018when they will be reported in the company accounts for FY2026\u2019 I can only assume you are taking the p**s",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149389+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20262208-skid35-44001507",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629247",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun, so the orders haven't been received but are confirmed with no cancellation? The issue is the lack.of clarity of the value. And as a qualified accountant the contractual terms determine income recognition - you don't have to have shipped to the customer to recognise income, alternatively you still may not have income even if you have delivered.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149428+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261835-Tatty99-43135570",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629659",
        "source": "LSE_CHAT",
        "data": {
          "author": "Tatty99",
          "content": "Adyan is correct. No accounting entry can be made until goods dispatched.  So the order cannot be recognised as income or 'receivable' until goods dispatched i.e this year.",
          "sentiment": 0.0,
          "engagement": "947",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149465+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261315-Letitrun--3513588",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630080",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "It doesn\u2019t say received it says orders \u2018secured\u2019 as a great start for 2026. It doesn\u2019t need clarifying it\u2019s quite clear and literally quotes all will be reported in 2026 accounts.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149497+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261305-martinu--8482776",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630508",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "I would guess (and that's the point we shouldn't have to), that the Nov 25 order (included in the \u00a3800k total) will be booked in 2026.  This is an opportunity to seek clarity via the new Q&A portal.  Responses are coming within a day.",
          "sentiment": 0.0,
          "engagement": "1,677",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149532+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261247-skid35--8944262",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630938",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "\"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\" Looking at this again, this really is just appalling, shockingly poor. So - \u00a3800k from four partners where the order have been received in 2026 - but in a later sentence somehow the \u00a3800k of orders  received in 2026 now includes the order from November 2025 ??????? So it is 1. we have a record start with orders received in 2026 together with the order in November now providing a backlog of \u00a3800k  2. Or a higher amount (say \u00a3950k but not explicitly mentioned) will be recognised in 2026 - the \u00a3800k of new orders plus unknown value of the Nov deal.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149566+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261207-Adyan920--6427430",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631384",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "@skid35 - The RNS did confuse me too at first, but on second read it made sense. Generally, when customers place orders they won't be recorded in our accounts until delivery. By adding that line, it clarified that: 1. The Nov order won't show in the 2025 account 2. It is instead  included in the the \u00a3800k order confirmed for 2026, which should also be delivered in 2026. This actually is being more open, as they could have easily not included that line and investors could have easily assumed the Nov order will be in the 2025 accounts and all the \u00a3800k announced are all brand new orders not mentioned before.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "8.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149595+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262216-Letitrun-44691273",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631804",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "\u2018this approach has delivered a record start to FY2026, with over \u00a3800k in orders secured from four partners. These will be delivered at various points throughout 2026 where they will be reported and recorded in the company\u2019s full year 2026 accounts.\u2019 Later states these 4 partners are the order from November for delivery in H1 2026, Meelung and two other partners.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149614+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262159-Letitrun--1785872",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632226",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149633+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262058-skid35--6565852",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632642",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149651+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262020-Friedman-63094746",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633075",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149670+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262019-Adyan920--4478586",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633514",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149688+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261617-Letitrun--5862562",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633927",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149707+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261604-lordload-87006373",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634361",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149726+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261533-Adyan920-58943002",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-29T12:23:18.149744+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260727-AquaeSul-42280677",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469249",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "But it doesn't stop the big companies from investing in weight loss jabs rather than alternative treatments. www.londonstockexchange.com/news-article/AZN/astrazeneca-agrees-obesity-and-t2d-deal-with-cspc/17437893",
          "sentiment": 0.0,
          "engagement": "4,408",
          "price_at_post": "7.25",
          "thread_title": "RE: Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-01-31T00:08:51.579732+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260015-Adyan920-76613015",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469692",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "Interesting article about increase in gallbladder removals with people saying they have taken weight loss injections. https://www.bbc.co.uk/news/articles/cm24evgyyzpo",
          "sentiment": 0.0,
          "engagement": "176",
          "price_at_post": "7.25",
          "thread_title": "Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-01-31T00:08:51.579769+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261606-skid35--3865190",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470123",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Just need OPTI to be at a self sustaining breakeven position, a position it should be in now so as shareholders we \"bank\" the SBTX and PBT when looking at OPTIs market cap. If the holding continue to reduce with the cash then wasted in OPTI the value can be disregarded - as it currently is.",
          "sentiment": 0.0,
          "engagement": "3,922",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-31T00:08:51.579791+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261323-martinu-33740461",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470552",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Veritas,  absolutely agree re PBX.  I think Steen's aspiration of \u00a310m sales might take a while,  but I'm very happy with progress there. On SBTX, I agree they could appreciate this year, but is there some nervousness over Croda customers' delay in launching a Zenakine product. As for Opti, things are looking more positive there.  But consistently growing numbers will be needed to restore market confidence.",
          "sentiment": 0.0,
          "engagement": "1,683",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-31T00:08:51.579810+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261222-VeritasL--4845251",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470967",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-31T00:08:51.579829+00:00"
      },
      {
        "event_id": "SOCIAL-Today1222-VeritasL--4845251",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152145",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-31T00:08:51.579852+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261617-Makingmi--7723950",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152663",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Not sure that\u2019s true. Never actually made any short trades but when experimenting in the past, found shorting was available but not for any share you might decide on. Very unlikely to be available on tiny market cap shares like this. Agree though many more traders operate now, and happy to take a quick profit and move on. And it was a profit worth taking to many, obviously. Whether they will be waiting to get back in once it comes back a bit, we shall see, but a bit of a risky game to play. Without the potential here and the so low price, you could see the attraction of the quick gain, but given those factors, to me anyway, it is more sensible to hold for the much bigger rise to come.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-01-31T00:08:51.579872+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261448-Siouks-45489744",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153194",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Pump a buy orders to raise the price, once you get to the right level, open a short position, start selling all what you bought to drop the price down. This way you also make money on the way down and that's how thing are played here, not a huge secret...",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.25",
          "thread_title": "And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-01-31T00:08:51.579891+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261743-martinu--5709696",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153726",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Also, if any of you haven't signed up for new Q&A facility on website, I strongly recommend you do. This Q&A from / to Andy777 is particularly positive on Amazon, China (after change to partner) and for Asia in FY26 Andy777 \"Hi.  Have the ecommerce sales continued to grow significantly into H2 2025 and early 2026.  How important is the ecommerce relative to deals with companies like Morepen, and the other US and asian companies? Hi, Ecommerce is one of four areas we have been investing in to grow. These are Asia, India, USA and what we call Consumer Health (Amazon, our own website, Ebay, China and recently India). Amazon is one of the worlds biggest ecommerce market place which we have invested in to build a large customer base and it continued to grow in 2025 with marketing investment. Our focus now is on profitability on Amazon which we hope to achieve this month or next. This should then grow into a highly profitable business.  Our own website is already profitable. China should become profitable in Q2 as we changed our partner last summer and have been clearing stock with a short shelf life at discount. Once this is clear we should be profitable in China.  This is all part of building a business - building a brand, product range and customer base.  Ecommerce is part of that mix and reduces our dependency on partners. You cannot have a dependency on one part of the business, one product, one partner, or one country. We need more partners in India and the USA to reduce any future dependency. Asia is showing great growth and will make a significant contribution to sales in 2026. \"",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-31T00:08:51.579909+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261642-lordload-15691595",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154264",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Troajan - thanks for the interview link SOH has oft lamented Opti being undervalued by investors. But it's a bit chicken & egg. Until meaningful (& sustainable) sales come through & profits start to emerge, investors are understandably cautious. The year has started well. We need that momentum to continue - and something meaningful to happen with Sweetbiotix rather than just endless talks. Then the current SP will start looking somewhat ridiculous. But not until then I suspect.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-31T00:08:51.579927+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261519-Siouks--5200921",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154761",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "The same ones who bought shares at 6.00. Sold out at 07.00-08.00 Once they are out we will see what comes next;)",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.579945+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261344-Troajan-83087641",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155300",
        "source": "LSE_CHAT",
        "data": {
          "author": "Troajan",
          "content": "Https://www.proactiveinvestors.co.uk/companies/news/1086319/optibiotix-health-slimbiome-demand-grows-as-glp-1-alternatives-surge-1086319.html",
          "sentiment": 0.0,
          "engagement": "125,652",
          "price_at_post": "7.75",
          "thread_title": "Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-01-31T00:08:51.579964+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261219-Makingmi--8239412",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155877",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Siouks, Looks like you may have been right. Seems their  patience levels ran out after a week. lol",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.579982+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261532-Siouks-58671505",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.682699",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "As I said. There is a huge potential in a market, all depends how they going to use it. In my opinion marketing is the key but we all have our own opionion",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-31T00:08:51.580000+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261509-Bottmzup--6761053",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683390",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bottmzup",
          "content": "In my experience, after a positive update on a lot of shares, there's always a slow or delayed reaction while the news is digested by the wider market. After being in an oversold level for a period of time, I'm guessing the same thing to happen here. Todays high volume has broken above a falling trend line on the chart which has been falling since Aug '25, that will get noticed.",
          "sentiment": 0.0,
          "engagement": "6,753",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-31T00:08:51.580018+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261446-Siouks--2727476",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683859",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Such a high volume today with over 100k buys and this is only on 17% raise... wierd.  With such an important update I was looking for over a 10 with sp, and we are basicly were it was. Whoever bought at 6 will sell it at over 7 and we still wait for proper news. If it would be higher maybe worth again to open shorts",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-01-31T00:08:51.580036+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261110-Friedman-69055505",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.684398",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Good news. Actual numbers. Let\u2019s hope we can build from here.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580054+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261100-Dad41325--6109798",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.685311",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Was looking back on RNS 23/05/25 \u00a3500k investment from an American institutional investor at 14p a share, Asia seems to be going well maybe the US will be next to bring in some big orders.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "7.50",
          "thread_title": "Bold investment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=86086D0C-7204-4260-867E-ED4A91DB1A3E"
        },
        "ingested_at": "2026-01-31T00:08:51.580072+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-Letitrun--5584288",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686138",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Should be an easy bag or possibly 2 from here following today\u2019s news. With \u00a3800k in the bag for the year ahead & 11+ months left the share price seems to have fallen well below where it should on sentiment alone. They also have \u00a3100k milestone for Sweetbiotix & in 2024 their e-commerce business did just shy of \u00a3400k to add to 2026. Looking like momentum is actually gathering here. Any serious news on sweetbiotix this will have a major rerate",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580091+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-martinu--8952392",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686917",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes positive update.  Good that clarification was given that these orders will be recorded as revenues in FY 26. As sometimes Opti orders take months to be recognised.  Fingers crossed for more progress.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580130+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260943-skid35-75228410",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.687742",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Positive RNS today, glad to see all shareholders being treated equally from yesterdays RNS. Still hope there was something in the director buys late last year well above the current share price.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580149+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260802-Makingmi-54003986",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.688556",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well pleased with today\u2019s and yesterday\u2019s news. Things starting to look more positive going forward. No need to be racing to buy in now as already all in. Just sit and wait. Very positive feelings confirmed and even Blubs must consider those comments justified. lol.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580168+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun-34609055",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.689333",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-31T00:08:51.580186+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu-88828471",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690126",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-01-31T00:08:51.580204+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu--6765020",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690882",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580222+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu-41782342",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.691677",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580240+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920-28494319",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.692465",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580257+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu--3721770",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.693251",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580276+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul-22312569",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694043",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580294+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman--7848772",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694840",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580313+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul-32164303",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115085",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580330+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons--3024586",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115632",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580349+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-31856348",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116172",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580367+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--4372134",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116742",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-01-31T00:08:51.580385+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL-21717445",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117282",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-31T00:08:51.580403+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi--2673507",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117789",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-31T00:08:51.580422+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu-58806357",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118243",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-01-31T00:08:51.580439+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman-15777121",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118672",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580458+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks-49999359",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119114",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580475+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba-10437924",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119536",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-01-31T00:08:51.580494+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi--8203825",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119960",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580512+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35--1977213",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.120680",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580530+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49-26606217",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.121481",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580548+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi-49839726",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.122281",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580566+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu-32372289",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123073",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580585+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi--1208281",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123876",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580604+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload--8573942",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.124713",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580623+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi-45587867",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.125517",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580641+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex--5135904",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.126329",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "128",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-01-31T00:08:51.580660+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu-91558494",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127088",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-31T00:08:51.580678+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu--5131776",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127864",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-31T00:08:51.580696+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35--1688893",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.128643",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-31T00:08:51.580714+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang-49511914",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.129432",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "2,062",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-31T00:08:51.580732+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload--3022548",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.130214",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-31T00:08:51.580751+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks--4827672",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.131000",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-01-31T00:08:51.580769+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261414-Makingmi-59630267",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624513",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Good to get a positive users review. Take a look at the share price graph. I would describe this as being very much still at a low. Very low in fact",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-01-31T00:08:51.580788+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261413-Siouks-47728233",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624946",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I believe that the market did not react to those news yet, but will see soon enough if I was right. At those lvls we see in and out gamblers more then serious holders. Time will tell",
          "sentiment": 0.0,
          "engagement": "984",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580805+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261322-Dad41325--1979141",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625401",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Just bought online gut health 3 boxes with free delivery, very easy to use website delivery was quick & packaging is very good. Product instructions are very clear and easy to use which is great for people like me who hate reading small print! 40% off voucher for next order and a free tomato soup to try. Very happy with the service\u2026 Thinking of buying a few shares a bit annoyed I missed the low but still think it\u2019s worth a go\u2026.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "8.00",
          "thread_title": "Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-01-31T00:08:51.580824+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261312-Makingmi--8553398",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625817",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think I said before, but it\u2019s amazing how people will wait until the price is moving up and buy at much higher prices, missing the perfect opportunity to buy now as we are seeing signs of improvement going forward but still in my view at  a very oversold price. Yes it seems to have taken a long time coming and especially so for long term holders. But if things fall into place it could move up considerably and probably quite quickly once more evidence comes through.",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580842+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261216-Friedman-75116176",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626247",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only surprise for me so far is that word is taking so long to get out and investors haven\u2019t reacted more to this news. I know initially the volume was huge but I expected the price  to grow over the following days",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580860+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261152-skid35-60956397",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626676",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. You shouldn't have to read an RNS a few times to understand it. The title of the RNS is \"Large order and Record Early Orders for 2026\" - its about orders. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". They didnt \"secure\" the \u00a3800k of orders in 2026 did they, what they secured is the backlog and 2026 income associated with the backlog from Nov 25 and Jan 26 orders. You shouldn't have to realise this from other paragraphs. This is like a conversation with a two year old.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580879+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261046-Letitrun-47534693",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627111",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not really Skid they\u2019re being transparent that part of the \u00a3800k for delivery and for reporting in accounts in fy 2026 includes the order from November. They\u2019re quite clearly talking about secured orders for reporting in FY2026. It doesn\u2019t say anywhere these orders were all received in 2026, just that they have \u00a3800k secured for 2026. This is like conversations with my wife!",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580897+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260957-skid35-75860911",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627540",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. 1. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". So these are ordered RECIEVED wholly in 2026 from four partners for \u00a3800k 2. \"These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners\". So still the four partners, but now one of these was from an order in November 2025. So contradictory statements.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580915+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260955-lordload-91734655",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627959",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - totally agree. Hopefully, when it comes to updates, the days of talking in riddles are now over. There suddenly seems to be a concerted attempt to engage with investors much more clearly & directly. Rather than through dodgy middlemen with personal agendas. Long may it continue.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580934+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260908-Friedman--6317661",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628384",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I\u2019m pretty cynical with SOH these days but for what it\u2019s worth, I thought that this RNS was refreshingly clear. It tells me how much revenue there is and when that revenue will be booked and it also adds that this is guaranteed.",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580952+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260848-Letitrun--5250410",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Sorry Skid would have to say you wouldn\u2019t cut it as my accountant\u2026 not sure how there is any issue of clarity \u201cThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts\u201d Clearly defines the value and when they will be delivered AND \u2018when they will be reported in the company accounts for FY2026\u2019 I can only assume you are taking the p**s",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580970+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20262208-skid35-58271044",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629247",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun, so the orders haven't been received but are confirmed with no cancellation? The issue is the lack.of clarity of the value. And as a qualified accountant the contractual terms determine income recognition - you don't have to have shipped to the customer to recognise income, alternatively you still may not have income even if you have delivered.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.580989+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261835-Tatty99-29099807",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629659",
        "source": "LSE_CHAT",
        "data": {
          "author": "Tatty99",
          "content": "Adyan is correct. No accounting entry can be made until goods dispatched.  So the order cannot be recognised as income or 'receivable' until goods dispatched i.e this year.",
          "sentiment": 0.0,
          "engagement": "947",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581007+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261315-Letitrun-37569697",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630080",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "It doesn\u2019t say received it says orders \u2018secured\u2019 as a great start for 2026. It doesn\u2019t need clarifying it\u2019s quite clear and literally quotes all will be reported in 2026 accounts.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581025+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261305-martinu-87147692",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630508",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "I would guess (and that's the point we shouldn't have to), that the Nov 25 order (included in the \u00a3800k total) will be booked in 2026.  This is an opportunity to seek clarity via the new Q&A portal.  Responses are coming within a day.",
          "sentiment": 0.0,
          "engagement": "1,677",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581044+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261247-skid35--3176215",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630938",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "\"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\" Looking at this again, this really is just appalling, shockingly poor. So - \u00a3800k from four partners where the order have been received in 2026 - but in a later sentence somehow the \u00a3800k of orders  received in 2026 now includes the order from November 2025 ??????? So it is 1. we have a record start with orders received in 2026 together with the order in November now providing a backlog of \u00a3800k  2. Or a higher amount (say \u00a3950k but not explicitly mentioned) will be recognised in 2026 - the \u00a3800k of new orders plus unknown value of the Nov deal.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581062+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261207-Adyan920--6419381",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631384",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "@skid35 - The RNS did confuse me too at first, but on second read it made sense. Generally, when customers place orders they won't be recorded in our accounts until delivery. By adding that line, it clarified that: 1. The Nov order won't show in the 2025 account 2. It is instead  included in the the \u00a3800k order confirmed for 2026, which should also be delivered in 2026. This actually is being more open, as they could have easily not included that line and investors could have easily assumed the Nov order will be in the 2025 accounts and all the \u00a3800k announced are all brand new orders not mentioned before.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "8.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581080+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262216-Letitrun--3204024",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631804",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "\u2018this approach has delivered a record start to FY2026, with over \u00a3800k in orders secured from four partners. These will be delivered at various points throughout 2026 where they will be reported and recorded in the company\u2019s full year 2026 accounts.\u2019 Later states these 4 partners are the order from November for delivery in H1 2026, Meelung and two other partners.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581110+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262159-Letitrun--1654052",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632226",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581132+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262058-skid35--6196946",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632642",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581150+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262020-Friedman-77629576",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633075",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581168+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262019-Adyan920-53941434",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633514",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581187+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261617-Letitrun-57580495",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633927",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581205+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261604-lordload--9070973",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634361",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581223+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261533-Adyan920-49344224",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-01-31T00:08:51.581241+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20262201-Adyan920-18901868",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.528759",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "The big issue has been: 1. The DSM Merger, which really delayed work on Swetbiotix. Meant new teams etc. 2. DSM were trying to go straight to a 100 ton batch rather than working their way up. Because of the long time they've taken, it does seem SOH has decided to try and partner with some smaller suppliers in case DSM keep delaying and taking so long. This is the right thing to do, imagine if we had done that before, we could have had sweetbiotix fully commercialised a long time ago.",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451262+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20262105-Friedman-20278928",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.529591",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks AS, Sounds like we may have multiple Sweet offerings then with different formulations. I hadn\u2019t realised that (or I\u2019d forgotten).",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451307+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261639-martinu--2872925",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.530435",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "AS, thanks for clarifying that.  The question was  a bit above my pay grade. :) Because the progress on Sweet has been so slow with the big partners , possibly due to non prioritisation,  I was hoping SOH would pursue Sweet with smaller partners with perhaps more focus on Opti.  I think that was a \"yes\" from SOH.  So fingers crossed.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451348+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261520-AquaeSul-30735795",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.531246",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Friedman, unlike the US Partner who pays a pre Launch royalty for exclusivity for Monkfruit based sweetbiotix, DSM Firmenich pay no such royalty for stevenoil based sweetbiotix and have no exclusivity. Also, the extra dimension of sucrose based sweetbiotix has subsequently been introduced following the discovery of the new enzyme which neither partner has exclusive rights to",
          "sentiment": 0.0,
          "engagement": "4,417",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451386+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261230-Friedman-51232274",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.531883",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Martinu, I\u2019ve since worked out how to read them Good questions from you and others. There is a little bit of confusion for me and what appears to be conflicting information on the change in the manufacturing process of Sweet. He talks about working with DSM to help scale up manufacturing and the discovery of a new enzyme, and yet also talks working with smaller manufacturers to manufacture Sweet. I guess he could be talking about manufacturing at scale for larger buyers and lesser quantities for smaller buyers but wouldn\u2019t that breach the contract with DSM to have someone else manufacture it",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451424+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261141-martinu-68698474",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.532506",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "FS, it's not a summary it lists all questions and answers and is too long to cut and paste.  You will get the same info if you go to the website.  Though you do have to go through the menu to find Q&A. I couldn't submit questions on phone as the submit tab dropped out of sight.  But no problems using laptop.  Good luck.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451463+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261122-Friedman-46190439",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.533334",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...read it",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451502+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261048-Friedman--5777807",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.533780",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I joined the Q&A bit too late to receive the summary email. Any chance someone could post the main parts here please. Thank you. It also is a bit of a bugger to use on you phone so I'm struggling to r",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451540+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261224-Makingmi-26951530",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.534314",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think the new feature is an excellent tool for both the company and investors. It seems to be working well judging by Q & A to date. The biggest challenge is to get folk looking forward positively, rather than backwards negatively. It\u2019s been a long journey but there seems some very positive potential going forward. This, to be expected dip, allows for good time to join the ride up.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451580+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261021-martinu--8563655",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.534968",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Agree.  I've asked and had responses to a few questions.  A great initiative which might give prospective shareholders a bit of confidence.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.40",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451617+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260236-aspex--3224752",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.535414",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "Surprised there is no response here to the mail out summary. Of course there is nothing new but it is good to have a renewed base.",
          "sentiment": 0.0,
          "engagement": "129",
          "price_at_post": "7.65",
          "thread_title": "Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-07T00:18:57.451656+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261559-Bk2011-50329866",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.535823",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bk2011",
          "content": "Delayed 200k buy showing as a sell",
          "sentiment": 0.0,
          "engagement": "255",
          "price_at_post": "7.65",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-07T00:18:57.451693+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261520-Makingmi--7804346",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.536352",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "It\u2019s just out there. Please yourself how you view it. Just seemed to be attacking fruit in flavouring as well and thought could increase opportunity for us to fill another gap. I can only read it, but can\u2019t vouch for accuracy.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.65",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-07T00:18:57.451731+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261513-skid35--4188825",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.537145",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Daily mail, bound to be 100% accurate then.",
          "sentiment": 0.0,
          "engagement": "3,933",
          "price_at_post": "7.40",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-07T00:18:57.451769+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261508-Makingmi-35787755",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.537941",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Looks like price ready to make next leg up.  Still a good way to go yet in my view.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.40",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-07T00:18:57.451807+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261321-Makingmi-13076038",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.538938",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "By Xantha Leatham, Executive Science Editor Listen to article TOMATOES and fruit could be stripped from pasta sauces and yogurts under Labour's sugar crackdown, supermarket bosses have warned Government plans to label thousands of products containing sugar as 'unhealthy' would encourage manufacturers to replace natural ingredients such as bananas with artificial sweeteners, food chiefs say. Last week, officials updated the classification system for what foods are deemed healthy and unhealthy. The new rules would mean 'free sugars' - released from fruit and vegetables when pureed - would be in the same category as salt and saturated fats. This means products containing fruit and vegetable purees could join crisps, sweets and biscuits in the TV ban on advertising between 5.30am and 9pm. Stuart Machin, the chief executive of Marks & Spencer, said the plans were 'nonsensical' ', and 'encourages us to remove fruit purees from yogurts or tomato paste from pasta sauces and replace them with artificial sweeteners, The Sunday Telegraph reported. Meanwhile a spokesman for Mars Food & Nutrition, makers of Dolmio sauce, said the rules could mean vegetable and fruit purees and pastes are replaced with ingredients of 'lower nutrient density'. '. The Food and Drink Federation said the policy would make it harder for consumers to reach government targets of five fruit or vegetables each day. A report from yogurt maker Danone warned consumers are becoming 'overwhelmed' by conflicting advice on 'healthy' food. A Department of Health spokesman said: 'Most children are consuming more than twice the recommended amount of free sugars, and more than one in three 11-year-olds are growing up overweight or obese. 'We want to work with the food industry to make sure it is the healthy choices being advertised and not the less healthy ones so families have the right information to be able to make the healthy choice.' 4)) \u51f8 Was article in Daily Mail today. OPTI to the rescue again perhaps.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-07T00:18:57.451844+00:00"
      },
      {
        "event_id": "SOCIAL-1Feb20260936-7777--5585471",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.539490",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "CHELSEA 3 WEST HAM UNITED 2 & SWBTX is coming soon LoL",
          "sentiment": 0.0,
          "engagement": "56",
          "price_at_post": "7.25",
          "thread_title": "GET THE OUZO OUT !!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=1334E49F-B073-4060-9FAB-75832F5D04CA"
        },
        "ingested_at": "2026-02-07T00:18:57.451882+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260727-AquaeSul-19371207",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469249",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "But it doesn't stop the big companies from investing in weight loss jabs rather than alternative treatments. www.londonstockexchange.com/news-article/AZN/astrazeneca-agrees-obesity-and-t2d-deal-with-cspc/17437893",
          "sentiment": 0.0,
          "engagement": "4,408",
          "price_at_post": "7.25",
          "thread_title": "RE: Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-02-07T00:18:57.451922+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260015-Adyan920--6618605",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469692",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "Interesting article about increase in gallbladder removals with people saying they have taken weight loss injections. https://www.bbc.co.uk/news/articles/cm24evgyyzpo",
          "sentiment": 0.0,
          "engagement": "176",
          "price_at_post": "7.25",
          "thread_title": "Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-02-07T00:18:57.451961+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261606-skid35-31442471",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470123",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Just need OPTI to be at a self sustaining breakeven position, a position it should be in now so as shareholders we \"bank\" the SBTX and PBT when looking at OPTIs market cap. If the holding continue to reduce with the cash then wasted in OPTI the value can be disregarded - as it currently is.",
          "sentiment": 0.0,
          "engagement": "3,922",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-07T00:18:57.452000+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261323-martinu-29955063",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470552",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Veritas,  absolutely agree re PBX.  I think Steen's aspiration of \u00a310m sales might take a while,  but I'm very happy with progress there. On SBTX, I agree they could appreciate this year, but is there some nervousness over Croda customers' delay in launching a Zenakine product. As for Opti, things are looking more positive there.  But consistently growing numbers will be needed to restore market confidence.",
          "sentiment": 0.0,
          "engagement": "1,683",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-07T00:18:57.452038+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261222-VeritasL--1277993",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470967",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-07T00:18:57.452077+00:00"
      },
      {
        "event_id": "SOCIAL-Today1222-VeritasL--1277993",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152145",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-07T00:18:57.452126+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261617-Makingmi-69335971",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152663",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Not sure that\u2019s true. Never actually made any short trades but when experimenting in the past, found shorting was available but not for any share you might decide on. Very unlikely to be available on tiny market cap shares like this. Agree though many more traders operate now, and happy to take a quick profit and move on. And it was a profit worth taking to many, obviously. Whether they will be waiting to get back in once it comes back a bit, we shall see, but a bit of a risky game to play. Without the potential here and the so low price, you could see the attraction of the quick gain, but given those factors, to me anyway, it is more sensible to hold for the much bigger rise to come.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-07T00:18:57.452164+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261448-Siouks--3429951",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153194",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Pump a buy orders to raise the price, once you get to the right level, open a short position, start selling all what you bought to drop the price down. This way you also make money on the way down and that's how thing are played here, not a huge secret...",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.25",
          "thread_title": "And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-07T00:18:57.452202+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261743-martinu-45855276",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153726",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Also, if any of you haven't signed up for new Q&A facility on website, I strongly recommend you do. This Q&A from / to Andy777 is particularly positive on Amazon, China (after change to partner) and for Asia in FY26 Andy777 \"Hi.  Have the ecommerce sales continued to grow significantly into H2 2025 and early 2026.  How important is the ecommerce relative to deals with companies like Morepen, and the other US and asian companies? Hi, Ecommerce is one of four areas we have been investing in to grow. These are Asia, India, USA and what we call Consumer Health (Amazon, our own website, Ebay, China and recently India). Amazon is one of the worlds biggest ecommerce market place which we have invested in to build a large customer base and it continued to grow in 2025 with marketing investment. Our focus now is on profitability on Amazon which we hope to achieve this month or next. This should then grow into a highly profitable business.  Our own website is already profitable. China should become profitable in Q2 as we changed our partner last summer and have been clearing stock with a short shelf life at discount. Once this is clear we should be profitable in China.  This is all part of building a business - building a brand, product range and customer base.  Ecommerce is part of that mix and reduces our dependency on partners. You cannot have a dependency on one part of the business, one product, one partner, or one country. We need more partners in India and the USA to reduce any future dependency. Asia is showing great growth and will make a significant contribution to sales in 2026. \"",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-07T00:18:57.452241+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261642-lordload-85275881",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154264",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Troajan - thanks for the interview link SOH has oft lamented Opti being undervalued by investors. But it's a bit chicken & egg. Until meaningful (& sustainable) sales come through & profits start to emerge, investors are understandably cautious. The year has started well. We need that momentum to continue - and something meaningful to happen with Sweetbiotix rather than just endless talks. Then the current SP will start looking somewhat ridiculous. But not until then I suspect.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-07T00:18:57.452280+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261519-Siouks--2661429",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154761",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "The same ones who bought shares at 6.00. Sold out at 07.00-08.00 Once they are out we will see what comes next;)",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.452318+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261344-Troajan--7866280",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155300",
        "source": "LSE_CHAT",
        "data": {
          "author": "Troajan",
          "content": "Https://www.proactiveinvestors.co.uk/companies/news/1086319/optibiotix-health-slimbiome-demand-grows-as-glp-1-alternatives-surge-1086319.html",
          "sentiment": 0.0,
          "engagement": "125,652",
          "price_at_post": "7.75",
          "thread_title": "Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-07T00:18:57.452357+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261219-Makingmi-65612391",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155877",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Siouks, Looks like you may have been right. Seems their  patience levels ran out after a week. lol",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.452394+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261532-Siouks--8245900",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.682699",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "As I said. There is a huge potential in a market, all depends how they going to use it. In my opinion marketing is the key but we all have our own opionion",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-07T00:18:57.452432+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261509-Bottmzup-53300741",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683390",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bottmzup",
          "content": "In my experience, after a positive update on a lot of shares, there's always a slow or delayed reaction while the news is digested by the wider market. After being in an oversold level for a period of time, I'm guessing the same thing to happen here. Todays high volume has broken above a falling trend line on the chart which has been falling since Aug '25, that will get noticed.",
          "sentiment": 0.0,
          "engagement": "6,753",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-07T00:18:57.452470+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261446-Siouks-67835008",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683859",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Such a high volume today with over 100k buys and this is only on 17% raise... wierd.  With such an important update I was looking for over a 10 with sp, and we are basicly were it was. Whoever bought at 6 will sell it at over 7 and we still wait for proper news. If it would be higher maybe worth again to open shorts",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-07T00:18:57.452507+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261110-Friedman-14137450",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.684398",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Good news. Actual numbers. Let\u2019s hope we can build from here.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.452545+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261100-Dad41325--6825611",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.685311",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Was looking back on RNS 23/05/25 \u00a3500k investment from an American institutional investor at 14p a share, Asia seems to be going well maybe the US will be next to bring in some big orders.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "7.50",
          "thread_title": "Bold investment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=86086D0C-7204-4260-867E-ED4A91DB1A3E"
        },
        "ingested_at": "2026-02-07T00:18:57.452584+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-Letitrun-15244978",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686138",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Should be an easy bag or possibly 2 from here following today\u2019s news. With \u00a3800k in the bag for the year ahead & 11+ months left the share price seems to have fallen well below where it should on sentiment alone. They also have \u00a3100k milestone for Sweetbiotix & in 2024 their e-commerce business did just shy of \u00a3400k to add to 2026. Looking like momentum is actually gathering here. Any serious news on sweetbiotix this will have a major rerate",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.452621+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-martinu--2420216",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686917",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes positive update.  Good that clarification was given that these orders will be recorded as revenues in FY 26. As sometimes Opti orders take months to be recognised.  Fingers crossed for more progress.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.452659+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260943-skid35--8077609",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.687742",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Positive RNS today, glad to see all shareholders being treated equally from yesterdays RNS. Still hope there was something in the director buys late last year well above the current share price.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.452698+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260802-Makingmi--8251614",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.688556",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well pleased with today\u2019s and yesterday\u2019s news. Things starting to look more positive going forward. No need to be racing to buy in now as already all in. Just sit and wait. Very positive feelings confirmed and even Blubs must consider those comments justified. lol.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.452737+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun-34028898",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.689333",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-02-07T00:18:57.452774+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu--2481557",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690126",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-02-07T00:18:57.452812+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu-72364317",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690882",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.452850+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu-91334535",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.691677",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.452888+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920--6721789",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.692465",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.452927+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu--8850005",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.693251",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.452964+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul-31324970",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694043",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.453003+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman--7318430",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694840",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.453041+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul-49269605",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115085",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.453080+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons-41869413",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115632",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.453131+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-29439868",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116172",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.453171+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--6492030",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116742",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-07T00:18:57.453209+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL--7848628",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117282",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-02-07T00:18:57.453248+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi--6207323",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117789",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-02-07T00:18:57.453287+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu--3468619",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118243",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-02-07T00:18:57.453325+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman--3380126",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118672",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453365+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks-50327306",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119114",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453403+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba-60437797",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119536",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-02-07T00:18:57.453442+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi-90767339",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119960",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453480+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35--7082211",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.120680",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453519+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49--4292166",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.121481",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453557+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi-75079284",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.122281",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453597+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu--2027989",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123073",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453644+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi-90795514",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123876",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453684+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload-39764023",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.124713",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453721+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi--8998075",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.125517",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.453761+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex--5598817",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.126329",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "128",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-02-07T00:18:57.453800+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu-10442590",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127088",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-07T00:18:57.453839+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu--6643211",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127864",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-07T00:18:57.453877+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35--1698867",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.128643",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-07T00:18:57.453917+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang--1246580",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.129432",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "2,062",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-07T00:18:57.453956+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload-31216417",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.130214",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-07T00:18:57.453995+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks--2817506",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.131000",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-07T00:18:57.454032+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261414-Makingmi-47141598",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624513",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Good to get a positive users review. Take a look at the share price graph. I would describe this as being very much still at a low. Very low in fact",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-02-07T00:18:57.454071+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261413-Siouks-88358668",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624946",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I believe that the market did not react to those news yet, but will see soon enough if I was right. At those lvls we see in and out gamblers more then serious holders. Time will tell",
          "sentiment": 0.0,
          "engagement": "984",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454122+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261322-Dad41325--8741712",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625401",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Just bought online gut health 3 boxes with free delivery, very easy to use website delivery was quick & packaging is very good. Product instructions are very clear and easy to use which is great for people like me who hate reading small print! 40% off voucher for next order and a free tomato soup to try. Very happy with the service\u2026 Thinking of buying a few shares a bit annoyed I missed the low but still think it\u2019s worth a go\u2026.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "8.00",
          "thread_title": "Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-02-07T00:18:57.454161+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261312-Makingmi--4701393",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625817",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think I said before, but it\u2019s amazing how people will wait until the price is moving up and buy at much higher prices, missing the perfect opportunity to buy now as we are seeing signs of improvement going forward but still in my view at  a very oversold price. Yes it seems to have taken a long time coming and especially so for long term holders. But if things fall into place it could move up considerably and probably quite quickly once more evidence comes through.",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454201+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261216-Friedman--2842005",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626247",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only surprise for me so far is that word is taking so long to get out and investors haven\u2019t reacted more to this news. I know initially the volume was huge but I expected the price  to grow over the following days",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454240+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261152-skid35--6333098",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626676",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. You shouldn't have to read an RNS a few times to understand it. The title of the RNS is \"Large order and Record Early Orders for 2026\" - its about orders. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". They didnt \"secure\" the \u00a3800k of orders in 2026 did they, what they secured is the backlog and 2026 income associated with the backlog from Nov 25 and Jan 26 orders. You shouldn't have to realise this from other paragraphs. This is like a conversation with a two year old.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454278+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261046-Letitrun-98685374",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627111",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not really Skid they\u2019re being transparent that part of the \u00a3800k for delivery and for reporting in accounts in fy 2026 includes the order from November. They\u2019re quite clearly talking about secured orders for reporting in FY2026. It doesn\u2019t say anywhere these orders were all received in 2026, just that they have \u00a3800k secured for 2026. This is like conversations with my wife!",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454317+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260957-skid35--3570362",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627540",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. 1. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". So these are ordered RECIEVED wholly in 2026 from four partners for \u00a3800k 2. \"These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners\". So still the four partners, but now one of these was from an order in November 2025. So contradictory statements.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454354+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260955-lordload--7184751",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627959",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - totally agree. Hopefully, when it comes to updates, the days of talking in riddles are now over. There suddenly seems to be a concerted attempt to engage with investors much more clearly & directly. Rather than through dodgy middlemen with personal agendas. Long may it continue.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454392+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260908-Friedman-85031480",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628384",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I\u2019m pretty cynical with SOH these days but for what it\u2019s worth, I thought that this RNS was refreshingly clear. It tells me how much revenue there is and when that revenue will be booked and it also adds that this is guaranteed.",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454430+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260848-Letitrun--5087182",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Sorry Skid would have to say you wouldn\u2019t cut it as my accountant\u2026 not sure how there is any issue of clarity \u201cThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts\u201d Clearly defines the value and when they will be delivered AND \u2018when they will be reported in the company accounts for FY2026\u2019 I can only assume you are taking the p**s",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454468+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20262208-skid35-74454947",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629247",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun, so the orders haven't been received but are confirmed with no cancellation? The issue is the lack.of clarity of the value. And as a qualified accountant the contractual terms determine income recognition - you don't have to have shipped to the customer to recognise income, alternatively you still may not have income even if you have delivered.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454507+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261835-Tatty99--4105786",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629659",
        "source": "LSE_CHAT",
        "data": {
          "author": "Tatty99",
          "content": "Adyan is correct. No accounting entry can be made until goods dispatched.  So the order cannot be recognised as income or 'receivable' until goods dispatched i.e this year.",
          "sentiment": 0.0,
          "engagement": "947",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454546+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261315-Letitrun--6029636",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630080",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "It doesn\u2019t say received it says orders \u2018secured\u2019 as a great start for 2026. It doesn\u2019t need clarifying it\u2019s quite clear and literally quotes all will be reported in 2026 accounts.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454586+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261305-martinu--8223533",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630508",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "I would guess (and that's the point we shouldn't have to), that the Nov 25 order (included in the \u00a3800k total) will be booked in 2026.  This is an opportunity to seek clarity via the new Q&A portal.  Responses are coming within a day.",
          "sentiment": 0.0,
          "engagement": "1,677",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454625+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261247-skid35-60538774",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630938",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "\"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\" Looking at this again, this really is just appalling, shockingly poor. So - \u00a3800k from four partners where the order have been received in 2026 - but in a later sentence somehow the \u00a3800k of orders  received in 2026 now includes the order from November 2025 ??????? So it is 1. we have a record start with orders received in 2026 together with the order in November now providing a backlog of \u00a3800k  2. Or a higher amount (say \u00a3950k but not explicitly mentioned) will be recognised in 2026 - the \u00a3800k of new orders plus unknown value of the Nov deal.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454663+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261207-Adyan920--5253703",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631384",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "@skid35 - The RNS did confuse me too at first, but on second read it made sense. Generally, when customers place orders they won't be recorded in our accounts until delivery. By adding that line, it clarified that: 1. The Nov order won't show in the 2025 account 2. It is instead  included in the the \u00a3800k order confirmed for 2026, which should also be delivered in 2026. This actually is being more open, as they could have easily not included that line and investors could have easily assumed the Nov order will be in the 2025 accounts and all the \u00a3800k announced are all brand new orders not mentioned before.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "8.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454701+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262216-Letitrun-42170810",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631804",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "\u2018this approach has delivered a record start to FY2026, with over \u00a3800k in orders secured from four partners. These will be delivered at various points throughout 2026 where they will be reported and recorded in the company\u2019s full year 2026 accounts.\u2019 Later states these 4 partners are the order from November for delivery in H1 2026, Meelung and two other partners.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454739+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262159-Letitrun--7786660",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632226",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454778+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262058-skid35--5992999",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632642",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454816+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262020-Friedman-47905894",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633075",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454854+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262019-Adyan920-25519030",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633514",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454894+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261617-Letitrun--1838159",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633927",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454932+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261604-lordload-90708403",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634361",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.454971+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261533-Adyan920--4559813",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-07T00:18:57.455011+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20261254-Friedman--3574196",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.310995",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I posited the same idea a couple of years ago. Seeing adverts on US TV for fizzy drinks using a sweetener made with monkfruit recently hasn't disabused me totally of the notion either.",
          "sentiment": 0.0,
          "engagement": "411",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281470+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20260848-lordload--2635984",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.311727",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - yes that remains a mystery, as I believe those annual payments kicked in from 2020/1 FY. The conspiracy theorist in me wonders whether it could be a deliberate ploy, keeping Opti out of the market with a relatively modest $100, 000 annual sweetener (no pun intended!), whilst the partner develops their own alternative. Hopefully reality is something far less sinister though\u2026.",
          "sentiment": 0.0,
          "engagement": "3,774",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281505+00:00"
      },
      {
        "event_id": "SOCIAL-7Feb20261411-Friedman-36176621",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.312424",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only flaw in that logic is the question of why the US partners who are paying a lot of money for exclusive rights, haven't reached that stage yet without any of the barriers that DSM have faced/created.",
          "sentiment": 0.0,
          "engagement": "411",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281525+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20262201-Adyan920--3433597",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.528759",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "The big issue has been: 1. The DSM Merger, which really delayed work on Swetbiotix. Meant new teams etc. 2. DSM were trying to go straight to a 100 ton batch rather than working their way up. Because of the long time they've taken, it does seem SOH has decided to try and partner with some smaller suppliers in case DSM keep delaying and taking so long. This is the right thing to do, imagine if we had done that before, we could have had sweetbiotix fully commercialised a long time ago.",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281545+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20262105-Friedman-45997713",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.529591",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks AS, Sounds like we may have multiple Sweet offerings then with different formulations. I hadn\u2019t realised that (or I\u2019d forgotten).",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281563+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261639-martinu--2840905",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.530435",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "AS, thanks for clarifying that.  The question was  a bit above my pay grade. :) Because the progress on Sweet has been so slow with the big partners , possibly due to non prioritisation,  I was hoping SOH would pursue Sweet with smaller partners with perhaps more focus on Opti.  I think that was a \"yes\" from SOH.  So fingers crossed.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281582+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261520-AquaeSul--4028114",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.531246",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Friedman, unlike the US Partner who pays a pre Launch royalty for exclusivity for Monkfruit based sweetbiotix, DSM Firmenich pay no such royalty for stevenoil based sweetbiotix and have no exclusivity. Also, the extra dimension of sucrose based sweetbiotix has subsequently been introduced following the discovery of the new enzyme which neither partner has exclusive rights to",
          "sentiment": 0.0,
          "engagement": "4,417",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281600+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261230-Friedman--1377010",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.531883",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Martinu, I\u2019ve since worked out how to read them Good questions from you and others. There is a little bit of confusion for me and what appears to be conflicting information on the change in the manufacturing process of Sweet. He talks about working with DSM to help scale up manufacturing and the discovery of a new enzyme, and yet also talks working with smaller manufacturers to manufacture Sweet. I guess he could be talking about manufacturing at scale for larger buyers and lesser quantities for smaller buyers but wouldn\u2019t that breach the contract with DSM to have someone else manufacture it",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281619+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261141-martinu--3130301",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.532506",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "FS, it's not a summary it lists all questions and answers and is too long to cut and paste.  You will get the same info if you go to the website.  Though you do have to go through the menu to find Q&A. I couldn't submit questions on phone as the submit tab dropped out of sight.  But no problems using laptop.  Good luck.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281637+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261122-Friedman--7174055",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.533334",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...read it",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281655+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261048-Friedman--5237313",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.533780",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I joined the Q&A bit too late to receive the summary email. Any chance someone could post the main parts here please. Thank you. It also is a bit of a bugger to use on you phone so I'm struggling to r",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281673+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261224-Makingmi--2541550",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.534314",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think the new feature is an excellent tool for both the company and investors. It seems to be working well judging by Q & A to date. The biggest challenge is to get folk looking forward positively, rather than backwards negatively. It\u2019s been a long journey but there seems some very positive potential going forward. This, to be expected dip, allows for good time to join the ride up.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281692+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261021-martinu--8346704",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.534968",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Agree.  I've asked and had responses to a few questions.  A great initiative which might give prospective shareholders a bit of confidence.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.40",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281709+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260236-aspex-64349760",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.535414",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "Surprised there is no response here to the mail out summary. Of course there is nothing new but it is good to have a renewed base.",
          "sentiment": 0.0,
          "engagement": "129",
          "price_at_post": "7.65",
          "thread_title": "Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-10T01:21:46.281728+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261559-Bk2011-56041583",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.535823",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bk2011",
          "content": "Delayed 200k buy showing as a sell",
          "sentiment": 0.0,
          "engagement": "255",
          "price_at_post": "7.65",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-10T01:21:46.281747+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261520-Makingmi-55623506",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.536352",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "It\u2019s just out there. Please yourself how you view it. Just seemed to be attacking fruit in flavouring as well and thought could increase opportunity for us to fill another gap. I can only read it, but can\u2019t vouch for accuracy.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.65",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-10T01:21:46.281765+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261513-skid35-40772639",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.537145",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Daily mail, bound to be 100% accurate then.",
          "sentiment": 0.0,
          "engagement": "3,933",
          "price_at_post": "7.40",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-10T01:21:46.281783+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261508-Makingmi--3510459",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.537941",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Looks like price ready to make next leg up.  Still a good way to go yet in my view.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.40",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-10T01:21:46.281801+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261321-Makingmi-21878866",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.538938",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "By Xantha Leatham, Executive Science Editor Listen to article TOMATOES and fruit could be stripped from pasta sauces and yogurts under Labour's sugar crackdown, supermarket bosses have warned Government plans to label thousands of products containing sugar as 'unhealthy' would encourage manufacturers to replace natural ingredients such as bananas with artificial sweeteners, food chiefs say. Last week, officials updated the classification system for what foods are deemed healthy and unhealthy. The new rules would mean 'free sugars' - released from fruit and vegetables when pureed - would be in the same category as salt and saturated fats. This means products containing fruit and vegetable purees could join crisps, sweets and biscuits in the TV ban on advertising between 5.30am and 9pm. Stuart Machin, the chief executive of Marks & Spencer, said the plans were 'nonsensical' ', and 'encourages us to remove fruit purees from yogurts or tomato paste from pasta sauces and replace them with artificial sweeteners, The Sunday Telegraph reported. Meanwhile a spokesman for Mars Food & Nutrition, makers of Dolmio sauce, said the rules could mean vegetable and fruit purees and pastes are replaced with ingredients of 'lower nutrient density'. '. The Food and Drink Federation said the policy would make it harder for consumers to reach government targets of five fruit or vegetables each day. A report from yogurt maker Danone warned consumers are becoming 'overwhelmed' by conflicting advice on 'healthy' food. A Department of Health spokesman said: 'Most children are consuming more than twice the recommended amount of free sugars, and more than one in three 11-year-olds are growing up overweight or obese. 'We want to work with the food industry to make sure it is the healthy choices being advertised and not the less healthy ones so families have the right information to be able to make the healthy choice.' 4)) \u51f8 Was article in Daily Mail today. OPTI to the rescue again perhaps.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-10T01:21:46.281819+00:00"
      },
      {
        "event_id": "SOCIAL-1Feb20260936-7777-58185880",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.539490",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "CHELSEA 3 WEST HAM UNITED 2 & SWBTX is coming soon LoL",
          "sentiment": 0.0,
          "engagement": "56",
          "price_at_post": "7.25",
          "thread_title": "GET THE OUZO OUT !!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=1334E49F-B073-4060-9FAB-75832F5D04CA"
        },
        "ingested_at": "2026-02-10T01:21:46.281836+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260727-AquaeSul-72096479",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469249",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "But it doesn't stop the big companies from investing in weight loss jabs rather than alternative treatments. www.londonstockexchange.com/news-article/AZN/astrazeneca-agrees-obesity-and-t2d-deal-with-cspc/17437893",
          "sentiment": 0.0,
          "engagement": "4,408",
          "price_at_post": "7.25",
          "thread_title": "RE: Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-02-10T01:21:46.281854+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260015-Adyan920--3968389",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469692",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "Interesting article about increase in gallbladder removals with people saying they have taken weight loss injections. https://www.bbc.co.uk/news/articles/cm24evgyyzpo",
          "sentiment": 0.0,
          "engagement": "176",
          "price_at_post": "7.25",
          "thread_title": "Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-02-10T01:21:46.281872+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261606-skid35-83454337",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470123",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Just need OPTI to be at a self sustaining breakeven position, a position it should be in now so as shareholders we \"bank\" the SBTX and PBT when looking at OPTIs market cap. If the holding continue to reduce with the cash then wasted in OPTI the value can be disregarded - as it currently is.",
          "sentiment": 0.0,
          "engagement": "3,922",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-10T01:21:46.281890+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261323-martinu-35141022",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470552",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Veritas,  absolutely agree re PBX.  I think Steen's aspiration of \u00a310m sales might take a while,  but I'm very happy with progress there. On SBTX, I agree they could appreciate this year, but is there some nervousness over Croda customers' delay in launching a Zenakine product. As for Opti, things are looking more positive there.  But consistently growing numbers will be needed to restore market confidence.",
          "sentiment": 0.0,
          "engagement": "1,683",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-10T01:21:46.281908+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261222-VeritasL--3361699",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470967",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-10T01:21:46.281926+00:00"
      },
      {
        "event_id": "SOCIAL-Today1222-VeritasL--3361699",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152145",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-10T01:21:46.281943+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261617-Makingmi-67619187",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152663",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Not sure that\u2019s true. Never actually made any short trades but when experimenting in the past, found shorting was available but not for any share you might decide on. Very unlikely to be available on tiny market cap shares like this. Agree though many more traders operate now, and happy to take a quick profit and move on. And it was a profit worth taking to many, obviously. Whether they will be waiting to get back in once it comes back a bit, we shall see, but a bit of a risky game to play. Without the potential here and the so low price, you could see the attraction of the quick gain, but given those factors, to me anyway, it is more sensible to hold for the much bigger rise to come.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-10T01:21:46.281961+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261448-Siouks-28303632",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153194",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Pump a buy orders to raise the price, once you get to the right level, open a short position, start selling all what you bought to drop the price down. This way you also make money on the way down and that's how thing are played here, not a huge secret...",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.25",
          "thread_title": "And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-10T01:21:46.281979+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261743-martinu--8523476",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153726",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Also, if any of you haven't signed up for new Q&A facility on website, I strongly recommend you do. This Q&A from / to Andy777 is particularly positive on Amazon, China (after change to partner) and for Asia in FY26 Andy777 \"Hi.  Have the ecommerce sales continued to grow significantly into H2 2025 and early 2026.  How important is the ecommerce relative to deals with companies like Morepen, and the other US and asian companies? Hi, Ecommerce is one of four areas we have been investing in to grow. These are Asia, India, USA and what we call Consumer Health (Amazon, our own website, Ebay, China and recently India). Amazon is one of the worlds biggest ecommerce market place which we have invested in to build a large customer base and it continued to grow in 2025 with marketing investment. Our focus now is on profitability on Amazon which we hope to achieve this month or next. This should then grow into a highly profitable business.  Our own website is already profitable. China should become profitable in Q2 as we changed our partner last summer and have been clearing stock with a short shelf life at discount. Once this is clear we should be profitable in China.  This is all part of building a business - building a brand, product range and customer base.  Ecommerce is part of that mix and reduces our dependency on partners. You cannot have a dependency on one part of the business, one product, one partner, or one country. We need more partners in India and the USA to reduce any future dependency. Asia is showing great growth and will make a significant contribution to sales in 2026. \"",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-10T01:21:46.281998+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261642-lordload-21592224",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154264",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Troajan - thanks for the interview link SOH has oft lamented Opti being undervalued by investors. But it's a bit chicken & egg. Until meaningful (& sustainable) sales come through & profits start to emerge, investors are understandably cautious. The year has started well. We need that momentum to continue - and something meaningful to happen with Sweetbiotix rather than just endless talks. Then the current SP will start looking somewhat ridiculous. But not until then I suspect.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-10T01:21:46.282016+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261519-Siouks-80445563",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154761",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "The same ones who bought shares at 6.00. Sold out at 07.00-08.00 Once they are out we will see what comes next;)",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282034+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261344-Troajan-22229323",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155300",
        "source": "LSE_CHAT",
        "data": {
          "author": "Troajan",
          "content": "Https://www.proactiveinvestors.co.uk/companies/news/1086319/optibiotix-health-slimbiome-demand-grows-as-glp-1-alternatives-surge-1086319.html",
          "sentiment": 0.0,
          "engagement": "125,652",
          "price_at_post": "7.75",
          "thread_title": "Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-10T01:21:46.282052+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261219-Makingmi-88336828",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155877",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Siouks, Looks like you may have been right. Seems their  patience levels ran out after a week. lol",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282070+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261532-Siouks--8079545",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.682699",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "As I said. There is a huge potential in a market, all depends how they going to use it. In my opinion marketing is the key but we all have our own opionion",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-10T01:21:46.282088+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261509-Bottmzup-43051624",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683390",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bottmzup",
          "content": "In my experience, after a positive update on a lot of shares, there's always a slow or delayed reaction while the news is digested by the wider market. After being in an oversold level for a period of time, I'm guessing the same thing to happen here. Todays high volume has broken above a falling trend line on the chart which has been falling since Aug '25, that will get noticed.",
          "sentiment": 0.0,
          "engagement": "6,753",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-10T01:21:46.282128+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261446-Siouks-72103442",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683859",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Such a high volume today with over 100k buys and this is only on 17% raise... wierd.  With such an important update I was looking for over a 10 with sp, and we are basicly were it was. Whoever bought at 6 will sell it at over 7 and we still wait for proper news. If it would be higher maybe worth again to open shorts",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-10T01:21:46.282146+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261110-Friedman-81131575",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.684398",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Good news. Actual numbers. Let\u2019s hope we can build from here.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282164+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261100-Dad41325-19058530",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.685311",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Was looking back on RNS 23/05/25 \u00a3500k investment from an American institutional investor at 14p a share, Asia seems to be going well maybe the US will be next to bring in some big orders.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "7.50",
          "thread_title": "Bold investment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=86086D0C-7204-4260-867E-ED4A91DB1A3E"
        },
        "ingested_at": "2026-02-10T01:21:46.282183+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-Letitrun-44330089",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686138",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Should be an easy bag or possibly 2 from here following today\u2019s news. With \u00a3800k in the bag for the year ahead & 11+ months left the share price seems to have fallen well below where it should on sentiment alone. They also have \u00a3100k milestone for Sweetbiotix & in 2024 their e-commerce business did just shy of \u00a3400k to add to 2026. Looking like momentum is actually gathering here. Any serious news on sweetbiotix this will have a major rerate",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282201+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-martinu--1713174",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686917",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes positive update.  Good that clarification was given that these orders will be recorded as revenues in FY 26. As sometimes Opti orders take months to be recognised.  Fingers crossed for more progress.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282219+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260943-skid35--1786364",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.687742",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Positive RNS today, glad to see all shareholders being treated equally from yesterdays RNS. Still hope there was something in the director buys late last year well above the current share price.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282237+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260802-Makingmi--5360485",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.688556",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well pleased with today\u2019s and yesterday\u2019s news. Things starting to look more positive going forward. No need to be racing to buy in now as already all in. Just sit and wait. Very positive feelings confirmed and even Blubs must consider those comments justified. lol.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282256+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun--4171372",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.689333",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-02-10T01:21:46.282274+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu--8812775",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690126",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-02-10T01:21:46.282292+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu-42411516",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690882",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282318+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu-22548099",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.691677",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282337+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920-67622932",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.692465",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282355+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu-90189786",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.693251",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282373+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul-43933344",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694043",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282392+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman--5934006",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694840",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282410+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul--6204973",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115085",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282428+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons-24953602",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115632",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282446+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--1022553",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116172",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282464+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--5246241",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116742",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-10T01:21:46.282482+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL-77478476",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117282",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-02-10T01:21:46.282500+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi-50771835",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117789",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-02-10T01:21:46.282518+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu--4068615",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118243",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-02-10T01:21:46.282535+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman-41195677",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118672",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282553+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks--4986959",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119114",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282572+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba--6066194",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119536",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-02-10T01:21:46.282590+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi--5160934",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119960",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282608+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35-38683740",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.120680",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282626+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49--9005327",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.121481",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282645+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi--1307624",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.122281",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282663+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu--8896469",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123073",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282681+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi-35620649",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123876",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282698+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload--4014482",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.124713",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282716+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi-22250020",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.125517",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282734+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex-80701733",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.126329",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "128",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-02-10T01:21:46.282752+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu--7585313",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127088",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-10T01:21:46.282770+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu--7282246",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127864",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-10T01:21:46.282788+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35--2074429",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.128643",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-10T01:21:46.282806+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang--3361236",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.129432",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "2,062",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-10T01:21:46.282825+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload-25979694",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.130214",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-10T01:21:46.282843+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks-17828477",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.131000",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-10T01:21:46.282861+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261414-Makingmi--3167099",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624513",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Good to get a positive users review. Take a look at the share price graph. I would describe this as being very much still at a low. Very low in fact",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-02-10T01:21:46.282880+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261413-Siouks-69969956",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624946",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I believe that the market did not react to those news yet, but will see soon enough if I was right. At those lvls we see in and out gamblers more then serious holders. Time will tell",
          "sentiment": 0.0,
          "engagement": "984",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282898+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261322-Dad41325--9178255",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625401",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Just bought online gut health 3 boxes with free delivery, very easy to use website delivery was quick & packaging is very good. Product instructions are very clear and easy to use which is great for people like me who hate reading small print! 40% off voucher for next order and a free tomato soup to try. Very happy with the service\u2026 Thinking of buying a few shares a bit annoyed I missed the low but still think it\u2019s worth a go\u2026.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "8.00",
          "thread_title": "Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-02-10T01:21:46.282916+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261312-Makingmi-87762807",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625817",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think I said before, but it\u2019s amazing how people will wait until the price is moving up and buy at much higher prices, missing the perfect opportunity to buy now as we are seeing signs of improvement going forward but still in my view at  a very oversold price. Yes it seems to have taken a long time coming and especially so for long term holders. But if things fall into place it could move up considerably and probably quite quickly once more evidence comes through.",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282934+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261216-Friedman-38249459",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626247",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only surprise for me so far is that word is taking so long to get out and investors haven\u2019t reacted more to this news. I know initially the volume was huge but I expected the price  to grow over the following days",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282952+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261152-skid35--5631746",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626676",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. You shouldn't have to read an RNS a few times to understand it. The title of the RNS is \"Large order and Record Early Orders for 2026\" - its about orders. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". They didnt \"secure\" the \u00a3800k of orders in 2026 did they, what they secured is the backlog and 2026 income associated with the backlog from Nov 25 and Jan 26 orders. You shouldn't have to realise this from other paragraphs. This is like a conversation with a two year old.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282971+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261046-Letitrun--4911453",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627111",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not really Skid they\u2019re being transparent that part of the \u00a3800k for delivery and for reporting in accounts in fy 2026 includes the order from November. They\u2019re quite clearly talking about secured orders for reporting in FY2026. It doesn\u2019t say anywhere these orders were all received in 2026, just that they have \u00a3800k secured for 2026. This is like conversations with my wife!",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.282989+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260957-skid35-78203450",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627540",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. 1. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". So these are ordered RECIEVED wholly in 2026 from four partners for \u00a3800k 2. \"These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners\". So still the four partners, but now one of these was from an order in November 2025. So contradictory statements.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283007+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260955-lordload--1551926",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627959",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - totally agree. Hopefully, when it comes to updates, the days of talking in riddles are now over. There suddenly seems to be a concerted attempt to engage with investors much more clearly & directly. Rather than through dodgy middlemen with personal agendas. Long may it continue.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283026+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260908-Friedman-12805428",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628384",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I\u2019m pretty cynical with SOH these days but for what it\u2019s worth, I thought that this RNS was refreshingly clear. It tells me how much revenue there is and when that revenue will be booked and it also adds that this is guaranteed.",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283044+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260848-Letitrun--2901495",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Sorry Skid would have to say you wouldn\u2019t cut it as my accountant\u2026 not sure how there is any issue of clarity \u201cThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts\u201d Clearly defines the value and when they will be delivered AND \u2018when they will be reported in the company accounts for FY2026\u2019 I can only assume you are taking the p**s",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283062+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20262208-skid35--3492272",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629247",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun, so the orders haven't been received but are confirmed with no cancellation? The issue is the lack.of clarity of the value. And as a qualified accountant the contractual terms determine income recognition - you don't have to have shipped to the customer to recognise income, alternatively you still may not have income even if you have delivered.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283080+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261835-Tatty99-37221575",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629659",
        "source": "LSE_CHAT",
        "data": {
          "author": "Tatty99",
          "content": "Adyan is correct. No accounting entry can be made until goods dispatched.  So the order cannot be recognised as income or 'receivable' until goods dispatched i.e this year.",
          "sentiment": 0.0,
          "engagement": "947",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283109+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261315-Letitrun--3681083",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630080",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "It doesn\u2019t say received it says orders \u2018secured\u2019 as a great start for 2026. It doesn\u2019t need clarifying it\u2019s quite clear and literally quotes all will be reported in 2026 accounts.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283131+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261305-martinu--8010863",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630508",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "I would guess (and that's the point we shouldn't have to), that the Nov 25 order (included in the \u00a3800k total) will be booked in 2026.  This is an opportunity to seek clarity via the new Q&A portal.  Responses are coming within a day.",
          "sentiment": 0.0,
          "engagement": "1,677",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283149+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261247-skid35--4901389",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630938",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "\"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\" Looking at this again, this really is just appalling, shockingly poor. So - \u00a3800k from four partners where the order have been received in 2026 - but in a later sentence somehow the \u00a3800k of orders  received in 2026 now includes the order from November 2025 ??????? So it is 1. we have a record start with orders received in 2026 together with the order in November now providing a backlog of \u00a3800k  2. Or a higher amount (say \u00a3950k but not explicitly mentioned) will be recognised in 2026 - the \u00a3800k of new orders plus unknown value of the Nov deal.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283167+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261207-Adyan920--2645618",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631384",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "@skid35 - The RNS did confuse me too at first, but on second read it made sense. Generally, when customers place orders they won't be recorded in our accounts until delivery. By adding that line, it clarified that: 1. The Nov order won't show in the 2025 account 2. It is instead  included in the the \u00a3800k order confirmed for 2026, which should also be delivered in 2026. This actually is being more open, as they could have easily not included that line and investors could have easily assumed the Nov order will be in the 2025 accounts and all the \u00a3800k announced are all brand new orders not mentioned before.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "8.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283185+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262216-Letitrun--1203701",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631804",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "\u2018this approach has delivered a record start to FY2026, with over \u00a3800k in orders secured from four partners. These will be delivered at various points throughout 2026 where they will be reported and recorded in the company\u2019s full year 2026 accounts.\u2019 Later states these 4 partners are the order from November for delivery in H1 2026, Meelung and two other partners.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283203+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262159-Letitrun--8808892",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632226",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283222+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262058-skid35-38117757",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632642",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283240+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262020-Friedman-11408615",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633075",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283258+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262019-Adyan920--1945817",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633514",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283276+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261617-Letitrun--6791132",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633927",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283295+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261604-lordload-73407021",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634361",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283313+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261533-Adyan920--5197014",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-10T01:21:46.283331+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20261254-Friedman--8443398",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.310995",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I posited the same idea a couple of years ago. Seeing adverts on US TV for fizzy drinks using a sweetener made with monkfruit recently hasn't disabused me totally of the notion either.",
          "sentiment": 0.0,
          "engagement": "411",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438161+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20260848-lordload-66863306",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.311727",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - yes that remains a mystery, as I believe those annual payments kicked in from 2020/1 FY. The conspiracy theorist in me wonders whether it could be a deliberate ploy, keeping Opti out of the market with a relatively modest $100, 000 annual sweetener (no pun intended!), whilst the partner develops their own alternative. Hopefully reality is something far less sinister though\u2026.",
          "sentiment": 0.0,
          "engagement": "3,774",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438206+00:00"
      },
      {
        "event_id": "SOCIAL-7Feb20261411-Friedman--6784718",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.312424",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only flaw in that logic is the question of why the US partners who are paying a lot of money for exclusive rights, haven't reached that stage yet without any of the barriers that DSM have faced/created.",
          "sentiment": 0.0,
          "engagement": "411",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438238+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20262201-Adyan920--4524417",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.528759",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "The big issue has been: 1. The DSM Merger, which really delayed work on Swetbiotix. Meant new teams etc. 2. DSM were trying to go straight to a 100 ton batch rather than working their way up. Because of the long time they've taken, it does seem SOH has decided to try and partner with some smaller suppliers in case DSM keep delaying and taking so long. This is the right thing to do, imagine if we had done that before, we could have had sweetbiotix fully commercialised a long time ago.",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438271+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20262105-Friedman--2372908",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.529591",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks AS, Sounds like we may have multiple Sweet offerings then with different formulations. I hadn\u2019t realised that (or I\u2019d forgotten).",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438291+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261639-martinu--3174219",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.530435",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "AS, thanks for clarifying that.  The question was  a bit above my pay grade. :) Because the progress on Sweet has been so slow with the big partners , possibly due to non prioritisation,  I was hoping SOH would pursue Sweet with smaller partners with perhaps more focus on Opti.  I think that was a \"yes\" from SOH.  So fingers crossed.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438311+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261520-AquaeSul--4312813",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.531246",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Friedman, unlike the US Partner who pays a pre Launch royalty for exclusivity for Monkfruit based sweetbiotix, DSM Firmenich pay no such royalty for stevenoil based sweetbiotix and have no exclusivity. Also, the extra dimension of sucrose based sweetbiotix has subsequently been introduced following the discovery of the new enzyme which neither partner has exclusive rights to",
          "sentiment": 0.0,
          "engagement": "4,417",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438330+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261230-Friedman--1319295",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.531883",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Martinu, I\u2019ve since worked out how to read them Good questions from you and others. There is a little bit of confusion for me and what appears to be conflicting information on the change in the manufacturing process of Sweet. He talks about working with DSM to help scale up manufacturing and the discovery of a new enzyme, and yet also talks working with smaller manufacturers to manufacture Sweet. I guess he could be talking about manufacturing at scale for larger buyers and lesser quantities for smaller buyers but wouldn\u2019t that breach the contract with DSM to have someone else manufacture it",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438349+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261141-martinu-25343627",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.532506",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "FS, it's not a summary it lists all questions and answers and is too long to cut and paste.  You will get the same info if you go to the website.  Though you do have to go through the menu to find Q&A. I couldn't submit questions on phone as the submit tab dropped out of sight.  But no problems using laptop.  Good luck.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438368+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261122-Friedman-29846983",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.533334",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...read it",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438393+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261048-Friedman-64721929",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.533780",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I joined the Q&A bit too late to receive the summary email. Any chance someone could post the main parts here please. Thank you. It also is a bit of a bugger to use on you phone so I'm struggling to r",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438423+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261224-Makingmi-34775212",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.534314",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think the new feature is an excellent tool for both the company and investors. It seems to be working well judging by Q & A to date. The biggest challenge is to get folk looking forward positively, rather than backwards negatively. It\u2019s been a long journey but there seems some very positive potential going forward. This, to be expected dip, allows for good time to join the ride up.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438442+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261021-martinu-89915489",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.534968",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Agree.  I've asked and had responses to a few questions.  A great initiative which might give prospective shareholders a bit of confidence.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.40",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438461+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260236-aspex--8036504",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.535414",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "Surprised there is no response here to the mail out summary. Of course there is nothing new but it is good to have a renewed base.",
          "sentiment": 0.0,
          "engagement": "129",
          "price_at_post": "7.65",
          "thread_title": "Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T00:06:34.438479+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261559-Bk2011-86723924",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.535823",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bk2011",
          "content": "Delayed 200k buy showing as a sell",
          "sentiment": 0.0,
          "engagement": "255",
          "price_at_post": "7.65",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T00:06:34.438498+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261520-Makingmi--8617097",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.536352",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "It\u2019s just out there. Please yourself how you view it. Just seemed to be attacking fruit in flavouring as well and thought could increase opportunity for us to fill another gap. I can only read it, but can\u2019t vouch for accuracy.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.65",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T00:06:34.438519+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261513-skid35--5133054",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.537145",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Daily mail, bound to be 100% accurate then.",
          "sentiment": 0.0,
          "engagement": "3,933",
          "price_at_post": "7.40",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T00:06:34.438551+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261508-Makingmi-70073490",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.537941",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Looks like price ready to make next leg up.  Still a good way to go yet in my view.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.40",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T00:06:34.438571+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261321-Makingmi--2283137",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.538938",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "By Xantha Leatham, Executive Science Editor Listen to article TOMATOES and fruit could be stripped from pasta sauces and yogurts under Labour's sugar crackdown, supermarket bosses have warned Government plans to label thousands of products containing sugar as 'unhealthy' would encourage manufacturers to replace natural ingredients such as bananas with artificial sweeteners, food chiefs say. Last week, officials updated the classification system for what foods are deemed healthy and unhealthy. The new rules would mean 'free sugars' - released from fruit and vegetables when pureed - would be in the same category as salt and saturated fats. This means products containing fruit and vegetable purees could join crisps, sweets and biscuits in the TV ban on advertising between 5.30am and 9pm. Stuart Machin, the chief executive of Marks & Spencer, said the plans were 'nonsensical' ', and 'encourages us to remove fruit purees from yogurts or tomato paste from pasta sauces and replace them with artificial sweeteners, The Sunday Telegraph reported. Meanwhile a spokesman for Mars Food & Nutrition, makers of Dolmio sauce, said the rules could mean vegetable and fruit purees and pastes are replaced with ingredients of 'lower nutrient density'. '. The Food and Drink Federation said the policy would make it harder for consumers to reach government targets of five fruit or vegetables each day. A report from yogurt maker Danone warned consumers are becoming 'overwhelmed' by conflicting advice on 'healthy' food. A Department of Health spokesman said: 'Most children are consuming more than twice the recommended amount of free sugars, and more than one in three 11-year-olds are growing up overweight or obese. 'We want to work with the food industry to make sure it is the healthy choices being advertised and not the less healthy ones so families have the right information to be able to make the healthy choice.' 4)) \u51f8 Was article in Daily Mail today. OPTI to the rescue again perhaps.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T00:06:34.438590+00:00"
      },
      {
        "event_id": "SOCIAL-1Feb20260936-7777-78320568",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.539490",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "CHELSEA 3 WEST HAM UNITED 2 & SWBTX is coming soon LoL",
          "sentiment": 0.0,
          "engagement": "56",
          "price_at_post": "7.25",
          "thread_title": "GET THE OUZO OUT !!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=1334E49F-B073-4060-9FAB-75832F5D04CA"
        },
        "ingested_at": "2026-02-11T00:06:34.438608+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260727-AquaeSul-64607003",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469249",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "But it doesn't stop the big companies from investing in weight loss jabs rather than alternative treatments. www.londonstockexchange.com/news-article/AZN/astrazeneca-agrees-obesity-and-t2d-deal-with-cspc/17437893",
          "sentiment": 0.0,
          "engagement": "4,408",
          "price_at_post": "7.25",
          "thread_title": "RE: Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-02-11T00:06:34.438627+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260015-Adyan920--1613189",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469692",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "Interesting article about increase in gallbladder removals with people saying they have taken weight loss injections. https://www.bbc.co.uk/news/articles/cm24evgyyzpo",
          "sentiment": 0.0,
          "engagement": "176",
          "price_at_post": "7.25",
          "thread_title": "Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-02-11T00:06:34.438645+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261606-skid35-91227495",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470123",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Just need OPTI to be at a self sustaining breakeven position, a position it should be in now so as shareholders we \"bank\" the SBTX and PBT when looking at OPTIs market cap. If the holding continue to reduce with the cash then wasted in OPTI the value can be disregarded - as it currently is.",
          "sentiment": 0.0,
          "engagement": "3,922",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T00:06:34.438680+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261323-martinu-87939602",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470552",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Veritas,  absolutely agree re PBX.  I think Steen's aspiration of \u00a310m sales might take a while,  but I'm very happy with progress there. On SBTX, I agree they could appreciate this year, but is there some nervousness over Croda customers' delay in launching a Zenakine product. As for Opti, things are looking more positive there.  But consistently growing numbers will be needed to restore market confidence.",
          "sentiment": 0.0,
          "engagement": "1,683",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T00:06:34.438701+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261222-VeritasL--3561667",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470967",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T00:06:34.438720+00:00"
      },
      {
        "event_id": "SOCIAL-Today1222-VeritasL--3561667",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152145",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T00:06:34.438738+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261617-Makingmi-51952416",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152663",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Not sure that\u2019s true. Never actually made any short trades but when experimenting in the past, found shorting was available but not for any share you might decide on. Very unlikely to be available on tiny market cap shares like this. Agree though many more traders operate now, and happy to take a quick profit and move on. And it was a profit worth taking to many, obviously. Whether they will be waiting to get back in once it comes back a bit, we shall see, but a bit of a risky game to play. Without the potential here and the so low price, you could see the attraction of the quick gain, but given those factors, to me anyway, it is more sensible to hold for the much bigger rise to come.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T00:06:34.438757+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261448-Siouks-76898326",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153194",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Pump a buy orders to raise the price, once you get to the right level, open a short position, start selling all what you bought to drop the price down. This way you also make money on the way down and that's how thing are played here, not a huge secret...",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.25",
          "thread_title": "And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T00:06:34.438775+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261743-martinu--1833942",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153726",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Also, if any of you haven't signed up for new Q&A facility on website, I strongly recommend you do. This Q&A from / to Andy777 is particularly positive on Amazon, China (after change to partner) and for Asia in FY26 Andy777 \"Hi.  Have the ecommerce sales continued to grow significantly into H2 2025 and early 2026.  How important is the ecommerce relative to deals with companies like Morepen, and the other US and asian companies? Hi, Ecommerce is one of four areas we have been investing in to grow. These are Asia, India, USA and what we call Consumer Health (Amazon, our own website, Ebay, China and recently India). Amazon is one of the worlds biggest ecommerce market place which we have invested in to build a large customer base and it continued to grow in 2025 with marketing investment. Our focus now is on profitability on Amazon which we hope to achieve this month or next. This should then grow into a highly profitable business.  Our own website is already profitable. China should become profitable in Q2 as we changed our partner last summer and have been clearing stock with a short shelf life at discount. Once this is clear we should be profitable in China.  This is all part of building a business - building a brand, product range and customer base.  Ecommerce is part of that mix and reduces our dependency on partners. You cannot have a dependency on one part of the business, one product, one partner, or one country. We need more partners in India and the USA to reduce any future dependency. Asia is showing great growth and will make a significant contribution to sales in 2026. \"",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T00:06:34.438810+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261642-lordload--9187297",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154264",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Troajan - thanks for the interview link SOH has oft lamented Opti being undervalued by investors. But it's a bit chicken & egg. Until meaningful (& sustainable) sales come through & profits start to emerge, investors are understandably cautious. The year has started well. We need that momentum to continue - and something meaningful to happen with Sweetbiotix rather than just endless talks. Then the current SP will start looking somewhat ridiculous. But not until then I suspect.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T00:06:34.438830+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261519-Siouks-73034686",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154761",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "The same ones who bought shares at 6.00. Sold out at 07.00-08.00 Once they are out we will see what comes next;)",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.438849+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261344-Troajan-41423215",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155300",
        "source": "LSE_CHAT",
        "data": {
          "author": "Troajan",
          "content": "Https://www.proactiveinvestors.co.uk/companies/news/1086319/optibiotix-health-slimbiome-demand-grows-as-glp-1-alternatives-surge-1086319.html",
          "sentiment": 0.0,
          "engagement": "125,652",
          "price_at_post": "7.75",
          "thread_title": "Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T00:06:34.438867+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261219-Makingmi--8892063",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155877",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Siouks, Looks like you may have been right. Seems their  patience levels ran out after a week. lol",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.438893+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261532-Siouks--4939089",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.682699",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "As I said. There is a huge potential in a market, all depends how they going to use it. In my opinion marketing is the key but we all have our own opionion",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-11T00:06:34.438914+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261509-Bottmzup-24798990",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683390",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bottmzup",
          "content": "In my experience, after a positive update on a lot of shares, there's always a slow or delayed reaction while the news is digested by the wider market. After being in an oversold level for a period of time, I'm guessing the same thing to happen here. Todays high volume has broken above a falling trend line on the chart which has been falling since Aug '25, that will get noticed.",
          "sentiment": 0.0,
          "engagement": "6,753",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-11T00:06:34.438948+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261446-Siouks-43765076",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683859",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Such a high volume today with over 100k buys and this is only on 17% raise... wierd.  With such an important update I was looking for over a 10 with sp, and we are basicly were it was. Whoever bought at 6 will sell it at over 7 and we still wait for proper news. If it would be higher maybe worth again to open shorts",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-11T00:06:34.438967+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261110-Friedman--2599007",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.684398",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Good news. Actual numbers. Let\u2019s hope we can build from here.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.438986+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261100-Dad41325--7919385",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.685311",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Was looking back on RNS 23/05/25 \u00a3500k investment from an American institutional investor at 14p a share, Asia seems to be going well maybe the US will be next to bring in some big orders.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "7.50",
          "thread_title": "Bold investment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=86086D0C-7204-4260-867E-ED4A91DB1A3E"
        },
        "ingested_at": "2026-02-11T00:06:34.439004+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-Letitrun-41499661",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686138",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Should be an easy bag or possibly 2 from here following today\u2019s news. With \u00a3800k in the bag for the year ahead & 11+ months left the share price seems to have fallen well below where it should on sentiment alone. They also have \u00a3100k milestone for Sweetbiotix & in 2024 their e-commerce business did just shy of \u00a3400k to add to 2026. Looking like momentum is actually gathering here. Any serious news on sweetbiotix this will have a major rerate",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439023+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-martinu-70266370",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686917",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes positive update.  Good that clarification was given that these orders will be recorded as revenues in FY 26. As sometimes Opti orders take months to be recognised.  Fingers crossed for more progress.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439045+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260943-skid35--3074221",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.687742",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Positive RNS today, glad to see all shareholders being treated equally from yesterdays RNS. Still hope there was something in the director buys late last year well above the current share price.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439078+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260802-Makingmi-28042154",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.688556",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well pleased with today\u2019s and yesterday\u2019s news. Things starting to look more positive going forward. No need to be racing to buy in now as already all in. Just sit and wait. Very positive feelings confirmed and even Blubs must consider those comments justified. lol.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439112+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun-77520545",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.689333",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-02-11T00:06:34.439137+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu-66378319",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690126",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-02-11T00:06:34.439156+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu--1521647",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690882",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439175+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu-40631911",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.691677",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439200+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920--6894395",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.692465",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439231+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu-52420485",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.693251",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439250+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul--5862485",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694043",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439269+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman-35976534",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694840",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439287+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul--2172805",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115085",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439306+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons--7934239",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115632",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439333+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-54992752",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116172",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439360+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-59174417",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116742",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T00:06:34.439379+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL--6631612",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117282",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-02-11T00:06:34.439398+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi-59923984",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117789",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-02-11T00:06:34.439417+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu-88141737",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118243",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-02-11T00:06:34.439436+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman--1574864",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118672",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439462+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks-61830749",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119114",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439490+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba--5450403",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119536",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-02-11T00:06:34.439510+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi--7166418",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119960",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439529+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35--7257054",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.120680",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439548+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49-21034864",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.121481",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439566+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi-54927578",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.122281",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439592+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu-61191353",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123073",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439621+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi-76733254",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123876",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439640+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload-69278035",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.124713",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439660+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi--6640321",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.125517",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439678+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex--7143564",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.126329",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "128",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-02-11T00:06:34.439698+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu-68530542",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127088",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T00:06:34.439724+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu--5162021",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127864",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T00:06:34.439752+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35-16972850",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.128643",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T00:06:34.439771+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang-12273831",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.129432",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "2,062",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T00:06:34.439790+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload-71275968",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.130214",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T00:06:34.439808+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks-41976141",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.131000",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T00:06:34.439827+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261414-Makingmi-10738984",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624513",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Good to get a positive users review. Take a look at the share price graph. I would describe this as being very much still at a low. Very low in fact",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-02-11T00:06:34.439854+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261413-Siouks--5745410",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624946",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I believe that the market did not react to those news yet, but will see soon enough if I was right. At those lvls we see in and out gamblers more then serious holders. Time will tell",
          "sentiment": 0.0,
          "engagement": "984",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439882+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261322-Dad41325--2898654",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625401",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Just bought online gut health 3 boxes with free delivery, very easy to use website delivery was quick & packaging is very good. Product instructions are very clear and easy to use which is great for people like me who hate reading small print! 40% off voucher for next order and a free tomato soup to try. Very happy with the service\u2026 Thinking of buying a few shares a bit annoyed I missed the low but still think it\u2019s worth a go\u2026.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "8.00",
          "thread_title": "Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-02-11T00:06:34.439901+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261312-Makingmi--6357517",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625817",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think I said before, but it\u2019s amazing how people will wait until the price is moving up and buy at much higher prices, missing the perfect opportunity to buy now as we are seeing signs of improvement going forward but still in my view at  a very oversold price. Yes it seems to have taken a long time coming and especially so for long term holders. But if things fall into place it could move up considerably and probably quite quickly once more evidence comes through.",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439920+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261216-Friedman--5178434",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626247",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only surprise for me so far is that word is taking so long to get out and investors haven\u2019t reacted more to this news. I know initially the volume was huge but I expected the price  to grow over the following days",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439938+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261152-skid35-25072577",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626676",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. You shouldn't have to read an RNS a few times to understand it. The title of the RNS is \"Large order and Record Early Orders for 2026\" - its about orders. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". They didnt \"secure\" the \u00a3800k of orders in 2026 did they, what they secured is the backlog and 2026 income associated with the backlog from Nov 25 and Jan 26 orders. You shouldn't have to realise this from other paragraphs. This is like a conversation with a two year old.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439957+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261046-Letitrun--4602099",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627111",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not really Skid they\u2019re being transparent that part of the \u00a3800k for delivery and for reporting in accounts in fy 2026 includes the order from November. They\u2019re quite clearly talking about secured orders for reporting in FY2026. It doesn\u2019t say anywhere these orders were all received in 2026, just that they have \u00a3800k secured for 2026. This is like conversations with my wife!",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.439979+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260957-skid35-73257232",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627540",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. 1. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". So these are ordered RECIEVED wholly in 2026 from four partners for \u00a3800k 2. \"These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners\". So still the four partners, but now one of these was from an order in November 2025. So contradictory statements.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440011+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260955-lordload--3923057",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627959",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - totally agree. Hopefully, when it comes to updates, the days of talking in riddles are now over. There suddenly seems to be a concerted attempt to engage with investors much more clearly & directly. Rather than through dodgy middlemen with personal agendas. Long may it continue.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440032+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260908-Friedman-26517368",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628384",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I\u2019m pretty cynical with SOH these days but for what it\u2019s worth, I thought that this RNS was refreshingly clear. It tells me how much revenue there is and when that revenue will be booked and it also adds that this is guaranteed.",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440050+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260848-Letitrun-82256768",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Sorry Skid would have to say you wouldn\u2019t cut it as my accountant\u2026 not sure how there is any issue of clarity \u201cThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts\u201d Clearly defines the value and when they will be delivered AND \u2018when they will be reported in the company accounts for FY2026\u2019 I can only assume you are taking the p**s",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440069+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20262208-skid35-71158345",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629247",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun, so the orders haven't been received but are confirmed with no cancellation? The issue is the lack.of clarity of the value. And as a qualified accountant the contractual terms determine income recognition - you don't have to have shipped to the customer to recognise income, alternatively you still may not have income even if you have delivered.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440087+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261835-Tatty99-41712102",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629659",
        "source": "LSE_CHAT",
        "data": {
          "author": "Tatty99",
          "content": "Adyan is correct. No accounting entry can be made until goods dispatched.  So the order cannot be recognised as income or 'receivable' until goods dispatched i.e this year.",
          "sentiment": 0.0,
          "engagement": "947",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440125+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261315-Letitrun--8546700",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630080",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "It doesn\u2019t say received it says orders \u2018secured\u2019 as a great start for 2026. It doesn\u2019t need clarifying it\u2019s quite clear and literally quotes all will be reported in 2026 accounts.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440155+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261305-martinu--3875633",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630508",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "I would guess (and that's the point we shouldn't have to), that the Nov 25 order (included in the \u00a3800k total) will be booked in 2026.  This is an opportunity to seek clarity via the new Q&A portal.  Responses are coming within a day.",
          "sentiment": 0.0,
          "engagement": "1,677",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440174+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261247-skid35--7923405",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630938",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "\"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\" Looking at this again, this really is just appalling, shockingly poor. So - \u00a3800k from four partners where the order have been received in 2026 - but in a later sentence somehow the \u00a3800k of orders  received in 2026 now includes the order from November 2025 ??????? So it is 1. we have a record start with orders received in 2026 together with the order in November now providing a backlog of \u00a3800k  2. Or a higher amount (say \u00a3950k but not explicitly mentioned) will be recognised in 2026 - the \u00a3800k of new orders plus unknown value of the Nov deal.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440192+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261207-Adyan920--1410748",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631384",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "@skid35 - The RNS did confuse me too at first, but on second read it made sense. Generally, when customers place orders they won't be recorded in our accounts until delivery. By adding that line, it clarified that: 1. The Nov order won't show in the 2025 account 2. It is instead  included in the the \u00a3800k order confirmed for 2026, which should also be delivered in 2026. This actually is being more open, as they could have easily not included that line and investors could have easily assumed the Nov order will be in the 2025 accounts and all the \u00a3800k announced are all brand new orders not mentioned before.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "8.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440211+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262216-Letitrun-18931180",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631804",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "\u2018this approach has delivered a record start to FY2026, with over \u00a3800k in orders secured from four partners. These will be delivered at various points throughout 2026 where they will be reported and recorded in the company\u2019s full year 2026 accounts.\u2019 Later states these 4 partners are the order from November for delivery in H1 2026, Meelung and two other partners.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440229+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262159-Letitrun-55578735",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632226",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440249+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262058-skid35--4293176",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632642",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440283+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262020-Friedman--7454720",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633075",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440303+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262019-Adyan920-84661991",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633514",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440322+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261617-Letitrun--6383643",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633927",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440340+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261604-lordload--7436879",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634361",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440359+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261533-Adyan920--2815753",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T00:06:34.440565+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20261254-Friedman--8183464",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.310995",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I posited the same idea a couple of years ago. Seeing adverts on US TV for fizzy drinks using a sweetener made with monkfruit recently hasn't disabused me totally of the notion either.",
          "sentiment": 0.0,
          "engagement": "411",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.865977+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20260848-lordload--5702652",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.311727",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - yes that remains a mystery, as I believe those annual payments kicked in from 2020/1 FY. The conspiracy theorist in me wonders whether it could be a deliberate ploy, keeping Opti out of the market with a relatively modest $100, 000 annual sweetener (no pun intended!), whilst the partner develops their own alternative. Hopefully reality is something far less sinister though\u2026.",
          "sentiment": 0.0,
          "engagement": "3,774",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866002+00:00"
      },
      {
        "event_id": "SOCIAL-7Feb20261411-Friedman--8093580",
        "event_type": "social_post",
        "date": "2026-02-10T01:21:37.312424",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only flaw in that logic is the question of why the US partners who are paying a lot of money for exclusive rights, haven't reached that stage yet without any of the barriers that DSM have faced/created.",
          "sentiment": 0.0,
          "engagement": "411",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866022+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20262201-Adyan920--1037259",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.528759",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "The big issue has been: 1. The DSM Merger, which really delayed work on Swetbiotix. Meant new teams etc. 2. DSM were trying to go straight to a 100 ton batch rather than working their way up. Because of the long time they've taken, it does seem SOH has decided to try and partner with some smaller suppliers in case DSM keep delaying and taking so long. This is the right thing to do, imagine if we had done that before, we could have had sweetbiotix fully commercialised a long time ago.",
          "sentiment": 0.0,
          "engagement": "177",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866041+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20262105-Friedman-47337273",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.529591",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks AS, Sounds like we may have multiple Sweet offerings then with different formulations. I hadn\u2019t realised that (or I\u2019d forgotten).",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866060+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261639-martinu-39654675",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.530435",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "AS, thanks for clarifying that.  The question was  a bit above my pay grade. :) Because the progress on Sweet has been so slow with the big partners , possibly due to non prioritisation,  I was hoping SOH would pursue Sweet with smaller partners with perhaps more focus on Opti.  I think that was a \"yes\" from SOH.  So fingers crossed.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866079+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261520-AquaeSul--8759527",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.531246",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Friedman, unlike the US Partner who pays a pre Launch royalty for exclusivity for Monkfruit based sweetbiotix, DSM Firmenich pay no such royalty for stevenoil based sweetbiotix and have no exclusivity. Also, the extra dimension of sucrose based sweetbiotix has subsequently been introduced following the discovery of the new enzyme which neither partner has exclusive rights to",
          "sentiment": 0.0,
          "engagement": "4,417",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866116+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261230-Friedman--7151966",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.531883",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Martinu, I\u2019ve since worked out how to read them Good questions from you and others. There is a little bit of confusion for me and what appears to be conflicting information on the change in the manufacturing process of Sweet. He talks about working with DSM to help scale up manufacturing and the discovery of a new enzyme, and yet also talks working with smaller manufacturers to manufacture Sweet. I guess he could be talking about manufacturing at scale for larger buyers and lesser quantities for smaller buyers but wouldn\u2019t that breach the contract with DSM to have someone else manufacture it",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866141+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261141-martinu--6921548",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.532506",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "FS, it's not a summary it lists all questions and answers and is too long to cut and paste.  You will get the same info if you go to the website.  Though you do have to go through the menu to find Q&A. I couldn't submit questions on phone as the submit tab dropped out of sight.  But no problems using laptop.  Good luck.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866160+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261122-Friedman--6617821",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.533334",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...read it",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866179+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261048-Friedman--8464130",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.533780",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I joined the Q&A bit too late to receive the summary email. Any chance someone could post the main parts here please. Thank you. It also is a bit of a bugger to use on you phone so I'm struggling to r",
          "sentiment": 0.0,
          "engagement": "409",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866198+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261224-Makingmi-75815779",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.534314",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think the new feature is an excellent tool for both the company and investors. It seems to be working well judging by Q & A to date. The biggest challenge is to get folk looking forward positively, rather than backwards negatively. It\u2019s been a long journey but there seems some very positive potential going forward. This, to be expected dip, allows for good time to join the ride up.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.65",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866217+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261021-martinu--7231344",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.534968",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Agree.  I've asked and had responses to a few questions.  A great initiative which might give prospective shareholders a bit of confidence.",
          "sentiment": 0.0,
          "engagement": "1,691",
          "price_at_post": "7.40",
          "thread_title": "RE: Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866235+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260236-aspex--1620699",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.535414",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "Surprised there is no response here to the mail out summary. Of course there is nothing new but it is good to have a renewed base.",
          "sentiment": 0.0,
          "engagement": "129",
          "price_at_post": "7.65",
          "thread_title": "Summary of Opti Q & A email",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=A8FD97F7-2C78-4D41-8EE1-8FBCDA400AF9"
        },
        "ingested_at": "2026-02-11T16:43:35.866253+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261559-Bk2011-70407314",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.535823",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bk2011",
          "content": "Delayed 200k buy showing as a sell",
          "sentiment": 0.0,
          "engagement": "255",
          "price_at_post": "7.65",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T16:43:35.866272+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261520-Makingmi-78594958",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.536352",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "It\u2019s just out there. Please yourself how you view it. Just seemed to be attacking fruit in flavouring as well and thought could increase opportunity for us to fill another gap. I can only read it, but can\u2019t vouch for accuracy.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.65",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T16:43:35.866290+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261513-skid35--1502886",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.537145",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Daily mail, bound to be 100% accurate then.",
          "sentiment": 0.0,
          "engagement": "3,933",
          "price_at_post": "7.40",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T16:43:35.866308+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261508-Makingmi-53967633",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.537941",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Looks like price ready to make next leg up.  Still a good way to go yet in my view.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.40",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T16:43:35.866326+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261321-Makingmi-51996531",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.538938",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "By Xantha Leatham, Executive Science Editor Listen to article TOMATOES and fruit could be stripped from pasta sauces and yogurts under Labour's sugar crackdown, supermarket bosses have warned Government plans to label thousands of products containing sugar as 'unhealthy' would encourage manufacturers to replace natural ingredients such as bananas with artificial sweeteners, food chiefs say. Last week, officials updated the classification system for what foods are deemed healthy and unhealthy. The new rules would mean 'free sugars' - released from fruit and vegetables when pureed - would be in the same category as salt and saturated fats. This means products containing fruit and vegetable purees could join crisps, sweets and biscuits in the TV ban on advertising between 5.30am and 9pm. Stuart Machin, the chief executive of Marks & Spencer, said the plans were 'nonsensical' ', and 'encourages us to remove fruit purees from yogurts or tomato paste from pasta sauces and replace them with artificial sweeteners, The Sunday Telegraph reported. Meanwhile a spokesman for Mars Food & Nutrition, makers of Dolmio sauce, said the rules could mean vegetable and fruit purees and pastes are replaced with ingredients of 'lower nutrient density'. '. The Food and Drink Federation said the policy would make it harder for consumers to reach government targets of five fruit or vegetables each day. A report from yogurt maker Danone warned consumers are becoming 'overwhelmed' by conflicting advice on 'healthy' food. A Department of Health spokesman said: 'Most children are consuming more than twice the recommended amount of free sugars, and more than one in three 11-year-olds are growing up overweight or obese. 'We want to work with the food industry to make sure it is the healthy choices being advertised and not the less healthy ones so families have the right information to be able to make the healthy choice.' 4)) \u51f8 Was article in Daily Mail today. OPTI to the rescue again perhaps.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T16:43:35.866345+00:00"
      },
      {
        "event_id": "SOCIAL-1Feb20260936-7777--5074434",
        "event_type": "social_post",
        "date": "2026-02-07T00:18:49.539490",
        "source": "LSE_CHAT",
        "data": {
          "author": "7777",
          "content": "CHELSEA 3 WEST HAM UNITED 2 & SWBTX is coming soon LoL",
          "sentiment": 0.0,
          "engagement": "56",
          "price_at_post": "7.25",
          "thread_title": "GET THE OUZO OUT !!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=1334E49F-B073-4060-9FAB-75832F5D04CA"
        },
        "ingested_at": "2026-02-11T16:43:35.866363+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260727-AquaeSul-41051474",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469249",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "But it doesn't stop the big companies from investing in weight loss jabs rather than alternative treatments. www.londonstockexchange.com/news-article/AZN/astrazeneca-agrees-obesity-and-t2d-deal-with-cspc/17437893",
          "sentiment": 0.0,
          "engagement": "4,408",
          "price_at_post": "7.25",
          "thread_title": "RE: Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-02-11T16:43:35.866382+00:00"
      },
      {
        "event_id": "SOCIAL-30Jan20260015-Adyan920-48743794",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.469692",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "Interesting article about increase in gallbladder removals with people saying they have taken weight loss injections. https://www.bbc.co.uk/news/articles/cm24evgyyzpo",
          "sentiment": 0.0,
          "engagement": "176",
          "price_at_post": "7.25",
          "thread_title": "Weight loss jabs - gallstones",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=5717CDDF-9242-47F2-9B62-40C7FE7253A2"
        },
        "ingested_at": "2026-02-11T16:43:35.866401+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261606-skid35-88479988",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470123",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Just need OPTI to be at a self sustaining breakeven position, a position it should be in now so as shareholders we \"bank\" the SBTX and PBT when looking at OPTIs market cap. If the holding continue to reduce with the cash then wasted in OPTI the value can be disregarded - as it currently is.",
          "sentiment": 0.0,
          "engagement": "3,922",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T16:43:35.866418+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261323-martinu--9556832",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470552",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Veritas,  absolutely agree re PBX.  I think Steen's aspiration of \u00a310m sales might take a while,  but I'm very happy with progress there. On SBTX, I agree they could appreciate this year, but is there some nervousness over Croda customers' delay in launching a Zenakine product. As for Opti, things are looking more positive there.  But consistently growing numbers will be needed to restore market confidence.",
          "sentiment": 0.0,
          "engagement": "1,683",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T16:43:35.866436+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261222-VeritasL-84236324",
        "event_type": "social_post",
        "date": "2026-01-31T00:08:44.470967",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T16:43:35.866455+00:00"
      },
      {
        "event_id": "SOCIAL-Today1222-VeritasL-84236324",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152145",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "Hi, The value of OPTIs assets (PBX and SBTX) are around \u00a38.4m whilst its market cap is around \u00a37.5m.  I would expect both SBTX and PBX to increase in value this year as they are close to profitability.  PBX looks incredibly cheap compared to M&A deals in this market which are typically 10-20X sales. With sales just reported on \u00a32.7m that would give  a valuation of \u00a327m plus at the lowest multiple.  It looks from Opti Q&A responses that Amazon and China ecommerce will soon be profitable so with the big increase in sales in Asia would expect a big change in OPTi valuation this year if it shows strong progress towards profitability.  A launch of SweetBiotix would also be a big multiplier in SP.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "7.25",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T16:43:35.866474+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261617-Makingmi--2680129",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.152663",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Not sure that\u2019s true. Never actually made any short trades but when experimenting in the past, found shorting was available but not for any share you might decide on. Very unlikely to be available on tiny market cap shares like this. Agree though many more traders operate now, and happy to take a quick profit and move on. And it was a profit worth taking to many, obviously. Whether they will be waiting to get back in once it comes back a bit, we shall see, but a bit of a risky game to play. Without the potential here and the so low price, you could see the attraction of the quick gain, but given those factors, to me anyway, it is more sensible to hold for the much bigger rise to come.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.25",
          "thread_title": "RE: And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T16:43:35.866492+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261448-Siouks-89997087",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153194",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Pump a buy orders to raise the price, once you get to the right level, open a short position, start selling all what you bought to drop the price down. This way you also make money on the way down and that's how thing are played here, not a huge secret...",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.25",
          "thread_title": "And that way you're always a winner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=0B111415-F347-4285-8931-E8E6CE0BBC30"
        },
        "ingested_at": "2026-02-11T16:43:35.866510+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261743-martinu-21509178",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.153726",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Also, if any of you haven't signed up for new Q&A facility on website, I strongly recommend you do. This Q&A from / to Andy777 is particularly positive on Amazon, China (after change to partner) and for Asia in FY26 Andy777 \"Hi.  Have the ecommerce sales continued to grow significantly into H2 2025 and early 2026.  How important is the ecommerce relative to deals with companies like Morepen, and the other US and asian companies? Hi, Ecommerce is one of four areas we have been investing in to grow. These are Asia, India, USA and what we call Consumer Health (Amazon, our own website, Ebay, China and recently India). Amazon is one of the worlds biggest ecommerce market place which we have invested in to build a large customer base and it continued to grow in 2025 with marketing investment. Our focus now is on profitability on Amazon which we hope to achieve this month or next. This should then grow into a highly profitable business.  Our own website is already profitable. China should become profitable in Q2 as we changed our partner last summer and have been clearing stock with a short shelf life at discount. Once this is clear we should be profitable in China.  This is all part of building a business - building a brand, product range and customer base.  Ecommerce is part of that mix and reduces our dependency on partners. You cannot have a dependency on one part of the business, one product, one partner, or one country. We need more partners in India and the USA to reduce any future dependency. Asia is showing great growth and will make a significant contribution to sales in 2026. \"",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T16:43:35.866528+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261642-lordload-22339855",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154264",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Troajan - thanks for the interview link SOH has oft lamented Opti being undervalued by investors. But it's a bit chicken & egg. Until meaningful (& sustainable) sales come through & profits start to emerge, investors are understandably cautious. The year has started well. We need that momentum to continue - and something meaningful to happen with Sweetbiotix rather than just endless talks. Then the current SP will start looking somewhat ridiculous. But not until then I suspect.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "7.75",
          "thread_title": "RE: Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T16:43:35.866546+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261519-Siouks--1993178",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.154761",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "The same ones who bought shares at 6.00. Sold out at 07.00-08.00 Once they are out we will see what comes next;)",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.866563+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261344-Troajan-40171717",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155300",
        "source": "LSE_CHAT",
        "data": {
          "author": "Troajan",
          "content": "Https://www.proactiveinvestors.co.uk/companies/news/1086319/optibiotix-health-slimbiome-demand-grows-as-glp-1-alternatives-surge-1086319.html",
          "sentiment": 0.0,
          "engagement": "125,652",
          "price_at_post": "7.75",
          "thread_title": "Opti interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=56EE7F04-8BFB-40B2-A253-9286AC0B6769"
        },
        "ingested_at": "2026-02-11T16:43:35.866581+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261219-Makingmi--5438142",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:11.155877",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Siouks, Looks like you may have been right. Seems their  patience levels ran out after a week. lol",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.866606+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261532-Siouks-35677484",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.682699",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "As I said. There is a huge potential in a market, all depends how they going to use it. In my opinion marketing is the key but we all have our own opionion",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-11T16:43:35.866623+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261509-Bottmzup--2635350",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683390",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bottmzup",
          "content": "In my experience, after a positive update on a lot of shares, there's always a slow or delayed reaction while the news is digested by the wider market. After being in an oversold level for a period of time, I'm guessing the same thing to happen here. Todays high volume has broken above a falling trend line on the chart which has been falling since Aug '25, that will get noticed.",
          "sentiment": 0.0,
          "engagement": "6,753",
          "price_at_post": "7.50",
          "thread_title": "RE: Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-11T16:43:35.866641+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261446-Siouks-54197957",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.683859",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "Such a high volume today with over 100k buys and this is only on 17% raise... wierd.  With such an important update I was looking for over a 10 with sp, and we are basicly were it was. Whoever bought at 6 will sell it at over 7 and we still wait for proper news. If it would be higher maybe worth again to open shorts",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "7.50",
          "thread_title": "Stanger things",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=22AD36DC-0F34-45FD-8FD6-9292C0745CE0"
        },
        "ingested_at": "2026-02-11T16:43:35.866659+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261110-Friedman--7347787",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.684398",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Good news. Actual numbers. Let\u2019s hope we can build from here.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.866677+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261100-Dad41325--5271314",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.685311",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Was looking back on RNS 23/05/25 \u00a3500k investment from an American institutional investor at 14p a share, Asia seems to be going well maybe the US will be next to bring in some big orders.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "7.50",
          "thread_title": "Bold investment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=86086D0C-7204-4260-867E-ED4A91DB1A3E"
        },
        "ingested_at": "2026-02-11T16:43:35.866695+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-Letitrun--1329539",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686138",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Should be an easy bag or possibly 2 from here following today\u2019s news. With \u00a3800k in the bag for the year ahead & 11+ months left the share price seems to have fallen well below where it should on sentiment alone. They also have \u00a3100k milestone for Sweetbiotix & in 2024 their e-commerce business did just shy of \u00a3400k to add to 2026. Looking like momentum is actually gathering here. Any serious news on sweetbiotix this will have a major rerate",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.866713+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261053-martinu--8415871",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.686917",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Yes positive update.  Good that clarification was given that these orders will be recorded as revenues in FY 26. As sometimes Opti orders take months to be recognised.  Fingers crossed for more progress.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.866730+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260943-skid35-35607466",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.687742",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Positive RNS today, glad to see all shareholders being treated equally from yesterdays RNS. Still hope there was something in the director buys late last year well above the current share price.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.866748+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260802-Makingmi-24035976",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.688556",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well pleased with today\u2019s and yesterday\u2019s news. Things starting to look more positive going forward. No need to be racing to buy in now as already all in. Just sit and wait. Very positive feelings confirmed and even Blubs must consider those comments justified. lol.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.866766+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262133-Letitrun-71694688",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.689333",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Quite impressed by this new open and direct approach to communicate with shareholders. I like the fact the questions & answers are made public. Theres also a really interesting question & answer on sweetbiotix from someone called ryanlee worth checking out.",
          "sentiment": 0.0,
          "engagement": "191",
          "price_at_post": "6.40",
          "thread_title": "RE: Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-02-11T16:43:35.866784+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261839-martinu-35581461",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690126",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Here is a link to the responses.  Obviously nothing market sensitive and nothing game changing, but renewed optimism over SweetBiotix.   Refers back to Dec RNS and reiterates those points.  Hoping to have products with SweetBiotix in, in H1 for investors to see and taste. https://optibiotix.com/7276382#question-155831",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "Response to my questions via new interactive facility.",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=3BD056C7-CFAF-4BAF-9633-000B1C07872C"
        },
        "ingested_at": "2026-02-11T16:43:35.866802+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261046-martinu-18044826",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.690882",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Done.  On computer, there seemed to be two Q&A boxes.  When typing in LH one submit box disappeared.   No apparent sidebar to reveal.  But on RH box submit stayed visible.  Thanks again.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866820+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-martinu--2837074",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.691677",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Thanks Adyan.  I didn't see any green button. Was trying on phone.",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866838+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261030-Adyan920-18043063",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.692465",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "If you go to the announcement https://optibiotix.com/announcements/7326843 once you have registered,  on the left side you should see a Ask a question box, start typing and the [Post question] button should turn green for you to press.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866856+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261020-martinu-39583715",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.693251",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Just registered for the Q&A.  Typed in questions but couldn't figure out how to submit.  Anyone else tried?",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866874+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260833-AquaeSul-48500933",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694043",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "You're welcome Friedman, might be worth making use of the new Q&A Forum set up by Opti if you have any questions going forward. Whilst I remain on the side-lines, there is no doubt that sweetbiotix would be a game changer if it ever launches. Onefirst generation product, Wellbiome, might also be worth keeping an eye on. if the Hull Teaching hospital trial proves positive, then any NHS endorsement would be significant for the future of the product. https://research.reading.ac.uk/inform-innovation-hub/fs-hobkirk/",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866892+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260819-Friedman--4248865",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:13.694840",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Thanks Aquae, and good to see you still haunt these parts occasionally \ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866910+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260757-AquaeSul--6406250",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115085",
        "source": "LSE_CHAT",
        "data": {
          "author": "AquaeSulis01",
          "content": "Rest easy Friedman, Red Bull have had to add both erythritol (associated with health risks) and sucralose to their zero cal drink alongside Monkfruit extract to get the required sweetness so far from a healthy dietary fiber. \"Monk fruit extract, sucralose and erythritol Monk fruit extract: Monk fruit extract is a non-caloric sweetener derived from Siraitia grosvenorii, a fruit also called \u201cmonk fruit\", which has a long history of human consumption. Monk fruit extracts are intensely sweet, and depending on their composition, range from being 100-250 times sweeter than sucrose. Monk fruit extracts are used in a wide range of products, like juices, soft drinks, candies, and desserts. Sucralose: Sucralose is a non-caloric sweetener that is made from sugar and tastes like sugar. Sucralose is produced synthetically. Sucralose is used in a wide variety of products, including beverages, baked goods, desserts, dairy products, canned fruits, and syrups. Erythritol: Erythritol naturally occurs in fruits, vegetables, and fermented foods. It is less sweet than sucrose and contains negligible caloric energy. Erythritol is commonly used in many low-calorie and low-sugar versions of baked goods, ice cream, confectionary, fruit spreads and protein bars.\" https://www.redbull.com/us-en/energydrink/products/red-bull-zero-ingredients-list#Ingredient%20-%20Monk%20Fruit%20Extract ,%20Sucralose For at least two days, the erythritol levels grew more than high enough to trigger changes in platelet function. These results suggest that consuming erythritol can increase blood clot formation. This, in turn, could increase the risk of heart attack or stroke. Given the prevalence of erythritol in artificially sweetened foods, further safety studies of the health risks of erythritol are warranted. \u201cSweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,\u201d Hazen says. \u201cCardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to make sure the foods we eat aren\u2019t hidden contributors.\u201d https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=For%20at%20least%20two%20days ,aren't%20hidden%20contributors.%E2%80%9D",
          "sentiment": 0.0,
          "engagement": "4,405",
          "price_at_post": "6.25",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866928+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260756-DireCons--1227155",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.115632",
        "source": "LSE_CHAT",
        "data": {
          "author": "DireCons",
          "content": "I think they have now found out that you can modify refined sugar, after all the time wasting.",
          "sentiment": 0.0,
          "engagement": "923",
          "price_at_post": "6.50",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866946+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman--5168110",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116172",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "...past year as they might be able to shed some light on it.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "RE: Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866963+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262218-Friedman-59590111",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.116742",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I was watching the NFL on US TV yesterday and there was an advert for Red Bull containing Monk Fruit. Obviously my thoughts went straight to  Sweet. I don't know if this is a new thing, my fear is that they've circumvented Opti. Shame we've lost some really well informed investors in the pa",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.40",
          "thread_title": "Red bull with monk fruit",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=9285A6ED-F563-4224-9A9F-2AC2D334CB43"
        },
        "ingested_at": "2026-02-11T16:43:35.866981+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261630-VeritasL--5213219",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117282",
        "source": "LSE_CHAT",
        "data": {
          "author": "VeritasLSE",
          "content": "This fits nicely into the growing interest in gut health and its impact on overall health - just the areas OPTI are in.  Could be good timing.",
          "sentiment": 0.0,
          "engagement": "12",
          "price_at_post": "6.35",
          "thread_title": "RE: News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-02-11T16:43:35.866999+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261408-Makingmi-58507657",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.117789",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Permission to speak please Blubs. Just wanted to thank Martin for posting.  Will stick with \u201c I\u2019m hopeful too.\u201d Not too ramping I hope. I know my place.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.35",
          "thread_title": "RE: SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-02-11T16:43:35.867016+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261238-martinu-80718884",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118243",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "SOH still hopefully. Interims (March?) will tell. https://www.linkedin.com/posts/optibiotix-health-plc_a-reliable-supply-chain-and-proven-market-activity-7417545110722121730-7nim?utm_source=share&utm_medium=member_android&rcm=ACoAAFXQ2o4BrXK1UNjlDeSnr-KvEIv-NvKRvbs",
          "sentiment": 0.0,
          "engagement": "1,681",
          "price_at_post": "6.35",
          "thread_title": "SOH on LinkedIn-time to trust the traction",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49154289-FC33-4B4E-BA66-F85EDB426CD6"
        },
        "ingested_at": "2026-02-11T16:43:35.867034+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261010-Friedman-64907115",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.118672",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Ramping, deramping, I doubt any of that matters at this stage and any attempt manipulation of the price is unlikely to be effective. Results pure and simple is what will drive share price.",
          "sentiment": 0.0,
          "engagement": "405",
          "price_at_post": "6.45",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867053+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261412-Siouks--5391842",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119114",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "What's the difference when you are doing all around? Deramping - mean usually here shorting or looking for lower entry point etc. I find it very concerning when you invest a lot of money in a company and slagging them of all year on all different portals - will that help you getting back your money?  Where is a Logic to it? I have my own thoughts about all those games",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.35",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867070+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261352-Masterba--1712842",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119536",
        "source": "LSE_CHAT",
        "data": {
          "author": "Masterbaker",
          "content": "Https://www.bbc.co.uk/news/articles/c1m8m47jl5eo",
          "sentiment": 0.0,
          "engagement": "11,170",
          "price_at_post": "6.35",
          "thread_title": "News I can stomach",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=D39A5791-1FA2-42EA-85F0-FF90F0AAC418"
        },
        "ingested_at": "2026-02-11T16:43:35.867089+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261237-Makingmi-91311926",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.119960",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Apologies. Really intended as notes to myself, and the fact is that any actions I take are for my benefit only and do not need or want to drag anyone else along. But agree, not always good at putting out the research behind it. Anyway as requested will try and stay quiet and curb my enthusiasm, just as intended on these forums. Regards",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867126+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261232-skid35-55853008",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.120680",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Lolly, unfortunately most of the rises have come from SOH of a promise of what is about to come in the commercial / strategic updates - most of which just doesn't happen and then the share price falls. Rinse and repeat. Hope the move away from communications moving away from the investor version of \"only fans\", a lack of recent promises and the director buys might be a sign that there may be more stable news in the financials.",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867145+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261216-Bubs49--8873714",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.121481",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bubs49",
          "content": "What happened to \u2018no more pointless comment\u2019? Is baseless ramping not included in that? Tbf there probably is a point to it as you\u2019re clearly trying to temp mugs to follow you in. Laughable.",
          "sentiment": 0.0,
          "engagement": "170",
          "price_at_post": "6.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867163+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261150-Makingmi--7756759",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.122281",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "An AI search indicates they are still partners at the current time. Hopefully we will learn more details soon",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867181+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261054-martinu-35859500",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123073",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Results from the Hut Group.  See below.  Not sure if they are still on Opti partner (for LeanBiome?).  Would be good if they are. https://www.lse.co.uk/news/thg-hails-strong-trading-momentum-after-record-second-half-of-2025-xearhp7rln8psap.html",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867198+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-Makingmi-76400657",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.123876",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I would suggest a current price of 12 is where it should be sitting now at least. Just look at the chart.",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867216+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260923-lordload-15572303",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.124713",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Looking at Opti\u2019s long term SP history, I very much doubt 7p will be this year\u2019s high. After past significant falls, something has always come along to re-inject investor confidence (albeit temporarily!). And that\u2019s normally led to a doubling or more of the SP from its previous low. Look at the 3 & 5 year SP chart if you don\u2019t believe me. Triggers this time could be continued decent sales from Morepen / Iovate / Amazon. Or - finally - some positive Sweetbiotix news. I suspect we\u2019re in for a decent year here. Possibly even something spectacular.",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867235+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260809-Makingmi-23531283",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.125517",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Marked as sells but all buys. I did first one as further top up so that is certain. Difficult to see how this low price can really be justified for the potential in here. How can it have got to this level with the news during latter part of 2025. Anyway didn\u2019t want to be trying to buy more once news dropped or progress became apparent. And yes I understand the history but this is surely oversold even at over 10",
          "sentiment": 0.0,
          "engagement": "84",
          "price_at_post": "6.70",
          "thread_title": "All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867253+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261806-aspex--5127629",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.126329",
        "source": "LSE_CHAT",
        "data": {
          "author": "aspex",
          "content": "SOH has got this far,  much based on scientific research. Opti has an opportunity to research a blend of the weight loss market with its own products. Get some evidence using a base of current or recent users of these drugs free of cost for a time. If the results are that good then get active in the INFLUENCER market and open the results to the market. That could well produce a more positive outcome than more scientific developments.",
          "sentiment": 0.0,
          "engagement": "128",
          "price_at_post": "6.75",
          "thread_title": "The Influence of Research",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=57E4C4A6-8AC1-448A-8F6F-39CA6A9C83EB"
        },
        "ingested_at": "2026-02-11T16:43:35.867270+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261801-martinu--5062239",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127088",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "Our (Opti) mcap is close to \u00a37m according to LSE today.  Just to be picky.  So (haven't checked) but SBTX + PBX must be close to that.  I think PBX q4/ fy figures , due later this month, will be very positive.",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T16:43:35.867288+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261743-martinu-69105065",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.127864",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "And PBX stake.  About the same?",
          "sentiment": 0.5,
          "engagement": "1,681",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T16:43:35.867306+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261724-skid35--6934537",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.128643",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Its worth \u00a33m at the moment, unless SOH hasnt sold some more !",
          "sentiment": 0.0,
          "engagement": "3,919",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T16:43:35.867324+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261635-newgrang-40712693",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.129432",
        "source": "LSE_CHAT",
        "data": {
          "author": "newgrange",
          "content": "Our stake in SBTX is worth our entire mkt cap...",
          "sentiment": 0.0,
          "engagement": "2,062",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T16:43:35.867342+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261620-lordload-52016606",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.130214",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "There was a legal wrangling between SOH & the subsequent buyer of his previous company. It hinged around whether the buyer had deliberately run it down &/or badly to monimise future kickback payments to SOH. From memory, SOH largely lost the argument but was awarded a small ex-gratia payment though I could be wrong. Ultimately, the conclusion was he'd valued the company's potential higher than reality warranted. Hmm, now where have we heard that since?",
          "sentiment": 0.0,
          "engagement": "3,754",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T16:43:35.867360+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261536-Siouks-12949918",
        "event_type": "social_post",
        "date": "2026-01-29T12:23:18.131000",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "If SOH said he sold previous company to cheap it say it all, mean he won't sell this one that cheap... further more he believes this company to grow and not sink in like sp for the last many many weeks years etc.",
          "sentiment": 0.0,
          "engagement": "986",
          "price_at_post": "6.75",
          "thread_title": "RE: And more",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&share=OPTI&thread=0E33A838-3D16-4FAD-AA6D-115E6D85793A"
        },
        "ingested_at": "2026-02-11T16:43:35.867378+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261414-Makingmi--5748491",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624513",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Good to get a positive users review. Take a look at the share price graph. I would describe this as being very much still at a low. Very low in fact",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-02-11T16:43:35.867396+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261413-Siouks-60917132",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.624946",
        "source": "LSE_CHAT",
        "data": {
          "author": "Siouks",
          "content": "I believe that the market did not react to those news yet, but will see soon enough if I was right. At those lvls we see in and out gamblers more then serious holders. Time will tell",
          "sentiment": 0.0,
          "engagement": "984",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867414+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261322-Dad41325--5764824",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625401",
        "source": "LSE_CHAT",
        "data": {
          "author": "Dad413252",
          "content": "Just bought online gut health 3 boxes with free delivery, very easy to use website delivery was quick & packaging is very good. Product instructions are very clear and easy to use which is great for people like me who hate reading small print! 40% off voucher for next order and a free tomato soup to try. Very happy with the service\u2026 Thinking of buying a few shares a bit annoyed I missed the low but still think it\u2019s worth a go\u2026.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "8.00",
          "thread_title": "Online purchase",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=9903CD07-56CD-4E88-8996-92E2322E33E1"
        },
        "ingested_at": "2026-02-11T16:43:35.867432+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261312-Makingmi--6748823",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.625817",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "I think I said before, but it\u2019s amazing how people will wait until the price is moving up and buy at much higher prices, missing the perfect opportunity to buy now as we are seeing signs of improvement going forward but still in my view at  a very oversold price. Yes it seems to have taken a long time coming and especially so for long term holders. But if things fall into place it could move up considerably and probably quite quickly once more evidence comes through.",
          "sentiment": 0.0,
          "engagement": "82",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867450+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261216-Friedman-18804186",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626247",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "The only surprise for me so far is that word is taking so long to get out and investors haven\u2019t reacted more to this news. I know initially the volume was huge but I expected the price  to grow over the following days",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867468+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261152-skid35--4815188",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.626676",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. You shouldn't have to read an RNS a few times to understand it. The title of the RNS is \"Large order and Record Early Orders for 2026\" - its about orders. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". They didnt \"secure\" the \u00a3800k of orders in 2026 did they, what they secured is the backlog and 2026 income associated with the backlog from Nov 25 and Jan 26 orders. You shouldn't have to realise this from other paragraphs. This is like a conversation with a two year old.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867486+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261046-Letitrun--7381073",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627111",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not really Skid they\u2019re being transparent that part of the \u00a3800k for delivery and for reporting in accounts in fy 2026 includes the order from November. They\u2019re quite clearly talking about secured orders for reporting in FY2026. It doesn\u2019t say anywhere these orders were all received in 2026, just that they have \u00a3800k secured for 2026. This is like conversations with my wife!",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867505+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260957-skid35-97126558",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627540",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun. 1. \"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners\". So these are ordered RECIEVED wholly in 2026 from four partners for \u00a3800k 2. \"These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners\". So still the four partners, but now one of these was from an order in November 2025. So contradictory statements.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867523+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260955-lordload--7150237",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.627959",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "FS - totally agree. Hopefully, when it comes to updates, the days of talking in riddles are now over. There suddenly seems to be a concerted attempt to engage with investors much more clearly & directly. Rather than through dodgy middlemen with personal agendas. Long may it continue.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867541+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260908-Friedman-29923702",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628384",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "I\u2019m pretty cynical with SOH these days but for what it\u2019s worth, I thought that this RNS was refreshingly clear. It tells me how much revenue there is and when that revenue will be booked and it also adds that this is guaranteed.",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867559+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20260848-Letitrun-13705862",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.628811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Sorry Skid would have to say you wouldn\u2019t cut it as my accountant\u2026 not sure how there is any issue of clarity \u201cThis approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts\u201d Clearly defines the value and when they will be delivered AND \u2018when they will be reported in the company accounts for FY2026\u2019 I can only assume you are taking the p**s",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867577+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20262208-skid35-76567616",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629247",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Letitrun, so the orders haven't been received but are confirmed with no cancellation? The issue is the lack.of clarity of the value. And as a qualified accountant the contractual terms determine income recognition - you don't have to have shipped to the customer to recognise income, alternatively you still may not have income even if you have delivered.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867595+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261835-Tatty99--1478832",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.629659",
        "source": "LSE_CHAT",
        "data": {
          "author": "Tatty99",
          "content": "Adyan is correct. No accounting entry can be made until goods dispatched.  So the order cannot be recognised as income or 'receivable' until goods dispatched i.e this year.",
          "sentiment": 0.0,
          "engagement": "947",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867614+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261315-Letitrun--2040475",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630080",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "It doesn\u2019t say received it says orders \u2018secured\u2019 as a great start for 2026. It doesn\u2019t need clarifying it\u2019s quite clear and literally quotes all will be reported in 2026 accounts.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867632+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261305-martinu-19298814",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630508",
        "source": "LSE_CHAT",
        "data": {
          "author": "martinu",
          "content": "I would guess (and that's the point we shouldn't have to), that the Nov 25 order (included in the \u00a3800k total) will be booked in 2026.  This is an opportunity to seek clarity via the new Q&A portal.  Responses are coming within a day.",
          "sentiment": 0.0,
          "engagement": "1,677",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867650+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261247-skid35--4051753",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.630938",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "\"This approach has delivered a record start to FY2026, with over \u00a3800K in orders secured from four partners. These will be delivered at various point throughout FY2026 when they will be recorded and reported in the Company's FY2026 accounts. These are confirmed orders with a no cancellation clause and includes the low six figure order received in November 2025 from a well-known weight management company (RNS: 17 November 2025) planned for delivery and launch in H1 2026, the Meelung orders, and two other partners.\" Looking at this again, this really is just appalling, shockingly poor. So - \u00a3800k from four partners where the order have been received in 2026 - but in a later sentence somehow the \u00a3800k of orders  received in 2026 now includes the order from November 2025 ??????? So it is 1. we have a record start with orders received in 2026 together with the order in November now providing a backlog of \u00a3800k  2. Or a higher amount (say \u00a3950k but not explicitly mentioned) will be recognised in 2026 - the \u00a3800k of new orders plus unknown value of the Nov deal.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "8.00",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867668+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261207-Adyan920-28873298",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631384",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "@skid35 - The RNS did confuse me too at first, but on second read it made sense. Generally, when customers place orders they won't be recorded in our accounts until delivery. By adding that line, it clarified that: 1. The Nov order won't show in the 2025 account 2. It is instead  included in the the \u00a3800k order confirmed for 2026, which should also be delivered in 2026. This actually is being more open, as they could have easily not included that line and investors could have easily assumed the Nov order will be in the 2025 accounts and all the \u00a3800k announced are all brand new orders not mentioned before.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "8.25",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867687+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262216-Letitrun--3139962",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.631804",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "\u2018this approach has delivered a record start to FY2026, with over \u00a3800k in orders secured from four partners. These will be delivered at various points throughout 2026 where they will be reported and recorded in the company\u2019s full year 2026 accounts.\u2019 Later states these 4 partners are the order from November for delivery in H1 2026, Meelung and two other partners.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867705+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262159-Letitrun--4094993",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632226",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "Not sure on that Skid may just be you as pretty clear they have \u00a3800k of orders all for delivery in 2026 and thus revenue recognition in 2026. It is qualifying that part of this \u00a3800k figure includes the order from November which is to be delivered in 2026 (therefore counted in 2026 accounts). They can\u2019t book it as revenue until delivery is complete.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867723+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262058-skid35--7773763",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.632642",
        "source": "LSE_CHAT",
        "data": {
          "author": "skid35",
          "content": "Adyan. The RNS is terribly badly worded between the \u00a3800k orders in Jan 26, and then mentioning the order from Nov 26. I took this as the both are due for income recognition in 26. I cannot understand how many people must have proof read this, and thought it was correct.",
          "sentiment": 0.0,
          "engagement": "3,911",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867741+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262020-Friedman--2244526",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633075",
        "source": "LSE_CHAT",
        "data": {
          "author": "FriedmanSowell",
          "content": "Lots of good comments today. This particularly made me chuckle \"multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\" I'm heartened that a lot of the previous criticism from investors may have landed and the company seems to have taken it on board. The new site is a good idea and a much better medium for interacting with us that the previous method of interviews with friendly bloggers. Today's RNS and the hard figures it gives is excellent. I also liked the previous comment or who mentioned how this is from repeat custom. It certainly does show a high degree of confidence from a customer when they have committed to ordering this amount backed by hard cash. This time next year Rodders...",
          "sentiment": 0.0,
          "engagement": "404",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867759+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20262019-Adyan920--6825743",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633514",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "\"e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade.\", lol, that gave me a chuckle. I'm not going to get my hopes too high as I've done that with this share too many times. I'm happy to wait and see now, what is another half year when you've been a LTH for many many years and many false dawn's. As I mentioned in previous post, there are 2 very positive developments: Direct Q&A with Shareholders and providing proper numbers in RNS. These steps are massive improvement, and hope it will continue. I see there was around \u00a3300k Morepen orders in 2025, let's hope they place some soon for 2026.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867776+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261617-Letitrun--7610657",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.633927",
        "source": "LSE_CHAT",
        "data": {
          "author": "Letitrun",
          "content": "From what I gather reading the RNS today the change in being able to provide forward looking figures is they have partners locking in future orders from confidence in repeat sales. Good position to be in and a very positive change for the outlook here. Should get new investors looking at the risers list and taking further interest here as this news gets around.",
          "sentiment": 0.0,
          "engagement": "190",
          "price_at_post": "7.75",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867794+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261604-lordload-65229701",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634361",
        "source": "LSE_CHAT",
        "data": {
          "author": "lordloadsoflolly",
          "content": "Adyan - certainly a promising start to 2026. As you allude to, we\u2019re finally getting an update with some concrete figures. For way too long, sales growth was given in riddles - e.g. H1 represents a 48% increase on last year\u2019s H2, multiplied by SOH\u2019s inside leg divided by the number of RNS\u2019s issued over the past decade. Now we get a proper revenue figure with a guarantee it\u2019ll all be \u201cbanked\u201d in this FY\u2019s accounts. Propped up by contractual commitments, so customers can\u2019t backtrack.",
          "sentiment": 0.0,
          "engagement": "3,747",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867812+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261533-Adyan920--3823993",
        "event_type": "social_post",
        "date": "2026-01-24T02:34:41.634811",
        "source": "LSE_CHAT",
        "data": {
          "author": "Adyan9200",
          "content": "This is good news, however it did mention \"and includes the low six figure order received in November 2025\" so it's not orders just received this month so far. But I assume it's all confirmed order for delivery in FY2026 that can't be cancelled etc. Looking forward to trading update for 2025, I'll like to know if Morepen succeeded in reaching the Year 1 figures SOH showed us (the 5 year estimate plan). I quite like the new website, mainly the Q&A, which have been good to read answers to. Positives 1. New site with Q&A, where SOH has been answering questions. 2. An RNS with actual figures, which is fantastic to see. Too often we don't get figures. 3. Good start to year in order book, but important that we get many more orders to get anywhere near profitability. 4. Q&A answers around Sweetbiotix. We've had positive RNS' in past, which all look great and think we have finally turned a corner, and then nothing happens. I really hope as a Long term share holder, that this year is the year. I still very much believe it all depends on Sweetbiotix.",
          "sentiment": 0.0,
          "engagement": "175",
          "price_at_post": "7.50",
          "thread_title": "RE: All buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=OPTI&thread=49B56C93-CBF3-4B4E-88FD-C22B6EC3BD63"
        },
        "ingested_at": "2026-02-11T16:43:35.867830+00:00"
      }
    ],
    "catalyst_dates": {
      "proxy_date": "2023-08-04"
    }
  },
  "ai_insights": {
    "key_insights": [],
    "hidden_patterns": [],
    "contrarian_signals": [],
    "risk_warnings": [],
    "opportunity_flags": [],
    "narrative_summary": "OPTI.L presents a standard crash recovery setup without unusual patterns detected. Monitor for catalyst developments and trend shifts.",
    "_is_real": false
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "BIOTECH_PHARMA",
      "name": "Biotech & Pharma",
      "icon": "\ud83e\uddec",
      "color": "#10b981",
      "crash_patterns": [
        "Clinical trial failures (Phase 1/2/3)",
        "FDA/EMA rejection or delay",
        "Safety concerns or adverse events",
        "Patent expiry or IP challenges",
        "Funding gaps (cash runway concerns)"
      ],
      "recovery_paths": [
        "Positive trial data (efficacy endpoints met)",
        "Regulatory approvals (FDA/EMA)",
        "Partnership deals (big pharma licensing)",
        "Orphan drug designation or fast track",
        "New trial initiations (pipeline expansion)"
      ],
      "active_patterns": [],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Clinical stage (preclinical, Phase 1/2/3, commercialized)",
        "Cash runway (months until next funding)",
        "Addressable market size (indication)",
        "Trial enrollment progress",
        "Intellectual property strength"
      ]
    },
    "panic_analysis": {
      "panic_score": 50.0,
      "signal": "MODERATE_FEAR",
      "interpretation": "\ud83d\udfe1 Cautious sentiment - assess risk/reward",
      "breakdown": {
        "price_destruction": 16.0,
        "volume_death": 18,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\udcca Moderate fear detected - monitor for escalation"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udcc9 Volume death: 18/20 points"
      ],
      "facts_points": [
        "\ud83d\udcc8 Historical upside: 509% proven capacity"
      ],
      "verdict": "\u2696\ufe0f Mixed signals - Fear and facts balanced, wait for clarity"
    },
    "crashhunter_signals": [
      {
        "type": "BUILDING",
        "icon": "\ud83d\udcca",
        "text": "Building",
        "color": "#10b981"
      },
      {
        "type": "MODERATE_QUALITY",
        "icon": "\ud83c\udf1f",
        "text": "APEX 60",
        "color": "#3b82f6"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Large Order and Record Early Orders for 2026",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "New Investor Website",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "SweetBiotix Overview and Update",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Order with well-known Weight Management Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "expected",
        "date": "Expected soon",
        "title": "Watch for: Funding announcement or operational update",
        "status": "pending",
        "icon": "\ud83d\udd2e"
      },
      {
        "type": "expected",
        "date": "Expected soon",
        "title": "Watch for: Volume expansion confirmation",
        "status": "pending",
        "icon": "\ud83d\udd2e"
      }
    ],
    "decision_matrix": {
      "decision": "WATCH",
      "reason": "\u23f3 Monitor for timing regime change or panic escalation",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "50/100",
          "pass": false,
          "icon": "\ud83d\udfe2"
        },
        {
          "criterion": "Timing Regime",
          "value": "EARLY_BUILD",
          "pass": true,
          "icon": "\u2705"
        },
        {
          "criterion": "APEX Quality",
          "value": "60/100",
          "pass": true,
          "icon": "\u2b50"
        },
        {
          "criterion": "Data Confidence",
          "value": "40/100",
          "pass": true,
          "icon": "\ud83c\udfaf"
        },
        {
          "criterion": "Industry Pattern",
          "value": "0 active",
          "pass": true,
          "icon": "\ud83e\uddec"
        }
      ],
      "pass_rate": "4/5"
    },
    "contrarian_panic": {
      "total_score": 54,
      "band": "\ud83d\udfe1 MODERATE COMPRESSION (Top 30% - GOOD SETUP)",
      "components": {
        "compression": {
          "score": 26,
          "max": 40,
          "signals_30d": 4,
          "signals_60d": 4,
          "signals_90d": 4,
          "signals_per_week": 1.4,
          "total_signals": 4,
          "rsi_extreme_count": 3,
          "rsi_ultra_count": 2,
          "escalation_count": 1,
          "density_score": 12,
          "rsi_score": 7,
          "escalation_score": 4,
          "description": "1.4 signals/week | 3 RSI<20 | 1 escalations | \u26a1 HIGH COMPRESSION"
        },
        "intensification": {
          "score": 5,
          "max": 20,
          "recent_types": [
            "CRASH ZONE BOTTOM",
            "DEEP CRASH BOTTOM",
            "CRASH ZONE BOTTOM"
          ],
          "escalating": false,
          "sustained": false,
          "current_intensity": 1,
          "pattern": "NORMAL CRASH LEVEL"
        },
        "volume_death": {
          "score": 8,
          "max": 15,
          "relative_volume": 7.07,
          "description": "High volume - Panic spike or interest"
        },
        "pop_potential": {
          "score": 15,
          "max": 15,
          "best_historical_rally": 550.0,
          "avg_rally": 488.4,
          "signal_count": 4,
          "description": "BIG POPPER - Historical 5x+ (550%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation detected"
        }
      },
      "ticker": "OPTI.L",
      "signal_date": "2023-06-29",
      "total_signals_history": 4
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +12 (AI_Technical_Score=10.0/20)",
      "Drawdown reversion potential: +17 (Drawdown_Pct=84.0%)",
      "Volume confirmation: +10 (Relative_Volume=7.1)",
      "Pattern reliability: +5 (Rally_Count=2.0)",
      "Upside history: +16 (best_rally_pct=509%)"
    ],
    "technical_score": {
      "points": 12,
      "ai_score": 10.0,
      "reason": "AI Technical Score 10.0/20 translates to 12/25 points"
    },
    "drawdown_score": {
      "points": 17,
      "drawdown_pct": 84.0,
      "reason": "Drawdown of 84.0% gives 17/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 7.07,
      "reason": "Relative volume 7.07x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 2.0,
      "reason": "2.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 16,
      "best_rally_pct": 509.38,
      "reason": "Best rally of 509% gives 16/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Historically strong runner - massive upside when it moves",
        "tag": "HIGH",
        "evidence": [
          "best_rally_pct=509%",
          "Rally_Count=2.0"
        ]
      },
      {
        "reason": "Early stage positioning offers best R:R if catalysts appear",
        "tag": "MED",
        "evidence": [
          "timing_regime=EARLY_BUILD",
          "current_return_pct=32.4%"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical",
          "signal_date=2023-06-29"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Watch / Starter",
      "action": "Wait for base + catalyst confirmation; starter position only",
      "sizing": "0-1% until CONFIRMED",
      "risk": "Invalidation = breaks recent lows / dilution / suspension",
      "profit_taking": "Scale out 25% at +15%, 25% at +50%, runner above"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "EARLY_BUILD",
    "run_multiple": 0.06,
    "current_run_pct": 32.42,
    "avg_historical_run_pct": 509.38
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows EARLY_BUILD timing with 60/100 APEX score. Historical data shows 2 rallies averaging 509% upside. Current position: +32.4%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Strong historical rally behavior (509% best run)",
      "Early regime often offers best risk/reward"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Early accumulation phase. Watch for confirmation before committing size.",
    "confidence_explained": "Confidence 40/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": true
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  },
  "report_version": "5.0",
  "comprehensive_apex": {
    "score": 60,
    "rating": "MODERATE",
    "color": "#f59e0b",
    "calculation": "APEX Score: 60/100",
    "components": {
      "setup": {
        "score": 48,
        "weight": 0.25
      },
      "trust": {
        "score": 40,
        "weight": 0.2
      },
      "panic": {
        "score": 50.0,
        "weight": 0.3
      },
      "compression": {
        "score": 54,
        "weight": 0.25
      }
    },
    "timing": {
      "regime": "EARLY_BUILD",
      "multiplier": 1.0
    }
  }
};</script>
  <script src="../../apex_trust_panel.js"></script>
</body>
</html>
